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Abstract  
Antimicrobial resistance (AMR) is a global threat to the health and wealth of nations. 
The AMR crisis has been attributed to the overuse and misuse antimicrobials. Excessive 
use of antimicrobials in animal production is one of the contributing factors to this 
global threat. This thesis aims to characterize antimicrobial used (AMU) in small-scale 
chicken farms in the Mekong Delta region of Vietnam. This includes consumption of 
antimicrobials mixed with water by the farmer as well those included in commercial 
feeds as antimicrobial growth promoters (AGPs). The epidemiological data gathered is 
used to investigate the relationship between AMU and disease.  
First, I conducted a systematic literature review to provide an overview of metrics and 
methodologies used to measure AMU in animal production in the scientific literature, 
as well as reviewing existing data on AMU in different species in order to identify data 
gaps worldwide. Then, I performed a longitudinal study on a large cohort of small-scale 
chicken farms in Dong Thap province in the Mekong Delta region of Vietnam from 
October 2016 to May 2018 to investigate in detail the types and amounts of 
antimicrobials consumed, as well as the relationship between AMU and disease. On 
average, chickens consumed antimicrobials mixed in water over 382.6 per 1,000 days, 
or 323.4 mg (SEM ±11.3mg) per kg of chicken produced. The average amounts of AAIs 
in commercial feed given to produce one kg of chicken was 84.8mg (SEM ±9.3mg). 
Prophylactic AMU did not reduce the probability of disease, and administration of some 
antimicrobial classes did increase the risk of disease. Therapeutic AMU often had an 
effect on mortality but the pattern was inconsistent across the combinations of 
antimicrobial classes and clinical signs. Thirdly, I performed a study in mixed-species 
small-scale farms typical of the Mekong Delta in order to investigate whether AMU 
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data could be gathered using a simple cross-sectional study design. Results highlight 
the disproportionately high levels of AMU in animal production in the Mekong Delta 
region, and provide a guideline for the estimation of AMU from simple cross-sectional 
surveys on farms  
Results from this thesis suggest that efforts to promote responsible use of antimicrobials 
and limit excessive AMU should primarily target animal production. The message 
‘prophylactic AMU does not overall reduced the probability of disease in flocks’ should 
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 The global issue of antimicrobial resistance 
Antimicrobial resistance (AMR) has been defined as a global emergency (O'Neill 
2015a; WHO 2015). This phenomenon often occurs when microorganisms are exposed 
to antimicrobial agents (Prestinaci 2015). Since the discovery of the first antibacterial 
antimicrobial over nearly a century ago, virtually all infection-causing microorganisms, 
have, in varying degrees, developed resistance to any new antimicrobials released 
(Gaynes 2017). The AMR health crisis has been attributed to the overuse and misuse 
of antimicrobials (Ventola 2015). The situation has been worsening since the number 
of resistance organisms is mounting and many have developed resistance to multiple 
antimicrobials (Levy and Marshall 2004). This increase in AMR has been reported not 
only in hospitals but also in community and animal production (i.e. farms) settings. 
Since antimicrobial resistance-encoding genes (ARG) can be transferred between 
different organisms, the AMR situation in humans is interlinked with that of animals 
and the environment (Woolhouse, Ward et al. 2015). Excessive antimicrobial use 
(AMU) is the major factor driving AMR (FAO 2016). In addition, other factors such as 
high human and animal population densities, inefficient hygiene/biosecurity in farming 
practices or hygiene/infectious disease control practices, spillage of sewage/farm 
manure control and bacterial contamination of food may also contribute to the spread 
of AMR (Holmes, Moore et al. 2016; Robert Davies 2015). The emergence and spread 
of drug-resistant pathogens further enhanced by economic booming and international 
travel, continues to threaten our ability to treat common infections (Frost, Van Boeckel 
et al. 2019; Jasovsky, Littmann et al. 2016).  
AMR affects all countries, but its burden on low- and middle-income countries 
(LMICs) is disproportionately high (Pokharel, Raut et al. 2019). LMICs are particularly 
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vulnerable because they generally lack adequate healthcare (including animal 
veterinary) systems (Semret and Haraoui 2019). In these countries, farming systems are 
typically small-scale, and often used antimicrobial extensively, while practicing poor 
standards of biosecurity and disease control (Van Boeckel, Pires et al. 2019). The 
Southeast Asia region has a high incidence of infectious diseases and AMR, and is 
regarded as a hotspot (Zellweger, Carrique-Mas et al. 2017). Data on phenotypic 
resistance in commensal E. coli from Vietnam and Thailand have shown an increase in 
prevalence of AMR over the years (Nhung, Cuong et al. 2016). AMR is not bound by 
country borders, and may affect multiple geographic locations, becoming therefore a 
global threat to the health and wealth of all nations (O'Neill 2015a). AMR has been 
identified as the top priority for global health action (Chioro, Coll-Seck et al. 2015). 
Similar to climate change, global AMR is a shared global concern that requires local 
solutions. Tackling AMR at national and local levels can produce direct benefits and 
improve the situation on a global scale (Gelband and Laxminarayan 2015).  
 Mechanisms of generation and transmission of AMR 
Since the first introduction of antimicrobials, microorganisms have gradually 
developed resistance over time (Reygaert 2018). These resistance mechanisms may be 
native to the microorganisms, or may be acquired. Acquired resistance may be the result 
of gene mutations or ‘horizontal gene transfer’ (HGT) (i.e. ARGs that are transferable 
among microorganisms through ‘transformation’, ‘transposition’ or ‘conjugation’). 
Four main mechanisms of resistance have been identified, including: (1) limiting uptake 
of an antimicrobial, (2) modification of its cell target, (3) inactivation, and (4) active 
efflux of antimicrobial drugs (Reygaert 2018). 
Page 21 of 342
The transmission of AMR bacteria and genes across systems can occur through 
complex pathways that may include humans and animals and the environment 
(Graham, Bergeron et al. 2019; Woolhouse, Ward et al. 2015; Da Costa, Loureiro et al. 
2013). A number of bacterial (pathogenic and/or commensals) species and ARGs 
(plasmid, mobiles genetics elements) may be exchanged between humans (hospital and 
community), animals (farm, domestic, wildlife and aquatic animals), and the 
environment (Baquero, Coque et al. 2019). Resistant organisms may be transmitted 
between animal, between humans or across species through direct (i.e. exposure to 
infected individuals/animals, handling and consumption of contaminated food,) or 
indirect (i.e. through environment/water contaminated with untreated human 
waste/animal manure) contact.  
 Use of antimicrobials in animal production 
 Purposes of AMU in animal production 
Since their discovery and introduction during the earlier part of the previous century, 
antimicrobials have yielded considerable improvements in human and veterinary 
medicine. In animal production settings (including terrestrial and aquatic animal farms, 
feed mills); antimicrobials are used for four main purposes: (1) to increase feed 
conversion ratio (i.e. to make animals grow faster with less feed) (i.e. ‘antimicrobial 
growth promotion’); (2) to prevent disease occurring in healthy animals (‘prophylactic’ 
use), and (3) to treat flocks/herds before experiencing any level of disease onset or 
‘metaphylactic’ and finally to cure infectious disease or ‘therapeutic’ (Kirchhelle 2018; 
Pagel and Gautier 2012). Antimicrobials added to food rations in low concetrations 
with the aim of increasing the grow of animal and feed conversion efficiency are called 
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‘antimicrobial growth promoters’ (AGPs) (Butaye, Devriese et al. 2003), although their 
mechanism of action remain unknown (Dibner and Richards 2005). Also, 
antimicrobials at sub therapeutic doses are often used prophylactically in certain animal 
production settings (Landers, Cohen et al. 2012). Metaphylactic use is defined as the 
mass treatment of animal population currently not experiencing disease, but at risk of 
disease as observed in contact animals. There are some differences between AMU in 
humans and food animals, particularly with regards to AMU for ‘growth promotion’ 
and ‘prophylactic’ purposes. The former is not practiced in human medicine, and the 
latter only takes place in the context of surgical procedures or in the case of high risk 
of exposure to an infectious agent (Prescott 2017). In humans, administration of 
antimicrobials is overwhelmingly therapeutic, with doses usually based on age (less 
frequent on body weight) (Pagel and Gautier 2012).  
 AMU in poultry production 
Poultry meat is one of the most common food commodities worldwide. Antimicrobials 
play a positive role in poultry production since they help control disease and may 
contribute to improve the flock performance (Christian Agyare 2018). An estimate from 
the literature showed that, in term of doses, poultry is the target of the highest amount 
of antimicrobials worldwide (138 doses per 1,000 animal-days. The most used 
antimicrobial classes used in poultry are tetracyclines, followed by macrolides, 
polypeptides and penicillins (Cuong, Padungtod et al. 2018). There are knowledge gaps 
regarding how AMU are used in industry scale production compared with small-scale 
flocks. Antimicrobial agents are often administered at flock level through via drinking 
water or feed, depending on the objective of the administration. Because it enables large 
numbers of birds to be treated conveniently and cheaply at the same time. Drinking 
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water is the preferred mode of therapeutic or metaphylactic administration, because 
diseased birds usually tend to stop eating but will often continue to drink. An alternative 
to the drinking water, is the administration of a drug through the feed, often is the 
preferred mode of prophylactic or AGP administration (Landoni and Albarellos 2015).  
1.3.3 Classification of antimicrobials according to WHO and OIE  
The WHO has defined three categories of antimicrobials based on two criteria: (i) 
Whether the antimicrobial is the sole therapy or one of few alternatives to treat serious 
human disease; and  (ii) whether the antimicrobial is used to treat diseases caused by 
organisms that may be transmitted via non-human sources or diseases causes by 
organisms that may acquire resistance genes from non-human sources. The three 
categories defined are: (1) Critically important antimicrobials (criteria 1 and 2), (2) 
Highly important antimicrobials (criteria 1 or 2) and (3) Important antimicrobials 
(neither criteria 1 nor 2) (FAO 2007) .  
The OIE has defined three different categories of antimicrobials based on two criteria: 
(i) Whether the response rate to the questionnaire regarding Veterinary Critically 
Important Antimicrobials was met (more than 50% of the respondents identified the 
importance of the antimicrobial class in their response to the questionnaire) and (ii) 
whether the antimicrobial were identified as essential against specific infections and 
there was a lack of sufficient therapeutic alternatives. The three categories defined are: 
(1) Veterinary critically important antimicrobials (criteria 1 and 2), (2) Veterinary 
highly important antimicrobials (criteria 1 or 2) and (3) Veterinary important 
antimicrobials (neither criteria 1 nor 2) (FAO 2007).  
The major different between WHO and OIE was in the critically important 
antimicrobials (CIA) category. A number of antimicrobials classes appear only in the 
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WHO list included: carbapenems, ansamycins, glycopeptides, streptogramins and 
oxazolidinones; whereas phenicols, sulfonamides and diaminopyrimidines, and 
tetracyclines was considered only as critically important for animal health by OIE (FAO 
2008). 
There are several different points that only existed in WHO CIA which included: (1) 
only glycylcycline of tetracyclines class is categorized as critically important 
antimicrobial, the other class members are categorized as highly important 
antimicrobials, (2) the cephalosporins were separated into two different groups; 1st/2nd 
generation cephalosporins and 3rd/4th generation cephalosporins, (3) quinolones and 
fluoroquinolones were grouped together in the same class. 
Many antimicrobials used in food-producing animals are identical, or closely related, 
to antimicrobials used in humans. The WHO and OIE lists demonstrated that critically 
important antimicrobials are needed in both human and food animal therapy. To 
mitigate the adverse human health consequences of use of CIA in food-producing 
animals.  A guideline on use of CIA in food-producing animals, recommending that 
farmers and the food industry stop using antibiotics routinely to promote growth and 
prevent disease in healthy animals. This guideline aim to help preserve the effectiveness 
of antibiotics that are important for human medicine by reducing their use in animals 
(WHO 2017). 
1.3.4 Impact of AMU in animal production on the global burden of AMR 
There is a strong scientific consensus that AMU in animal production is a substantial 
driver of AMR in animal populations (O'Neill 2015b). This has been firmly established 
from on-farm observational studies (Burow, Simoneit et al. 2014; Simoneit, Burow et 
al. 2015), from country AMU/AMR surveillance data (Asai, Kojima et al. 2005; 
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Chantziaras, Boyen et al. 2014), as well from meta-analyses of published data (Bell, 
Schellevis et al. 2014; Tang, Caffrey et al. 2017). There is also a large body of evidence 
of an association between AMU in food animals and the emergence of AMR in humans, 
although this type of evidence often based on case studies (Landers, Cohen et al. 2012; 
Marshall and Levy 2011). Demonstration of this association is difficult probably a 
reflection of the diversity of ARG and the complexity of AMR transmission 
mechanisms, which would require very costly longitudinal study. However, there is a 
consensus that AMR is a One Health issue, and this has provided much of the recent 
impetus for monitoring and reducing AMU in animal production.  
1.3.5 Impact of AMR on disease control and farm productivity 
The presence of AMR in animal pathogens are likely to have considerable (negative) 
impact on livestock health and productivity by reducing the capacity of treating sick 
animals (FAO 2016; Bengtsson and Greko 2014). A recent study showed that the 
administration of antimicrobials in the context of small-scale chicken flocks in the 
Mekong Delta (Vietnam) is likely to result in unsuccessful treatment of disease (i.e. 
‘treatment failure’) in a large fraction of cases. This is because often antimicrobials are 
used in the absence of confirmatory diagnosis, and are likely to be used in situations of 
resistant bacterial (Yen, Nhung et al. 2020) or viral infections (Choisy, Van Cuong et 
al. 2019).  
As a result of excessive AMU, bacterial population in animal settings will, to a variable 
degree, acquire AMR traits, and this may eventually resulted in reducing the 
effectiveness of antimicrobials, and thus the loss of the necessary armory required for 
infection control (Landers, Cohen et al. 2012).  
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 Surveillance systems of AMU in animal production 
 International surveillance systems 
The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC), 
launched by the European Medicine Agency (EMA) in September 2009 was the first 
multi-country surveillance system on AMU in animal production. ESVAC presented a 
harmonised approach for the collection and reporting of data on the use of antimicrobial 
agents in animals in EU and European Economic Area (EEA) Member States (EMA 
2009). Antimicrobials used/sold in each country is related to animal populations using 
the mg/PCU AMU metric:  
AMU (mg/PCU)= 
𝑎𝑛𝑡𝑖𝑚𝑖𝑐𝑟𝑜𝑏𝑖𝑎𝑙 𝑎𝑔𝑒𝑛𝑡𝑠 𝑟𝑒𝑝𝑜𝑟𝑡𝑒𝑑 (𝑚𝑔)
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑈𝑛𝑖𝑡 
 
The numerator corresponds to the sales data corresponding to each antimicrobial active 
ingredient (AAI), the denominator corresponds to the animal population at country 
level, expressed as ‘Population Correction Unit’ (PCU). One PCU is equivalent to 1 kg 
of animal treated. The total number of PCUs per country, year and animal category are 
calculated by multiplying the numbers of the various animal categories (number of 
animals slaughtered, number of livestock, number of animal imported/exported) by 
their average weight at treatment, estimated as a consensus value for each species across 
the EU. The average weight values at treatment used to calculate the PCU is given in 
Table 3, Appendix 2 of the 1st ESVAC report (EMA 2011). Currently the ESVAC 
report gives overall estimates for all animal species combined (excluding domestic 
animals). In most EU countries, data on AMU is provided by the industry, and this sales 
information is combined to animal production statistics (expressed as PCU). EMA has 
also established standardised units of measurement for reporting antimicrobial 
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consumption in specific animal species, called the 'defined daily dose' and 'defined 
course dose' for animals. This metric is expected to be used in future reports of ESVAC, 
alongside mg/PCU (EMA 2020). In July 2018, EMA launched a project for stratifying 
sales data of veterinary antimicrobials by animal species, by allocating a proportion of 
the total sales. This project has piloted in six EU member states to investigate whether 
this approach may be used in the future for the whole of the EU. The latest ESVAC 
report includes AMU data on veterinary antibiotics collected from the 31 countries of 
the ESVAC network. The consumption data excludes companion animals. An overall 
decrease of 34.6% (from 161.4 down to 105.6 mg/PCU) in sales were observed for the 
25 countries that reported sales data to ESVAC from 2011 to 2018. A decrease in sales 
of all antimicrobial classes has been observed except for aminoglycosides, amphenicols 
and lincosamides (EMA 2020).  
The OIE has taken the lead by creating a global database on the use of antimicrobial 
agents in animals, in the framework of the Global Action Plan on Antimicrobial 
Resistance (OIE 2016). In its fourth OIE annual report (2020) on the use of 
antimicrobial agents intended for use in animals, data on AMU during 2018 was 
submitted by 153/184 (84%) OIE member countries, but only 118 (64%) countries were 
able to provide quantitative data on sales of antimicrobial agents. By OIE region, the 
proportion of countries responded to the survey was highest in America (94%) and 
Europe (91%) and lowest in Africa (81%), Asia-Far East-Oceania (78%) and Middle 
East (50%). The fundamental barriers to collect AMU data were lack of regulator 
frameworks for veterinary products and lack of IT tools, funds and human resources 
(OIE 2020).  
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In the OIE report, quantitative sales data of antimicrobials is adjusted for ‘animal 
biomass’ using following metric:  
AMU (mg/kg) = 
𝑎𝑛𝑡𝑖𝑚𝑖𝑐𝑟𝑜𝑏𝑖𝑎𝑙 𝑎𝑔𝑒𝑛𝑡𝑠 𝑟𝑒𝑝𝑜𝑟𝑡𝑒𝑑 (𝑚𝑔)
𝑎𝑛𝑖𝑚𝑎𝑙 𝑏𝑖𝑜𝑚𝑎𝑠𝑠 (𝑘𝑔)
  
The quantities used in animals are grouped into ‘all animal species’, ‘companion 
animals’, ‘all food-producing animals’, ‘terrestrial food-producing animals’, and 
‘aquatic food-producing animals’. Unlike the EU ‘PCU’, the OIE animal ‘biomass’, is 
calculated as the total weight of any live domestic animals living or having been raised 
over a year in a specific area. It is used as a proxy to represent those likely exposed to 
the quantities of antimicrobial agents reported. This methodology of calculating animal 
biomass was developed by the OIE using globally available datasets such as the OIE 
World Animal Health Information System (WAHIS) and the United Nations Food and 
Agriculture Organization Statistics (FAOSTAT) (Góchez, Raicek et al. 2019). By OIE 
region, the quantities adjusted by animal biomass of countries responded to the survey 
in 2016 was highest in Asia-Far East-Oceania (240.5mg/kg), followed by the America 
(138.0mg/kg), Europe (68.5mg/kg) and lowest in Africa (45.2mg/kg). Although the 
report provided global estimates for 2104 and 2015, these results should not be 
compared and should be interpreted with caution due to the identification of errors of 
those early reports.  
 Country-specific AMU surveillance systems 
Countries that are able to provide antimicrobial quantity data for either ESVAC or the 
OIE reports normally have their own in-country data collection mechanisms, although 
few LMICs have fully developed AMU surveillance systems. Japan established its 
Antimicrobial Consumption Surveillance (JACS) in 2019. The sales volume of 
antimicrobials was collect from each marketing authorization holder of veterinary 
drugs, using a designated reporting form. (Laboratory 2019). Thailand is the only 
country in the SE Asian region that annually publishes comprehensive AMU data in 
animals and humans The second report of consumption of antimicrobial agent in 
Thailand in 2018 was issued in 2020. This report provided baseline data on 
antimicrobial consumption in humans and animals. On average, Thai people 
consumed 74.4 Defined Daily Doses (DDD)/1,000 inhabitants-days in 2018 
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(increased 8.8% compared to 2017 data). The most common antimicrobial classes 
consumed were beta-lactams, penicillins and tetracyclines. Nearly 65% of total 
antimicrobial consumption belongs to WHO Critical Importance Antimicrobial (CIA) 
classes. The overall antimicrobial consumption among food-producing animal in 2018 
was 522.1mg/PCUThailand (a 6.4% reduction compared to 2017). Penicillins and 
tetracyclines were the most antimicrobial classes consumed. However, the 
consumption of CIA has increased compared to 2017 data. For the highest priority 
group of CIA, macrolides were consumed the most, followed by polypeptides and 
quinolones.  
 (Thailand 2020).  
 Challenges for monitoring AMU 
A major challenge for monitoring AMU countrywide is the diversity and rate of change 
of production systems. Surveillance of AMU in animal production may address 
different aims: to monitor AMU over time; to compare between different populations; 
as a benchmark to promote reductions of AMU; and to investigate the association 
between AMU and AMR. However, the diversity of metrics used in different studies 
and surveillance systems presents an additional challenge to the comparability of the 
data (Collineau, Belloc et al. 2017). Recent study review intensively 38 active farm-
level AMU monitoring systems from 16 countries showed that these systems differ in 
many ways, including which data are collected, the type of analyses conducted and their 
respective output (Sanders, Vanderhaeghen et al. 2020).  
As a part of this thesis, I reviewed antimicrobial usage in animal production. The review 
summarized the methodologies and metrics that available in the literature. Result of this 
study was included in Chapter 3. 
1.5 International efforts aimed at curbing excessive AMU in animal production 
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A number of global, regional and country-level initiatives aimed at promoting 
responsible AMU whilst curbing excessive AMU in animal production have been 
implemented in recent years (Carrique-Mas and Rushton 2017; Health 2016; Nations 
2016; Postma, Stark et al. 2015; 'RUMA sets out AMR strategy action plan'  2014). 
Reduction of unnecessary AMU is considered imperative if the global aim of preserving 
the efficacy of existing antimicrobials is to be achieved. Large efforts to reduce AMU 
in livestock in Denmark and Sweden started in the early 1990s through restriction of 
AGPs in feeds. AGPs have been banned since 2006 across all of the European Union 
(EU) (Castanon 2007). In the USA, voluntary phasing out of certain AGPs have been 
implemented since 2013 (FDA 2013). In the Asia-Pacific region, several countries have 
implemented a full or partial bans of AGP in animal feeds in Korea (2011), Australia 
(2013) (Laxminarayan 2015), Thailand (2015) (Thamlikitkul, Rattanaumpawan et al. 
2015), China (2016) (Walsh and Wu 2016), Vietnam (2018) (Development) 2017) and 
India (2019) (MOH-FW 2109). In 2018, the EU Parliament approved legislation that 
came into force in 2020 including a full ban on prophylactic use of antimicrobials in 
livestock and aquaculture production (Anon. 2020). 
1.6 Small-scale chicken production in the Mekong Delta of Vietnam 
In LMICs, poultry meat is the most consumed protein commodity because its relatively 
low capital investment and production costs, as well as the lack of religious objections 
to its consumption (Anon. 2013). Worldwide annual consumption of animal protein, 
poultry meat (2018) stands at 33%, second only to pork (40%) (Checkoff 2018). 
According to the Vietnamese official statistics (2019), of a census of 382M chickens, 
only 26.1% corresponded to chickens raised in industrial systems (Anon. 2019a), the 
remainder being raised in backyard and small-scale (semi-intensive) commercial farms.  
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The Mekong Delta, consists of 13 provinces, located at the southernmost part of 
Vietnam with a total natural area of 40,000 square km, accounting for 12.2% of the 
country's natural area, is home to more than 17 million people. The climate in this 
region is influenced by monsoons with dry (from December to April) and wet (from 
May to November) season. In the wet season, large areas of the Delta are flooded. In 
the dry season, water volumes on the Mekong decrease, leading to saline intrusion and 
the salinization of waterways in the lower Delta. The economy of the Mekong Delta is 
dominated by agriculture, producing more than 50% of the country’s rice. Other 
agricultural activities such as fruit, vegetable and animals farming, also play an 
important role (GIZ 2015). 
In the Mekong Delta region in 2019 of 82M poultry heads, 63.4% corresponded to 
chickens (Anon. 2019b), the remaining being mostly ducks, Muscovy ducks and quails. 
The majority of chicken flocks in this area consist of native breeds, of slow growth 
flocks over long period (~ 18 weeks) (Carrique-Mas, Van et al. 2019). Raising poultry 
in mixed species small-scale farms (often including pigs and other species) is very 
common in this region. This type of farming practice enable farmers to produce enough 
meat and eggs for household consumption and obtain an income, in addition to other 
key activities such as rice and aquaculture (Delabouglise, Nguyen-Van-Yen et al. 
2019). This region has a large number (est. in 1.5 million) ‘market seasonal farms’. 
These farms only raising flocks during certain times of the year, often targeting specific 
festivities, notably the Vietnamese New Lunar Year (‘Tet’)’. These flocks often 
experienced high disease and mortality risks (Delabouglise, Nguyen-Van-Yen et al. 
2019; Carrique-Mas, Van et al. 2019). High amount of AMU was reported in chicken 
production in this area. However, the existing information on AMU comes from cross-
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sectional study designs are often bias by limited record keeping practiced by many such 
farmers (Carrique-Mas, Bryant et al. 2014; Nguyen, Nguyen et al. 2016). In addition, 
information gathered form those studies often provide the number of active ingredient 
used with the total amount used only. When and how antimicrobials were used in those 
studies are not often described adequately.  
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1.7 Research questions, aims and objectives of this thesis 
This thesis aims to characterize AMU in small-scale chicken farming systems in the 
Mekong Delta region of Vietnam. The research questions of this study are:  
1. What and how antimicrobials (both in water and in feed) are used in chicken 
flocks raised in in small-scale farming conditions in the Mekong Delta.  
2. How AMU affects disease and mortality in flocks raised in these systems.  
3. How to measure and compare of AMU in humans and animals in small-scale 
farming settings in the Mekong Delta of Vietnam.  
To address these research questions above, I have conducted five studies to achieve 
specific objectives including: 
1. A literature review to summarize metrics and methodologies used for 
quantitatively assess AMU in animal production systems.  
2. A longitudinal study to describe the types, quantities and critical time points 
when antimicrobials are used in water using different metrics. 
3. A descriptive study to review the labels and to calculate the amounts of 
antimicrobial active ingredients (AAIs) in commercial feeds. 
4. To investigate the impact of prophylactic and therapeutic AMU on flock disease 
using longitudinal epidemiological data gathered on AMU. 
5. A cross-sectional study to measure and compare AMU in humans and animals 
using different metrics, and extrapolate these magnitudes for the Mekong Delta 
region of Vietnam. 
These five studies are written as five result chapters (Chapters 3 to 7) and are 
presented in as scientific manuscripts.   
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Chapter 2 
Materials and Methods  
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 Literature review  
The ‘ISI Web of Knowledge’ engine (Clarivate Analytics, Philadelphia, PA, USA) was 
used to search for original scientific articles published in English over the period 
January 1998 to April 2018. I summarized data from 89 scientific studies reporting 
AMU data in animal production published in English since 1998. Publications not 
reporting original research data, or written in languages other than English, were further 
excluded. Detail of the literature review was presented in Chapter 3.  
 Longitudinal study  
Data for chapters 4, 5 and 6 came from ViParc project. The ViParc project (acronym 
for “Vietnamese Platform for Antimicrobial Reduction in Chicken production” , is one 
of the field-based intervention trials, aiming to reduce antimicrobial usage in food 
animal systems in the Southeast Asian region, funded by the Wellcome Trust (Carrique-
Mas and Rushton 2017). The project targets the small poultry producers. It recruited 
and followed-up of 120 randomly selected meat chicken farms in Dong Thap province, 
in the Mekong Delta region of Vietnam. These farms represented about one fourth of 
the total number of chicken farms (459 farms) that raised for commercial purpose in 
the two districts (Cao Lanh and Thap Muoi) registered in the farm census. However, 
this information is impossible to know since the selection was based on the existing 
census, which is only updated every 4-5 years. The project delivered in two phases, a 
“baseline” phase (12 months), followed by an intervention phase (18 months). During 
the ‘baseline phase’, farmers are required to keep a project log-book where all relevant 
data (antimicrobial and feed consumption, disease, mortality, vaccination, etc.) is 
weekly annotated. Farmers are asked to keep containers of all medicines and 
commercial feed products used. The ‘baseline’ phase data are used for the analysis of 
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chapter 4. During the ‘intervention’ phase, randomly selected farms were allocated into 
three intervention groups including two intervention groups with different level of 
veterinary supported and a control group. The ‘baseline’ and ‘intervention’ phase data 
are used for the analysis of Chapters 5 and 6. The details of relevant data are presented 
separately in each chapter.  
 Cross-sectional study  
A cross-sectional survey of poultry-raising households in five of 12 districts of Dong 
Thap province (Mekong Delta, Vietnam) was conducted. The five districts were chosen 
based on convenience criteria. The chosen criterion were farms that located less than 
30km from the provincial capital. We aimed to sample ~100 households. In each 
selected household, the person identified as being responsible for taking care about 
family members and animals the most were interviewed. The data collected, based on 
frequency (days) of antimicrobial consumption, was used to calculate AMU, both in 
terms of doses and quantities (weight of AAI) for the province and the Mekong Delta 
region by species. All visits were conducted by affiliated staff of the Sub-Department 
of Animal Health and Production of Dong Thap (SDAHP-DT) during July 2019.  
 Statistical methods 
All analyses and figures of this thesis were carried out using R statistical software 
(www.r-project.org). Chapters 3-7 included intensively descriptive statistic on 
observational data. A generalized logistic model was used in chapter 4 and a logistic 
generalized additive model was used in chapter 6.  
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Abstract: Antimicrobial use (AMU) in animal production is a key contributor to antimicrobial
resistance (AMR) worldwide. As consumption of animal protein and associated animal production
is forecast to increase markedly over coming years in low- and middle-income countries (LMICs),
accurate monitoring of AMU has become imperative. We summarized data from 89 scientific
studies reporting AMU data in animal production published in English since 1998, identified
through the ‘ISI Web of Knowledge’ search engine. The aims were as follows: (a) to describe
methodologies and metrics used to quantify AMU; (b) to summarize qualitative (on-farm prevalence
of use) and quantitative (amounts of antimicrobial active principle) data, in order to identify
food animal species at the highest risk of AMU; and (c) to highlight data gaps from LMICs.
Only 17/89 (19.1%) studies were conducted in LMICs. Sixty (67.3%) reported quantitative data
use, with ‘daily doses per animal-time’ being the most common metric. AMU was greatest in
chickens (138 doses/1000 animal-days [inter quartile range (IQR) 91.1–438.3]), followed by swine
(40.2 [IQR 8.5–120.4]), and dairy cattle (10.0 [IQR 5.5–13.6]). However, per kg of meat produced,
AMU was highest in swine, followed by chickens and cattle. Our review highlights a large deficit of
data from LMICs, and provides a reference for comparison with further surveillance and research
initiatives aiming to reduce AMU in animal production globally.
Keywords: antimicrobial use; livestock; poultry; metrics; pigs; cattle; chickens
1. Introduction
Antimicrobials are used worldwide both in humans and in animals for the prevention and
treatment of infectious diseases [1]. In addition, in some countries, antimicrobials are used in animal
farming as growth promoters [2]. A correlation between antimicrobial use (AMU) and antimicrobial
resistance (AMR) in animal production has been firmly established from observational studies [3,4],
country AMU/AMR surveillance data [5,6], and statistical meta-analyses [7]. Increased levels of
AMR have a negative impact on livestock production, either by reducing farm productivity, or by
higher costs of disease treatment [8]. However, much of the impetus for monitoring AMU/AMR in
animal production has stemmed from an emerging scientific consensus supporting the contribution of
AMU/AMR in animal production on the overall burden of AMR in humans [9–11]. As a consequence
of this, a number of global, regional, and national initiatives have recently been implemented to
promote responsible use of antimicrobials and to curb excessive AMU in animal production [12–16].
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In the European Union (EU), a supranational system to monitor AMU in both humans and
animals across EU member states has become a reality [17]. A 2014 joint European Centre for Disease
Control/European Food Safety Agency/European Medicines Agency surveillance report estimated
that, across 28 EU member states, 8927 tonnes of antimicrobial active ingredients were used for animals,
compared with 3821 tonnes used for medical purposes [18]. In the USA, antimicrobials used in food
animal production accounted for 70% of total antimicrobial consumption in 2014 [10].
The World Health Organization has projected a global increase in meat production from
218 million tonnes in 1999 to 376 million tonnes in 2030, with relatively greater increases in developing
countries [19]. The amounts of antimicrobials aimed at animal production worldwide have been
forecast to increase by 67% from 2010 to 2030, mostly driven by increased demand for animal protein
and intensification of farming systems in low- and middle-income countries (LMICs) [20], although
there is considerable uncertainty around the magnitude of this increase. Very little is known about what
food animal species are the target of highest levels of AMU in LMICs, while data from high-income
countries (HICs) are far from comprehensive. Because of this, international technical agencies have set
up initiatives aimed at monitoring AMU/AMR in animal production with a focus on LMICs [21,22].
Measuring AMU in animal production may address different objectives: monitoring AMU over
time, setting benchmarks to promote AMU reductions, and investigating associations between AMU
and AMR. However, because AMU can be measured using a large diversity of metrics, posing a
considerable difficulty to the comparability of data across studies [17]. In addition, limitations in
resources and research capacity typical of many LMIC countries represent an additional challenge [23].
In this article, we reviewed and summarized peer-reviewed original research on AMU in terrestrial
food animal production worldwide. The aims were as follows: (1) to document methodologies and
metrics used to quantify AMU; and (2) to compile qualitative (i.e., prevalence of usage of specific
antimicrobials and antimicrobial classes) and quantitative (amounts of antimicrobial active principle),
identifying those food animal species (pigs, poultry, or cattle) at highest risk of AMU. We extracted
all raw data and metrics reported in these studies, discussed the limitations of the methodologies
used, and documented data gaps in LMICs. We hope that this review helps to encourage further
harmonization of methodologies aiming at measuring AMU and achieving AMU reductions in animal
production globally.
2. Materials and Methods
2.1. Article Selection
The ‘ISI Web of Knowledge’ engine (Clarivate Analytics, Philadelphia, PA, USA) [24] was used to
search for original scientific articles published in English over the period January 1998 to April 2018.
The following terms were used to search publications with titles using the following keywords:
(antimicrobial* OR antibiotic*) AND (use* OR usage* OR consumption* OR amount* OR quantity*)
AND (animal* OR livestock* OR swine* OR pig* OR poultry* OR chicken* OR cattle* OR dairy* OR
beef*)]. A wildcard “*” was used to find plurals and word variants, and “multiple terms” used to find
similar concept according to the website guidelines [24]. All retrieved records were saved for further
review. Publications not reporting original research data, or written in languages other than English
were further excluded. Publications containing AMU data in the abstract were selected and their full
content was reviewed. Publications were broadly classified by the country where the research took
place, and further categorized into whether they were carried out in a LMIC or a high-income country
(HIC), based on the World Bank country classification for 2016 [25].
2.2. Data Extraction
From each selected publication, the following information was compiled as separate records
(data points): (1) country of study; (2) year; (3) study unit (farm/veterinarian/veterinary
prescriptions/sales data); (4) number of study units; (5) animal production type: level 1 (species),
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cattle, poultry, swine, all species combined; level 2, beef cattle, dairy cattle, calves, heifers,
broilers, layer chickens, turkeys, weaners, finishing pigs, adult pig/sows; (6) observation period
(in months); (7) purpose of usage (non-specified/prophylactic/therapeutic/growth promotion);
(8) route of administration (oral/water/feed/injectable/intra-mammary); and (9) source of data
in the original publication.
The qualitative data included the reported ‘prevalence of use’ of antimicrobials/antimicrobial
classes, or the relative distribution of antimicrobials sold. Quantitative data indicated the amounts used
reported, in addition to the relevant expression units. All data were entered as single records (‘data
points’) in Excel (Microsoft Office). Antimicrobials and antimicrobial classes listed were those included
in the World Organisation for Animal Health (OIE) classification: veterinary critically important
antimicrobial (VCIA) agents (10 classes); veterinary highly important antimicrobial (VHIA) agents
(8 classes); and veterinary important antimicrobial (VIA) agents (8 classes) [26].
2.3. Data Analyses
We further analysed AMU data at farm level, and excluded information from studies based
on veterinary prescriptions or pharmacies. AMU estimates from the same study, on the same
animal species but on different years, different routes of administration, different production phases,
or different types of use, were consolidated into a single data point. The usage rate (probability of use
per month) (UR) was solved from the standard epidemiological formula:
P = 1 − e−UR×t
Therefore,
UR = − log (1 − P)
t
where P is the reported prevalence of usage (cumulative incidence) and t is the reported period of
observation (months) [27].
The median (and 75% interquartile range) of the reported UR for each of the 10 most used classes
of antimicrobials were calculated for cattle, poultry, and swine data.
For quantitative studies, the type of numerator, the population at risk, and the mathematical
expressions used to quantify AMU were compiled. The data corresponding to different antimicrobials
were added up by class (using the metrics reported). Metrics corresponding to animal-time (i.e.,
the product of the number of animals times the number of observed time units) were converted to ‘doses
per 1000 animal-days’ for swine, cattle (dairy, beef), and poultry. The median (and 75% interquartile
range) were given. For antimicrobials where the median across studies was 0, the arithmetic mean and




A total of 658 scientific publications were identified using the search terms listed above. Of those,
390 contained original research and 362 were written in English. AMU data (both quantitative
and qualitative) was included in the abstract of 144 publications, and all of them were examined.
Ninety-two articles contained AMU data within the body of the publication, but three contained
extrapolation estimates, rather than survey data [20,28,29], and were thus further excluded, resulting
in 89 publications to be reviewed (Figure 1).
Page 42 of 342
Antibiotics 2018, 7, 75 4 of 20
Figure 1. Selection and exclusion criteria for scientific publications on antimicrobial use (AMU) in
animal production.
The 89 selected studies came from 29 countries (18 of which were classified as HICs and 11 as
LMICs, according to the World Bank). Seventy-two (80.9%) studies came from HICs, and 17 (19.1%)
from LMICs (8 from Asia, 7 from Africa, and 2 from the Americas). The countries with the highest
volume of studies were Canada (11), Denmark (7), Belgium (6), and Germany (5). The studies were
classified by publication year, country location, data source, and food animal species (Table 1).
Qualitative (‘prevalence of use’ of antimicrobials/antimicrobial classes, or the relative distribution
of antimicrobials sold) and quantitative data (amounts of antimicrobial active ingredient) on AMU
were reported in 46 and 60 studies, respectively. Seventeen (19.1%) studies reported both qualitative
and quantitative data. Forty-eight percent of studies were published during the recent 2014–2018
period (70.6% of studies from LMICs). Over half (53%) of the studies were performed in Europe,
followed by the Americas (23%), Asia (13%), Africa (8%), and Oceania (3%). About 38/47 (80.8%)
of European studies reported quantitative AMU data, versus 9/18 (50%) studies from the Americas.
A total of 66.3% studies were based on farm survey data, followed by 16.8% based on antimicrobial
sales data. The most common animal species investigated were swine and cattle (43.8% studies),
followed by poultry (24.7%). Ten percent of studies covered AMU in all species. Of the 17 publications
from LMICs, only 7 (41%) reported quantitative data.
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Table 1. Summary of 89 publications on antimicrobial use (AMU) stratified by year of study, country location, study design, and animal species, stratified by type of
data (quantitative and/or qualitative) and type of country according to the World Bank income classification (2016). Individual studies are identified in the footnote
(countries classified as low- to middle-income countries (LMICs) by the World Bank in 2016 are underlined). HICs—high-income countries.
Category Sub-Category
Number of Studies (%)



















Year of publication 2014–2018 9 (28) 26 (55) 31 (43) 10 (72) 6 (86) 12 (70) 19 (41) 35 (59) 43 (48)
2009–2013 8 (25) 13 (24) 19 (26) 2 (14) 1 (14) 3 (18) 10 (22) 14 (23) 22 (25)
2004–2008 12 (38) 8 (15) 17 (24) 2 (14) 0 (0) 2 (12) 14 (30) 8 (13) 19 (21)
1998–2003 3 (9) 3 (6) 5 (7) 0 (0) 0 (0) 0 (0) 3 (7) 3 (5) 5 (6)
Country location * Europe 13 (41) 38 (73) 47 (65) 0 (0) 0 (0) 0 (0) 13 (28) 39 (65) 47 (53)
Americas 17 (53) 9 (17) 18 (25) 2 (14) 1(14) 2 (12) 19 (42) 10 (16) 20 (23)
Asia 1 (3) 2 (4) 3 (4) 6 (42) 5 (72) 8 (47) 7 (15) 7 (12) 11 (12)
Africa 0 (0) 0 (0) 0 (0) 6 (42) 1(14) 7 (41) 6 (13) 1 (2) 7 (8)
Oceania 1 (3) 2 (4) 4 (6) 0 (0) 0 (0) 0 (0) 1 (2) 3 (5) 4 (4)
Study design Farm survey 27 (84) 33 (62) 48 (67) 11 (79) 6 (86) 13 (76) 38 (83) 38 (60) 59 (66)
Sales data 1 (3) 15 (28) 15 (28) 0 (0) 1 (14) 0 (0) 1 (2) 15 (24) 15 (16)
Veterinarian survey 4 (13) 6 (11) 10 (19) 1 (7) 0 (0) 1 (6) 5 (11) 7 (11) 11 (12)
Pharmacy survey 0 (0) 2 (4) 2 (4) 2 (14) 0 (0) 3 (18) 2 (4) 3 (5) 5 (6)
Animal species Swine 11 (31) 25 (47) 36 (50) 3 (19) 1 (11) 4 (23) 14 (30) 26 (43) 39 (44)
Cattle 20 (56) 23 (43) 36 (50) 3 (19) 2 (29) 3 (18) 23 (50) 27 (45) 39 (44)
Poultry 5 (14) 11 (21) 13 (18) 7 (44) 5 (71) 9 (53) 12 (26) 16 (27) 22 (25)
Combined data 0 (0) 5 (9) 5 (7) 3 (19) 1 (11) 4 (23) 3 (7) 6 (10) 9 (10)
* Europe, qualitative (13): Austria [30], Belgium [31], Germany [32], Norway [33], Italy [34–36], Spain [37,38], Finland [39], France [40]; UK [41,42], several EU countries [42]; Europe,
quantitative (39): Denmark [43–49], Belgium [31,50–54], Germany [32,33,55–59] Austria [59–62], Switzerland [63,64], Netherlands [65–67], Sweden [68,69], France [40,70], Norway [33],
Ireland [71,72], Italy [36], several EU countries [5,73], UK [74]; The Americas, qualitative (19): Canada [75–85], USA [86–91], Peru [92], Argentina [93]; The Americas, quantitative (9):
Canada [75,80–85], USA [91,94], Argentina [93]. Asia, qualitative (7): Vietnam [95–97], Cambodia [98], Thailand [99], Japan [100], Iran [101]; Asia, quantitative (7): Vietnam [96,97,102],
Thailand [103], Japan [6,104], Iran [101]. Africa, qualitative (6): Nigeria [105–108], Cameroon [109], Tanzania [110]; Africa, quantitative (1): South Africa [111]. Oceania, qualitative (1):
Australia [112]; Oceania, quantitative (3): New Zealand [113–115].
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3.2. Qualitative Data
Forty-six publications reported qualitative AMU data (Supplementary Material S1).
These publications generated 50 data points on AMU by class, and 176 data points on use of specific
antimicrobials. Data from 19 publications were not further analysed, because either the time frame
was not provided, or the data presented reflected the distribution of different antimicrobials used
or prescribed, not a prevalence of use. From the remaining 27 publications, 29 data points were
compiled, corresponding to use of specific antimicrobials (11) or antimicrobial classes (18). Five data
points corresponded to publications from LMICs (from poultry in Vietnam [96,97], Nigeria [105],
Tanzania [110], and from cattle in Peru [92]. The usage rate (UR) (per month) for the most commonly
reported antimicrobials and antimicrobial classes by type of animal production (poultry, swine,
and cattle) is displayed in Figure 2.
Figure 2. Boxplots representing monthly usage rage (UR) of antimicrobials (Right) and antimicrobial
classes (Left). Six, three, and two estimates on antimicrobial classes were available for cattle, poultry,
and swine, respectively. Nine, five, and four estimates on specific antimicrobials were available for
cattle, swine, and poultry, respectively. The thickness of the boxes reflects the number of studies.
HICs—high-income countries; LMICs—low- to middle-income countries.
Two, six, and three estimates on antimicrobial classes were available for swine, cattle, and poultry,
respectively. In swine, tetracyclines had the highest UR (median 0.209; range 0.108–0.309), followed by
polypeptides (0.091; range 0.000–0.183), penicillins (0.080; range 0.062–0.098), and aminoglycosides
(0.062; range 0.057–0.067). In cattle, penicillins were the most frequently used antimicrobials in
cattle with a median UR of 0.130 [inter quartile range (IQR) 0.090–0.320], followed by cephalosporins
(0.058 [IQR 0–0.154]), and tetracyclines (0.051 [IQR 0.035–0.059]). The most used antimicrobial classes
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in poultry were tetracyclines (median 0.095; range 0.095–0.156), followed by macrolides (median 0.071
[range 0.023–0.071]), polypeptides (median 0.069 [range 0.0–0.069]), and penicillins (median 0.057
[range 0.037–0.057]).
Five, nine, and four estimates on specific antimicrobials were available for swine, cattle,
and poultry, respectively. Among studies reporting individual antimicrobials in pig farms,
the highest UR corresponded to penicillin (median 0.075 [IQR 0.068–0.790]), tetracycline (0.041
[IQR 0.040–0.059]), neomycin (0.041 [IQR 0.003–0.046]), and tylosin (0.039, [IQR 0.029–0.063]). In cattle,
penicillin was the most used antimicrobial (median 0.096 [IQR 0.039–0.291]), followed by ceftiofur
(0.079 [IQR 0.013–0.40]), ampicillin (0.021 [IQR 0–0.060]), and sulphonamides (0.020 IQR [0–0.66]).
In chicken farms, the most common antimicrobials used were doxycycline (0.056 [IQR 0–0.605]),
followed by tiamulin (0.037 [IQR 0–0.90].
3.3. Quantitative Data
Accurate quantification of AMU in animal production requires the integration of two magnitudes,
a ‘numerator’, and a ‘population at risk’ denominator (or ‘target population’). The ‘numerator’
indicates the quantities of antimicrobial agent administered (farm surveys), prescribed (survey
of veterinary practices), or sold (studies based on sales), in terms of the weight of antimicrobial,
the number of animals treated, the number of treatment courses, or the number of animal daily doses.
The ‘population at risk’ can be expressed as number of animals (expressed as animals produced, or a
‘stationary’ population census), bodyweight of animals (at slaughter or treatment), or ‘animal-time’
(the product of the number of animals times the number of observed time units) (Table 2).
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Table 2. Classification of 60 publications reporting antimicrobial use (AMU) quantitative data by the type of metrics used and animal production types. Studies
performed in LMICs are underlined. The number of publications reporting using those metrics is given in parentheses.
Type of Animal Production (N)
All Studies (N)
Population at Risk Dairy Beef Cattle (Unsp.) Poultry Swine Total Use
Weight of
antimicrobial
Animal-time [63] (1) [81] (1) - [97] (1) [94] (1) - (4)
No. animals produced [69] (1) - - [80,97] (2) [47] (1) - (4)
Weight of animal production [104] (1) [104] (1) [101] (1) [101–104] (4) [44,102,104] (3) - (6)
Weight of animal at treatment [74,113] (2) - [64] (1) [84] (1) [60,61,64] (3) [5,70,114] (3) (10)
Weight of animal time [63] (1) - - - - - (1)
No population at risk [71,115] (2) - [5,43] (2) [5] (1) [5,43] (2) [111] (1) (5)
No. animals treated
Animal-time - - - - [75] (1) - (1)
No. animals produced - - - [33] (1) - - (1)
No. treatment courses
Animal-time [63] (1) - - - - - (1)
No. animals produced - [40,41] (1) - - - - (1)
No. daily doses Animal-time [30,31,53,63,65,69,72,
74,82,83,85,91,93] (13)





No population at risk [58] (1) - - - [58] (1) [59] (1) (2)
No. studies (18) (5) (5) (13) (27) (5) (60)
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The most common quantitative metric was the ‘animal daily dose’ (ADD) [47,54,81], or a related
expression such as the used daily dose (UDD) [54,57], the prescribed daily dose (PDD) [62], the animal
daily dose x (ADDx) [60,61], and the used course dose (UCD) [63]. In conjunction with an animal-time
denominator, data on doses can be presented as a ‘treatment incidence’, which can be interpreted as
the fraction of time over which animals are under treatment [49].
Thirty-two out of 60 studies reported AMU in animal daily doses related to animal-time, followed
by studies reporting weight of antimicrobials related to the following: weight of animal at time of
treatment (10), weight of animal production (6), animal-time (4), and number of animals produced (4).
Five studies included quantitative AMU data, but the authors did not relate these to a population
at risk. The formulae and calculations used in each publication are described in Supplementary
Material S2. These 60 studies generated 939 data points related to total AMU use (528), AMU by class
(310), and use of specific antimicrobials (108) (Supplementary Material S3). Only 7/60 (11.7%) studies
were performed in LMICs.
Data from studies reporting animal daily doses were standardized as ‘doses per 1000 animal-days’
(equivalent to ‘daily doses per 1000 animals’). Seventeen studies (all from European countries) reported
AMU data in swine using these units. Two studies reported partial data (AMU in feeds only) [55,62].
Of the remaining 15 studies, eight reported ‘overall’ AMU on farms [45,47,50,51,54,61,67,116], whereas 7
reported AMU for specific age groups (sows, fattening pigs, suckling pigs, etc.) [32,46,49,56,57,66,68,117]
(Figure 3). Across studies, pigs received a median of 40.2 doses per 1000 animals per day (or per
1000 animal-days) [IQR 8.5–120.4]. However, there were differences depending on whether the figures
quantified overall (or average) farm AMU, or usage targeted to specific age groups within farms.
Data from four studies reported a median of 134.2 [IQR 79.7–134.5] doses per 1000 pig-days for suckling
piglets [57,58,70], 8.5 [range 7.9–30.4] to sows/adult pigs [47,57,70,117], and 29.6 [IQR 17.0–34.9]
to fattening/finishing pigs [46,50,57,58,68,70]. In decreasing order, the following antimicrobials
were given: penicillins (median 10.1 [IQR 2.7–39.7]), trimethoprim-sulphonamides (median 0.10;
[IQR 0–31.2]); tetracyclines (median 5.6; [IQR 0–13.8]); macrolides (median 6.1 [IQR 0.16–16.7]);
polymyxins (median 0 [IQR 0–7.1]); third generation cephalosporins (median 0.6 [IQR 0–10.6]),
aminoglycosides (median 0, [IQR 0–0.2], mean 1.7; SD ± 3.5); and lincosamides (0 [IQR 0–0.5], mean 1.5;
SD ± 4.0). Other antimicrobials were used less than 1 mean dose per 1000 pig-days. Antimicrobials in
pigs were predominantly administered through the oral route, rather than through the parenteral
route [50,54].
Thirteen studies reported dose-based data from dairy farms. All studies came from Europe,
except one each from Argentina [93], the USA [91], and Canada [85]. One study reported AMU in
heifers before calving [69], and another one reported AMU to treat mastitis [91] exclusively. One study
reported separate data for calves, heifers, and dairy cows [63]. The remaining 10 studies reported
overall farm AMU (Figure 3). The median number of doses reported in adult cattle was 10.0 doses
per 1000 cow-days [IQR 5.5–13.6]. The most used antimicrobials were as follows (in decreasing order):
penicillins (median 4.7 [IQR 1.8–5.8]); third generation cephalosporins (median 1.4 [IQR 0.1–2.1]); first
generation cephalosporins (median 0.7 [IQR 0.1–0.9]); fourth generation cephalosporins (median 0.1
[IQR 0–1.9]); and aminoglycosides (median 0.6 [IQR 0–1.1]). Five publications reported AMU data as
dose-based units in poultry, including three from Europe [51,52,67], one from Canada [84], and one
from Vietnam [96]. One of the European studies only reported total use data [51], and data from
the remaining four studies are shown in Figure 3. Except the study from Vietnam, which included
small- and medium-scale chicken farms, other studies reported data from industrial broiler farms.
The median AMU reported was 138 daily doses per 1000 chicken-days [IQR 91.1–438.3]. The Canadian
study included in feed antimicrobial growth promoters (AGP) bacitracin and streptogramins, whereas
the Vietnamese study did not. AGPs were banned in Europe at the time of the two other studies
reported. The most commonly reported antimicrobials were penicillins (median 51.1 [IQR 40.1–52.9]),
macrolides (median 33.0 [IQR 17.3–55.4]), trimethoprim-sulfonamides (median 25.0 [IQR 11.4–53.7]),
tetracyclines (median 3.8 [IQR 0–49.1]), and fluoroquinolones (median 4.8 [IQR 0–26.9]). Only three
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studies reported dose-based metrics in beef cattle, of which two reported AMU in veal production in
the Netherlands and Belgium [51,67]. A study on beef farms from Canada reported a range of 3.3 to
10.7 per 1000 animal days depending on the type of farm; highest in cow-calf farms, and lowest in
mixed feedlot and cow-calf farms. The antimicrobials most commonly given were tylosin (oral) and
tetracyclines (injectable) [81].
Figure 3. Boxplots representing the summary of AMU by antimicrobial classes from studies reporting
quantitative data as doses (per 1000 animal-days) in swine (15), dairy (10), and poultry (4) farms.
The thickness of the boxes reflects the number of studies.
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A number of studies reported AMU related to weight of animal at treatment, standardized as
‘population correction unit’ (PCU) [50,60,61,64,70,74,84,113,114]. One PCU is equivalent to 1 kg of
animal body mass at the time of treatment, which is set for each species (i.e., 1 kg for broilers, 65 kg for
pigs, and 425 kg for cattle). A similar standardized measure is the LU (‘livestock unit’). One LU was
considered to be equivalent to 500 kg of animal biomass (i.e., one adult cow corresponds to ~1 LU, one
fattening pig to ~0.15 LU, and one layer hen to ~0.004 LU) [59]. In a recent study, Danish researchers
have proposed the use of an ‘adjusted population correction unit’ (APCU), which combines the PCU
with the lifespan of the species treated, in order to reflect selection pressure of the antimicrobial over a
kilogram of animal per unit time. Calculations using APCU demonstrated that PCU overestimated
usage in short-living animal categories (i.e., poultry and, to a lesser extent, pigs), but underestimated
AMU in long-living animals (i.e., cattle) [117].
4. Discussion
Here, we reviewed 89 studies on AMU in animal production published in English since 1998.
In spite that LMICs are home to 84.2% of the global world population, only 17 (19%) publications came
from such countries. This imbalance should be addressed, especially given that LMICs will account
for the highest increase of AMU over coming years [20]. Interestingly, only one publication (from
South Africa) was identified among all five BRICS ‘emerging’ economies (Brazil, Russia, India, China,
and South Africa) [111]. It is highly likely, although could not be verified, that this somehow reflects
a language bias, and some research has probably been published in languages other than English,
or that falls outside the reach of the search engine. Most of the publications from LMICs were obtained
from ad hoc farm surveys, as national AMU monitoring systems have not yet been established in most
countries. A relatively small fraction of studies (7/17) included quantitative data.
Surveys based on a single farm visit may incur in recall biases, because often farmers do not keep
records, especially in small-holder farms typical of many LMICs [118]. Although costly, longitudinal
study designs where farmers are requested to keep records and/or antimicrobial product containers
can potentially yield more accurate data than unannounced ‘one-off’ visits. However, there is also
a risk that farmers may change their behavior or not provide accurate data, the latter being possible
if farm visits are carried out by veterinary authorities that are perceived to negatively judge farmers’
AMU practices.
Longitudinal study designs may allow insights into the seasonality of disease [57] and
repeated behavior of consumption over time (especially when consecutive cycles of production
are investigated) [65]. Such studies may also shed insights into treatment practices for different
diseases or types of animal [46,83]. Finally, they may also allow to identify production types,
farm sizes, and animal groups at higher risk of usage [45,116], as well as problems with over-
and under-dosing [50,54,60,74]. Because longitudinal on-farm surveys are time-consuming and
require considerable farmer commitment, they may be affected by a low response rate, limiting
their representativeness [50]. In situations where there is a vast diversity of antimicrobial products,
but the prevalence of use of each individual product is low, a small sample size may result in a
0 median [51,82], making results difficult to interpret. It would thus be preferable to report the mean
and its associated standard deviation. The EU has recently issued recommendations on farm sampling
strategies to investigate AMU at species level. These largely depend on the complexity and the
size of the country. In the most complex situations (i.e. large countries with high heterogeneity of
farming systems), a two-step cluster sampling procedure is recommended. It involves first, randomly
selecting regions within the country (clusters), followed by stratification by farm type within each
region, and systematic random sampling of farms with a selection probability proportional to their size.
The EU also provides recommendations on required sample sizes [119]. In addition, the AACTING
initiative aims to provide specific guidelines on monitor AMU at farm-level to monitor antimicrobial
stewardship [120].
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A number of publications (n = 10, of which 5 were from LMICs) reported prevalence of usage
without providing a time frame, making interpretation difficult, because usage is dependent on the
observation period. A further difficulty in interpreting prevalence of usage data is that in the studies
reviewed, no information was provided as to whether antimicrobials were administered to whole
flock/herds, or to individual animals. This is particularly relevant in large animal farming (i.e., pigs,
ruminants), where individual treatment is common.
None of the studies from LMICs, except one from South Africa [111], included estimates on
national sales. Sales data alone does not allow insights into species and production types at highest
risk of use. However, if comprehensive, they can be useful to monitor general trends over time,
provided that animal production figures remain stable. AMU data collated by national surveillance
systems can be used to measure the impact of large-scale interventions, as performed in Norway and
Switzerland after the EU compulsory withdrawal of AGPs [33,62], or changes in AMU over time due to
the incursion of epidemics [44,49]. In recent years, the EU has implemented joint monitoring of AMU
in humans and animals, although the data are mostly reported for all food animals combined [18].
Quantitative data on AMU in specific production types coupled with AMR data may potentially allow
the elucidation of the relationship between AMU and AMR [119]. For countries with a considerable
fraction of animal production aimed at the export market, it is imperative to include export data in the
calculations [47].
As antimicrobials’ active ingredients vary considerably in their potency, the use of dose-based
metrics results in more fair comparison between antimicrobials. However, there is no universally
accepted dose standards, as these vary by country, species, route of application, and indication [117].
Even if doses are standardized, estimating the number of doses from gross amounts of active
ingredient is challenging because animals (especially poultry and pigs) may increase their body
size over the production cycle for a factor of 50–100. For oral formulations (often given for flock/herd
treatment), the feed and water intake needs to be estimated [80,96], and these data are rarely
collected in small-holder farming systems typical of many LMICs. In situations when records are
available, it is possible to contrast actual with theoretical use (UDDanimal/ADDanimal or UDDkg/ADDkg
ratios), and thus estimate the magnitude of over/under-dosing [54,61]. The change of technical
specifications of doses may also lead to overall changes in AMU estimates, as shown in Denmark [47].
Comparing dose-based data (i.e., animal daily doses) across studies may present difficulties, because
some report overall farm summaries, whereas others report AMU for specific subgroups (i.e., sows,
piglets, calves).
In studies where weight and dose-based measures have been compared, some discrepancies
have been found for some antimicrobials. For example, doses of tetracycline typically involve higher
weights than polypeptides [57,81], fluoroquinolones, and cephalosporins [58]. Recently, the EU has
standardized animal daily doses to encourage harmonized reporting across EU member states (termed
defined daily dose for animals (DDDvet) [121].
For calculations at national level, animal-time denominator metrics should also take into account
the length of empty periods on farms [67]. The definition of denominators based on weights at
slaughter is challenging, especially because for long-living animals (i.e., dairy cows, sows, boars), only
a small fraction of the standing population of these animals is slaughtered annually. This has been
circumvented by using biomass data based on slaughter weight of animals for short living species
(poultry, fattening pigs) and standing populations for long-living animals [104]. AMU has also been
related to animal produce beyond meat (i.e., eggs and milk) [101]. Estimates of AMU related to food
product could be used to define antimicrobial footprints to encourage responsible AMU in food animal
production [103].
The European Union countries have agreed on the values assigned to PCU for animal species,
which are used to standardize denominator data. However, animal production across the world
is highly diverse, and this would require the definition of specific PCU values depending on the
production systems. For example, the final slaughter weight of a traditional chicken in southern
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Vietnam is 1.5–2.2 kg, whereas a typical broiler chicken may reach 2.6 kg. These values, as well as the
variability in prescribing practices, are likely to affect the weight of animals at time of treatment.
Our review suggests a great variability in levels of AMU, between countries and species, as well as
across age/production groups within species. Overall, AMU expressed as doses per unit of animal-time
was highest in broiler production, followed by pig and dairy. An exception to this was a study from
Belgium, where treatment incidence was higher in pig than in broiler production [51]. A study
from Japan using estimates related to weight of animal production suggests that the amounts of
antimicrobials used to produce 1 kg of pork far outweigh the amounts used to produce 1 kg of broilers
or cattle [104]. This is likely to reflect the longer production cycle of pigs versus broilers (6 months vs.
1–1.5 months). Although adult cattle used generally fewer doses of antimicrobials per unit time, the use
of critically important antimicrobials such as broad spectrum β-lactams and cephalosporins to treat
mastitis infections is of great concern [30,31,83]. A considerable target of AMU in dairy cattle is the
treatment of clinical mastitis and dry cow therapy [93]. We would like to highlight the lack of studies
on AMU in poultry breeding flocks, laying flocks, and hatcheries worldwide. In some countries, it is
common practice to dip or inject hatching eggs with antimicrobials to reduce the incidence of early
infections [122].
This review confirmed a considerable deficit of studies on AMU from LMICs. Because of these
data limitations, it cannot be concluded whether farms in LMICs are at higher or lower risk of
AMU than their HIC counterparts. Also, it not clear to what extent animals in small-scale farms
are raised using more or less antimicrobials than animals raised in larger (i.e., industrial) farms.
There is conflicting evidence on this. One study from Vietnam showed higher levels of AMU in small-
compared with medium-scale chicken farms [97]. Another study from the same country showed that
pork, beef, and chicken meat samples purchased from wet markets were more commonly contaminated
with antimicrobial residues than samples purchased from supermarkets. As supermarkets generally
source their meat from industrial farms, this suggests higher levels of AMU in smaller farms [123].
However, another study on Thai pig farms reported the higher levels of antimicrobial usage in medium
farms compared with small farms [99]. Although income limitations among farmers in LMICs may
theoretically result in lower levels of AMU, in practice this may be offset by a higher incidence of
infectious diseases, easier access to veterinary drugs, limited veterinary services, and generally looser
legislative enforcement [124,125]. It is hoped that as more research/surveillance data on AMU in
LMICs becomes available, this will become clearer.
5. Conclusions
We reviewed English-language scientific literature covering metrics and data pertaining to AMU
in terrestrial animal production. Examination of these data indicates a considerable diversity of
methodologies, as well as biases towards data from HICs and a concomitant data deficit from LMICs.
Given the challenges posed by the variability of animal production systems, it would seem a priority
to encourage the performance of on-farm surveys, and to recommend as a priority the collection of
data as gross amounts (weight) of antimicrobial active ingredient by production system, and to further
integrate these with production data collected at country level. The quantification of AMU using
dose-based metrics should be carried out after the baseline data become available, but this requires
standardization of dose definitions. In terms of treatment incidence, usage in poultry production is
the highest, followed by AMU in swine and cattle production. We hope these data encourage the
further investigation of AMU especially in LMICs with the aim of reducing the pressing threat of
AMR worldwide.
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Chicken is, among farmed species, the target of the highest levels of antimicrobial
use (AMU). There are considerable knowledge gaps on how and when antimicrobials
are used in commercial small-scale chicken farms. These shortcomings arise from
cross-sectional study designs and poor record keeping practiced by many such farmers.
Furthermore, there is a large diversity of AMU metrics, and it is not clear how these
metrics relate to each other. We performed a longitudinal study on a cohort of small-scale
chicken farms (n = 102) in the Mekong Delta (Vietnam), an area regarded as a hotspot
of AMU, from October 2016 to May 2018. We collected data on all medicine products
administered to 203 flocks with the following aims: (1) to describe types and quantities
of antimicrobial active ingredients (AAIs) used; (2) to describe critical time points of AMU;
and (3) to compare AMU using three quantitative metrics: (a) weight of AAIs related to bird
weight at the time of treatment (mg/kg at treatment); (b) weight of AAIs related to weight
of birds sold (mg/kg sold); and (c) “treatment incidence” (TI), or the number of daily doses
per kilogram of live chicken [Vietnamese animal daily dose (ADDvetVN)] per 1,000 days.
Antimicrobials contained in commercial feed, administered by injection (n = N = 6), or
antimicrobials for human medicine (n = N = 16) were excluded. A total of 236 products
were identified, containing 42 different AAIs. A total of 76.2% products contained AAIs
of “critical importance” according to the World Health Organization (WHO). On average,
chickens consumed 791.8 (SEM ±16.7) mg/kg at treatment, 323.4 (SEM ±11.3) mg/kg
sold, and the TI was 382.6 (SEM ±5.5) per 1,000 days. AMU was more common early
in the production cycle and was highly skewed, with the upper 25% quantile of flocks
accounting for 60.7% of total AMU. The observed discrepancies between weight- and
dose-basedmetrics were explained by differences in the strength of AAIs, mortality levels,
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and the timing of administration. Results suggest that in small-scale chicken production,
AMU reduction efforts should preferentially target the early (brooding) period, which is
when birds are most likely to be exposed to antimicrobials, whilst restricting access to
antimicrobials of critical importance for human medicine.
Keywords: antimicrobial use, chicken, small-scale farms, metrics, quantification, Vietnam
INTRODUCTION
Antimicrobial resistance (AMR) is a global threat to the health
and wealth of nations (1). Antimicrobial usage (AMU) in animal
production is regarded as a key driver of AMR in animal
populations and a contributor to AMR in humans (2). AMU
in animal production has been predicted to increase by 67%
from 2010 to 2030 (3), while livestock production may increase
by 74% between 1999 and 2030 (4). This increase is mostly
driven by increased animal protein consumption in low- and
middle-income countries (LMICs).
Chicken meat is the most consumed protein commodity in
LMICs because of its comparative advantages. These include the
relatively low capital investment and production costs, as well
as the lack of religious objections to its consumption (5). In
Vietnam, chicken meat currently ranks, after pork, the second
most popular type of meat, and by 2020, it is forecast to surpass
pork consumption (6).
In 2015, the World Health Organization (WHO) launched
its Global Action Plan on AMR, with one of its key objectives
being the development and enhancement of monitoring systems
for AMU worldwide (7). However, measuring AMU in animal
production in LMICs is often challenging due to the large
numbers of small-scale farming units, high disease incidence,
access of antimicrobials “over the counter,” and generally loose
regulatory framework (8). According to the Vietnamese official
census (2018), of 245M chickens, only 26.1% corresponded to
chickens raised in industrial systems (9), with the remainder
corresponding to chickens raised in backyard and small-scale
(semi-intensive) commercial farms.
AMU can be measured using a large diversity of metrics
(10), and the choice of one metric over the other may lead
to inconsistent results (11). Several studies have highlighted a
very high level of AMU in Vietnamese chicken production, in
terms of both frequency and quantities. A study in 210 poultry
farms in northern Vietnam reported the use of 45 different
antimicrobial active ingredients (AAIs) (12). A cross-sectional
study in the Mekong Delta region indicated that, excluding feed,
farmers used approximately 470mg of AAIs to raise one chicken
(13). In terms of treatment intensity, AMU in chicken flocks
in a neighboring Mekong Delta province (Tien Giang) was 371
defined daily doses (DDD) per 1,000 chicken-days (14). Factors
associated with such a high amount of AMU include ease of
access to antimicrobials (i.e., density of veterinary drug shops)
and the presence of disease and mortality in flocks, which has
been described as very high (15).
However, most published studies in Vietnam (and in other
LMICs) on AMU to date are based on cross-sectional study
designs (i.e., a one-off visit) focused on the prevalent small-scale
farm units. Since many farmers do not keep accurate records on
AMU, they are likely to be prone to recall biases (16).
Using longitudinal active surveillance on a large cohort of
small-scale commercial chicken flocks, we aimed (1) to describe
the types of health-supporting products used, with a focus
on antimicrobial active ingredients (AAIs); (2) to describe the
critical time points for antimicrobial use (AMU) during the
production cycle; and (3) to compare AMU using three common
metrics of AMU in chicken production in the Mekong Delta
of Vietnam. Detailed information about the types and timing
of AMU, as well as its magnitude and the relationship between
study metrics, is essential in order to improve the design of
national/regional monitoring systems. Furthermore, this should
help formulate more targeted campaigns aimed at promoting
responsible use of antimicrobials among chicken farmers.
MATERIALS AND METHODS
Farms, Flocks, and Data Collection
The study was conducted fromOctober 2016 to May 2018 during
the baseline (observational) phase of a research project (17).
Chicken farm owners of two districts (Cao Lanh and ThapMuoi)
in the province of Dong Thap (Mekong Delta of Vietnam) were
randomly selected from the official farm census held by the
veterinary authorities (Sub-Department of Animal Health and
Production of Dong Thap, SDAH-DT). These two study districts
were chosen based on the availability of qualified veterinary
staff to conduct the study. The two chosen districts have, on
average, a human population of 331 and 354 chickens per square
kilometer (2011); these figures are close to the average for the
whole Mekong Delta region (410 humans and 478 chickens per
square kilometer) (2011).
Farm owners registered in the census (n = 207) were
convened and introduced to the project. Farmers intending
to raise chickens in flocks of >100 chickens were invited to
join the study prospectively as soon as they restocked their
follow-on cycle. Project staff provided participating farmers with
purposefully designed record books organized by week, where
they were requested to record in detail the quantities of all health-
supporting products used (including antimicrobial-containing
products). Farmers were also asked to keep all packages (bottles,
sachets, etc.) of any products purchased/used in their flock
in a dedicated container. Study farms were visited four times
during each flock production cycle to review the product
containers (i.e., active ingredients, function, concentration, and
instructions for use) and to verify the collected data. All data
(commercial product names and quantities used) were entered
into a database using a web-based application. The information
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collected included number of chickens present in the flock each
week and the number of chickens that died over the week. From
these data, the flock cycle (cumulative) incidence of mortality was
calculated for each production cycle by dividing the total number
of birds that died during the period from restocking to sale by
the total number of birds restocked for that cycle. A total of 203
flocks that completed at least one entire cycle (from 1-day-old
chick until all chicken sold) raised in 102 farms were investigated.
Of the 102 farms, 33 (32.3%) completed one cycle, 40 (39.2%)
completed two cycles, 19 (18.6%) completed three cycles, 8
(7.8%) completed four cycles, and 2 (19.6%) completed five
cycles. Recruited flocks ranged between 100 and 1,530 chickens
at restocking. The median flock size at restocking was 300 [Inter-
quartile range (IQR) 200–495]. The median duration of one
production cycle was 18 [IQR 16–20] weeks, and the median
cumulative mortality over the whole production cycle of flocks
was 14.1% [IQR 6.8–29.2].
Description of Health-Supporting
Medicinal Products
All health-supportingmedicinal products were identified by their
composition, and those products containing antimicrobials were
singled out. They were described by type (human or veterinary
medicine), composition (antimicrobial active ingredient only or
mixed with other substances), number of active ingredients,
administration route (drinking water, feed, injection), and
formulation (powder, liquid). AAIs were classified based on
the World Organisation for Animal Health (OIE) list of
antimicrobial agents (18).
Timing of Antimicrobial Usage
The probability of a flock being medicated by age (production
week) was calculated by dividing the total number of flocks where
at least one antimicrobial-containing product was administered
by the total number of flocks observed in the same week. In
order to investigate potential seasonal variations in AMU, a Lexis
diagram was created, with both the probabilities of AMU by
production week and week calendar time plotted. A generalized
logistic model was fitted with flock identity as the clustering
variable and age and calendar week (sine and cos transformed) as
covariates. The timing of AMU was investigated for the 20 most
commonly used AAIs. The distribution of times of usage of each
AAI from week 1 to week 21 (last week of AMU) was plotted.
Quantification of Antimicrobial Usage
The total live weight (body mass in kilograms) of chickens
present in each flock at each week was calculated from the
number of chickens present in the flock and their estimated
weight. The latter was based on weekly weightings of 10
randomly-selected chickens from each of 11 representative
flocks, from week 1 until week 22 of their production cycle
(Supplementary Data 1). The amounts of AAI administered
were calculated from farmers’ records. The following two weight-
based metrics were calculated: (1) weight of active ingredient
related to the weight of bird at the time of treatment (mg/kg
at treatment) and (2) weight of active antimicrobial active
ingredient given over the whole production cycle related to
weight of chickens sold (mg/kg sold). This was estimated from
the number of chickens present in the flock and their weight
at the time of sale. The instructions for mixing the products
in water and/or feed (dilution factor) and the estimated daily
water and feed consumption were used to estimate for each AAI
the daily dose (in mg) associated with treating 1 kg of chicken
(ADDvetVN). The weekly water consumption was estimated
from the daily intake of a standard meat type pullet at an
ambient temperature of 32◦C (225ml per kilogram of live
chicken) (19); the weekly feed consumption was estimated from
published data related to native Vietnamese layer pullets (i.e.,
63.4 g daily per kilogram of live chicken) (20). The expressions
used for the calculation of the above metrics are provided in
Supplementary Material S1.
The number of ADDvetVN of each AAI administered on
any given week to each flock (nADDvetVN) was inferred from
the amounts of antimicrobial products consumed. The total
nADDvetVN administered was divided by the duration of
the cycle (in weeks) and multiplied by 1,000. This “treatment
incidence” (TI) can be interpreted as the number of days (per
1,000 days) when one chicken is treated.
For antimicrobial products containing two or four AAIs,
the number of doses (nADDvetVN) assigned to each AAI
contained in the product was calculated as the total number
of doses associated with the product divided by two or four,
respectively. Products administered through the parenteral route
(injection) and human medicines (tablets) were excluded, since
the number of chickens receiving injection was not recorded,
and guidelines for preparation of human medicines were not
available. In addition, antimicrobials contained in purchased
commercial feeds were not included in the analyses since they
contained ambiguous formulations. Quantitative AMU metrics
at the flock level were compared using Pearson’s correlation
coefficient (PCC). We calculated the mean and coefficient of
variation of ADDvetVN values corresponding to AAIs present
in Vietnamese antimicrobials and compared them with the




A total of 619 different health-supporting products
were identified among the 203 flocks investigated, of
which 236 (38.1%) contained antimicrobials (Table 1).
The most common non-antimicrobial health-supporting
products (n = 383) consisted (in decreasing order) of
vitamins/minerals (21.5%), digestive enzymes (8.1%),
vaccines (3.7%), coccidiostats (3.6%), electrolytes (3.6%),
anthelminthics (2.9%), and interferon/immunoglobulins
(0.5%). Of the 112 “other” categories of product, most
(∼80%) were anti-inflammatory/anti-pyretic products (i.e.,
paracetamol, prednisolone).
Of the 236 antimicrobial-containing products, 176 (74.5%)
contained only AAIs (apart from excipient), whereas 25.5%
contained AAIs mixed with other substances (i.e., vitamins,
mineral, electrolytes, anti-inflammatory, and anti-pyretic
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TABLE 1 | Summary of health-supporting products used by study flocks.
Type of product No. of products
(n = 619) (%)
Farms
(n = 102) (%)
Flocks
(n = 203) (%)
Weeks
(n = 3,663) (%)
Antimicrobial-containing 236 (38.1) 100 (98.0) 192 (94.5) 933 (25.5)
Non-antimicrobial 383 (61.9) 102 (100) 202 (99.5) 2,128 (63.3)
Vitamins/minerals 133 (21.5) 99 (97.1) 189 (93.6) 1,428 (67.1)
Probiotics 50 (8.1) 86 (84.3) 157 (77.7) 942 (44.3)
Vaccines 23 (3.7) 102 (100) 203 (100) 784 (29.4)
Coccidiostats 22 (3.6) 76 (74.5) 137 (67.8) 304 (14.3)
Electrolytes 22 (3.6) 63 (61.8) 100 (49.5) 299 (14.1)
Anthelminthics 18 (2.9) 49 (48) 71 (35.1) 96 (4.5)
Interferon/immunoglobulins 3 (0.5) 88 (86.3) 144 (71.3) 293 (13.8)
Other (unclassified) 112 (18.1) 81 (79.4) 139 (68.8) 517 (24.3)
TABLE 2 | Description of antimicrobial-containing products administered to 203 chicken flocks.
Category Sub-category Products
(n = 236) (%)
Farms
(n = 102) (%)
Flocks
(n = 203) (%)
Week
(n = 3,663) (%)
Type of product Animal medicine 220 (93.2) 100 (98.0) 191 (94.1) 697 (19.0)
Human medicine 16 (6.8) 6 (5.9) 9 (4.4) 32 (0.9)
Composition AAI only 176 (74.6) 92 (90.3) 169 (83.2) 629 (16.9)
AAIs mixed with other substances 60 (25.4) 87 (85.3) 162 (79.8) 448 (12.2)
No. of AAIs per product One 94 (39.9) 78 (76.5) 135 (66.5) 359 (9.8)
Two 141 (59.7) 100 (98.0) 190 (93.6) 697 (19.0)
Four 1 (0.4) 1 (1.0) 1 (0.5) 3 (0.1)
Administration route Oral 227 (96.2) 100 (98) 192 (95.5) 928 (25.3)
Oral—water 209 (88.9) 98 (96.1) 191 (94.1) 860 (23.7)
Oral—feed 21 (8.9) 31 (29.4) 35 (17.2) 190 (5.2)
Injection 6 (2.5) 13 (12.7) 14 (6.9) 19 (0.5)
Type of formulation Powder 215 (91.1) 100 (98.0) 191 (94.1) 889 (24.3)
Liquid 21 (8.9) 36 (35.3) 43 (21.2) 73 (1.9)
AAI, antimicrobial active ingredients.
substances). A total of 141 (59.7%) products contained two
AAIs, and 1 (0.4%) contained four AAIs. Overwhelmingly, 227
products (96.2%) were intended for oral administration and 215
products (91.1%) were intended for powder-based formulations
(Table 2). A total of 16 human medicine products were used
by 4.4% of the study flocks. Antimicrobials were used in 25.5%
observation weeks (n= 3,663).
Description of Antimicrobial Active
Ingredients
A total of 42 different AAIs belonging to 13 classes were
identified (Table 3). A total of 180 (76.2%) products contained
antimicrobials of critical importance according to the WHO
(22). Of those, 132 (55.9%) products contained AAIs of critical
importance (“highest priority”) and 91 (38.5%) products
contained critically important (“high priority”) antimicrobials.
The most common AAI used were colistin (25.8% products,
83.7% flocks), followed by oxytetracycline (15.7%; 76.4%),
tylosin (13.6%; 36.9%), doxycycline (11%; 30%), and amoxicillin
(10.2%, 24.6%) (Table 3). Antimicrobials for human use
consisted of tablets containing amoxicillin and tetracycline
AAI (three products each); ampicillin, chloramphenicol,
ciprofloxacin, and sulfaguanidine (two products each);
and cefotaxime (one product). Supplementary Material S2
includes the list of all AAIs contained in all antimicrobial
products investigated.
Antimicrobial Use by Week
A Lexis diagram displaying the probability of AMU of flocks by
production age and calendar time (weeks) is shown in Figure 1.
The probability of AMU decreased with the age of the flock
(from 0.76 in week 1, 0.41 in week 2, and 0.02 in week 21).
From the Lexis graph, there was an indication of increased
AMU during certain calendar periods (peaks in December 2016,
June 2017, and February 2018). However, when both variables
were fit into the same logistic model with the probability of
AMU as an outcome, only the age of the flock (weeks) was
significant (data not shown). A median of 5.0 [IQR 2.25–
10.0] products and 6.0 [IQR 3.0–10.0] AAIs were used in each
flock cycle.
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TABLE 3 | AAIs administered to study flocks.
Antimicrobial class AAI Products (n = 236) (%) Farms (n = 102) (%) Flocks (n = 203) (%) Weeks (n = 3,663) (%)
Aminoglycosides* Neomycin 17 (7.2) 33 (32.4) 43 (21.2) 85 (3.1)
Gentamicin 15 (6.4) 41 (40.2) 60 (29.6) 87 (3.2)
Streptomycin 8 (3.4) 30 (29.4) 41 (20.2) 79 (2.9)
Spectinomycin 7 (3) 10 (9.8) 12 (5.9) 18 (0.6)
Apramycin 1 (0.4) 3 (2.9) 3 (1.5) 3 (0.1)
Any aminoglycoside 50 (21.2) 69 (67.6) 115 (56.7) 259 (9.7)
Amphenicols Florfenicol 13 (5.5) 24 (23.5) 27 (13.3) 40 (1.5)
Thiamphenicol 3 (1.3) 20 (19.6) 27 (13.3) 36 (1.3)
Chloramphenicol 2 (0.8) 2 (2.0) 5 (2.5) 15 (0.5)
Any amphenicol 18 (7.6) 40 (39.2) 53 (26.1) 90 (3.4)
1st- and 2nd-gen. cephalosporins Cefadroxil 1 (0.4) 1 (1.0) 1 (0.5) 2 (0.1)
Cefotaxime 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Cefalexin 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Any 1st and 2nd gen. cephalosporin 2 (0.8) 2 (2.0) 2 (1.0) 4 (0.2)
Diaminopyrimidines Trimethoprim 17 (7.2) 31 (30.4) 39 (19.2) 72 (2.7)
Lincosamides Lincomycin 13 (5.5) 16 (15.7) 21 (10.3) 32 (1.2)
Macrolides** Tylosin 32 (13.6) 48 (47.1) 75 (36.9) 160 (6.0)
Tilmicosin 7 (3) 20 (19.6) 24 (11.8) 37 (1.3)
Erythromycin 6 (2.5) 16 (15.7) 18 (8.9) 27 (1.0)
Spiramycin 6 (2.5) 11 (10.8) 12 (5.9) 15 (0.5)
Kitasamycin 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Josamycin 1 (0.4) 2 (2.0) 2 (1.0) 4 (0.1)
Any macrolide 51 (21.6) 57 (55.9) 91 (44.8) 227 (8.5)
Penicillins* Amoxicillin 24 (10.2) 43 (42.2) 50 (24.6) 87 (3.2)
Ampicillin 17 (7.2) 27 (26.5) 38 (18.7) 78 (2.9)
Any penicillin 41 (17.4) 56 (54.9) 91 (44.8) 164 (6.2)
Pleuromutilins Tiamulin 1 (0.4) 1 (1) 1 (0.5) 1 (0.0)
Polypeptides** Colistin 61 (25.8) 94 (92.2) 170 (83.7) 413 (15.5)
Enramycin 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Any polypeptide 61 (25.8) 94 (92.2) 170 (83.7) 414 (15.5)
Quinolones/fluoroquinolones** Enrofloxacin 13 (5.5) 32 (31.4) 45 (22.2) 76 (2.8)
Flumequine 9 (3.8) 12 (11.8) 16 (7.9) 27 (1.0)
Norfloxacin 2 (0.8) 7 (6.9) 9 (4.4) 13 (0.4)
Ciprofloxacin 2 (0.8) 2 (2.0) 3 (1.5) 5 (0.2)
Marbofloxalin 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Any quinolone 27 (11.4) 42 (41.2) 66 (33.5) 122 (4.6)
Sulfonamides Sulphamethoxazole 7 (3.0) 26 (25.5) 34 (16.7) 68 (2.5)
Sulfadimidine 6 (2.5) 8 (7.8) 9 (4.4) 11 (0.4)
Sulfadimethoxine 6 (2.5) 14 (13.7) 16 (7.9) 21 (0.8)
Sulfaguanidin 2 (0.8) 2 (2.0) 4 (2.0) 11 (0.4)
Sulfadiazine 2 (0.8) 2 (2.0) 2 (1.0) 4 (0.1)
Sulfamethoxypyridazine 1 (0.4) 2 (2.0) 2 (1.0) 4 (0.1)
Sulfachloropyridazine 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Sulfamethazine 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Sulfathiazole 1 (0.4) 1 (1.0) 1 (0.5) 1 (0.0)
Any sulfonamide 25 (10.6) 45 (44.1) 60 (29.6) 118 (4.4)
Tetracyclines Oxytetracycline 37 (15.7) 87 (85.3) 155 (76.4) 332 (12.4)
Doxycycline 26 (11.0) 42 (41.2) 61 (30.0) 129 (4.8)
Tetracycline 6 (2.5) 7 (6.9) 10 (4.9) 28 (1.0)
Any tetracycline 69 (29.2) 93 (91.2) 173 (85.2) 474 (17.8)
Unclassified Methenamine 1 (0.4) 15 (14.7) 23 (11.3) 31 (1.1)
Critically important antimicrobial classes according to the World Health Organization (WHO) are highlighted: *High priority, **Highest priority.
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FIGURE 1 | Lexis diagram and probability of antimicrobial use (AMU) (Yes/No) by production week and calendar week during the study period.
Timing of Antimicrobial Use
In terms of timing of use, the AAIs used earlier in the
production cycle were oxytetracycline [median timing of use, 2
weeks (IQR 1–5)], thiamphenicol [median 2.0 (IQR 1.0–6.0)],
and colistin [median 3 (IQR 1.0–7.0)]. Tilmicosin [median 9
(IQR 6.0–12.0)], flumequine [median 9.0 (IQR 7.0–13.0)], and
tetracycline [median 10.0 (IQR 6.0–12.0)] were the three AAIs
that were administered latest to study flocks (Figure 2).
Quantification of Antimicrobial Use
Chicken flocks were administered a mean of 791.8 (±16.7)
mg AAI per kilogram of chicken at treatment time [median
512mg (IQR 264–1,094)] and 323.4 (±11.3) mg per kilogram of
chicken sold [median 134mg (IQR 62–279)]. The mean TI was
382.6 (±5.5) ADDs per 1,000 days [median 290 (IQR 125–583)
per 1,000 days] (Figure 3). These calculations excluded AAIs
contained in commercial feed, injectables, or human medicine
antimicrobials. The data were quite skewed in all three metrics,
with the mean being always greater than the median value.
In terms of mg/kg at treatment, the upper 25% quantile of
flocks accounted for 60.7% of total use. In addition, 23 (12.0%)
flocks used more than 1,000 doses per 1,000 chicken days. For
the “mg/kg sold” metric calculation, 9/203 (4.4%) flocks were
excluded, since they experienced 100% mortality and therefore
no live chickens were sold from such flocks.
Tetracyclines were the most used antimicrobial class reflected
in both metrics: 285.1 mg/kg at treatment (SEM ±23.4) and
a TI of 150.9 (±9.3) per 1,000 days. In terms of mg/kg
at treatment, the highest magnitude of AMU corresponded
to oxytetracycline 231.5mg (29.2%), methenamine 105.8mg
(13.2%), and amoxicillin 48.7mg (6.2%); in contrast, the highest
TI corresponded to colistin 145.5, oxytetracycline 141.8, and
enrofloxacin 16.1 (Table 4).
Correlation Between Antimicrobial Use
Metrics
Figure 4 shows the three correlation plots between each pair of
the three AMU metrics used. Correlation was highest between
“mg/kg sold” and “mg/kg at treatment” (PCC = 0.457; p <
0.001) (moderate positive relationship). The metric “mg/kg at
treatment” was weakly correlated with “treatment incidence”
(PCC = 0.212; p < 0.001). There was no correlation between TI
andmg/kg sold metric (PCC= 0.008; p= 0.223). The proportion
of flocks with high mortality (≥14.1%) was significantly greater
among flocks with higher than average AMU expressed with
the mg/kg sold metric (0.64 vs. 0.34, χ2 = 15.52; p < 0.001).
In the case of the other two metrics, there were no significant
differences in mortality between high and low AMU users
(both p > 0.407).
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FIGURE 2 | Distribution of the timing of use of the 20 most common antimicrobial active ingredients (AAIs) by week among study flocks.
Vietnamese Animal Daily Dose for Chicken
Production
The mean ADDvetVN corresponding to each of 37 AAIs was
calculated from 223 different veterinary medicine products
(Supplementary Material S3). ADDvetVN values ranged from
4.4mg (sulfamethazine) to 320.6mg (methenamine). However,
most of the values were lower than 50mg (35/38 AAI). A very
high coefficient of variation (>100%) was also observed in several
AAIs such as colistin, gentamicin, doxycycline, trimethoprim,
tylosin, neomycin, spectinomycin, sulfadimidine, and florfenicol.
There were 27 AAIs with data on DDDvet for poultry available in
the European Union (EU). Of those, 14/27 antimicrobials from
Vietnamese products had lower ADDs, while 13/27 had higher
ADDs. Notably, the values of several DDDvet from the EU (i.e.,
spectinomycin, tylosin, ampicillin, and spiramycin) were four to
five times higher than ADDvetVN.
Antimicrobial Use by Antimicrobial Active
Ingredients
Figure 5 shows the correlation between TI and weight-
based metrics (mg/kg at treatment and total weight
of antimicrobials ignoring population treated) by AAI
(Supplementary Material S3). The two metrics were moderately
correlated (PPC > >0.480, p < 0.001 in both cases). However,
the greater deviation from perfect correlation was observed
for those AAIs with very low (i.e., colistin) or very high (i.e.,
methenamine) ADDvetVN values (5.2 and 320.6 mg/kg chicken,
respectively). Comparing antimicrobials with similar TI, such
as methenamine and spectinomycin (i.e., both ∼1 ADD per
1,000 chicken-days), given that the former has a much higher
ADDvetVN value (320.6 mg/kg) than the latter (33 mg/kg),
this results in quantitatively larger estimates for methenamine
in terms of “total amounts (grams) of active ingredient”
(Figure 5, right).
DISCUSSION
Our study deliberately focused on small-scale commercial
farming systems. In doing so, we excluded both larger industrial
(broiler) and backyard production systems. The small-scale
commercial chicken sector represented here, alongside industrial
broiler production, is increasingly important in Vietnam: from
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FIGURE 3 | Distribution of quantitative metrics of AMU in study flocks. Dotted black line: median. Solid red line: mean.
2011 to 2016 the number of registered units raising more than
100 chickens has experienced a 41.5% increase (23).
Using three different metrics, this study provided an accurate
characterization of AMU in small-scale chicken flocks in the
Mekong Delta of Vietnam, an area regarded as a hotspot of AMU.
AMU levels were 791.8 (SEM ±16.7) mg of AAI per kilogram
at treatment and 323.4 (SEM ±11.3) mg per kilogram sold. In
terms of TI, chicken flocks were treated on average 382.6 days
(SEM±5.5) per 1,000 days. These results excluded antimicrobials
included in purchased commercial feed formulations and a
few antimicrobial products that were administered through the
injectable route or human medicine antimicrobials products.
In Vietnam, antimicrobials included in commercial feed have
been quantified to be in the order of 77.4mg per kilogram
of live chicken raised in a previous study. In terms of TI,
chickens in our study consumed three times more than global
average levels (estimated in 138.0 doses per 1,000 chicken-
days) (10).
It is particularly concerning that around three quarters
(76.2%) of the products examined contained AAIs of “critical
importance,” and over half (55.9%) contained at least one AAI of
critical importance (highest priority) according to theWHO (i.e.,
colistin, quinolones, and macrolides). The magnitude of colistin
use is of particular concern, since this is one of the antimicrobials
of last resort for hospital-acquired infections in humans (24).
Colistin was found either alone or in combination with other
antimicrobials such as oxytetracycline, ampicillin, neomycin,
tylosin, enrofloxacin, etc. A possible reason for its popularity is
its low cost, since it is an older-generation antimicrobial. Most
(∼60%) antimicrobial-containing products were formulated with
two AAIs. This scenario is different from European countries,
where one active ingredient is allowed, except for a few drugs
that are always formulated as combination (i.e., trimethoprim
and sulphonamides) (21). In a small percentage of flocks (4%), we
found that farmers had used chloramphenicol, an antimicrobial
that has been banned for almost two decades in the country
(25). In 2% of farms, ciprofloxacin (also banned for use in
animal production) had also been used.We found a large number
of farms that administered more doses than those technically
necessary over the life of the flock. We believe that this is
a reflection of errors in the preparation resulting in excessive
concentration of the AAI during the early phases, since the costs
of administering antimicrobials in small birds is relatively lower.
Results from this study highlight significant discrepancies
between metrics. Relating AMU to chicken weight at treatment
results in estimates of a magnitude two to three times higher than
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TABLE 4 | Amounts of AAIs used through the oral route in study flocks.
Mean AMU by flock (±SEM)
Antimicrobial class AAI mg/kg at treatment mg/kg sold Treatment
incidence
Aminoglycosides Neomycin 38.0 (±16.4) 14.7 (±5.9) 4.4 (±1.1)
Gentamicin 12.5 (±3.2) 6.3 (±3.5) 2.1 (±0.4)
Streptomycin 22.5 (±10.5) 14.3 (±16) 6.0 (±1.3)
Spectinomycin 2.2 (±3) 0.6 (±0.7) 1.0 (±1.0)
Apramycin 0.5 (±1.1) 1.2 (±7.2) <0.1 (±nc)
Josamycin 0.9 (±3.2) 7.5 (±68) <0.1 (±nc)
Total aminoglycosides 75.7 (±5.9) 37.5 (±24.2) 13.5 (±2.7)
Amphenicols Florfenicol 7.3 (±3.7) 9.4 (±12.1) 1.9 (±0.8)
Thiamphenicol 26.2 (±12.5) 4.4 (±3.7) 3.1 (±0.6)
Chloramphenicol nc nc nc
Total amphenicols 33.5 (±6.6) 13.8 (±1.2) 5.0 (±1.6)
1st and 2nd gen. cephalosporins Cefadroxil 0.5 (±nc) <0.1 (±nc) <0.1 (±nc)
Cefotaxime nc nc nc
Cefalexin <0.1 (±nc) <0.1 (±nc) <0.1 (±nc)
Total 0.5 (±nc) <0.1 (±nc) <0.1 (±nc)
Diaminopyrimidines Trimethoprim 25.7 (±nc) 11.7 (±nc) 4.3 (±nc)
Lincosamides Lincomycin 3.2 (±nc) 2.3 (±nc) 1.4 (±nc)
Macrolides Tylosin 34.8 (±8.5) 27.7 (±17.3) 6.5 (±1.2)
Tilmicosin 25.9 (±19.2) 20.9 (±25.4) 7.8 (±4.6)
Erythromycin 12.2 (±16.1) 5.7 (±12.3) 3.8 (±2.9)
Spiramycin 1.5 (±1.4) 0.2 (±0.5) 1.1 (±0.5)
Kitasamycin <0.1 (±nc) 0.4 (±nc) <0.1 (±nc)
Josamycin 0.9 (±3.2) 7.5 (±68) < 0.1 (±nc)
Total 75.3 (±7.9) 62.0 (±10.4) 19.2 (±7.5)
Penicillins Amoxicillin 48.7 (±24.7) 25.8 (±28.7) 14.4 (±3.4)
Ampicillin 11.1 (±6.1) 5.5 (±4) 1.5 (±0.8)
Total 59.8 (±13.2) 31.3 (±17.5) 15.9 (±7.5)
Pleuromutilins Tiamulin <0.1 (±nc) <0.1 (±nc) <0.1 (±nc)
Polypeptides Colistin 41.6 (±5.7) 8.8 (±1.6) 145.8 (±4.6)
Enramycin <0.1 (±nc) <0.1 (±nc) <0.1 (±nc)
Total 41.6 (±3.5) 8.8 (±0.9) 145.8 (±5.9)
Quinolones/Fluoroquinolones Enrofloxacin 24.1 (±8.4) 7.4 (±4.6) 16.1 (±2.6)
Flumequine 5.4 (±3.2) 3.4 (±2) 0.6 (±0.2)
Norfloxacin 6.4 (±6.5) 2.4 (±3.5) 1.1 (±0.8)
Ciprofloxacin nc nc nc
Marbofloxalin nc nc nc
Total 35.9 (±5.6) 13.2 (±4.8) 17.8 (±7.8)
Sulfonamides Sulphamethoxazole 30.2 (±1.2) 11.7 (±15.1) 3.6 (±0.6)
Sulfadimidine 4.1 (±4.8) 2.3 (±2.5) 0.1 (±nc)
Sulfadimethoxine 13.5 (±27.7) 2.4 (±2) 1.9 (±1.4)
Sulfaguanidin nc nc nc
Sulfadiazine 2.4 (±10) 0.7 (±4.8) 0.2 (±0.3)
Sulfamethoxypyridazine 0.5 (±2) 0.3 (±0.8) <0.1 (±nc)
Sulfachloropyridazine <0.1 (±nc) <0.1 (±nc) <0.1 (±nc)
Sulfamethazine 0.7 (±nc) <0.1 (±nc) 1.0 (±nc)
Sulfathiazole <0.1 (±nc) <0.1 (±nc) <0.1 (±nc)
Total 51.4 (±9.5) 17.4 (±5.1) 4.9 ±1.4)
(Continued)
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TABLE 4 | Continued
Mean AMU by flock (±SEM)
Antimicrobial class AAI mg/kg at treatment mg/kg sold Treatment
incidence
Tetracyclines Oxytetracycline 231.5 (±21.0) 43.7 (±9.8) 141.8 (±4.6)
Doxycycline 42.6 (±13.3) 14.0 (±3.4) 7.5 (±1.2)
Tetracycline 7.4 (±46.8) 7.9 (±52.5) 1.6 (±4.0)
Total 285.1 (±23.4) 65.6 (±27.9) 150.9 (±9.3)
Unclassified Methenamine 105.8 (±nc) 58.0 (±nc) 1.1 (±nc)
Total 791.8 (±16.7) 323.4 (±11.3) 382.6 (±5.5)
nc, not calculated.
FIGURE 4 | Correlation between three quantitative AMU metrics (“mg/kg at treatment,” “mg/kg sold,” and “treatment incidence”). Solid black lines represent the
median value of each metric. PCC is Pearsons’s correlation coefficient. Red dot: flock with high (≥14.1%) mortality; blue dot: flock with low (<14.4%) mortality. Note
the log 10-transformed scale for easier visualization.
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FIGURE 5 | Relationship between study metrics by AAI in study flocks. The size of the dot is proportional to the magnitude of the Vietnamese animal daily dose
(ADDvetVN) for each AAI (in mg). Note the log 10-transformed scale for easier visualization.
relating AMU to chicken weight at the end of the production
cycle. The “mg/kg at treatment” metric was largely influenced
by the timing of AMU, with higher values resulting from
administration of the product early in the production cycle (i.e.,
brooding), therefore resulting in larger estimates. The “mg/kg at
treatment” use is expected to always be higher than “mg/kg sold,”
since the weight at the end of production is typically the highest.
This latter metric was, however, largely affected by mortality,
with flocks experiencing high mortality having considerably
higher AMU estimates due to the smaller denominator in such
flocks. If national estimates of AMU were to be calculated from
production data, it is therefore essential to factor in the high
levels of mortality that are typical of each production system.
The “treatment incidence” metric is the most balanced overall
metric, since it incorporates the variability associated with the
variable strength of the AAIs administered. However, a challenge
associated with the latter is the definition of a “daily dose,” given
that most antimicrobial products included guidelines for both
prophylactic and therapeutic use, and information on the actual
preparation procedures used by the farmer (dilution factor) was
not collected. Indications for prophylactic use involve mixing the
product with approximately half the strength of indication for
therapeutic use. In addition, most products contain two AAIs,
and each AAI amounted to half a theoretical daily dose in the
overall calculation. The major discrepancies observed between
weight-based and dose-based metrics can be explained because
of differences in strength of different AAIs, timing of use, and
variable mortality. In situations where AAIs characterized by
large technical units are used, calculations using weight-based
metrics will result in the overestimation of results using weight-
based metrics over treatment incidence metrics.
We report differences in the timing of usage of different
antimicrobials. Some antimicrobials, such as tetracycline and
tilmicosin, have withdrawal times of over 1 week (26), and in
several cases were administered late in the production cycle.
This probably explains the high rate of detection of macrolide
and tetracycline residues (10.3% each) in chicken meat samples
purchased from the study area (27).
The study highlighted a huge diversity of AAIs used
by small-scale chicken farmers. In Vietnam, about 10,000
products are currently licensed for veterinary use (28, 29),
and ∼50% contain AAIs (author’s observation). We established
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the Vietnamese “animal daily dose” for antimicrobials used
in chicken production (ADDvetVN). Athough our calculations
of ADDvetVN were based on the indication displayed in the
label for therapeutic purpose, most values were still lower than
the DDDvet from the European Union, and for several AAIs
(i.e., spiramycin, ampicillin) they were four to five times lower.
In addition, many products included a recommendationa for
prophylactic use, where the product is diluted by a factor of
two, and the AAI is therefore administered at an even lower
concentration. This is a concern, since such low doses may
contribute to increased generation of AMR (30).
We are confident that farmers did provide an honest record
of all antimicrobial products used and that the data collected
in our study accurately represent AMU in these small-scale
farming systems. This was possible since project staff were
not perceived to judge farmers’ practices negatively. However,
obtaining longitudinal high-resolution data required several
visits during the production cycle, and a considerable degree of
both farmer and research staff commitment. Therefore, these
types of studies may not be feasible at a large (i.e., national
surveillance) scale, unless considerable resources are dedicated.
We understand that the small-scale sector is the target of the
largest quantities of AMU in Vietnam, and most of this use
is for prophylactic purposes (15). This category of farmers
should be the focus of policy makers to reduce excessive AMU
in animal production. In Vietnam, most antimicrobials used
in animal production are procured by farmers in licensed
veterinary pharmacies. Because of this, we believe that setting up
monitoring systems at these retail points, coupled with detailed
animal production statistics (to be collected at local level), would
represent a much more cost-effective surveillance system for
AMU compared with conducting farm surveys.
Results highlight the need for training chicken farmers
to improve their awareness on AMR while discouraging
prophylactic use of antimicrobials, particularly during
the brooding period. Such training should emphasize
the need to improve day-old chick quality and farming
practices (biosecurity, cleaning and disinfection, brooding
management, and vaccination). Furthermore, in view of
the high usage levels of AMU of critical importance (high
priority), we recommend authorities to introduce phased
restrictions, starting with those AAIs belonging to the highest
priority group.
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Abstract 
Antimicrobials are included in commercial animal feed rations in many low- and middle-income 
countries (LMICs). We measured antimicrobial use (AMU) in commercial feed products 
consumed by 338 small-scale chicken flocks in the Mekong Delta of Vietnam, before a gradual 
nationwide ban on prophylactic use of antimicrobials (including in commercial feeds) to be 
introduced over the coming five years. We reviewed the labels of commercial feeds and calculated 
amounts of antimicrobial active ingredients (AAIs) given to flocks. We framed these results in the 
context of overall AMU in chicken production, and highlighted those products that did not comply 
with Government regulations. Thirty-five of 99 (35.3%) different antimicrobial-containing feed 
products included at least one AAI. Eight different AAIs (avilamycin, bacitracin, chlortetracycline, 
colistin, enramycin, flavomycin, oxytetracycline, virginamycin) belonging to five classes were 
identified. Brooding feeds contained antimicrobials the most (51.2%), followed by grower (34.6%) 
and finisher feeds (12.5%). The average amount of AAIs given to flocks per kg of chicken at 
consumption time was 84.8 mg (SEM ±9.3mg). Quantitatively, chlortetracycline was consumed 
most (42.2mg/kg SEM ±0.34; 50.0% of total use), followed by enramycin (18.4 mg SEM ±0.03, 
21.8%) and bacitracin (16.4mg SEM ±0.20, 19.4%). Antimicrobials in commercial feeds were 
more commonly given to flocks in the earlier part of the production cycle. A total of 10 (9.3%) 
products were not compliant with existing Vietnamese regulation (06/2016/TT-BNNPTNT) either 
because they included a non-authorised AAI (4), had AAIs over the permitted limits (4), or both 
(2). We estimated that consumption of antimicrobials in feed represented ~10% of total AMU (in 
feed and in water) in our study farms. A number of commercial feed formulations examined 
included colistin (polymyxin E), a critically important antimicrobial of highest priority for human 
medicine. These results illustrate the challenges for effective implementation and enforcement of 
restrictions of antimicrobials in commercial feeds in LMICs. Results from this study should help 
encourage discussion about policies on medicated feeds in LMICs. 
Keywords: Antimicrobial Growth Promoters (AGPs), Commercial feeds, AGPs ban, Vietnam, 
small-scale, Chicken. 
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Introduction 
Antimicrobials are used in veterinary medicine. The global annual consumption of antimicrobials 
intended for animal use has been estimated in the region of 63 thousand tonnes [1]. In European 
Union (EU) countries, all of which have well-developed antimicrobial consumption surveillance 
systems, antimicrobials intended for animal use quantitatively represent approximately 2/3 of total 
AMU [2]. It is believed that excessive use of antimicrobials in animal production is one factor 
contributing to the global rise in antimicrobial resistance (AMR), although its magnitude is 
unknown [3, 4]. The total amounts of antimicrobials intended for animal production are expected 
to increase in coming years due to intensification of livestock production, mostly in low- and 
middle-income countries [1]. Antimicrobials are used in veterinary medicine to treat and prevent 
animal disease. In addition, in many countries they are also added to feed rations in sub-therapeutic 
concentrations in order to increase animal growth and productivity (antimicrobial growth 
promoters, AGPs). Their mechanism of action is however, poorly understood [5].  
Over the last years, the issue of AMR and excessive antimicrobial use (AMU) has attracted 
considerable attention worldwide. Many policy instruments on AMU/AMR have been recently 
developed by global organizations such as the World Health Organization (WHO) [6], the Food 
and Agriculture Organization of the United Nations (FAO) [7], and the World Organization for 
Animal Health (OIE) [8].  
Antimicrobials in feed (including AGPs) have been the subject of much debate over recent years. 
Those opposing banning/restrictions of AGPs often express concerns based on potential losses in 
productivity, as well as the likelihood of emergence of certain diseases (i.e. necrotic enteritis in 
chickens) [9]. Positions in favour of their restriction often align themselves with the need to protect 
the efficacy of antimicrobials for human health. In the European Union (EU), mostly because of 
public health pressure, AGPs were banned in 2006 [10]. In recent years, and in line with FAO 
recommendations [7], some countries have started implementing bans or restrictions on AGPs in 
animal feeds, In the USA, voluntary phasing out of certain AGPs commenced in 2013 [11]. In the 
Asia-Pacific region, countries such as Korea (2011), Australia (2013) [12] have implemented bans 
of AGPs in animal feeds. Countries such as Thailand (2015) [13], China (2016) [14] and India 
(2019, Ministry of Health) have also recently adopted policies that restrict AGPs in commercial 
feeds.  
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Worldwide annual consumption of poultry meat (2013-2015) stood at 110,280 tonnes, second only 
to pork (117,005 tonnes). By 2025, chicken production is expected to surpass that of pork 
production [15].  
In Vietnam, antimicrobials are often found in both commercial pig and poultry rations. A study 
estimated in-feed consumption of antimicrobials extrapolated from a retail survey of commercial 
feeds in 77mg of AGPs per kg of chicken produced [16]. A study of medium-sized chicken farms 
estimated that chickens consumed 57mg of AGPs per kg of animal produced [17]. However, that 
study was based on a small sample of 6 farms.  
A 2002 Vietnamese government regulation on animal feeds (54/2002/QĐ-BNN) included a ban 
on 18 chemicals (including chloramphenicol, metronidazole and nitrofurans). Further (2014), 
legislation (28/2014/TT-BNNPTNT) expanded this list to bacitracin, carbadox and olaquindox. In 
May 2016 Vietnam issued Circular 06/2016/TT-BNNPTNT, listing those antimicrobial active 
ingredients (AAIs) authorized for inclusion in commercial feed types as AGPs, as well as the 
maximum levels allowed in each feed type. According to this regulation, the maximum number of 
different AAIs to be included in each feed was limited to two. In 2018, Vietnam introduced its 
Animal Husbandry Law (32/2018/QH14) generically banning the use of AGPs in commercial 
feeds. A further Decree (13/2020/ND-CP) included the timeframe for a ban on AMU for 
prophylactic purposes (including AGPs), with phased bans for different antimicrobials classes: 
WHO ‘highest’ and ‘high priority’ critically important AAIs to be banned from 2021, highly 
important AAIs from 2022, important AAIs from 2023 and all other antimicrobial classes from of 
2026 [18].  
This study aimed at investigating the types and quantities of AAIs in commercial feed in a large 
representative cohort of small-scale chicken flocks in the Mekong Delta region of Vietnam 
immediately before the implementation of the new Decree. This information complements existing 
data on antimicrobials administered in water administered by the farmer [19], and provides the full 
picture on antimicrobial consumption in small-scale commercial chicken flocks in the area. This 
knowledge should form the basis of informed decisions aiming at reducing AMU in animal 
production in Vietnam.  
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Materials and Methods 
Farm selection 
Farm owners in two districts (Cao Lanh, Thap Muoi) within Dong Thap (Mekong Delta, Vietnam) 
were randomly selected from the official (Sub-Department of Animal Health) farm census and 
were contacted by the veterinary authorities. Farmers about to start raising flocks of ≥100 chickens 
using native breeds that practiced all-in/all-out management were recruited, and flocks were 
followed up longitudinally. A total of 115 farms were recruited (59 in Cao Lanh; 66 in Thap Muoi). 
This study was performed in the context of a large field based trial aimed at reducing AMU in 
chicken production through the provision of veterinary advice [20]. Owners of selected farms were 
requested to record in detail the types of commercial feed used and to keep the sacs of all feed 
products used. A field study team visited farms four times over the production cycle to collect data 
on commercial feed products used by week. A total of 338 flocks raised in these farms were 
investigated. Of the 115 farms, 44 completed 1 cycle (38.3.4%), 25 (21.7%) 2 cycles, 8 (7.0%) 3 
cycles, 11 (9.6%) 4 cycles, 12 (10.4%) 5 cycles, and 15 (13.0%) more than 5 cycles. The median 
flock size at restocking was 303 [IQR 200-500]. A total of 6,041 weeks of data were collected. 
The median duration of these native meat chicken production cycles was 19 [IQR 17-21] weeks. 
All farm visits were conducted from October 2016 to Oct 2019. 
AAIs in commercial feed products 
All commercial feed products containing an antimicrobial active ingredient (AAI) were singled 
out after reviewing their label. AAIs were described by: (1) target species (duck, chicken or pig); 
(2) indication by stage of production (brooder, grower or finisher); and (3) type of formulation 
(crumbs, mash or pellets). From each feed product, we described the AAIs contained and their 
concentration (expressed in mg/kg product). AAIs were classified based on the OIE list of 
antimicrobial agents [21] and any antimicrobials regarded as critically important by WHO [22] 
were highlighted. We excluded ionophore coccidiostats (aimed at controlling coccidial infections) 
since it is thought that these substances do not have a link with resistance against antimicrobials 
commonly used to treat human or animal bacterial disease. We identified those feed products 
containing antimicrobials at concentrations not permitted under Vietnamese legislation [23]. 
Data analyses 
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We calculated AMU consumption in feed by week by relating the amounts of AAI (mg) to the 
weight of birds at the time of consumption (standard weight of the flock) (kg) (mg/kg live 
chicken) for all weeks (n) over the flock’s life duration (Expression 1).  
mg/kg chicken at time of consumption = ∑
𝐴𝐴𝐼 𝑢𝑠𝑒𝑑 (𝑚𝑔) 𝑖𝑛 𝑤𝑒𝑒𝑘 𝑘
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑙𝑜𝑐𝑘 (𝑘𝑔) 𝑎𝑡 𝑤𝑒𝑒𝑘 𝑘
𝑛
𝑘=1  
Weekly consumption of AAIs in feed was calculated by multiplying weekly feed consumption by 
the AAIs concentration indicated in that feed. The feed consumption was estimated from 
unpublished data related to native Vietnamese layer pullets, where 443g of feed were consumed 
by 1 kg of live chicken per week. The denominator (total weight of the flock at week k) was 
calculated from the number of chickens present in the flock multiplied by an estimated (standard) 
weight. The latter was based on weekly weight data from 10 randomly selected chickens from 11 
representative flocks, collected from week 1 until week 22 of their production cycle [19].  
The concentration (strength) of AAI in each feed product was obtained from its label. However, 
information for a number of feed products contained uncertain information in their labels, 
concerning the identity of the AAI and the amounts included. For feed products with AAI content 
ambiguously labeled (i.e. indicating inclusion of one of >1 listed AAIs), the amount of each AAIs 
was calculated by assigning each antimicrobial a probability corresponding being included 
(probability=1), and not being included (probability=0). For products indicating their AAIs 
concentration as a range, lowest and highest estimates were calculated for each antimicrobial. The 
amounts of each AAIs were summarized in each flock by AAI and by week. The total amounts of 
each AAI were aggregated to calculate total consumption by flock, including the estimation of a 
lower and upper limit from the above calculations.  
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Results 
Description of commercial feed products 
A total of 99 different commercial feed products were identified. Those products were intended 
for chicken (85 products, 85.9%), pig (12, 12.1%), and duck (2, 2.0%) feeding. Feed products 
intended for chickens were classified according to their indication (production stage): 38 for 
brooding, 22 for growing (i.e mid-production) and 25 for finishing. A total of 35 (35.3%) (all 
intended for chicken use) contained at least one antimicrobial. A total of 25 (65.8%), 9 (40.9%) 
and 5 (20%) commercial feeds intendend for brooding, growing and finishing, respectively, 
contained antimicrobials. Detailed information on all antimicrobial-containing feed products is 
available in S1 Table. All except one product (a brooder feed that contained both chlortetracycline 
and colistin) contained one AAI. A total of 12 (34%) products had an ambiguous label, indicating 
containing one of 2-4 listed AAIs. A total of 8 different AAIs belonging to 5 classes were listed in 
the 35 feed products. The most common AAIs listed were enramycin (18.8% feeds), followed by 
bacitracin (16.5% chicken feeds), chlortetracycline (15.3%), avilamycin (5.9%), flavomycin 
(4.6%), colistin (3.7%), virginamycin (2.4%), and oxytetracycline (1.2%) (Table 1). A total of 10 
(9.3%) products were not compliant with Regulation 06/2016/TT-BNNPTNT, either because they 
included a non-authorised AAI (avilamycin, flavomycin, oxytetracycline) (n=4), AAI/s over the 
permitted limits (n=4), or for both reasons (n=2). 
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Table 1. Antimicrobial active ingredients (AAIs) and their concentrations in 85 chicken feed products given to flocks in Dong Thap 





AAI mean concentration  





Brooder Grower Finisher 
Enramycin Polypeptides 16 (18.8) [7.7-10] (7) [8.2-10.0] (5) [11.6-11.6 ] (4) [1-10] 
Bacitracin Polypeptides 14 (16.5) [51.1-63.1] (8) [125.0] (1)   [50-60] (5) [4-50] 
Chlortetracycline Tetracyclines 13 (15.3) [52.7-61.1] (9) [40.0-50.0] (4) - [10-50] 
Avilamycin Orthosomycin 5 (5.9) [12.5] (2) ⸶⸶ [15.0] (1)  [10.0] (2) ⸶⸶ NAA 
Flavomycin Other⸶ 5 (5.9) [6.0] (2) ⸶⸶ [2.0] (1)  [10.0] (2) ⸶⸶ NAA 
Colistin* Polipeptides 4 (4.7) [70-136.6] (3)  - [60.0-160.0] (1) [2-20] 
Virginamycin Streptogramin A 2 (2.4) [5.0-15.0] (1) - [5.0] (1) ⸶⸶ [5-15] 
Oxytetracycline Tetracyclines 1 (1.2) [50.0] (1) - - NA 
*Critically important antimicrobial class according to WHO. **AAIs permitted in chicken feeds from 1 to 28 day old birds (brooder and grower feeds) 
[24]. NAA = Not allowed antimicrobial. ⸶Antibiotic complex obtained from Streptomyces bambergiensis and Streptomyces ghanaensis. ⸶⸶All feed 
products with this AAI had the same strength. 
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AMU through commercial feed intake 
All flocks were fed on commercial chicken feed. In addition, pig and duck feeds were given to 
12.1% and 0.6% flocks, respectively. Each flock had been given a median of 2 [Inter-quartile range 
(IQR) 2-3] different commercial feed products. Flocks received a median of 1 [IQR 1-1] 
antimicrobial-containing products. Chickens were fed a mean of 84.8 (Standard Error of the mean 
(SEM) ±9.3mg/kg) [range 71.4-98.2] of AAI/kg over their production cycle. Chickens raised in 
Thap Muoi and Cao Lanh districts were given 87.7 (Standard Error of the mean, SEM ±14.8) 
mg/kg [range 76.1-99.3] and 81.7 (SEM ±11.0) mg/kg [range 66.3-97.1], respectively. Overall, 
the highest amounts of AMU corresponded to chlortetracycline (42.2mg, SEM ±0.34), followed 
by enramycin (18.4mg, SEM ±0.03) and bacitracin (16.4mg SEM ±0.20) (Table 2). 
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Prevalence of AMU by week 
(mean ± SEM)  
[lowest-highest] 
Total AMU over the production cycle 
mg/kg chicken 
(mean ± SEM) [lowest-highest] (%) 
Enramycin 152 (45.4) 0.319 (± 0.004) [0.306-0.333] 18.4 (± 0.032) [17.3-19.5] (21.8) 
Chlortetracycline 73 (22.5) 0.134 (± 0.002) [0.134-0.135 42.2 (± 0.347) [40.6-43.9] (50.0) 
Bacitracin 103 (30.5) 0.095 (± 0.014) [0.080-0.111] 16.4 (± 0.201) [10.5-22.3] (19.4) 
Virginamycin 8 (2.9) 0.010 (± 0.032) [0.005-0.014] 0.5 (± 0.177) [0.1-0.8] (0.6) 
Colistin* 7 (2.0) 0.005 (± 0.037) [0.003-0.008] 6.4 (± 4.217) [2.6-10.3] (7.6) 
Avilamycin 8 (2.3) 0.005 (± NC) [0.0-0.010] 0.3 (± 0.088) [0.0-0.6] (0.4) 
Flavomycin 8 (2.3) 0.005 (± NC) [0.0-0.010] 0.2 (± 0.115) [0.0-0.4] (0.2) 
Oxytetracyline 4 (1.1) 0.0 (± NC) [0.0-0.001] 0.07 (± 0.731) [0.0-0.15] (0.1) 
Total 297 (87.8) 0.575 (± 0.028) [0.529-0.624]  84.8 (± 9.390) [71.4-98.2] (100) 
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Commercial feed rations were given to flocks over a total of 5,655 of 6,041 (93.6%) observation 
weeks. The probability of AMU in flocks decreased with the age of the flock (Fig 1a). On average, 
flocks were given AGPs in feed on 57.5% (SEM ±2.8%) weeks. Interestingly, a relatively high 
fraction of brooder products were used in later stages, while some finisher products were also used 
more in the growing period. Enramycin was used predominantly throughout the production cycle, 
while colistin was found only in later stages (Fig 1c).  
 
Fig 1: (a) Probability of consumption of AAIs in chicken feeds by week among study flocks; (b) 
Weekly distribution of types of feed (production stage) consumed by flocks; (c) Weekly 
distribution of AAIs consumed by flocks through commercial animal feeds.  
Discussion 
There are very few published data describing and quantifying consumption of AAIs in commercial 
feeds in poultry farming systems in LMICs [25]. Our findings complement existing data on 
antimicrobials administered (mainly through water) (~792 mg/kg) to Mekong Delta flocks [19]. 
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Consumption of in-feed antimicrobials therefore represents ~10% of total chicken AMU (~85 
mg/kg). This figure is consistent with previous estimates (77-95 mg/kg) [16, 17].  
This study is based on data from a large cohort study aiming at reducing AMU in chicken 
production in the Mekong Delta of Vietnam [20]; therefore we believe that results are 
representative of commercially chicken farming systems, since selection of farms was random. 
Even though our data came from an intervention study, our advice to farmers was focused on 
reducing prophylactic and therapeutic administration of antimicrobials in water, and did not 
include advice on feed. Furthermore, we did not find any difference in in-feed antimicrobial 
consumption between flocks allocated to the intervention compared with the baseline phase (data 
not shown).  
A major concern is the relatively high number of products that did not comply with Vietnamese 
regulations. Bacitracin, banned in feed rations in Vietnam since May 2016 [23], was the second 
most common AAI administered in feed. More worryingly, we found that 17% (6/35) 
antimicrobial-containing feeds included AAIs at concentrations higher than permitted by 
Vietnamese authorities. Notably, the strength of colistin was 3-5 times greater than permitted in 
all products examined, and non-authorised antimicrobials (avilamycin, flavomycin, 
oxytetracyline) were also found in some chicken feeds. This raises concerns regarding compliance 
of commercial feed mills with regulations, and casts doubts over the effective implementation of 
the phased bans [18]. An additional challenge is the ambiguous labelling of their AAI content in 
about a third of the rations investigated. 
Recent studies have reported a high prevalence of colistin resistance encoded by mcr-1 in chicken 
flocks in the area [17]. This antimicrobial, classified as highly critically important by WHO [26], 
was listed in 5% of feeds examined (brooder feeds) and we estimated that, on average, flocks 
consumed 5mg/kg of this antimicrobial (about 3% of total in-feed AMU). This is a modest amount 
compared with the reported magnitude of AMU through water administration (42 mg/kg). 
However, it is of concern that in our study farms these feeds were predominantly administerd 
towards the end of the production cycle, which may pose a risk of accumulation of antimicrobial 
residues in poultry meat [27]. It is of concern that only 16/35 (45.7%) AGP-containing feeds 
examined did not mention withdrawal times (data not shown). A recent survey showed that 8.4% 
of chicken meat samples in Vietnam contained antimicrobials residues, tetracyclines being the 
most common residue detected [28]. 
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Quantitatively, in our study chlortetracycline, bacitracin and enramycin were the AAIs most 
consumed through commercial feeds. These results are not dissimilar to previous extrapolations 
from a retail survey in Vietnam [16]. Tetracyclines are also the most consumed antimicrobials 
consumed by flocks through water [19], and the antimicrobial class against which resistance 
among Escherichia coli and non-typhoidal Salmonella strains in the Mekong Delta is highest [17, 
29, 30]. Bacitracin use has been shown to promote resistance among Clostridium perfringens 
isolates from chickens [31, 32]. With regards to enramycin, there is little information on its impact 
on AMR. A Japanese study that investigated Enterococcus faecium isolates from chicken flocks 
found no evidence of resistance against enramycin , although the study presented no enramycin 
use data [33]. 
Much of the debate on AMU in animals has often been framed in terms of bans on AGPs. 
Unfortunately, global data on total amounts of AGPs consumed or on the contribution of AGPs on 
total AMUare lacking. In Great Britain, in 2001 (5 years before the 2006 EU ban), AGPs 
represented 11.6% of 371 tonnes of antimicrobial active ingredients used in animal production 
[34]. We believe that AGPs represent a considerable fraction of total AMU globally, and probably 
these quantities have been decreasing over recent years, since more and more countries have 
phased out their use. A recent OIE survey reports that AGPs were used in 23% countries surveyed 
in 2018, compared with 51% countries in 2012 [35]. A review of the data of the impact of AGP 
from 1950 to 2010 on farm productivity indicate that productivity gains due to AGP in feeds 
decreased over the years [36], suggesting that any potential positive effects are of greater 
magnitude in low-biosecurity production systems. Indeed, recent studies in industrial (short cycle) 
broiler production systems showed that AGPs did not overall improve flock bodyweigth [37, 38], 
with one study resulting in a slight significant reduction over the whole cycle [38]. In the non-
industrial production systems investigated here, antimicrobials in commercial feeds represented a 
relatively small fraction of total AMU. It is conceivable that even if AGPs may have lead to 
marginal productivity gains, these are likely to have been offset by the high mortality rates due to 
pathogen circulation common in the area [39].  
Even though this study provides accurate quantification on consumption of AGPs in native chicken 
production in the country, more data are needed in order to accurately quantify levels of AGPs 
(and total AMU) in pig production, which by far for the most commonly consumed type of meat 
in Vietnam . Data from a survey in Vietnam suggest that in-feed antimicrobial consumpton in pig 
compared is of greater magnitude than in chicken production [16]. Similar to Vietnam, the use of 
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medicated feed in pig production in Thailand is common practice [40]. Because of a higher 
magnitude of use, the impact of reductions or bans on AGPs in the pig species is uncertain.  
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Conclusions 
Compared with antimicrobials administered through water, antimicrobials in feed represent a 
relatively small fraction (10%) of total AMU in Vietnamese chicken production. However, it is of 
great concern that some feed formulations examined included colistin (polymyxin E), a critically 
important antimicrobial of highest priority for human medicine. Furthermore, a considerable 
number of feed formulations did not comply with Government regulations with regards to their 
AAI content, strength and/or withdrawal times, suggesting that effective enforcing and monitoring 
of such restrictions in Vietnam may be challenging; this situation is likely to be common to many 
other LMICs. It is likely that the types and quantities of antimicrobials in feeds vary by country 
and production system, therefore more data are needed to support targeted policy initiatives..  
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Impact 
 This study uses a large volume of observational data on disease and antimicrobial usage in 
small-scale chicken farms of the Mekong Delta region of Vietnam in order to quantify the 
prophylactic and therapeutic effects of antibiotics from 13 different classes on diarrhoea, 
respiratory infections, legs lesions and central nervous system infections. 
 We show that prophylactic antimicrobial use never reduced the risk of diseases and that 
some classes actually increased the risk of some diseases (e.g. diarrhoea). 
 In small-scale flock settings, the therapeutic use of antimicrobials leads to an increased in 
mortality in about 50% of the investigated antimicrobial/disease combinations.  
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Summary 
Antimicrobials are extensively used both prophylactically and therapeutically in poultry 
production. Despite this, there are little data on the effect of antimicrobial use (AMU) on disease 
incidence rate and percent mortality. We investigated the relationships between AMU and disease 
and between AMU and mortality using data from a large (n=322 flocks) cohort of small-scale 
chicken flocks in the Mekong Delta, Vietnam, that were followed longitudinally from day-old to 
slaughter (5,566 observation weeks). We developed a parameterized algorithm to emulate a 
randomized control trial from observational data by categorizing the observation weeks into ‘non-
AMU’, ‘prophylactic AMU’ and ‘therapeutic AMU’. To evaluate the prophylactic AMU effect, 
we compared the frequencies of clinical signs in ‘non-AMU’ and ‘prophylactic AMU’ periods. To 
analyse therapeutic AMU, we compared weekly percent mortality between the weeks of disease 
episodes before and after AMU. Analyses were stratified by clinical signs (4) and antimicrobial 
classes (13). Prophylactic AMU never reduced the probability of disease, some antimicrobial 
classes such as lincosamides, amphenicols and penicillins increased the risk. The risk of diarrhoea 
consistently increased with prophylactic AMU. Therapeutic AMU often had an effect on mortality 
but the pattern was inconsistent across the combinations of antimicrobial classes and clinical signs 
with 14/29 decreasing and 11/29 increasing the percent weekly mortality. Lincosamides, 
methenamines and cephalosporins were the only three antimicrobial classes that always decreased 
the mortality when used therapeutically. Results were robust respective to the parameters values 
of the weeks categorization algorithm. This information should help support policy efforts and 
interventions aiming at reducing AMU in animal production.  
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Introduction 
Antimicrobials play a critical role in the maintenance of animal health, animal welfare, and food-
safety (FAO, 2016), and are used worldwide in food-producing animals for the prevention and 
treatment of infectious diseases. In addition, in some countries, antimicrobials are also added to 
commercial feed rations as growth promoters (Landers et al., 2012). Consumption of 
antimicrobials in animal production has been predicted to increase by two thirds from 2010 to 
2030, of which one third is likely to include antimicrobial usage (AMU) for disease prevention 
and growth promotion purposes (or sub-therapeutic doses), especially in pig and poultry 
production (Van Boeckel et al., 2015). 
In veterinary medicine, non-therapeutic administration of antimicrobials to individual animals is 
common in companion, bovine and equine medicine to prevent surgical site infections (Duclos et 
al., 2017; Dumas et al., 2016). In food animals, antimicrobials are often used to prevent bacterial 
infections (prophylactically) and also after potential exposure to a pathogen to reduce clinical signs 
and/or mortality (metaphylactically) (Pagel & Gautier, 2012; Rerat et al., 2012). Regardless of its 
purpose, in our study farms antimicrobials are typically administered to whole flocks via drinking 
water, making it difficult to distinguish therapeutic from metaphylactic use at flock level and both 
are generally indistinctly called therapeutic. Thus, in the rest of this article we define prophylactic 
or therapeutic use in relation to the use of antimicrobials before or after the onset of disease (i.e. 
clinical signs). Prophylactic AMU in poultry flocks often takes place during the brooding period 
and during other key events of the flocks’ life such as vaccination and prior to transport. In a recent 
study of 203 small-scale commercial flocks (of 102 farms) in the Mekong Delta region of Vietnam, 
antimicrobials were extensively used and the highest frequency of AMU corresponded to the 
brooding period.  
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The practice of prophylactic medication of flocks/herds is likely to promote a shift in enteric 
bacterial populations from susceptible towards resistance. This is likely to have potential public 
health implications (Lugsomya et al., 2018).  
There are limited data on the identity of pathogens circulating in the area. A study identified a 
range of global pathogens in diseased flocks in study area, the most common being, in descending 
order, Avibacterium paragallinarum (62.3% flocks), followed by Mycoplasma gallisepticum 
(26.2%), Infectious Bursal Disease (24.6%) and Infectious Bronchitis (21.3%). However, the 
diagnostic panel was limited to 9 pathogens and it is likely that many more pathogens are 
circulating in the area, and the pathogens are likely to change over time. In 47.5% of disease 
episodes more than one aetiological cause was found (BichVan et al., 2019). However, the exact 
reason for AMU (i.e. prophylactic versus therapeutic) in flocks remains unclear (Carrique‐Mas et 
al., 2015; Cuong et al., 2019). Despite extensive use of antimicrobials in poultry production, there 
are little empirical data on the overall effects of prophylactic and therapeutic AMU on flock health. 
A recent study in Dutch layer chicks indicated that early mass prophylactic antibiotic treatment 
had a negative impact on adaptive immunity later in life (Simon et al., 2016). 
Here we analysed observational data on AMU and disease (clinical signs) collected from a large 
cohort of small-scale chicken commercial flocks in the Mekong Delta of Vietnam (Cuong et al., 
2019). We aimed to estimate: (i) the effect of prophylactic AMU on the subsequent probability of 
occurrence of a disease episode, and (ii) the impact of therapeutic AMU on subsequent mortality 
rate during a disease episode. In order to make causal inference from observational data we develop 
a parameterized algorithm that emulates a randomized control trial from these observational data, 
as recently proposed by Glass et al. (2013). We also explore the robustness of our results respective 
to the exact values of the parameters of our algorithm. The analyses were stratified by classes of 
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antimicrobial active ingredient (AAI) and type of clinical sign. These results provide a scientific 
basis that underpins policies aimed at reducing prophylactic AMU in farming systems. 
Material and Methods 
Data collection 
Data on AMU, disease (clinical signs) and mortality from a random selection of commercial small-
scale native chicken flocks raised for meat in Dong Thap province (Mekong Delta of Vietnam) 
were used. Farmers listed in the official census were initially contacted and invited to join the 
study. The data collection methods have been described elsewhere (Cuong et al., 2019). In brief, 
farmers were provided with a structured diary and were trained by project veterinarians to identify 
and record the most common clinical signs of disease, as well as to weekly record information on 
AMU and number of dead animals. The clinical signs recorded were: (i) respiratory distress 
(sneezing, coughing, nasal/ocular discharge, difficult breathing), (ii) diarrhoea (watery faeces), 
(iii) alterations of the central nervous system (CNS) (ataxia, circling, torticollis), and (iv) leg 
lesions (lameness, swollen joints/foot pads). Antimicrobial active ingredients (AAIs) were 
grouped by antimicrobial classes based on World Organization for Animal Health (OIE) criteria 
(OIE, 2015). A total of 5,566 weeks of data were collected from 322 flock cycles raised in 116 
farms. The data were collected from October 2016 until May 2019. This is an observational study 
and thus did not require Institutional Review Board approval.  
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Analyses 
The main challenge of the analysis consists in emulating a randomized controlled trial from our 
observational data. Below we explain in detail how this is performed. 
The statistical unit in this study is a week of observation. The main challenge of the analyses is 
that antimicrobials were administered without mentioning the purpose of use (prophylactic or 
therapeutic). We thus had to use the information on the timing of presence of disease and AMU in 
order to categorize each week of the dataset into 3 categories: ‘non-AMU’ (used as control), 
‘prophylactic AMU’ and ‘therapeutic AMU’. Note that not all weeks could be assigned to one of 
these three categories as explained in the paragraph below that describes in detail the categorization 
algorithm. 
For the prophylactic AMU analysis, we considered only weeks (i) without clinical signs reported 
during that week, as well as during the y preceding weeks, and (ii) without any antimicrobials 
being used during the z preceding weeks (filtering, step 0 on Figure 1). These selected weeks were 
then labelled as ‘with AMU’ or ‘without AMU’, depending on whether they had or not had AMU 
(exposure, step 1 on Figure 1) and, for each of these weeks, we computed the occurrence of clinical 
signs during the x subsequent weeks of observation (outcome, step 2 on Figure 1). The analyses 
were additionally adjusted for 3 covariables in order to control for potential confounders: (i) AMU 
during the first a weeks of the flock (brooding period), (ii) AMU during the x weeks of the 
observation period, and (iii) flock age (all in orange on Figure 1). Comparisons were performed 
by building a logistic generalized additive model with the probability of a disease episode as the 
dependent variable and in which the potential non-linear effect of age was modelled using a spline-
based smoothing function, the optimal degree of which was obtained by cross-validation as 
implemented by the mgcv R package (Wood, 2017). 
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For the analysis of therapeutic AMU (i.e. therapeutic and metaphylactic combined), the statistical 
units were the weeks of an episode of disease, defined as a series of consecutive weeks with clinical 
signs recorded in a flock. Because clinical signs are likely to be under-reported, we allowed for 
the possibility of presence of weeks without any disease reporting in the middle of disease 
episodes. Figure 2 shows three examples of definition of disease episodes allowing gaps of 0, 1, 
and 2 consecutive weeks without any disease report. The weeks of disease episodes were then 
grouped into two arms (exposure): one with all the weeks (in blue on Figure 3) before the onset of 
AMU (if any, in red on Figure 3) in the disease episode, and the other one with all the weeks (in 
green on Figure 3) following onset of AMU (if any, in red on Figure 3). In case of absence of 
AMU during the disease episode, all the weeks were assigned to the first arm. In order to ensure 
that AMU can be considered as therapeutic, we excluded from the analysis all the weeks where 
other antimicrobials were used during the p weeks that preceded. The percent weekly mortality 
(proportion of chickens dying each week) were computed for the two arms and were compared 
using a logistic generalized additive model that included the spline-based smoothed age of the 
flock as a covariable as described above for the characterization of the prophylactic effect of AMU. 
The two analyses included a number of tuning parameters. For the prophylactic AMU analysis, 
these were: x, the duration (in weeks) of the observation period; y and z, the numbers of weeks 
filtering for previous presence of clinical signs and AMU respectively; and a, the duration of the 
first few weeks of the flock during which we look for potential AMU. For the therapeutic analysis, 
we set a gap g (in weeks) to define disease episodes and p, the number of weeks filtering for 
previous AMU. Furthermore, in both analyses, disease is defined by the presence of at least one 
of a set of clinical signs, and AMU is defined by the use of at least one of a set of antimicrobials. 
In absence of information on what the values of these tuning parameters should be, we considered 
various combinations of them in order to assess the robustness of our results. For the prophylactic 
AMU analysis, we considered all the combinations (n = 27) of x = 1, 2, 3, y = z = 1, 2, 3, and a = 
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1, 2, 3. For the therapeutic analysis, we considered all the combinations (n = 9) of g = 0, 1, 2 and 
p = 1, 2, 3. We performed the analyses separately for each antimicrobial class (n = 13) and type of 
clinical sign (n = 4), as well for any AMU and any clinical signs. 
Results 
Data on AMU and clinical signs 
Antimicrobials were administered to a total of 296/322 (91.9%) flocks and on 1,266/5,566 (22.7%) 
observation weeks. A total of 44 different AAIs corresponding to 13 antimicrobial classes were 
used, with tetracyclines, polypeptides, aminoglycosides, macrolides and penicillins being the most 
commonly used classes (both by flock and by week, table 1). In addition, clinical signs were 
reported on 530/5,566 (9.5%) weeks, with diarrhoea on 305 (5.5%) weeks, respiratory on 213 
(3.8%) weeks, leg lesions on 71 (1.3%) weeks and CNS on 51 (0.9%) weeks. 
Data for prophylactic and therapeutic AMU analysis 
Depending on the values of the tuning parameters, 353-686 (27.9%-54.2%) of the 1,266 AMU 
weeks were classified as prophylactic AMU. The highest frequency of prophylactic AMU 
corresponded to tetracyclines, polypeptides, aminoglycosides and macrolides classes. A range of 
1564-3251 (36.4%-75.6%) of all the 5,566 weeks was classified as non-AMU. A range of 144-310 
disease episodes was identified. The highest frequencies of first week therapeutic AMU 
corresponded to tetracyclines, polypeptides, aminoglycosides and penicillins class. Ranges of 21-
164 and 1-153 weeks was classified as weeks ‘before’ and ‘after’ therapeutic AMU respectively. 
The details of the data used for each class of antimicrobial is presented in Table 1. 
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Impact of prophylactic AMU on disease occurrence 
Figure 4 shows the odds ratio (OR) of the effects of prophylactic AMU per antimicrobial class and 
clinical sign, and for all the combinations of the tuning parameters. None of prophylactic AMU 
ever protects (i.e. OR significantly below 1) from any of the clinical signs. On the contrary, in 10 
of the 52 antimicrobial class x clinical sign combinations, prophylactic AMU actually increases 
the probability of occurrence of disease. Only the CNS was never affected. The risk of diarrhoea 
increased with the prophylactic use of lincosamides, methenamines and penicillines. The risk of 
respiratory infections increased with the prophylactic use of lincosamides and amphenicols. The 
significances of these effects are higher for short observation periods and longer initial period of 
flocks. The duration of the filtering period has little effect of the significance of these results. 
Impact of therapeutic AMU on mortality 
Figure 5 shows the odds ratio of the effects of therapeutic AMU on percent weekly mortality, 
stratified by antimicrobial class and clinical sign, and for all the combinations of the tuning 
parameters. Therapeutic AMU almost always has an effect on the mortality rate. However, this 
effect varies both between and within antimicrobial classes and clinical signs combinations. Out 
of the 31 combinations for which we have data, only 2 do not show any significant results. Among 
the 29 other ones, 11 showed robust increase in mortality rate (respective to the exact values of the 
tuning parameters), 14 showed robust decrease in mortality rate, and 4 showed inconsistent results 
depending of the values of the tuning parameters. The effects of the tuning parameters on the 
significance of the results were not consistent from combination to combination of antimicrobial 
classes and clinical signs. Lincosamides and methenamines always decrease the mortality and this 
is fairly robust respective to the exact values of the tuning parameters. AMU in response to leg 
lesions always increases mortality. 
Page 106 of 342
Discussion 
Based on disease reporting data collected longitudinally from chicken flocks, our study suggests 
that prophylactic AMU does not protect against disease. Instead, we found that prophylactic AMU 
did increase the risk of disease in a number of situations. Specifically, we found that some of the 
antimicrobial classes administered prophylactically resulted in increased risk of subsequent 
diarrhoea (lincosamides, penicillins, methenamines, and tetracyclines classes) and respiratory 
infections (lincosamides, penicillins, amphenicols and macrolides). The association between AMU 
and diarrhoea has a biological basis, since microbial communities of the gastro-intestinal tract of 
chickens play an important role in nutrient digestion, pathogen inhibition and interact with the gut-
associated immune system (Borda-Molina et al., 2018). These results are also consistent with 
previous studies: oral administration of clindamycin (lincosamide class) in humans results in 
considerable alterations of the intestinal microbiota even long after discontinuation of the 
antimicrobial course (Jakobsson et al., 2010). A study on pigeons receiving this drug resulted in 
an increased risk of secondary yeast infection, resulting in diarrhoea and sour crop (Lenarduzzi et 
al., 2011). Similarly, the therapeutic use of methenamines, tetracyclines and broad-spectrum 
penicillins in humans have been shown to have enteric side effects (Chwa et al., 2019; Rafii et al., 
2008). 
Our analyses also show that the significance of the effect of prophylactic AMU on clinical signs 
tends to decrease as the duration of the observation period increases, suggesting that the effect of 
AMU may be of relative short term, typically 2 weeks. It is believed that antibiotic treatment may 
trigger dysbiosis, which may impact host systemic energy metabolism and cause phenotypic and 
health modifications (Le Roy et al., 2019). Furthermore, a study indicated that bacterial phylotypes 
shifted after 14 days of antibiotic treatment in pigs (Looft et al., 2012), and 7 days in humans 
(Jakobsson et al., 2010). 
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The significance of the effect of prophylactic AMU on clinical signs increased with the duration 
of the brooding period we considered. AMU during the first weeks of life has been reported to 
decrease the diversity of intestinal microbiota, which may have health consequences later in life 
(Kers et al., 2018). It is not clear whether antimicrobials reduce the immune response of chicken, 
although a study in broiler indicates that hematological values fell after the administration of 
antibiotics to young chicks (1-5 day old) (Al-Saad & A.A. Yones, 2014). 
Contrary to the effect of prophylactic AMU on disease occurrence, the effect of therapeutic AMU 
on mortality was almost always significant. However, the general picture was less clear-cut than 
for prophylactic effects as it varied greatly both within and between combinations of antimicrobial 
classes and clinical signs, as well as depending on the values of the tuning parameters. Therapeutic 
AMU always increases mortality for leg lesions. For the 3 other clinical signs, it depends on the 
antimicrobial class. Lincosamides and methenamines always decrease the mortality. The effects 
of the other antimicrobial classes depend on the clinical signs under consideration. Interestingly, 
lincosamides and methenamines are also two classes that confer the highest risk of subsequent 
disease when used prophylactically. These strong effects of prophylactic and therapeutic use of 
these two classes of antimicrobials suggest that their activity is more potent than other classes. In 
our study farms, these two classes had a comparatively low level of usage both in terms of 
frequency and amount (Cuong et al., 2019). We could speculate that these low levels of usage may 
have selected very little resistance in the microbiota of our study population, making these classes 
of antibiotics more potent than the others. Demonstrating this, however, is not easy given the vast 
range of potential pathogens and commensal organisms that may be present in flocks. 
In addition to bacterial infections, other possible causes of diarrhoea in poultry include coccidiosis, 
helminths, viruses (such as rotavirus and adenovirus). Antimicrobials will not treat these non-
bacterial pathogens but these products might help to prevent superinfections. Indeed, the pathogens 
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listed above tend to damage the chicken intestine which allows harmful bacteria to grow out of 
control in the intestine, leading to a secondary bacterial diarrhoea, increasing the disease severity 
and ultimately the risk of death. 
Leg problems may be caused by a range of aetiologies including bacterial, viral diseases as well 
as metabolic and nutritional disorders. The observed findings indicating that AMU results in an 
increase in leg disease is consistent the involvement of non-bacterial pathogens such as Marek 
virus (leg paresis) and reovirus (viral arthritis with severe lameness and swollen hock) or 
metabolic/nutritional disorders in the aetiology of these problems.  
For episodes of respiratory and CNS diseases, there was not a clear association between therapeutic 
AMU and mortality, suggesting that, in our setting, primarily non-bacterial pathogens may be 
responsible for respiratory and CNS infections (i.e. avian influenza, Newcastle, infectious 
bronchitis, infectious laryngotracheitis, fowlpox, etc.). In the case of respiratory diseases, complex 
bacterial-viral-vaccine interactions and common, and therefore AMU may not contribute to 
mitigate the mortality outcome. A recent study has demonstrated the diverse number of viral 
pathogens that typically affect chickens with respiratory disease in the area (BichVan et al., 2019; 
Choisy et al., 2019).  
The optimal study design to compare the effect of prophylactic AMU would be a randomized 
controlled trial. However, there are important reasons against  such experiment  (i.e. high cost, 
ethical consideration since it involves administering healthy animals with antimicrobial products 
at large scale). The advantage of the emulation approach is that if the emulation is successful, the 
analysis of the observational data yields the same effect estimates as the target randomized trial. 
Inability to control all of eligibility criteria as in a randomized may result in wrong causal 
inferences. In this study, all potential confounding variables have been add to the model, but stills 
others need to be considered (i.e. breed of chicken, farming condition etc.). With more than 5,500 
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observation weeks, this is the first study showed that prophylactic AMU did not reduce the risk of 
diseases. 
To our knowledge, this is the first epidemiological study addressing the impact of prophylactic 
and therapeutic AMU on the health status of chicken flocks from a low- and middle-income 
country. The approach we used to define prophylactic and therapeutic AMU (with a pre-selection 
of weeks) was possible because of the high volume of data collected on a weekly basis 
(>5,000weeks). A structural limitation of the data is that when both AMU and clinical signs were 
reported on the same week for the first time in a flock, it was not possible to determine which of 
the two events occurred first. Because of this, about 50% of the data were excluded, thus 
decreasing the statistical power of the study. In addition, in most cases, antimicrobial products 
included two or more AAIs, and disease episodes presented with a combination of different clinical 
signs. Given the large number of combinations possible, we restricted our analyses to examining 
the impact of AMU by class on individual clinical signs. Our study also excluded any 
antimicrobials present in feed as AGPs. This is the case for about 40% of the feed formulations 
examined. However, the concentrations (strength) of antimicrobials included in these feeds is 
much lower than the ones used prophylactically. The reason why we did not attempt to measure 
AGP consumption was that farms often use different feed formulations simultaneously and the 
labelling is ambiguous (e.g. this feed product may include one of the following antimicrobials: A, 
B, or C). As many other countries worldwide, Vietnam is also currently engaged in legislative 
efforts leading to progressive reductions of antimicrobials. In Vietnam a recent Decree 
(13/2020/ND-CP) includes the timeframe for a ban of AMU for prophylactic purposes (including 
AGPs), with phased bans for different antimicrobials classes: WHO ‘highest’ and ‘high priority’ 
critically important AAIs to be banned from 2021, highly important AAIs from 2022, important 
AAIs from 2023 and all other antimicrobial classes from of 2026. We do not know, however, the 
level of compliance with this upcoming legislation.  
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Conclusions 
We found evidence that prophylactic AMU does not prevent infection and can instead increase the 
risk of clinical disease in chicken flocks. In general, prophylactic use of lincosamides, penicillins, 
methenamines, and tetracyclines tend to increase the risk of diarrhoea, and prophylactic use of 
lincosamides, penicillins, macrolides and amphenicols tend to increase the risk of respiratory 
infections. Therapeutic AMU of any classes of antimicrobial resulted in an overall increase in 
mortality. A majority of classes of antibiotics have a strong therapeutic effect in reducing the 
mortality associated with diarrhoea infections. However, any therapeutic use of antibiotic in case 
of leg problems tends on the contrary to increase the risk of death. For respiratory and CNS 
infection, therapeutic AMU appears highly inconsistent and unpredictable, even within a single 
class of antimicrobials. Lincosamides, methenamines and cephalosporins are the only 
antimicrobial classes that always decrease the mortality when used therapeutically. Lincosamides, 
methenamines are also the two classes of antimicrobials that increase the risk of disease the most 
when used prophylactically. 
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Table 1: Description of the AMU data, including data for prophylactic AMU analysis (No. weeks with prophylactic AMU and number 
of weeks without AMU), and therapeutic AMU analysis (No. weeks before and after therapeutic AMU). The data are stratified by 
antimicrobial class (by row). The ranges reflect the variability resulting from different combinations of the tuning parameters of the 
categorization algorithm. 
Classes 
 raw AMU data  Data for prophylactic effect analysis   Data for therapeutic effect analysis  
 




N = 5,566 
(%) 
 



















Aminolycosides  158 (45.3)  367   (6.6)  125-250 (34.1-68.1)  2841-4554 (54.6-87.6)  44-100  53-396   0-103  
Amphenicols  66 (18.9)  100   (1.8)  51-80       (51-80)  3236-4984 (59.2-91.2)  13-30  44-541   0-35  
Cephalosporins  7   (2.0)  9   (0.2)  2-8 (22.2-88.9)  3412-5139 (61.4-92.5)  0-1  298-623  0-4  
Diaminopyrimidines  56 (16.0)  106   (1.9)  33-74 (31.1-69.8)  3258-4978 (59.7-91.2)  18-34  191-568   0-29  
Lincosamides  24   (6.9)  33   (0.6)  15-30 (45.5-90.9)  3367-5093    (60.9-92)  4-9  197-607   0-9  
Macrolides  137 (39.3)  310   (5.6)  117-220    (37.7-71)  2909-4638 (55.3-88.2)  22-68  45-478   2-53  
Penicillins  113 (32.4)  208   (3.7)  95-160 (45.7-76.9)  3023-4791 (56.4-89.4)  34-61  145-498   0-57  
Pleuromutilins  1   (0.3)  1   (0.0)  1-1   (100-100)  3419-5154 (61.4-92.6)  0-0  0-0   0-0  
Polypeptides  252 (72.2)  605 (10.9)  261-407 (43.1-67.3)  2249-4158 (45.3-83.8)  63-133  37-340   0-109 
Quinolones  98 (28.1)  168   (3.0)  74-129    (44-76.8)  3113-4870 (57.7-90.2)  20-39  42-538   2-50  
Sulfonamides  83 (23.8)  148   (2.7)  65-109 (43.9-73.6)  3138-4906 (57.9-90.6)  22-50  46-527   1-52  
Tetracyclines  258 (73.9)  628 (11.3)  266-432 (42.4-68.8)  2223-4117    (45-83.4)  57-127  43-339   0-136  
Methenamines  26   (7.4)  36   (0.6)  15-31 (41.7-86.1)  3356-5091 (60.7-92.1)  7-16  201-619   0-1  
Any class  296 (84.8)  1,266 (22.7)  353-686 (27.9-54.2)  1564-3251 (36.4-75.6)  144-310  21-164   1-153  
Antimicrobial agents within each class: Aminolycosides: neomycin, gentamicin, streptomycin, spectinomycin, apramycin, josamycin. 
Amphenicols: florfenicol, thiamphenicol, chloramphenicol. Cephalosporins: cefadroxil, cefotaxime, cephalexin, ceftiofur. 
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Diaminopyrimidines: trimethoprim. Lincosamides: lincomycin. Macrolides: tylosin, tilmicosin, erythromycin, spiramycin, kitasamycin. 
Penicillins: amoxicillin, ampicillin. Pleuromutilins: tiamulin. Polypeptides: colistin, enramycin. Quinolones: enrofloxacin, flumequine, 
norfloxacin. Sulfonamides: sulfachloropyridazine, sulfadiazine, sulfadimethoxine, sulfadimidine, sulfaguanidin, sulfamethazine, 
sulfamethoxazole, sulfamethoxypyridazine, sulphamethoxazole, sulphathiazole. Tetracyclines: oxytetracycline, doxycycline, 
tetracycline. Methenamines: methenamine. 
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Figure 1: Data preparation for the estimation of the prophylactic effect of AMU. The horizontal 
arrow represents the time line of a flock, divided into weeks, represented by rectangles, starting on 
week 1 (on the left). For any given week w selected (by step 0, see below) for the analysis 
(represented here by the hashed rectangle), we computed (i) an exposure variable based on the use 
or not of antimicrobials (step 1, in green) and (ii) an outcome variable based on the occurrence or 
not of clinical signs over an observation period of x weeks after week w (step 2, in red). Statistical 
analyses then tested whether AMU on week w (exposure) affects the occurrence of clinical signs 
over the observation period (outcome). In order to make sure that AMU exposure on week w does 
correspond to prophylactic AMU, we filtered out all the weeks that were preceded by (i) the 
presence of clinical signs over a period of y weeks before week w (including week w), or (ii) AMU 
over a period of z weeks before week w (naturally excluding the candidate week, since this 
information is used to compute the exposure variable). This step 0 is shown in blue on the figure. 
Finally, the analysis includes potential confounding factors (shown in orange letters and circle) 
such as the age of the chicken (i.e. week w) as well as AMU during the first a weeks of the flock’s 
life (brooding period, in grey) and during the x weeks of the observation period.  




Figure 2: Defining a disease episode. The horizontal arrow represents the time line of a flock, 
divided into weeks, represented by rectangles, from the first week on the left to the last one on the 
right. The red dots represent the reporting of disease (clinical sign). In order to account for the fact 
that clinical signs may not be always reported, we allow the possibility to convert one or a few 
consecutive weeks without reported clinical signs and surrounded by weeks with reported clinical 
signs into one single disease episode. The gap parameter is the number of consecutive week(s) 
without clinical signs we allow when defining a disease episode. Below the time line arrow are 3 
examples of disease episodes definitions: 3 episodes when maximum gap = 0 (top), 2 episodes 
when maximum gap = 1 (middle) and 1 episode only when maximum gap = 2 (bottom). 
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Figure 3: Separating ‘before-AMU’ and ‘after-AMU’ arms in all the disease episodes. In this 
example, the horizontal arrows show the first 2 (top) and the last (bottom) flocks of the data set. 
Each flock starts on the left end and ends on the right end of the arrow and the length of the arrow 
is the duration of the flock. Coloured sections represent disease episodes as identified on Figure 2. 
The red rectangles represent the first week of AMU (if any) in the disease episodes. Sometimes 
there is no AMU at all during the disease episode (as on the third episode of the first flock) and 
some other times the first week of AMU is the first week of the episode (as on the second episode 
of the second flock or the first episode of the last flock). Once these first weeks of AMU are 
identified in all the disease episodes, we gathered, from all the disease episodes of all the flocks, 
all the weeks that occur before (in blue) in one arm “before”, and all the weeks that occur after (in 
green) these first weeks of AMU in another arm “after”. 
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Figure 4: OR (Odds Ratios) of occurrence of clinical signs when antimicrobials were used 
prophylactically. For the ease of visualization, confidence intervals are not represented. Instead, 
red colour indicates OR values that are statistically significant (p<0.05) and light blue colour 
indicates OR values that are not significant. Circle, triangle and cross shapes represent durations x 
of the observation period equal to 1, 2 and 3 weeks respectively. Numbers 1, 2 and 3 represent the 
duration y = z of the filtering period (the number of weeks without any AMU before prophylactic 
events). In each subpanel, each combination of three numbers 123 represented, from left to right, 
the AMU in the first 1, 2 and 3 weeks of life. The horizontal black line represents an OR value of 
1. OR values higher than the horizontal black line indicate that the prophylactic AMU increases 
the risk of having clinical signs. A linear scale instead of a logarithm one was chosen for the OR 
in order to show the spread of significant values better. Antimicrobial classes were ordered from 
the most to the least commonly used. Abbreviations: ‘ANY’ = any classes, ‘AMI’ = 
aminoglycosides, ‘AMP’ = amphenicols, ‘CEP’ = cephalosporins, ‘DIA’ = diaminopyrimidines, 
‘MAC’ = macrolides, ‘MET’ = methenamines, ‘LIN’ = lincosamides, ’PLE’ = pleuromutilins, 
‘POL’ = polypeptides, ‘QUI’ = quinolones, ‘SUL’ = sulfonamides, ‘TET’ = tetracyclines, ‘Freq. 
AMU’ = Frequency AMU, ‘Freq. clinical signs’ = Frequency clinical signs. First row and right 
column respectively show the ranges of frequencies of AMU and clinical signs observed in the 
study farms.
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Figure 5: OR (Odds Ratio) of the impact of therapeutic AMU on mortality. For the ease of 
visualization, confidence intervals are not represented. Instead, red colour indicates OR values that 
are statistically significant (p<0.05) and light blue colour indicates OR values that are not 
significant. Cross, circle, triangle shape represented 0, 1, and 2 weeks of gap in disease episodes 
respectively. The horizontal black line represents an OR of 1. OR values higher than the horizontal 
black line indicate that therapeutic AMU increases the mortality rate. Antimicrobial classes were 
ordered from the most to the least commonly used. Abbreviations: ‘ANY’ = any classes, ‘AMI’ = 
aminoglycosides, ‘AMP’ = amphenicols, ‘CEP’ = cephalosporins, ‘DIA’ = diaminopyrimidines, 
‘MAC’ = macrolides, ‘MET’ = methenamines, ‘LIN’ = lincosamides, ‘PLE’ = pleuromutilins, 
‘POL’ = polypeptides, ‘QUI’ = quinolones, ‘SUL’ = sulfonamides, ‘TET’ = tetracyclines. First 
row and right column respectively show the ranges of frequencies of AMU and clinical signs 
observed in the study farms. 
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Abstract  
Antimicrobial resistance (AMR) has a particularly high impact on rural human and animal 
populations in low- and middle-income countries (LMICs). The development of 
surveillance systems for AMU is a priority action point, but data collection is challenging; 
an additional complication is the diversity of animal species and metrics. The Mekong 
Delta region of Vietnam has a high density of human populations and numbers of small-
scale farming systems, with a high prevalence of resistance in animal commensal and 
foodborne pathogens. We collected AMU data from human residents and animals raised in 
101 small-scale farms in the Mekong Delta over a fixed period (last 90 days in humans, 
last 7 days in animals). The aims were to measure and quantitatively compare AMU in 
humans and the four most common animal species (chickens, ducks, Muscovy ducks, pigs) 
using different metrics (standing population, ‘biomass’ and ‘Population Correction Unit’) 
and use these estimates to infer consumption data for the Mekong Delta region of Vietnam. 
Humans used 5.9 DDDkg (SD ± 18.0), or 273.3 mg of AAIs (SD ±880.8) per kg standing 
bodymass per year; animals consumed 90.0 ADDkg (SD ±141.9) or 3,011 mg (SD ±7,431) 
of AAIs per kg standing bodymass per year. Individuals <5 and >65 years-old consumed 
significantly more than people in other age categories. For the estimation of total 
antimicrobial usage for the Mekong Delta region, pigs were the target of the greatest 
amounts of AMU, both in terms of frequency (40.6%) and quantity (36.1%). Over one year 
humans consumed a total of 122.2 tonnes, or 26.2% of total AMU. However, per kg of 
body weight, Muscovy ducks were the target of the greatest amounts of AMU and human 
consumed less than 5% of total AMU in all metrics. AAIs regarded of critical importance 
by WHO in animals (71.8% No. ADDkg) were considerably higher magnitude compared 
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with humans (47.4% No. DDDkg). In general, for animal AMU, metrics that related AMU 
to standing bodymass were higher than those relating AMU to biomass or PCU. Using a 
One Health approach, we demonstrated that accurate AMU can be estimated from a simple 
cross-sectional surveys, although results are very sensitive to the chosen metric. Results 
confirm the preponderance of AMU in animal populations. This methodology can 
potentially be applied in AMU surveillance in low-resource settings, allowing to focus 
reduction efforts AMU in particular animal species.  
Keywords: Antimicrobial use, farmer, animal, small-scale farms, Mekong Delta, One 
Health, Vietnam. 
  
Page 127 of 342
Introduction 
The global crisis of antimicrobial resistance (AMR) has a particular severe impact on rural 
human and animal populations of low- and middle-income countries (LMICs) due to 
limited medical and veterinary care resources [1, 2]. The presence of high densities of 
mixed species, small-scale farming systems, alongside excessive levels of antimicrobial 
use (AMU) in many of these areas contribute to the problem [3]. There is now considerable 
evidence of a link between excessive antimicrobial use (AMU) and the occurrence of 
resistance in humans and animals [4, 5].  
The Tripartite Global Action Plan on AMR, jointly developed by WHO, FAO and OIE [6], 
has established that AMU surveillance is a key priority action point under strategic 
Objective 2. However, many LMICs countries lack adequate systems for AMU 
surveillance due to limited resources and capacity to collect AMU data. The World 
Organization for Animal Health (OIE) compiles annual surveillance reports of AMU in 
animal production globally [7]. However, these reports do not attempt to compare AMU 
between different species or production types, a necessary calculation in order to identify 
those production types where AMU/AMR is likely to be highest (i.e. hotspots). 
Furthermore, beyond limited research studies, there are no official global data on AMU in 
human community populations [8].  
The selection of metrics for quantification of AMU is crucial, since different metrics can 
lead to considerable differences in estimates [9-11]. In its annual global report, the OIE 
relates quantities of antimicrobials (in mg) to the weight (biomass) of all animals produced, 
expressed as a sum of the bodyweight of slaughtered animals plus that of standing animals 
[7]. In contrast, the European Union (EU) in its Annual ESVAC reports relate weigth of 
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AAI to animal populations computed using Population Correction Units (PCU), which 
corresponds to the typical treatment weight for each of the standing and slaughtered animal 
species [12].  
A recent study estimated total AMU related to animal and human biomass in Vietnam. The 
animal population denominator was calculated following similar methodology to that 
adopted by the OIE in its annual report [13]. The study concluded that overall, 262mg and 
247mg of antimicrobial active ingredients (AAIs) were, respectively used per kg of animal 
and human biomass across the country. However, results were largely based on 
extrapolations from previous surveys on a limited number of species and locations, not on 
real survey data. More accurate species-specific information is required to properly 
production types where the selection pressure on AMR is greatest. The accurate estimation 
of AMU in humans and animals present considerable logistic challenges since this requires 
conducting longitudinal studies, which are both laborious and costly.  
The Mekong Delta region, located in the southwest region of Vietnam (40,500 km2 and 
17.8M population in 2019) is regarded as a hotspot of AMU and AMR in animal 
production. Previous studies conducted in this predominantly rural area have evidenced a 
high prevalence of AMR in commensal Escherichia coli from chickens, ducks, pigs [14, 
15] as well as from poultry farmers [16, 17]. Similarly, food-borne pathogens (i.e. non-
typhoidal Salmonella and Campylobacter spp.) isolated from pigs and poultry farms also 
display resistance against a large number of antimicrobials [18, 19]. Unsurprisingly, the 
quantities of antimicrobials used in chicken and pig farms in the area are high [10, 20]. 
However, in addition to chickens and pigs, many small-scale farms typically raise a range 
of species including fish, ducks, Muscovy ducks, and to a lesser extent, ruminants (cattle 
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and goats). The relative intensity of AMU in different animal species and humans has yet 
to be determined in the area and in Vietnam as a whole. Most owners of small-scale farms 
make decisions regarding AMU based on their own knowledge and experience [21].  
Using a cross-sectional, One Health study approach, we quantified AMU in human 
residents and animals raised in smallholder farms in the Mekong Delta region of Vietnam. 
The aims were: (i) to describe and compare the types and quantities of antimicrobials used 
by animals and humans; (ii) to extrapolate these AMU results to the Mekong Delta of 
Vietnam using different denominator units; and (iii) to compare levels of AMU in different 
animal species, as well as between animals and humans. This study should provide insights 
to help design AMU surveillance systems, whilst clarifying the implication of the choice 
of denominator units.  
Materials and Methods 
Study design 
We conducted a cross-sectional survey of poultry-raising households located in 5 of the 12 
districts of Dong Thap province (Mekong Delta, Vietnam) during July 2019. The five 
districts were chosen based on convenience to be located less than 30km from the 
provincial capital. We requested the veterinary authority in each district (District 
Veterinary Station, DVS) for a list of livestock farms of typical size and mix of species 
raised. From each district, 20-25 small-scale poultry farms (defined as raising chickens 
and/or ducks for commercial purposes, i.e. not for family consumption) were selected by 
the DVS veterinarian, and selected farm owners were invited to join the study. We aimed 
to sample ~100 households. All visits were conducted by staff affiliated to the Sub-
Department of Animal Health and Production of Dong Thap (SDAHP-DT) during July 
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2019. In each selected household, the person identified as being responsible for taking care 
about family members and animals the most was interviewed. The data collected, that 
included the identity of specific AAIs consumed and the frequency (days) was used to 
calculate AMU, both in terms of doses (treatment intensity) and quantities (weight of AAI) 
for the province and the Mekong Delta region by species. 
Data collection  
A structured questionnaire was developed to gather data on household farm human 
residents (age, gender, education, occupation, degree of contact with animals), as well as 
on numbers and age of food animals (i.e. excluding companion animals, frogs, ornamental 
birds and fish) present in the farm on the visit date (Appendix 1). To minimize recall bias, 
we enquired about administration of antimicrobials over a period consisting of the latest 
90 and 7 days (for humans and animals, respectively). In all visits, the investigators 
requested to inspect the cabinets used to keep medicines of humans and animals. The 
examination of the cabinets was taken as an opportunity to discuss information on types, 
doses, and concentration of any antimicrobials identified in the cabinets. All medicine 
products containing antimicrobial active ingredients (AAIs) were singled out after 
reviewing the label or the prescription (for human medicines). AAI were classified based 
on the WHO list of antimicrobial agents [22]. The concentration of AAIs contained in these 
products was described and was expressed in mg/tablet (human products) and mg or ml 
per kg of product (animal products). Those veterinary antimicrobials not appearing in the 
WHO list were classified according to the OIE list of antimicrobial agents [23].  
Quantification of AMU in the surveyed population 
Page 131 of 342
We first estimated annual consumption in the surveyed population using frequency-based 
metrics: No. of defined daily doses kg (DDDkg) for humans, and No. of Animal Daily Doses 
kg (ADDkg) for animals. This was achieved by multiplying the reported number of days 
when antimicrobials were consumed over the observed period (90 and 7 days for humans 
and animals, respectively) by the estimated bodymass (in kg) of each treated 
person/flock/herd. These frequency estimates were also related to the ‘standing bodymass’ 
of the surveyed population as well as to ‘bodymass-time’ denominator in order to compute 
the ‘treatment intensity’. The resulting estimates were averaged for each species. For 
example, consumption of ampicillin over 2 days (out of 90 days) by an 80kg person equates 
to consumption of 160 DDDkg (80*2), this equates to 160*(365/90)=648.9 DDDkg per year, 
or to 648.9/80=8.1 DDDkg per kg of bodymass. The body-mass time denominator for that 
individual would be 365*80=29,200 (kg-days), therefore the treatment intensity 
(equivalent to a daily probability of consuming antimicrobials) for that individual would 
be 648.9/29,200=0.022. Similarly, in a flock of 20 chickens (each weighing 2kg) where 10 
chicken were administered ampicillin for 4 days over a 7-day period, consumption for the 
flock was estimated in 80 ADDkg (2*4*10). Over a year, this flock would be expected to 
consume 4,170 ADDkg (80*365/7). The bodymass time denominator for that flock is 
365*2*20=14,600 kg-days. This flock would have consumed 104.2 ADDkg (4,170/40) per 
kg of bodymass per year, and the treatment intensity would be 0.286 (170/14,600).  
For humans, the quantities (weight) of AAIs consumed were estimated from the actual 
doctors’ prescriptions where available. For animals, they were inferred from frequency data 
and the preparation instructions of each product consumed. The estimated number of 
ADDkg was multiplied by the ‘technical dose’ of each of the AAI consumed. The ‘technical 
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dose’ values for each AAI were inferred from the antimicrobial products’ preparation 
instructions (as written in the label) and from the prescription data in the case of human 
antimicrobial products. For animals, the ‘technical ADDkg‘ was defined as 75% of the 
‘treatment’ daily dose for each AAI for 1 kg of live animal bodyweight, and was obtained 
from the preparation instructions as indicated in the products’ labels and consumption 
estimated from the weight (inferred from age) of the animal. Animal weight, feed and water 
consumption for each animal species by age (in weeks) were inferred from previous studies 
[10, 24, 25]. Respectively, 0.225 l and 0.120 l was taken as the daily water intake, and 
0.063kg and 0.037kg as the daily consumption of feed of a 1 kg bird (any species) and and 
pig. For injectable preparations (animal products), the preparation instruction (i.e. 
5ml/kg/day) were used to estimate the consumption of AMU. 
In cases where participants stated consumption of AAI, but did not remember for how 
many days, we assigned the average of the remaining observations. To account for 
individuals that reported using medicine, but did not remember whether it included AAI or 
not, we assumed that a fraction of them equivalent to the ratio of AAI to medicine 
consumed AAI. For individuals where AAI concentration or dosage data were missing, we 
extrapolated from similar products in the same species. Human medicine products 
administered to animals flocks were excluded from the estimation of ADDkg values since 
the guidelines for preparation for animal used were not available.  
Estimations of AMU in the Mekong Delta of Vietnam 
AMU data by species obtained from the survey was extrapolated for human and animal 
populations in the Mekong Delta region (2019). The data were presented using four 
different metrics: (i) No. doses-kg (either DDDkg or ADDkg) related to the total amount of 
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kg-bodymass-time for each species per year; (ii) Weight of AMU related to ‘standing 
bodymass’ of human and animal populations per year; (iii) Weight of AMU related to 
‘standing bodymass’ of human and ‘biomass’ of animal populations per year (i.e. OIE 
method) [26]; (4) Weight of AMU related to ‘standing bodymass’ of human and ‘PCU’ of 
animal populations per year (i.e. ESVAC method) [27].  
The human ‘standing bodymass’ was obtained by multiplying the number of individuals 
(census) by their bodyweight (estimated from their age and gender) [28, 29]. To estimate 
animal ‘standing bodymass’, the number of animals of each species (from census data) [30] 
was multiplied by their estimated bodyweight of each species in their mid-age [13]. To 
estimate ‘biomass’ of animals, the number of animals produced (from production data) of 
each species was multiplied by the total individual animal bodyweight at slaughter time. 
The number of ‘Population Correction Units’ (PCU) for each animal species was calculated 
as the total number of animals multiplied by the average weight at treatment based on 
ESVAC guidelines. Detailed calculations are presented in Appendix 2 (Table 1 and 2).  
Ethics 
Ethics approval for the study was obtained from the Oxford Tropical Research Ethics 
Committee (OxTREC), Oxford, UK (Reference No. 533-19). Informed consent was 
obtained from all participants. 
Results 
Participants and household farm characteristics 
A total of 101 household farms with 316 human residents that were present in the 
household at the time of the farm visit were investigated. Their sociodemographic 
characteristics are displayed in Supplementary Material 1. Each farm had a median of 3 
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residents [Inter-quartile range (IQR) 2-4], with a median age of 38 [IQR 13-55] years. Over 
half (51.9%) were males. All interviewees were above 18 year-old, and 82.2% were male. 
A total of 186 (58.8%) residents reported direct contact with animals in their farms.  
Of 101 farms investigated, chickens were the predominant species (71.3% farms), followed 
by ducks (54.5%), pigs (19.8%), Muscovy ducks (11.9%), fish (10.9%), cattle (5.9%), 
frogs (4.0%), goats (2.0%), geese and eels (1.0% each). Farms raising only one food animal 
species (42.6%) were predominant, followed by farms raising two (40.6%), three (11.9%), 
five (2.9%) and four (1.9%) species. The most common species combinations were 
‘chicken-duck’ (17.8%), followed by ‘chicken-Muscovy duck’ (4.9%), ‘chicken-duck-pig’ 
(4.9%), ‘chicken-pig’ (3.9%) and ‘duck-pig’ (3.9%). The median chicken flock age was 12 
weeks [IQR 4-24] and the median flock size was 30 [IQR 15-75]. For duck farms, the 
median flock age was 8 weeks [IQR 4-25], and a median flock size of 100 [IQR 40-700]. 
The median pig age was 15 weeks [IQR 8-51], with a median herd size of 10 [IQR 3-12]. 
Details on all species present in study farms is given in Supplementary Material 2. 
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AMU in humans and animals in the farms surveyed 
A total of 173/316 participants (54.7%) reported using medicine over the last 90 days. 
However, only 121 participants (38.2%) kept their records or doctor prescriptions. Forty 
two out of 121 participants (34.7%) (median age 43 [IQR 7-55.5] years) confirmed using 
antimicrobial-containing products during the last 90 days. For the 52 participants that 
consumed medicine, but did not remember whether it was a AAI or not, we assumed that 
34.7% used of them actually contained an AAI. Therefore antimicrobial consumption over 
the last 90 days was assumed for 60 (34.7%) individuals (42+[52*0.347]). AMU was 
reported in a total of 98/320 (30.6%) animal groups over the 7 days prior to the time of 
interview. AMU was reported in all farmed species except cattle (6 farms), goats (2) and 
geese (1). A total of 106 (32 in humans and 74 in animals) different AAI-containing 
products were identified. All human AAI-containing products had been administered 
through the oral route, and contained one AAI. Fifty-four % antimicrobial-containing 
products administered to animals contained two AAIs. Most products (75.6%) were 
administered through the oral route, the remaining were injectable. A total of 9 and 63 
antimicrobial-containing products were used in pig and poultry flocks, respectively. Four 
products were used both in pig and poultry flocks. In addition, 20 products administered to 
three animal species (chickens, ducks and pigs) were antimicrobials intended for human 
use. A summary of all antimicrobial-containing products and their associated ‘technical 
daily doses used’ is given in Supplementary Material 3). Among products, the average 
technical dose for humans (DDDkg) was 17.3 mg/kg. For pigs and poultry the average 
values of the technical dose (ADDkg) were respectively, 11.9 and 12.4 mg/kg for 
antimicrobials consumed orally, and 7.4 and 9.2 mg/kg for those injected. Among AAIs 
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used by humans, 3rd generations cephalosporins class has the lowest DDDkg (range 3.2-9.2 
mg/kg), whilst penicillins had the highest (range 23.0-26.6 mg/kg). The ADDkg for some 
AAIs were particulary high, notably doxycycline (29.6 mg/kg) sulfadimidines (63.4 
mg/kg), thiamphenicol (24.7 mg/kg) and gentamicin (23.2 mg/kg) intended for poultry 
administered orally, as well as oral sulfamethoxazole (40.5 mg/kg) intended for pigs. 
Surprisingly, the average injection dose of some AAIs were higher than the average oral 
doses (i.e. oxytetracycline, 12.1 vs 6.9 mg/kg; spectinomycin 10.3 vs 1.8 mg/kg). The daily 
doses of each AAI identified in the survey are summarized in Table 1. 
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Table 1. The average antimicrobials technical dose (TD) (DDDkg or ADDkg) from 32 human and 74 animal products used in 101 study 
farms (AAI used in animals intended for human use were excluded). CV: Coefficient of variation. Critically important antimicrobial 





 Poultry  Pigs 
 Oral  Injection  Oral  Injection 
 
n TD (±CV) 
 
n TD (±CV) 
 
n TD (±CV) 
 





Tetracyclines* Tetracycline#  1 23.0 (±NC)  3 12.5 (±53.5)          
 Oxytetracycline 
    
9 6.9 (±87.8)  4 
12.1 
(±98.5) 








 1 8.4 (±NC)       
Sulfonamides Sulfaquinoxaline     2 18.3 (±76.6)          
 Sulfamethoxazole#     1 18.7 (±NC)     1 40.5 (±NC)    
 Sulfaguanidine#                
 Sulfadimidine     2 63.4 (±66.1)          
 Sulfadimethoxine     1 15 (±NC)          
Quinolones Norfloxacin     2 8.5 (±104.5)          
 Marbofloxacin                
 Enrofloxacin     6 11.0 (±36.3)  4 5.6 (±47.1)       
 Ciprofloxacin#  1 18.4 (±NC)             
 Ofloxacin  1 7.3 (±NC)             
Polypeptides** Colistin     11 3.1 (±36.3)     2 3.7 (±28.9)    




26.6 (±49.2)  3 
13.7 (±28.3) 






 Penicillin V  1 23.0 (±NC)             
Macrolides** Tylosin 






 2 11.1 
(±129.9
) 
 Spiramycin  2 7.5 (±32.6)  1 0.45 (±NC)  1 3.0 (±NC)       
 Erythromycin     1 15.0 (±NC)          
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Table 1. (cont.) 
Class AAI Humans  
(Oral) 
 Poultry   Pigs  
   Oral  Injection  Oral  Injection  
  n TD (±CV)  n TD (±CV)  n TD (±CV)  n TD (±CV)  n TD (±CV)  















Cefuroxime 5 18.5 (±50.3)              
Cefotaxime#       1 9.7 (±NC)        
Cefalexin 4 13.8 (±44.5)  1 7.5 (±NC)           
Cefdinir 1 13.8 (±NC)              
3rd 
Cephalosporins** 
Ceftiofur#       1 3.75 (±NC)        
Cefixim 1 9.2 (±NC)              
Cefpodoxime 2 3.2 (±60.6)              
Cefadroxil 1 9.2 (±NC)              
Amphenicols Thiamphenicol    1 24.7 (±NC)  4 16.8 (±55.9)     1 7.5 (±NC)  
 Florfenicol    2 5.6 (±120.3)  1 1.8 (±NC)     1 3.7 (±NC)  
Aminoglycosides* Streptomycin    2 9.9 (±34.6)           
 Spectinomycin    1 1.8 (±NC)  4 10.3 (±34.8)        
 Kanamycin    2 8.0 (±75.6)           
 Gentamicin 











 32 17.3 (±61.2)  52 
12.4 
(±156.4) 
 17 9.2 (±79.3)  5 
11.9 
(±99.1) 
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Over one year human residents in the farms surveyed were estimated to consume on 
average 5.9 DDDkg (SD ±18.0) or 237.3 mg (SD ±880.8) per kg of standing bodymass. 
Averaging across species, animals consumed 90.0 ADDkg (SD ±141.9) or 3,011 mg (SD 
±7,431) of AAIs per kg bodymass per year. Consumption among Muscovy ducks was 
greatest (136.3 ADDkg), followed by ducks (80.3 ADDkg), pigs (73.3 ADDkg ) and chickens 
(70.3 ADDkg). In terms of quantities of AAI related to standing bodymass, Muscovy ducks 
also consumed the greatest amounts of AAIs (6,436 mg), followed by chickens (2,288 mg), 
ducks (1,803 mg) and pigs (1,516 mg) (Table 2). Individuals aged less than 5 and more 
than 65 years-old consumed significantly more antimicrobials than people in other age 
categories (Figure 1). There were no significant differences in antimicrobial consumption 
with respect to other sociodemographic factors such as gender, education, animal contact 
or district location.  
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Table 2. Estimations of AMU from the survey of 101 farming households. 




No. households 101 72 55 12 20 
No. individuals/animals 316 15,933 43,784 1,378 494 
Total bodymass (kg) 14,420 16,807 92,280 827 21,145 
Total kg-days per year 5,263,300 6,134,555 33,682,200 301,855 7,717,925 
Gross AMU      
No. daily doses kg per year 101,909 6,150,487 23,801,832 406,700 1,519,547 






AMU related to population      
No. doses per kg bodymass-year 











mg antimicrobials per kg bodymass-
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Figure 1. AMU in human participants by their sociodemographic characteristics.  
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AMU in the four animal species investigated is displayed in Figure 2 stratified by 
production purpose. AMU consumption varied across production types: In general, animals 
raised for meat consumed more antimicrobials than those raised for breeding purposes. An 
exception was ducks, where AMU was more frequent in breeding birds than in meat ducks 
(90.3 ADDkg vs 80.0 ADDkg); in terms of quantities, breeding pig were the target of higher 
levels of AMU than any other species.  
Figure 2. AMU consumption in animal by four species with specific type of production.   
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Antimicrobial active ingredients (AAIs) used in humans and animals 
Table 3 presents frequency data on AAI consumption among humans and animals from 
the household survey. In humans, 14 different AAIs belonging to 6 different classes were 
consumed. AAIs categorised as ‘of critical importance’ by WHO represented 47.4% of the 
total number of DDDkg. First and 2
nd generation cephalosporins were consumed the most 
(47.8% of total DDDkg), followed by penicillins (39.0%) and quinolones (8.8%). In 
animals, a total of 30 different AAIs belonging to 11 classes were idetified. AAIs regarded 
of critical importance by WHO represented 47.4% and 71.8% of the total number of doses 
given to humans and animals (chickens 64.3%, ducks 65.4%, Muscovy ducks 79.8% and 
pigs 77.7%), respectively. In terms of frequency, tetracyclines (23.1%), aminoglycosides 
(12.7%) and sulfonamides (9.9%) classes were the most consumed AAIs by chickens. For 
pigs, penicillins (50.9%) represented the most frequently used class, followed by 
quinolones (12.6%). Table 4 shows AMU in terms of weight of AAI. In humans, the 
highest quantities of AMU corresponded to the penicillins class (58.0% total), followed by 
1st and 2nd generation cephalosporins (39.5%) and 3rd generation cephalosporins (6.8%). In 
animals, sulfonamides (32.6%), tetracyclines (14.4%), and amphenicols (14.2%) classes 
were consumed the most by chickens. The highest target for duck and Muscovy duck were 
tetracyclines (26.9% and 47.0%) and macrolides (18.4% and 22.1%) and. In pigs, penicillin 
(41.1%) class was used the most frequent, followed by macrolides (30.2%).  
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Table 3. Estimated annual AAIs consumption expressed in terms of doses per kg of bodyweight (DDDkg in humans and ADDkg in 
animals) calculated from the small-scale farm survey. The percent is indicated in parenthesis. Critically important antimicrobial 
classes according to WHO are highlighted: *High priority, **Highest priority. #AAIs in products administered to animal populations 
that were intended for human use. 




Tetracyclines* Tetracycline# 0.03 (0.5) 1.3 (1.9) 1.4 (1.7) 18.3 (13.4)  
 Oxytetracycline   11.4 (16.3) 10.9 (13.6) 21.3 (15.6) 0.5 (0.6) 
 Doxycycline   3.5 (5.0) 9.2 (11.4) 8.2 (6.0)  
 Any tetracyclines 0.03 (0.5) 16.3 (23.1) 21.4 (26.7) 47.7 (35.0) 0.5 (0.6) 
Sulfonamides Sulfaquinoxaline   1.8 (2.6)    
 Sulfamethoxazole#   3.1 (4.4)   0.7 (0.9) 
 Sulfaguanidine#       
 Sulfadimidine   1.6 (2.2)    
 Sulfadimethoxine   0.5 (0.7)    
 Any sulfonamides   7.0 (9.9)   0.7 (0.9) 
Quinolones Norfloxacin    3.5 (4.3) 13.0 (9.6)  
 Marbofloxacin   1.4 (2.0)    
 Enrofloxacin   3.7 (5.3) 16.9 (21.1) 5.3 (3.8) 9.2 (12.6) 
 Ciprofloxacin# 0.39 (6.6)     
 Ofloxacin 0.13 (2.2)     
 Any quinolones 0.5 (8.8) 5.1 (7.3) 20.4 (25.4) 18.3 (13.4) 9.2 (12.6) 
Polypeptides** Colistin   7.9 (11.3) 14.6 (18.2) 26.5 (19.4) 5.5 (7.5) 
 Any polypeptides   7.9 (11.3) 14.6 (18.2) 26.5 (19.4) 5.5 (7.5) 
Penicillins* Ampicillin 0.07 (1.3) 1.6 (2.2) 5.7 (7.1) 2.6 (1.9) 2.7 (3.7) 
 Amoxicillin# 2.15 36.5) 2.9 (4.1) 1.6 (2.0)  34.6 (47.2) 
 Penicillin V 0.07 (1.3)     
 Any penicillins 2.29 (39.0) 4.4 (6.3) 7.3 (9.1) 2.6 (1.9) 37.3 (50.9) 
Macrolides** Tylosin   5.9 (8.4) 5.2 (6.4) 30.4 (22.3) 10.3 (14.0) 
 Spiramycin 0.03 (0.5) 1.0 (1.4) 1.4 (1.5)   
 Erythromycin  0.8 (1.1)    
 Any macrolides 0.03 (0.5) 7.7 (10.9) 6.6 (7.9) 30.4 (22.3) 10.3 (14.0) 
Lincosamides Lincomycin 0.04 (0.6) 5.1 (7.2) 0.3 (0.4)   
 Any lincosamides 0.04 (0.6) 5.1 (7.2) 0.3 (0.4)   
Diaminopyrimidines Trimethoprim  1.9 (2.7) 1.9 (2.4) 2.6 (1.9) 0.7 (0.9) 
 Any diaminopyrimidines  1.9 (2.7) 1.9 (2.4) 2.6 (1.9) 073 (097) 
1st &2nd gen. 
cephalosporins 
Cefuroxime 1.09 (18.5)     
Cefotaxime#   1.4 (1.7)   
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Cefalexin 1.34 27.3) 1.6 (2.2)    
Cefdinir 0.09 (2.0)     
 
Any 1st &2nd gen. 
cephalosporins 
2.5 (47.8) 1.6 (2.2) 1.4 (1.7)   
3rd Cephalosporins** 
Ceftiofur#   0.9 (1.2)   
Cefixim 0.17 (2.9)     
Cefpodoxime 0.17 (2.9)     
Cefadroxil 0.09 (1.6)     
Any 3rd cephalosporins 0.43 (7.4)  0.9 (1.2)   
Amphenicols Thiamphenicol  4.1 (5.9) 2.6 (3.2)  0.5 (0.6) 
 Florfenicol  0.3 (0.4) 0.2 (0.3)  5.1 (7.0) 
 Any amphenicols  4.4 (6.3) 2.8 (3.5)  5.6 (7.6)) 
Aminoglycosides* Streptomycin  1.8 (2.6) 0.3 (0.4)   
 Spectinomycin  5.1 (7.3) 0.3 (0.4)   
 Kanamycin  0.1 (0.2) 0.7 (0.9)   
 Gentamicin  1.8 (2.6) 1.4 (1.7) 8.2 (6.0) 3.4 (4.7) 
 Any aminoglycosides  8.9 (12.7) 2.8 (3.5) 8.2 (6.0) 3.4 (4.7) 
Grand total  5.9 (100) 70.3 (100) 80.3 (100) 136.3 (100) 73.3 (100) 
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Table 4. Estimated annual AMU expressed in terms of weight (mg) of AAI as calculated from the farm survey. The percent is 
indicated in parenthesis. Critically important antimicrobial classes according to WHO are highlighted: *High priority, **Highest 
priority. #AAIs in products administered to animal populations that were intended for human use. 
Class AAI Humans Chickens Ducks Muscovy ducks Pigs 
Tetracyclines* Tetracycline# 3.1 (1.3) 51.1 (2.2) 34.4 (1.9) 684.4 (10.6)  
 Oxytetracycline  162.1 (7.1) 147.9 (8.2) 190.4 (3.0) 3.4 (0.3) 
 Doxycycline  115.5 (5.0) 302.0 (16.7) 2,150.9 (33.4)  
 Any tetracyclines 3.1 (1.3) 328.7 (14.4) 484.3 (26.9) 3,025.7 (47.0) 3.4 (0.3) 
Sulfonamides Sulfaquinoxaline  155.5 (6.8)    
 Sulfamethoxazole#  58.2 (2.5)   55.6 (3.7) 
 Sulfaguanidine#      
 Sulfadimidine  517.7  (22.6)    
 Sulfadimethoxine  15.5 (0.7)    
 Any sulfonamides  746.7 (32.6)   55.6 (3.7) 
Quinolones Norfloxacin   7.8 (0.4) 195.5 (3.0)  
 Marbofloxacin  9.4 (0.4)    
 Enrofloxacin  43.5 (1.9) 299.2 (16.6) 97.8 (1.5) 92.6 (6.1) 
 Ciprofloxacin# 6.6 (2.7)     
 Ofloxacin 0.9 (0.4)     
 Any quinolones 7.4 (3.1) 52.9 (2.3) 307.0 (17.0) 293.3 (4.5) 92.6 (6.1) 
Polypeptides** Colistin  89.8 (3.9) 149.4 (8.3) 405.2 (6.3) 61.5 (4.1) 
 Any polypeptides  89.8 (3.9) 149.4 (8.3) 405.2 (6.3) 61.5 (4.1) 
Penicillins* Ampicillin 4 (1.7) 29.4 (1.3) 114.3 (6.3) 24.6 (0.4) 77.2 (5.1) 
 Amoxicillin# 129.8 54.7) 93.0 (4.1) 82.1 (4.6)  546.5 (36.0) 
 Penicillin V 4 (1.7)     
 Any penicillins 137.9 (58.0) 122.4 (5.3) 196.4 (10.9) 24.6 (0.4) 623.7 (41.1) 
Macrolides** Tylosin  242.3 (10.6) 329.8 (18.3) 1423.5 (22.1) 458.5 (30.2) 
 Spiramycin 0.4 (0.2) 4.4 (0.2) 2.2 (0.1)   
 Erythromycin  72.5 (3.2)    
 Any macrolides 0.4 (0.2) 319.2 (14.0) 331.9 (18.4) 1423.5 (22.1) 458.5  (30.2) 
Lincosamides Lincomycin 1.6 (0.7) 45.5 (2.0) 5.2 (0.3)   
 Any lincosamides 1.6 (0.7) 45.5 (2.0) 5.2 (0.3)   
Diaminopyrimidines Trimethoprim  20.4 (0.9) 16.7 (0.9) 35.2 (0.5) 11.1 (0.7) 
 Any diaminopyrimidines  20.4 (0.9) 16.7 (0.9) 35.2 (0.5) 11.1 (0.7) 
1st &2nd 
Cephalosporins 
Cefuroxime 28.3 13.1)     
Cefotaxime#   13.6 (0.6)   
Cefalexin 38.9 16.2) 46.6 (2.0)    
Cefdinir 2.9 (1.2)     
Any 1st &2nd cephalosporins 70.1 (29.5) 46.6 (2.0) 13.6 (0.6)   





Ceftiofur#   10.4 (0.6)   
Cefixim 11.3 (4.7)     
Cefpodoxime 2.3 (1.0)     
Cefadroxil 2.7 (1.1)     
 Any 3rd cephalosporins 16.3 (6.8)  10.4 (0.6)   
Amphenicols Thiamphenicol  324.3 (14.2) 135.1 (7.5)  6.9 (0.5) 
 Florfenicol  0.9 (0) 7.3 (0.4)  154.4 (10.2) 
 Any amphenicols  325.3 (14.2) 142.4 (7.9)  161.2 (10.7) 
Aminoglycosides* Streptomycin  41.6 (1.8) 10.4 (0.6)   
 Spectinomycin  95.0 (4.2) 10.4 (0.6)   
 Kanamycin  4.3 (0.2) 5.2 (0.3)   
 Gentamicin  49.7 (2.2) 119.9 (6.7) 1229.1 (19.1) 49.1 (3.2) 
 Any aminoglycosides  190.6 (8.3) 146.0 (8.1)  49.1 (3.2) 
Grand total  237.4 (100) 2,288 (100) 1,803 (100) 6,436 (100) 1,516 (100) 
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Estimation of AMU for the Mekong Delta region 
Details of human and animal body weight, the calculation of the total bodymass, the 
estimation of AMU and total antimicrobial consumption Mekong Delta region in 2019 both 
in frequency and quantities are presented in Supplementary Material 3 (Table 1 and 2). 
The estimates of annual AMU for each species (including humans) for the Mekong Delta 
is displayed in Figure 3. The intensity of AMU in each animal depended on metrics used. 
The intensity was highest in ‘animal standing bodymass’ metric and lowest in ‘biomass’ 
metric.  
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Figure 3. Two-dimensional diagrams representing total annual AMU in humans and 
animals in the Mekong Delta region of Vietnam using four different metrics: (A) Treatment 
intensity (expressed as No.DDD per 1,000 inhabitant/animal-days), (B) mg of AAI related 
to ‘standing animal bodyweight’; (C) mg of AAI related to ‘biomass’; (D) mg of AAI 
related to ‘No. PCUs’). The height of bars represents the population denominator, the width 
of bars the intensity of AMU by species. Colour code: Green: humans; yellow: pigs; dark 
blue: chickens; light blue: ducks; red: Muscovy ducks; black “*” (‘other’ species, including 
cattle, buffalo, goat, sheep, geese and quails, for which no AMU data are available). 
Vertical error bars represent the range between extreme scenarios (±50%).  
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The estimated total annual amounts of antimicrobials used (the area of the bars in Figure 
3) in each of species (including humans) in the Mekong Delta region are presented in 
Supplementary Material 3 (Table 3). A total of 7,055 billion doses-kg or 466.8 tonnes 
of AAIs were used. Pigs were the target of the greatest amounts of AMU, both in terms of 
frequency (40.6%) and quantity (36.1%). Human consumed a total of 1,334 billion doses 
(18.9% of all species) and 122.2 (26.2%) tonnes of of antimicrobials. However, per kg of 
body weight, human consumed less than 5% of the total  consumption of all species). 
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Discussion 
Quantification of AMU both in human and animals through the establishment of 
surveillance systems has been set by international agencies as a priority activity in order to 
successfully tackle the global threat of AMR [6, 31]. Although AMU surveillance systems 
both for humans and animals have already been established in a number of developed 
countries, (notably in European Union countries), in LMICs they are only starting to 
emerge. Most of these surveillance systems are based on sales data, and is limited by the 
difficulty of assigning species to the different antimicrobials sold since often products have 
a multi-species purpose.  
Our survey was restricted to small-scale farming units. Extrapolations of human 
antimicrobial consumption data from the survey to all human populations in the Mekong 
Delta may not be appropriate, even though that in the region over 50% raise animals. 
Furthermore, since our study is not based a truly random sample, these results need to be 
taken with caution.The cross-sectional survey conducted during a fixed period (July) may 
also limit the validity of our results. It is likely that seasonal effects may affect AMU, both 
in humans and animals. In the study area, there is an increase in animal disease during the 
rainy season (June-November), and probably increased AMU (author’s unpublished 
information). The increased diseases and relationship with AMU need to be further 
investigated. In our study, humans used approximately 15.2 DDDs per 1,000 inhabitants 
per day (TI=0.0152). These estimates were considerable modest, and lower than a previous 
published estimation for Vietnam (~32 DDDs), or even the 2019 EU average (20.1 DDDs, 
with a country range of 9.7–34.0) [32]. However, our study excluded antimicrobials used 
in human health care settings and hospitals. A recent report in Thailand suggests that AMU 
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for humans in Thailand in 2018 was considerably higher (74.4 DDDs) [33]. Children and 
the elderly used more, as in other countries. 
Our study reports for Mekong Delta region, overall greater quantities of use in animals 
(91.9 ADDkg or 912.3 mg/kg biomass or 1,591 mg/PCU) compared with published data 
from Thailand (711 mg/PCU in 2018), from EU (105.6 mg/PCU )and global estimates 
(240.5mg/kg biomass). In terms of treatment intensity, chickens consumed ~193 ADDkg 
per 1,000 chicken-day. These values are about 50% lower than those measured in a 
previous study based on a large sample (382 ADDkg per 1,000 chicken-days) [10]. This is 
probably a reflection that the flock size in our study included small (i.e. backyard) flocks 
which is likely to use lower amount of antimicrobials. This is likely to be explained since 
flocks in that study were ‘all-in-all-out’ (i.e. single age) which are known to use lesser 
amonts of antimicrobials, probably due to better disease control [20]. The antimicrobial 
amounts used in Muscovy duck farms were considerably higher magnitude compared with 
all other species. However, these estimates, were based on a small sample (the data are 
based on 12 farms raising Muscovy ducks). Therefore, future study should estimate sample 
size for each animal species separately in order to reduce the standard error.  
The study results highlighted that the intensity of AMU in each animal species highly 
depended on metrics used. Estimation AMU in different metrics allowed us to compare 
with current AMU reported in other region. Besides that, due to these different, the 
interpretation of human AMU when compared with animal AMU need to take into account 
chosen metrics. The intensity was highest in ‘animal standing bodymass’ metric, lower in 
‘PCU’ metric and lowest in ‘biomass’ metric. We found a greater diversity of 
antimicrobials used in animals (30 AAIs, belonging to 11 classes) compared with humans 
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(14 AAIs, belonging to 6 classes).  The types of antimicrobial classes found in animals in 
this study were very similar to previous longitudinal study in the same area [10]. It is of 
concern that a high proportion of critical important classes (CIAs) were used in the 
community, especially some of the last resort antimicrobial for hospital-acquired infection. 
AAIs regarded of critical importance by WHO in animals (71.8%) were considerably 
higher magnitude compared with humans (47.4%), although the CIAs classes were 
different among human and animals species (penicillins and 3rd gen. cephalosporins in 
humans and tetracylines, penicillins and polypeptides in animals).  
Using a relatively simple cross-sectional survey design, we measured AMU in different 
animal species, and compared it to that of humans in rural community settings using 
different metrics. We interviewed participants in their homes, allowing us to examine the 
antimicrobial products as well as their prescriptions and drug containers. This approach is 
remarkably affordable and appropriate to the modest economies of many LMICs for 
estimating total AMU in specific areas. On average, the on-farm interview in the cross-
sectional study took approximately one hour (time require for completing the 
questionnaire and reviewing antimicrobial products used). In the longitudinal study, 
AMU data only collected during whole production cycle of a chicken flock. There were 
four visits per flock. In my experience, the person-time required per visit in a cross-
sectional study is similar to that of a longitudinal study design. Therefore, the costs of the 
longitudinal-study are about four times higher. The cost to conduct a visit was between 
$15 and $20 in the study. We propose to expand this methodology in terms of geography 
(i.e. additional provinces), including a true representative sample of the study units to 
obtain a more precise and valid national AMU estimates.  
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Chapter 8 
General discussion and 
conclusions 
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8.1 Contribution of this thesis  
In this thesis I characterised AMU (what types of antimicrobials, in what quantities, 
when) in small-scale commercial chicken farming systems in the Mekong Delta region 
of Vietnam. The thesis also compared AMU in humans and as well as other animal 
species raised in farming communities in the Mekong Delta using different metrics. I 
also provided empirical evidence of the impact of untargeted use of antimicrobials on 
prevention and disease outcome. This understanding is crucial for designing effective 
intervention strategies to curb excessive antimicrobial consumption in low-resource 
settings.  
8.2 Longitudinal versus cross-sectional studies  
Antimicrobial consumption data may be gathered from farms either through 
longitudinal or cross-sectional surveys. Compared with unannounced ‘one-off’ visits to 
farms typical of cross-sectional studies, longitudinal study designs yield more accurate 
data on AMU coupled with other production variables over time. However, such studies 
are costly and time-consuming. In small-scale production units, farmers often do not 
keep records, and therefore this requires extra efforts by field teams in training farmers 
on data collection. Results from Chapter 4 indicated that overwhelmingly farmers used 
more antimicrobials during the ‘brooding’ period. Results from Chapter 7 demonstrated 
that quantitative AMU data can be gathered from a simple cross-sectional survey 
particularly if farmers are asked over AMU in their flocks/herds over a short period of 
time (7 days). This method is appropriate and affordable for a large scale survey (i.e. 
national survey) where longitudinal study might not be feasible.  
8.3 Metrics of AMU  
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In all cases, estimates of AMU obtained from surveillance or farm studies are very 
sensitive to the chosen metric. Due to the different on the chosen weight of animal as 
well as animal population (census or production data) in each metric, comparison 
among different metrics need to be consider with caution. As shown in Chapter 7 AMU, 
the amounts appear largest when the weight of antimicrobial is related to the ‘standing 
population’, followed by ‘PCU’ and lowest in ‘biomass’ metrics (the latter two being 
related to production statistics). Similarly, results from Chapter 4 indicated that AMU 
amount are two folds higher when antimicrobial quantities are related to weight 
measured at treatment time’ compared to slaughter time, when the animal is at its 
highest possible weight. A further consideration is that relating AMU to production 
output (i.e. kg of slaughtered animals) will, in situations of high mortality (such as the 
one described in this thesis) (Cuong, Phu et al. 2019; Carrique-Mas, Van et al. 2019), 
result in reduced estimates of AMU compared with situations of low mortality or no 
mortality at all.  
This shows the challenge for establishing a ‘single global metric’ for AMU, and 
contributes to the difficulty in drawing comparisons across studies that may encompass 
different countries or production types. A recent study that reviewed 38 farm-based 
AMU surveillance systems from 16 countries confirmed that metrics used by these 
systems differed in many ways. The chosen indicators were dependent on many factors 
including the type of data collected, the type of analyses conducted and their respective 
output (Sanders, Vanderhaeghen et al. 2020). The current metrics adopted by ESVAC 
and OIE in their reports are ‘weight-based’ (mg/PCU and mg/kg of biomass) (EMA 
2020; OIE 2020). These metrics are probably a good start, since may allow comparison 
in AMU across countries. However, these metrics do not reflect antimicrobials 
treatment intensity in different species, which might be important in the fight against 
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AMR. In its latest report (EMA 2020), EMA has established standardised units of 
measurement for reporting AMU in particular animal species (the 'defined daily dose' 
and 'defined course dose'). It is expected that this unit will be used in the future report 
of ESVAC alongside the current mg/PCU metric.  
8.4 AMU in small-scale chicken production in the Vietnamese context  
This thesis provides a full picture on AMU, including water and feed (323.4 mg and 
84.8 mg per kg of chicken at slaughter time) in small-scale native chicken production 
in the Mekong Delta region of Vietnam. Over the life of chicken, in-feed AMU 
represents approximately 20% of total AMU. AMU consumed by chicken through 
water in this study (791mg/kg at treatment time) are much higher than global estimates 
in 2017 (68mg/PCU) (Tiseo, Huber et al. 2020). In term of treatment intensity, chicken 
in our study (results from Chapter 4) consumed three times more than global average 
levels (381 vs 138 doses per 1,000 chicken-days) (Cuong, Padungtod et al. 2018). 
Results from Chapter 4 highlight the huge diversity of AAIs with a high proportion of 
CIA used in small-scale chicken farms. Results from Chapter 7 showed that 
consumption of CIAs in animals (71.8%) was of considerably higher magnitude than 
in humans (47.4%), although the CIAs classes were different among human and 
animals species (penicillins and 3rd gen. cephalosporins in humans and tetracylines, 
penicillins and polypeptides in animals). The high prevalence of colistin use and 
resistance found in the area (Nguyen, Phuong Yen et al. 2020) is of particular concern, 
since this is one of the antimicrobials of last resort for hospital-acquired infections in 
humans (Kadar, Kocsis et al. 2013).  
8.5 Impact of AMU on animal and human health  
As expected, given the high amounts of AMU in chicken production in the area, studies 
have identified a high prevalence of AMR in commensal flora microorganisms (i.e. 
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Escherichia coli) (Nguyen, Nguyen et al. 2016; Nhung, Cuong et al. 2015) and in food-
borne pathogens (i.e. non-typhoidal Salmonella and Campylobacter spp.) (Carrique-
Mas, Bryant et al. 2014; Tu, Hoang et al. 2015). A further concern is that antimicrobials 
products may be administerd towards the end of the production cycle (with or 
withdrawal tiem period), posing a risk of accumulation of antimicrobial residues in 
poultry meat (Patel, Marmulak et al. 2018). A number of recent studies have indicated 
a considerably high prevalence of antimicrobials residues in pork (23%) and in chicken 
meat samples (8.4%) (Ngoc Do, Yamaguchi et al. 2016; Nhung, Van et al. 2018). 
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8.6 Drivers of AMU in chicken production 
The reasons that explain the observed high amounts of AMU are complex. One of the 
most important drivers is the high incidence of disease and mortality in this typical type 
of chicken prodution. A study demonstrated that AMU was most common during the 
‘brooding period’ (3-4 first weeks of chicken life) when highest prevalence of disease 
was found (Carrique-Mas, Van et al. 2019). Furthermore, due to the complexity of 
infectious disease etiology in the area (Van, Yen et al. 2019), there is evidences that the 
probability of the effective treatment often very low (approximately 57%) (Choisy, Van 
Cuong et al. 2019). Farmers, when facing the failure of an antimicrobial treatment 
course, might look for new treatment courses with new antimicrobial classes, resulted 
in even higher amount of AMU overall. It is particularly worrying if this phenomenon 
is common in reality, since antimicrobials can be easily purchased over the counter at 
extremely low retail prices (Dung, Truong et al. 2020). Farmers’ behavior on disease 
management practices might explain such high quantities of AMU. A study showed 
that farmers believed the cost of AMU cheaper than other disease control management 
practices; and even these costs are more expensive, they would lead to more effective 
disease prevention (Truong, Doan et al. 2019). It is believed that authorities veterinarian 
were the most trusted sources of advice on AMU and many of them also own a private 
veterinary drug shops which were the main sources of supply antimicrobial products in 
the region. To increase profitability, these private drug shops might sell antimicrobial 
products even if it is not necessary. A study has demonstrated that high level of AMU 
are associated with high density of the veterinary pharmacies (Phu, Giao et al. 2019).  
In Vietnam, the legislation states that antimicrobial products intended for human usage 
can only be purchased with a medical prescription (MOH). Compliance with this 
regulation is monitored by the inspection services of the Health Ministry and the local 
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Health Services. However, it is unclear how the sales of antimicrobials is managed since 
there is no compulsory recording system or database in place (only for addictive drugs, 
poisonous medicament, psychotropic medicines and pre-substances used as drugs). In 
veterinary medicine, none of these regulations existed at present. 
Result from Chapter 6 indicated that antimicrobial products aiming for prophylactic 
purpose were used in half of the time of total AMU. This is because high ratio (65%) 
of antimicrobial products contain the ambiguous labelling by providing guidelines for 
both therapeutic and prophylactic AMU (Yen, Phu et al. 2019). This type of labels 
encouraged the prophylactically usage in healthy chicken that resulted in high amount 
AMU overall. 
8.7 Quality of antimicrobial products  
Vietnam is one of the largest markets of pharmaceutical industry in Southeast Asia. In 
the region, many poor quality pharmaceutical products are also manufactured 
(Kelesidis and Falagas, 2015). Vietnam only started to implement Good Manufacturing 
Practices (GMP) in 2004, and is lagging behind other countries in SEA region. 
Vietnamese authorities now require that all manufacturers of human medicinal products 
or vaccines must comply with GMP standards (GMP-ASEAN, GMP-WHO or an 
equivalent from 2012 (Joint Circular No.01/2012/TTLT-BYT-BTC) and in veterinary 
medicine from 2016 (Decree No. 35/2016/ND-CP). The country currently has more 
than 170 GMP human (78 veterinary) pharmaceutical manufacturing facilities, more 
than 9,000 pharmacies, 10,000 veterinary drug stores and more than 40,000 human 
licensed products (including over 12,000 veterinary products) (DAV 2020 and DAH 
2020). Due to limited financial and human resources, the number of products that 
routinely investigated is very low.  
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The most common type of poor quality antimicrobial products fall into three categories: 
poor workmanship (i.e. antimicrobial does not meet advertised quality), counterfeit (i.e. 
does not contain genuine active ingredients) and degraded drugs (Le Minor, 2011). 
Although a number of low quality antimicrobial products were reported in Vietnam in 
the past (WHO 1999), the number of counterfeit and substandard antimicrobial drugs 
in human medicine in Vietnam is unknown. However, a recent study showed that 
Vietnam had the largest proportion (among six countries of the study) of non-licensed 
antimicrobials products (high possibility of low quality products) circulating in the 
market. This situation is particularly more worrying since self-medication with 
antimicrobial products are wide-spread in Vietnam (55·2% of antimicrobial products 
dispensed without prescription) (Nga and Huong, 2021). 
In veterinary medicine, a recent study showed that about 7% of antimicrobial products 
(n=144) contained less than half of the labelled content concentrations (Huong and 
Thuy, 2021). Other study highlighted that only about 30% of veterinary antimicrobial 
products contained all AAIs within 10% of the declared strength (Yen and Phu, 2019).  
The usage of low quality antimicrobial drugs can lead to treatment failures in both 
animal and human health. Substandard antimicrobial drugs may resulted in the increase 
of morbidity, mortality and antimicrobial resistance. The low quality of antimicrobial 
products highlight the need of consistent and sustainable monitoring system for both 
human and veterinary medicines. 
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8.8 A ban of AMU for prophylactic purposes (including AGPs) 
Result from Chapter 6 indicated that antimicrobial products aiming for prophylactic 
purpose were used in half of the time of total AMU. A number of other studies showed 
that routine preventive AMU is still common in chicken production systems (Carrique-
Mas, Trung et al. 2014; Coyne, Arief et al. 2019). Results from this study model 
demonstrated that there were no impact of prophylactic AMU on the prevention of 
diseases in chicken. A number of recent studies have been highlighted the overall poor 
effects of AGPs in poultry productivity (Hamid, Zhao et al. 2019; Kumar, Chen et al. 
2018). In contrast, positive effects are only observed in low biosecurity production 
systems (Laxminarayan 2015). However, this small marginal productivity gains often 
offset by the high mortality rates found in this region.  
Vietnam is currently engaged in legislative efforts leading to progressive reductions of 
antimicrobials use in animals. A recent Decree issued by the VN Government 
(13/2020/ND-CP) includes the timeframe for a ban of AMU for prophylactic purposes 
(including AGPs), with phased bans for different antimicrobials classes. Data from this 
thesis showed that prophylactic AMU in chicken production in Vietnam is of 
considerable greater impact than AGPs, since the in-feed AMU represents a small 
fraction of total AMU and the most common AAIs found in chicken feeds often have 
little impact on human health. 
8.9 Limitations of this thesis  
This study focused on local breed chicken farms with average flocks size from 100 to 
1,500 birds (data for chapters 4, 5, 6). A large proportion of farms with larger size 
(industrial farms) were excluded. This might limit the representativeness of the AMU 
estimates. Although, only small fraction (26.1%) corresponded to chickens raised in 
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industrial systems in Vietnam, it is forecasted that the major increase of AMU mostly 
driven by increased number of the intensification of farming systems in the near future. 
It is not possible to define prophylactic and therapeutic AMU when both AMU and 
clinical signs were reported in the same week. Although, the approach used in Chapter 
6 provided a clear definition of prophylactic and therapeutic of AMU, still, about 50% 
of the data were excluded, thus decreased the statistical power of this study.  
8.10 Conclusions and recommendations 
Through the quantification of AMU in animals and in humans in small-scale farms in 
Mekong Delta region of Vietnam and the analysis of AMU in relation to disease of 
chicken flocks, this research yielded a number of important results.  
First, results from both longitudinal and cross-sectional studies showed significant 
discrepancies between AMU measurement metrics. The ‘dose-based’ and ‘weight-
based’ metrics resulted in quantitative different estimates in levels of AMU. It is 
importance to take into account when comparing AMU data across studies. 
Second, a complete picture of antimicrobials administered (both through water and 
feed) to chicken flocks in the Mekong Delta region of Vietnam, showed a high fraction 
of AMU in chicken production consists of CIAs. In addition, in terms of dosing, 
chickens are predominantly medicated during the ‘brooding period’. 
Third, compared with antimicrobials administered to chicken flocks through water, 
consumption of AGPs in feed represents a relatively small fraction of total AMU. 
Furthermore, a considerable number of feed formulations did not comply with 
Government regulations. 
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Fourth, study models clearly indicated the ineffective impact of prophylactic AMU and 
palliative effect of therapeutic AMU. Prophylactic AMU should not be used if 
unnecessary since it does not reduce the probability of disease. Therapeutic AMU 
should be used with a proper diagnostic.  
Finally, using a One Health approach, this study demonstrated that AMU can be 
estimated from a relatively simple cross-sectional survey, although results are very 
sensitive to the chosen metric. This methodology can be used in AMU surveillance in 
low-resource settings, allowing to focus reduction efforts AMU in particular animal 
species. 
Based on the results of this research and current situation in Vietnam, the following 
recommendations are put forward for the next steps in monitoring and reducing the 
AMU in Vietnam as well as in other similar LMICs: 
 The methodology used in Chapter 7 should be applied for a national survey of 
AMU because of its appropriate and affordable (cost-effective) approach in the 
Vietnamese context. This method should be further expanded in terms of 
geography (i.e. additional Vietnamese provinces) as well as performing a true 
representative sampling of the study units (i.e. random sampling). 
 The establishment of surveillance systems for AMU is imperative in Vietnam 
(as well as in other LMICs). Surveillance systems should allow establishing 
comparisons of AMU in different production types and geographical locations, 
and can be used to monitor changes in AMU over time. Both ‘dose-based’ and 
‘weight-based’ metrics should be used in Vietnam since the Vietnamese 
government collects comprehensive statistical data on animal production. The 
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collection of ‘dose-based’ data is relatively simple (i.e. number of days using 
antimicrobials), although it cannot be expected to be fully accurate since many 
farmers actually overdose (and some underdose).  
 Authorities should implement long-term, sustainable training programs 
targeting different stakeholders (farmers, veterinarian, veterinary pharmacists, 
feed producers etc.) to increase their awareness of the problem of AMR and the 
importance of AMU reduction. Such training should emphasize the need to 
improve day-old chick quality and farming practices (i.e. biosecurity, cleaning 
and disinfection, brooding management, vaccination). A feasible approach is to 
deliver these training programs through the veterinary authority (Sub-
Department of Animal Health in each province). A recent study showed that 
reducing current high levels of AMU through the provision of veterinary advice 
(i.e. improve diagnostic capacity) resulted in considerable reductions in AMU 
and mortality (Phu, Cuong et al. 2021). Since most veterinary antimicrobials are 
procured in local vet drug shops, the role of the veterinary pharmacists as 
gatekeepers of AMU should be reinforced. 
 Efforts to reduce AMU should focus the farming sector since quantitatively 
more than 80% amounts of AMU corresponds to animal production. Although 
new legislations on AMU management  has been released in Vietnam. A 
number of specific policies should be implemented. For example, the quality of 
day-old chicks are often not reliable and there are no law related to the quality 
control management on the day-old chicks. Other issues might relate to the 
ambigious labelling of antimicrobial products, espcially for prophylactic usage 
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purpose since it encouraged the unneccessary AMU. All antimicrobial products 
should indicate for specific usage, not for multiple purposes.  
 The policies on antimicrobial pricing should be revised to discourage the use of 
CIAs. Currently antimicrobials intended for animals are disproportionally 
cheap. The use of a number of antimicrobial alternative products already 
available in the market (i.e. plant essential oils, yeast extracts, probiotic, 
prebiotic etc.) should be promoted. 
 The last recommendation is that the human and animal AMU as well as AMR 
data should be collected in parallel. Due to complexity of the AMR 
phenomenon, complementation of these data might provide the best possible 
solution to combat AMR in both animals and humans.. 
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1 Crumb     10    Certain 42 127 
2 FE002 Growing 1 Pellet     10    Certain 9 11 




1 Crumb   50      Certain 6 13 








1 Crumb   50      Certain 4 6 












1 Crumb  30       Certain 27 79 








1 Crumb   50      Certain 13 26 








1 Crumb 10 50   10 10   Ambiguous 2 2 












1 Pellet   50      Certain 1 1 








1 Crumb  50   10    Ambiguous 3 3 












1 Pellet  4-50   1-10    Ambiguous 2 2 




1 Crumb        5-15 Certain 6 6 
























2 Crumb   75-150* 
100-
200* 
    Certain 1 1 
 
*Products that have AAIs concentration higher than permitted Vietnamese regulation 
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Nghiên cứu về kiến thức và thực hành trong việc sử dụng thuốc và thuốc kháng (trụ) sinh trong gia đình và chăn nuôi tại Đồng Tháp, Việt Nam 
Đơn vị Nghiên cứu Lâm sàng Đại học Oxford 















































Nghiên cứu của chúng tôi nhằm tìm hiểu về kiến thức và thực hành trong việc sử dụng thuốc và thuốc kháng sinh trong gia đình và chăn nuôi tại các hộ chăn 
nuôi nhỏ ở tỉnh Đồng Tháp, thông qua việc phỏng vấn trực tiếp người nông dân. Anh/chị đã được phổ biến về nội dung của nghiên cứu và đồng ý tham gia. 
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A. THÔNG TIN CHĂN NUÔI VÀ SỬ DỤNG THUỐC VÀ THUỐC KHÁNG SINH TRONG CHĂN NUÔI 
 
A1. THÔNG TIN CHUNG 
 
Các loài gia súc đang chăn nuôi 
(chọn tất cả các đáp án đúng) 
Sử dụng thuốc trong tuần vừa qua? 
 
 
    Gà 
 
   Có 
 
   Không/Không nhớ  
 
    Vịt 
 
   Có 
 
   Không/Không nhớ  
 
    Vịt xiêm 
 
   Có 
 
   Không/Không nhớ  
 
    Ngỗng 
 
   Có 
 
   Không/Không nhớ  
 
    Chim cút 
 
   Có 
 
   Không/Không nhớ  
 
    Heo 
 
   Có 
 
   Không/Không nhớ  
 
    Bò 
 
   Có 
 
   Không/Không nhớ  
 
    Trâu 
 
   Có 
 
   Không/Không nhớ  
 
    Dê, cừu 
 
   Có 
 
   Không/Không nhớ  
 
    Cá 
 
   Có 
 
   Không/Không nhớ  
 
    Tôm 
 
   Có 
 
   Không/Không nhớ  
 
    Khác (ghi rõ) 
 
   Có 
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A2. THÔNG TIN CHĂN NUÔI VÀ VIỆC SỬ DỤNG THUỐC VÀ THUỐC KHÁNG SINH TRONG CHĂN NUÔI 
 
A2A. Tên loài 1:  
 
A2B. Độ tuổi 
(theo tháng) 
1 










A2C. Số con 
 
 
__ __ __ __ 
 
 
__ __ __ __ 
 
__ __ __ __ 
 
__ __ __ __ 
A2D. Mục đích chăn nuôi  




   
A2E. Số con dùng thuốc  
(trên tổng cộng) 
 
__ __ __ __ /__ __ __ __ 
 
 
__ __ __ __ /__ __ __ __ 
 
__ __ __ __ /__ __ __ __ 
 
__ __ __ __ /__ __ __ __ 
A2F. Bao 
bì/đơn thuốc 
vẫn còn lưu 
giữ? 










A2G. Thông tin dùng theo nhóm tuổi (chỉ 
điền nếu xác định hoặc nghi ngờ là kháng sinh) 







Tên sản phẩm 
 
    
Thời gian dùng 


















Tên sản phẩm 
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Thời gian dùng  



















Tên sản phẩm 
 
 
    
Thời gian dùng  




















Tên sản phẩm 
 
    
Thời gian dùng  













    
A2H. Lời 
khuyên của ai 
trong việc 
dùng thuốc? 







Bác sĩ/nhân viên thú y   
 
  










Khác (ghi rõ) 
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A2. THÔNG TIN CHĂN NUÔI VÀ VIỆC SỬ DỤNG THUỐC VÀ THUỐC KHÁNG SINH TRONG CHĂN NUÔI 
 
A2A. Tên loài 2:  
 
A2B. Độ tuổi 
(theo tháng) 
1 










A2C. Số con 
 
 
__ __ __ __ 
 
 
__ __ __ __ 
 
__ __ __ __ 
 
__ __ __ __ 
A2D. Mục đích chăn nuôi  




   
A2E. Số con dùng thuốc  
(trên tổng cộng) 
 
__ __ __ __ /__ __ __ __ 
 
 
__ __ __ __ /__ __ __ __ 
 
__ __ __ __ /__ __ __ __ 
 
__ __ __ __ /__ __ __ __ 
A2F. Bao 
bì/đơn thuốc 
vẫn còn lưu 
giữ? 










A2G. Thông tin dùng theo nhóm tuổi (chỉ 
điền nếu xác định /nghi ngờ là kháng sinh) 








Tên sản phẩm 
 
    
Thời gian dùng 


















Tên sản phẩm 
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Thời gian dùng  




















Tên sản phẩm 
 
 
    
Thời gian dùng  





















Tên sản phẩm 
 
    
Thời gian dùng  













    
A2H. Lời 
khuyên của ai 
trong việc 
dùng thuốc? 







Bác sĩ/nhân viên thú y   
 
  










Khác (ghi rõ) 
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B. KIẾN THỨC 
B1. Kiến thức về kháng sinh trên người:  
Lưu ý: 
• Khoanh tròn một lựa chọn 
• Không tiết lộ người dân trả lời đúng hay sai trong quá trình hỏi. Có thể giải thích sau khi kết thúc tuỳ thời gian cho phép. 
• Khi người dân không hiểu câu hỏi, thay đổi cách diễn đạt. Nếu vẫn không biết hoặc không hiểu, khoanh tròn Không biết/không hiểu câu hỏi (99). 
• Ghi chép lại tất cả các câu trả lời đáng chú ý (e.g. người dân không biết vi khuẩn/vi-rút nhưng hiểu kháng sinh chống nhiễm trùng vết thương, khái niệm 
lờn thuốc v.v…)  
B1A. Trước khi tham gia vào nghiên cứu này, anh/chị đã nghe tới khái niệm thuốc kháng sinh/thuốc trụ sinh? 
 1. Có => mời tham gia trò chơi, sau đó hỏi tiếp bảng câu hỏi từ A2 đến A11 
 2. Không => chuyển sang phần B 
 
B1B. Thuốc kháng sinh được dùng để chữa cảm lạnh hoặc cảm cúm. 
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
B1C. Thuốc kháng sinh được dùng để trị bệnh sốt siêu vi, sốt xuất huyết. 
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi  
 
B1D. Nếu đang sử dụng một liều thuốc kháng sinh, khi nào có thể dừng? 
 1. Khi cảm thấy khoẻ hơn 
 2. Khi đã uống hết thuốc theo chỉ dẫn hoặc theo đơn 
 99. Không biết/không hiểu câu hỏi 
 
B1E. Thuốc kháng sinh đã sử dụng có thể được dùng tiếp cho bạn bè/người thân, nếu họ mắc những triệu chứng hoặc bệnh tương tự.    
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
 
Page 217 of 342
B1F. Khi bị bệnh cần sử dụng thuốc kháng sinh, có thể mua tiếp loại kháng sinh đó nếu lần sau mắc phải bệnh hoặc triệu chứng tương tự.    
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
B2. Kiến thức về kháng sinh trong chăn nuôi: 
B2A. Thuốc kháng sinh được dùng để trị bệnh cúm gia cầm, viêm gan vịt. 
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
B2B. Thuốc kháng sinh được dùng để trị bệnh E. coli trên gà, vịt. 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
B2C. Thuốc kháng sinh được dùng để thúc đẩy tăng trưởng gia súc và gia cầm. 
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
B2D. Thuốc kháng sinh được sử dụng chữa bệnh phổ biến trên người hơn là trên gia súc và gia cầm. 
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi 
 
B2E. Tồn dư kháng sinh trong thịt có thể bị hấp thụ bởi con người. 
 1. Đúng 
 2. Sai 
 99. Không biết/không hiểu câu hỏi
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C. THÔNG TIN GIA ĐÌNH VÀ VIỆC SỬ DỤNG THUỐC VÀ THUỐC KHÁNG SINH TRONG GIA ĐÌNH 
 
C1A. Số thành viên đã ký phiếu đồng ý tham gia:_____ 
Số trẻ em dưới 18 tuổi được bố/mẹ thay mặt ký:______ 
 
C1B. Tên thành viên 















(theo năm, viết 01 nếu nhỏ 



















Giới tính  
Nam 
 
      
Nữ  
 




Không đi học  
 
     
Cấp 1  
 
     
Cấp 2  
 
     
Cấp 3  
 


























[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 






[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
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(chọn tất 





[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 




[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 






[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 




[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
Công ty/doanh 
nghiệp tư nhân 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
 
[_ _ _,_ _ _, _ _ _] 
 
Khác (ghi rõ)  
____________ 
 
































gia đình?  
Hàng ngày 
 
      
Hơn 1 lần/tuần 
 
      
Hơn 1 lần/ 
tháng 
      
Hơn 1 lần/  
6 tháng 
      
Không tiếp xúc 
 

































































































































   
Không 
Có nhớ tên 
thuốc? (đánh 


























C1J. Thông tin thuốc 
(chỉ điền nếu xác định hoặc 
nghi ngờ là kháng sinh) 














    
Số lần dùng 




__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
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Lý do 

















    
Số lần dùng 




__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
























































    
Số lần dùng 




__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 




















































    
Số lần dùng 




__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 
__ __ /__ __ 
 
 


















































    
Bác sĩ/nhân 





    













    






    
Ghi chú: 
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Appendix 2.  
Table 1. The ‘standing bodymass’ of people living in the Mekong Delta region of Vietnam. It was estimated using age-gender-weight metrics from census 
(1) and published data (2).  




































0 to 4 779,689 677,961 1,457,650 8.0 7.8 6,237,511 5,288,093 11,525,605 
5 to 9 743,489 646,657 1,390,146 14.7 14.7 10,929,295 9,505,858 20,435,153 
10 to 14 684,944 603,585 1,288,529 25.6 27 17,534,568 16,296,790 33,831,357 
15 to 19 625,648 570,054 1,195,702 41.4 35.4 25,901,830 20,179,916 46,081,745 
20 to 40 3,029,801 2,852,915 5,882,716 58.4 50.8 176,940,398 144,928,062 321,868,460 
41 to 65 2,611,166 2,637,830 5,248,996 58.4 50.8 152,492,079 134,001,773 286,493,852 
> 65 535,755 805,206 1,340,961 58.4 50.8 31,288,117 40,904,446 72,192,563 
Total 9,010,493 8,794,207 17,804,700 - - 421,323,798 371,104,937 792,428,735 
(1). Population pyramid of Vietnam, 2019. 2019; Available from: https://www.populationpyramid.net/viet-nam/2019/. 
(2) Carrique-Mas, J.J., et al., An estimation of total antimicrobial usage in humans and animals in Vietnam. Antimicrob Resist Infect Control, 2020. 9: p. 16. 
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Table 2. The estimation of animal ‘standing bodymass’, animal ‘biomass’ and animal ‘PCU’. It was estimated from number of animal (from census (1), 
production data (2)) and weight of animals (from mid-point weight (3), slaughter weight (4) and treatment weight (5). Mid-point weight of meat animal 
equals 50% slaughter weight.  
   
No. animals  Weight of animals  Total animal weight 
Species Production type 
 
No. animals at a 







 Mid-point weight 
(kg) (3) 















1,487,452 2,974,904*  39.3 78.6 65.0  58,456,864 233,827,454 193,368,760 
Breeder 
 
198,481 198,481  240.0 240.0 240.0  47,635,440 47,635,440 47,635,440 
Chicken Meat 
 
40,853,000 74,381,000  0.9 1.8 1.0  36,767,700 133,885,800 74,381,000 
Breeder 
 
12,003,000 12,003,000  1.8 1.8 1.0  21,605,400 21,605,400 12,003,000 
Duck Meat 
 
15,923,000 46,070,000  1.0 2.0 1.1  15,923,000 92,140,000 50,677,000 
Breeder 
 
11,388,000 11,388,000  2.0 2.0 1.1  22,776,000 22,776,000 12,526,800 
Muscovy duck Meat 
 
1,959,000 3,760,000  1.6 3.2 1.7  3,134,400 12,032,000 6,392,000 
Breeder 
 
222,000 222,000  3.2 3.2 1.7  710,400 710,400 377,400 
Quails Meat 
 
2,871,900 6,980,000  0.07 0.13 0.08  186,674 907,400 558,400 
Breeder 
 
319,100 319,100  0.13 0.13 0.08  41,483 41,483 25,528 
Cattle Meat 
 
808,955 292,386  75.0 150.0 140.0  60,671,625 43,857,900 40,934,040 
Breeder 
 
70,707 70,707  300.0 300.0 425.0  21,212,100 21,212,100 30,050,475 
Buffalo Meat 
 
20,736 7,053  150.0 300.0 140.0  3,110,400 2,115,900 987,420 
Breeder 
 
2,303 2,303  500.0 500.0 425.0  1,151,500 1,151,500 978,775 
Goat Meat 
 
358,592 250,724  37.5 75.0 20.0  13,447,200 18,804,300 5,014,480 
Breeder 
 
39,843 39,843  75.0 75.0 75.0  2,988,225 2,988,225 2,988,225 
Sheep Meat 
 
838 560  37.5 75.0 20.0  31,425 42,000 11,200 
Breeder 
 
93 93  75.0 75.0 75.0  6,975 6,975 6,975 
Geese Meat 
 
203,000 164,000  1.6 3.2 1.7  324,800 524,800 280,440 
Breeder 
 
55,000 55,000  3.2 3.2 1.7  176,000 176,000 93,500 
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(1),(2) Thống kê chăn nuôi Việt Nam 01/01/2020. Available at: https://channuoivietnam.com/thong-ke-chan-nuoi/ 
(4) OIE Annual Report on Antimicrobial Agents Intended for Use in Animals: Methods Used. Available at: https://www.frontiersin.org/files/Articles/462898/fvets-06-00317-HTML/image_m/fvets-06-00317-t002.jpg  
(5) European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Sales Data and Animal Population Data Collection Protocol. Available at: https://www.ema.europa.eu/en/documents/other/european-surveillance-
veterinary-antimicrobial-consumption-esvac-web-based-sales-animal-population_en.pdf  
*Pig production data were estimated from census data. 
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Supplementary Material 1.  








District    
Cao Lanh 21 (20.8) 50 (23.3) 71 (22.5) 
Chau Thanh 20 (19.8) 45 (20.9) 65 (20.6) 
Lai Vung 21 (20.8) 39 (18.1) 60 (19) 
Thap Muoi 20 (19.8) 53 (24.7) 73 (23.1) 
Tam Nong 19 (18.8) 28 (13) 47 (14.9) 
Age    
 <5 0 (0) 31 (14.4) 31 (9.8) 
 5-19 0 (0) 65 (30.2) 65 (20.6) 
20-40 27 (26.7) 43 (20) 70 (22.2) 
 41-65 56 (55.4) 48 (22.3) 104 (32.9) 
 >65 18 (17.8) 28 (13) 46 (14.6) 
Gender    
Male 83 (82.2) 81 (37.7) 164 (51.9) 
Female 18 (17.8) 134 (62.3) 152 (48.1) 
Frequency of contact with 
animals    
No contact 2 (2) 112 (52.0) 114 (36.0) 
 Daily 96 (95) 77 (35.8) 173 (54.7) 
Weekly 1 (1) 12 (5.6) 13 (4.1) 
 More often  2 (2) 14 (6.5) 16 (5.0) 
    
Education achivement*    
 No school  5 (5) 20 (9.3) 25 (7.9) 
 Primary school 41 (40.6) 48 (22.3) 89 (28.2) 
 Secondary school  33 (32.7) 36 (16.7) 69 (21.8) 
 High school or higher 22 (21.8) 15 (7) 37 (11.7) 
*Applicable to residents aged >18 years. 
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Table 2. Species and production types of animals raised in 101 small-scale farming households. 
NC: Not calculated. NA: Not available. 





Flock size (median) 
[IQR] 
Chicken  72 (71.3) 12 [4-24] 30 [15-70] 
 Meat 53 (52.5) 10.5 [4-14] 40 [20-200] 
 Fighting 22 (21.8) 12 [4-27] 30 [20-50] 
 Breeding/layer 21 (20.7) 48 [30-66] 10 [6-23] 
Duck  55 (54.5) 8 [4-25] 100 [40-700] 
 Meat 37 (36.6) 6 [4-9] 80 [37-182] 
 Breeding/layer 21 (20.8) 28 [24-46] 1,500 [500-2,300] 
Pig  20 (19.8) 15 [8-51] 10 [3-12] 
 Meat 17 (16.8) 12 [8-20] 10 [7-12] 
 Breeding 6 (5.9) 48 [32-96] 3 [2-10] 
Muscovy duck 12 (11.9) 4 [2-12] 30 [10-77] 
 Meat 11 (10.9) 4 [2-8] 40 [13-100] 
 Breeding/layer 3 (3) 52 [32-81] 4 [3-11] 
Fish  11 (10.9) 14 [12-19] 1,000 [162-1,000] 
 Meat 9 (8.9) 14 [12-17] 1,000 [120-1,000] 
 Breeding 2 (2) 19 [13-25] NA 
Cattle  6 (5.9) 80 [52-240] 2 [1-2] 
 Meat 5 (5.0) 56 [40-92] 2 [1-2] 
 Breeding 2 (2.0) 276 [258-294] 1 [NC] 
Frog  4 (4.0) 5 [3-8] 15,000 [15000-55000] 
 Meat 4 (4.0) 4 [3-5] 22,500 [15,000-67,500] 
 Breeding 1 (1.0) 32 [32-32] 500 [NC] 
Goat  2 (2.0) 32 [26-40] 5 [NC] 
 Meat 1 (1.0) 20 [20-20] 5 [NC] 
 Breeding 1 (2.0) 40 [36-44] 5 [NC] 
Geese Breeding/layer 2 (2.0) 67 [48-85] 2 [NC] 
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route AAI_1 ADDkg_1 AAI_2 ADD2kg_2 
AB030 pig 2 injection oxytetracycline 3.8 thiamphenicol 7.5 
AB032 pig 2 injection florfenicol 7.5 tylosin 21.4 
AB009 pig 1 injection tylosin 0.9   
AB071 pig 1 injection enrofloxacin 3.8   
AB015 pig 2 oral colistin 3.0 gentamicin 5.0 
AB016 pig 2 oral ampicillin 9.4 colistin 4.5 
AB036 pig 1 oral amoxicillin 10.5   
AB073 pig 2 oral amoxicillin 20.3 gentamicin 6.1 
AB074 pig 2 oral sulfamethoxazole 40.5 trimethoprim 8.1 
AB012 poultry 1 injection doxycycline 8.4   
AB013 poultry 1 injection marbofloxacin 3.8   
AB014 poultry 2 injection tylosin 7.5 thiamphenicol 30.0 
AB017 poultry 1 injection ceftiofur 3.8   
AB023 poultry 1 injection cefotaxime 9.8   
AB024 poultry 2 injection spectinomycin 15.0 lincomycin 7.5 
AB028 poultry 1 injection florfenicol 1.8   
AB030 poultry 2 injection oxytetracycline 7.5 thiamphenicol 15.0 
AB043 poultry 1 injection marbofloxacin 7.5   
AB044 poultry 1 injection amoxicillin 0.8   
AB045 poultry 2 injection oxytetracycline 3.8 thiamphenicol 7.5 
AB045 poultry 2 injection lincomycin 3.8 spectinomycin 7.5 
AB047 poultry 2 injection oxytetracycline 7.5 thiamphenicol 15.0 
AB052 poultry 1 injection spiramycin 3.0   
AB055 poultry 2 injection tylosin 11.3 spectinomycin 7.5 
AB056 poultry 1 injection oxytetracycline 30.0   
AB057 poultry 2 injection lincomycin 4.2 spectinomycin 11.3 
AB001 poultry 2 oral doxycycline 13.2 ampicillin 18.9 
AB002 poultry 1 oral enrofloxacin 11.8   
AB003 poultry 1 oral enrofloxacin 18.8   
AB004 poultry 1 oral sulfamethoxazole 18.7   
AB005 poultry 1 oral sulfaquinoxaline 8.4   
AB006 poultry 1 oral doxycycline 16.9   
AB007 poultry 2 oral streptomycin 7.5 oxytetracycline 15.0 
AB008 poultry 1 oral oxytetracycline 1.5   
AB010 poultry 2 oral gentamicin 75.0 doxycycline 131.3 
AB011 poultry 1 oral enrofloxacin 8.4   
AB016 poultry 2 oral colistin 4.5 ampicillin 9.4 
AB018 poultry 1 oral florfenicol 10.5 doxycycline 5.3 
AB019 poultry 2 oral colistin 0.5 ampicillin 3.2 
AB020 poultry 2 oral ampicillin 7.5 colistin 1.1 
AB021 poultry 2 oral colistin 3.5 trimethoprim 5.1 
AB022 poultry 1 oral kanamycin 12.4   
AB025 poultry 1 oral sulfadimidine 33.8   
AB026 poultry 2 oral florfenicol 0.8 doxycycline 8.4 
AB027 poultry 2 oral tylosin 8.4 doxycycline 16.9 
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AB029 poultry 2 oral tylosin 7.5 sulfadimethoxine 15.0 
AB031 poultry 2 oral oxytetracycline 7.5 colistin 0.3 
AB033 poultry 1 oral tylosin 4.5   
AB034 poultry 1 oral thiamphenicol 24.8   
AB035 poultry 2 oral spiramycin 0.5 trimethoprim 1.5 
AB037 poultry 1 oral enrofloxacin 10.5   
AB038 poultry 2 oral gentamicin 3.0 tylosin 12.0 
AB039 poultry 1 oral norfloxacin 15.0   
AB040 poultry 1 oral oxytetracycline 1.0   
AB041 poultry 2 oral tetracycline 18.8 tylosin 7.5 
AB042 poultry 1 oral oxytetracycline 18.8   
AB046 poultry 2 oral amoxicillin 15.0 erythromycin 15.0 
AB048 poultry 2 oral cefalexin 7.5 gentamicin 7.5 
AB049 poultry 2 oral sulfadimidine 93.2 sulfaquinoxaline 28.4 
AB050 poultry 1 oral oxytetracycline 2.5   
AB051 poultry 2 oral tylosin 31.5 colistin 9.4 
AB053 poultry 2 oral doxycycline 7.5 tylosin 3.8 
AB054 poultry 1 oral streptomycin 12.4   
AB058 poultry 2 oral gentamicin 7.5 doxycycline 13.1 
AB059 poultry 2 oral amoxicillin 16.9 colistin 3.4 
AB060 poultry 1 oral enrofloxacin 8.4   
AB061 poultry 2 oral ampicillin 1.9 kamycin 3.8 
AB062 poultry 1 oral colistin 1.7   
AB063 poultry 2 oral colistin 4.5 oxytetracycline 5.6 
AB063 poultry 2 oral colistin 4.5 tetracycline 5.6 
AB064 poultry 2 oral tylosin 5.0 tetracycline 12.4 
AB065 poultry 1 oral norfloxacin 2.3   
AB066 poultry 1 oral oxytetracycline 5.1   
AB067 poultry 1 oral enrofloxacin 8.4   
AB068 poultry 1 oral amoxicillin 9.4   
AB069 poultry 2 oral lincomycin 0.8 spectinomycin 1.9 
AB070 poultry 2 oral trimethoprim 4.5 colistin 3.6 
AB072 poultry 2 oral colistin 1.7 oxytetracycline 5.5 
H1 human 1 oral ciprofloxacin 18.5   
H2 human 1 oral cefuroxime 27.7   
H3 human 1 oral cefdinir 13.8   
H4 human 1 oral amoxicillin 32.3   
H5 human 1 oral cefuroxime 9.2   
H6 human 1 oral penicillin v 23.1   
H7 human 1 oral spiramycin 9.2   
H8 human 1 oral ampicillin 23.1   
H9 human 1 oral tetracycline 23.1   
H10 human 1 oral amoxicillin 36.9   
H11 human 1 oral amoxicillin 17.7   
H12 human 1 oral cefuroxime 18.5   
H13 human 1 oral cefalexin 18.5   
H14 human 1 oral cefalexin 9.2   
H15 human 1 oral amoxicillin 9.2   
H16 human 1 oral cefalexin 8.1   
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H17 human 1 oral spiramycin 5.8   
H18 human 1 oral cefalexin 18.5   
H19 human 1 oral amoxicillin 18.5   
H20 human 1 oral cefuroxime 18.5   
H21 human 1 oral cefpodoxime 1.8   
H22 human 1 oral cefadroxil 9.2   
H23 human 1 oral amoxicillin 18.5   
H24 human 1 oral cefpodoxime 4.6   
H25 human 1 oral amoxicillin 23.1   
H26 human 1 oral amoxicillin 23.1   
H27 human 1 oral ofloxacin 7.4   
H28 human 1 oral cefuroxime 11.5   
H29 human 1 oral amoxicillin 23.1   
H30 human 1 oral cefixim 9.2   
H31 human 1 oral amoxicillin 40.4   
H32 human 1 oral lincomycin 23.1   
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Supplementary material 3.  









376.4 582.9 859.4 551.8 3844.8 5686 2519.2  
mg AAI/kg stading 
bodymass 
966.6 230.9 147.9 0 96 165.3 232.8 237.3 
No. DDDkg/kg 
stading bodymass 
10.5 8.9 3.9 0 2.8 4.8 9.8 5.9 
 Treatment 
intensity 





11,525,605 20,435,153 33,831,357 46,081,745 321,868,460 286,493,852 72,192,563 792,428,735 
Bodymass-days 
(kg-days) 
4,206,845,825 7,458,830,845 12,348,445,305 16,819,836,925 117,481,987,900 104,570,255,980 26,350,285,495 289,236,488,275 
No. DDDkg 121,018,853 181,872,862 131,942,292 0 901,231,688 1,375,170,490 707,487,117 3,418,723,302 
mg AAI 11,140,649,793 4,718,476,828 5,003,657,700 0 30,899,372,160 47,357,433,736 16,806,428,666 115,926,018,883 
mg AAI/kg stading 
bodymass 
       146.2 [73.1-219.4] 
No. DDDkg/kg 
stading bodymass 
       4.3 [2.1-6.4] 
Treatment 
intensity 
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Data from the survey Data from 
Appendix 2 
Numerator Denominator (Data from Appendix 2) Estimated AMU Mekong Delta region  
[50% lower-upper estimated AMU level]  














No. of doses 
(No.DDDkg )  



































Pig Meat 87.1 1287.4 58,456,864 1,858,431,379,139 75,257,366,199 21,336,755,214 58,456,864 233,827,454 193,368,760     
Breeder 57.9 1954 47,635,440 1,006,703,571,240 93,079,649,760 17,386,935,600 47,635,440 47,635,440 47,635,440     
















Chicken Meat 81.8 1711.3 36,767,700 1,097,773,218,900 62,920,565,010 13,420,210,500 36,767,700 133,885,800 74,381,000     
Breeder 43.8 787.8 21,605,400 345,405,529,800 17,020,734,120 7,885,971,000 21,605,400 21,605,400 12,003,000     
















Duck Meat 80 2224.4 15,923,000 464,951,600,000 35,419,121,200 5,811,895,000 15,923,000 92,140,000 50,677,000     
Breeder 90.3 1227.9 22,776,000 750,685,572,000 27,966,650,400 8,313,240,000 22,776,000 22,776,000 12,526,800     


















Meat 163.8 7923.6 3,134,400 187,396,372,800 24,835,731,840 1,144,056,000 3,134,400 12,032,000 6,392,000     
Breeder 34.7 651.7 710,400 8,997,571,200 462,967,680 259,296,000 710,400 710,400 377,400     
















Human   
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Table 3. Percentage of total usage across species (including human) 
Species  No. of doses (No.DDDkg ) 
(%) 
 Quantity (mg) (%) 
Pig  2,865,134,950,379 (40.6)  168,337,015,959 (36.1) 
Chicken  1,443,178,748,700 (20.5)  79,941,299,130 (17.1) 
Duck  1,215,637,172,000 (17.2)  63,385,771,600 (13.6) 
Muscovy duck  196,393,944,000 (2.8)  32,970,313,440 (7.1) 
Human  1,334,740,595,750 (18.9)  122,229,500,679 (26.2) 
Total   7,055,085,410,829 (100)  466,863,900,808  (100) 
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In the Mekong Delta of Vietnam, poultry farmers use high amounts of antimicrobials,
but little is known about the drivers that influence this usage. We aimed to identify
these drivers using a novel approach that combined participatory epidemiology (PE)
and Q-sorting (a methodology that allows the analysis of the subjectivity of individuals
facing a common phenomenon). A total of 26 semi-structured collective interviews
were conducted with 125 farmers representative of the most common farming systems
in the area (chickens, meat ducks, and mobile grazing ducks), as well as with
73 farmers’ advisors [veterinarians, veterinary drug shop owners, and government
veterinarians/commune animal health workers (CAHWs)] in five districts of Dong Thap
province (Mekong Delta). Through these interviews, 46 statements related to the
antimicrobials’ perceived reliability, costs, and impact on flock health were created.
These statements were then investigated on 54 individuals (28 farmers and 26
farmers’ advisors) using Q-sorting interviews. Farmers generally indicated a higher
propensity for antimicrobial usage (AMU) should their flocks encounter bacterial infections
(75.0–78.6%) compared with viral infections (8.3–66.7%). The most trusted sources
of advice to farmers were, in decreasing order: government veterinarian/CAHWs, their
own knowledge/experience, veterinary drug shop owners, and sales persons from
pharmaceutical and feed companies. The highest peak of AMU took place in the
early phase of the production cycle. Farmers and their advisors showed considerable
heterogeneity of attitudes with regards to AMU, with, respectively, four and three
discourses representing their views on AMU. Overall, farmers regarded the cost of
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AMU cheaper than other disease management practices implemented on their farms.
However, they also believed that even though these measures were more expensive,
they would also lead to more effective disease prevention. A key recommendation from
this finding would be for the veterinary authorities to implement long-term sustainable
training programs aiming at reducing farmers’ reliance on antimicrobials.
Keywords: antimicrobial usage, Q-sorting, participatory epidemiology, farmers’ attitude, discourse
INTRODUCTION
The misuse (over- and under-use) of antimicrobials in animal
production is one of the contributing factors of the global
emergency of antimicrobial resistance (AMR) (1). Levels of
antimicrobial usage (AMU) in low- andmiddle-income countries
(LMICs) are particularly high (2), and are expected to increase
markedly over coming years due to intensification of animal
production and increased demand for animal protein (3, 4).
In the Mekong Delta of Vietnam farmers typically use large
amounts of antimicrobials to raise poultry, and a high incidence
of disease has been reported in chicken flocks (5). A recent
study showed that, on average, 470mg antimicrobial compounds
were used to produce one meat chicken, and most of the AMU
was aimed at preventing, rather than treating disease (6, 7).
A survey conducted in Cambodia on small-scale pig farms
showed that the farmer’s own judgment was the most important
determinant associated with AMU (8). Another survey on small-
and medium-scale pig farms in northeastern Thailand indicated
that two thirds (68%) of small-scale farmers decided themselves
whether or not to give antimicrobials to their animals, whereas all
medium-scale farmers discussed antimicrobial treatments with
a veterinarian (9). When using antimicrobials to treat disease,
European pig farmers were more interested in the short-term
impact on their herds’ health than in the AMR “side effects”
(10). A study on Vietnamese poultry farms confirmed that, from
the farmers’ point of view, the main target is to maintain the
highest possible number of birds alive until end of production
(11). A study of poultry farmers in the Mekong Delta found that
the farmers’ sources of advice were: drug sellers (56%), followed
by the district veterinarian (18%), and farmers colleagues (12%)
(6). However, there is a gap in knowledge on the farmers’
perception of the antimicrobials’ effectiveness and the socio-
economic factors driving AMU in the Mekong Delta of Vietnam.
This knowledge is critical for the design and implementation of
intervention strategies.
The study used two well-documented methods to fill
this knowledge gap: Participatory Epidemiology and Q-
sorting. Participatory epidemiology (PE) is the systematic
use of participatory approaches and methods to improve the
understanding of diseases and options for animal disease control.
PE involves communities to define and prioritize animal health
problems, and to improve veterinary service delivery, control
and/or surveillance of diseases (12). PE draws on widely accepted
Abbreviations: AMU, Antimicrobial usage; PE, Participatory epidemiology; PCA,
Principal Component Analysis.
techniques of participatory rural appraisal, ethno-veterinary
surveys, and qualitative epidemiology (13). Q-sorting is a
qualitative method used to analyse the subjective perception of
individuals in relation to a particular situation or phenomenon.
Q-sorting helps identify trends and convergences of opinions
(14), and has been used in a wide variety of research areas, such
as political subjectivity (14), public health (15, 16), veterinary
science (17), and rural sociology (18, 19).
Specific objectives of the study were: (a) to identify the relative
frequency of disease in flocks and the farmers’ propensity for
using antimicrobials should disease appear; (b) to identify the
timing of antimicrobial administration in relation to the amounts
used; (c) to define the sources of advice and procurement
of antimicrobials to farmers; (d) to identify farmers’ positive
and negative opinions on AMU; and (e) to investigate socio-
economic factors influencing farmers’ attitudes on AMU.
MATERIALS AND METHODS
Study Population
The study was conducted in Dong Thap province (Mekong Delta
of Vietnam), from December 2017 to March 2018. The Mekong
Delta is a relatively homogeneous agro-ecological region, and
Dong Thap province is representative of this region. We chose
the five (of 12) districts with the highest poultry populations,
and focused on the three main types of poultry production in
this area. The production cycle was typically 4 months for meat
chickens, 2–3 months for meat ducks, and 2–3 years for free-
ranging ducks. The study population consisted of (a) farmers,
including owners of chicken, meat duck and free-grazing duck
flocks, and (b) farmer’ advisors, comprising veterinary drug shop
owners, CAHWs and government veterinarian.
Farmers and veterinary drug shop owners were randomly
selected from the official census held at the sub-Department
of Animal Health and Production in Dong Thap (SDAH-DT).
Government veterinarian/CAHWs were also randomly selected
from the staff list. We aimed to select 250 participants of the
five types of stakeholders (50 per district), organized into 25
semi-structured collective interviews (CIs) (five per district). The
term “CI” was chosen over “FGI” (focus group interview), since
the group of participants was heterogeneous and we were more
seeking for a consensus in the answers, rather than exploring
controversial points of view. The latter is normally applicable
to FGI. Each CI session included 10 participants of one type
of stakeholder. The number of CI chosen for each type of
stakeholder (five) was based on (a) the concept of “saturation
point,” that estimates that 90% themes within a research topic
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FIGURE 1 | Map of study areas in Dong Thap province. Blue: geographical
location of CIs; red: geographical location of participants of Q-sorting
interviews; triangle: chicken farmers; circle: meat duck farmers; square:
free-grazing duck farmers; rhombus: veterinary drug shop owners; star:
government veterinarian/CAHWs.
are normally discoverable by conducting three to six group
interviews with each type of stakeholder (20); and (b) the
objective of capturing the diversity opinion of farmers who
raised different types of poultry and lived in different districts
within the province. For Q-sorting, 55 participants of CIs were
randomly selected and were invited to participate in the Q-
sorting phase by conducting individual interviews. This number
of participants was based on the sampling criteria described by
Brown (14). The selection of participants formed a heterogeneous
group based on type of production, gender, age, education
level, location and experience in raising poultry (farmers). In
addition, five government veterinarians were invited to take
part in the Q-sorting step, since they are thought to play a
very important role in Vietnamese animal production. All five
interviewers and facilitators had previously been trained in
PE and Q-sorting methodologies. All steps were conducted in
Vietnamese since over 95% of the population in this province
are ethnic Vietnamese. The interview sessions (CI or Q-sorting
interview) took about 1 h each. Data were collected during the
discussions with a digital voice recorder, and during the PE
exercises information was recorded using written notes and
pictures. All participants were initially contacted by staff affiliated
to the SDAH-DT. For each interview (CI or Q-sorting interview),
written informed consent was obtained from all participants
before enrolment. The location of the interview sessions is shown
in Figure 1.
The study was performed in several sequential steps
(Supplementary Figure 1) (17).
Collection of Descriptive Data Using
PE Tools
Qualitative and semi-quantitative data about existing opinions
about AMU were collected during CI with farmers and their
advisors using both open-ended questions and a checklist
organized in four thematic areas (Supplementary 1): (a)
Characterize diseases in poultry farms (chicken and duck farmers
separately), and describe farmers’ strategies to prevent and
control them; (b) Identify the timing of AMU (chicken and
duck farmers separately); (c) Identify sources of advice and
procurement of antimicrobials to farmers (farmers and their
advisors); and (d) Identify positive and negative opinions on
AMU (farmers and their advisors). Various participatory tools
were used to collect the data. These included pair-wise ranking
for (a), time line tool for (b), proportional piling for (b) and (c),
and flow-chart for (d). The PE data collection was performed
following published guidelines (21). At the end of the discussions
on each thematic area, a consensus was sought. The facilitators
summarized the main CI findings and asked: “Do you all agree,
or would you like to change something?” Minority opinions were
discussed in all cases, after which the group was asked to accept
or reject those opinions.
Q-Sorting Interviews and In-Depth Post
Q-Sorting Interviews
The raw data gathered in the PE phase were used to generate a
list of statements. This process included: screening, summarizing
the data, creating statements, and modifying statements in line
with research team’s opinions. The Q-sorting interview process
has been described by Truong et al. (17). In short, participants
were invited to read, score, and allocate statements into a quasi-
normal grid of 46 boxes according to their option. Statements
were scored from −3 (extremely disagree) to +3 (extremely
agree) (i.e., seven discrete options). After Q-sorting interview,
additional questions were asked to participants to clarify the
reasons behind their choice of extreme values for statements.
Statistical Analyses
The non-standardized data (semi-quantitative) collected
from the pair-wise ranking exercise were transformed and
standardized with a rank-score process (21). CI participants were
asked to list poultry diseases important in their area and rank
them according to their importance. This rank was transformed
into a score, and results were averaged across CI for each disease
using the median and inter-quartile range. CI participants were
also asked whether they would use antimicrobials should they
encounter each of the diseases listed. The information generated
was converted into a probability of AMU conditional to each
disease listed being present, and binomial confidence intervals
were calculated around these estimates. Other descriptive
(semi-quantitative) data were summarized using median score
(MS), interquartile range (for proportional piling exercise),
and percentage (for frequency of information from the flow-
chart exercise) where appropriate. Data from each Q-sorting
interview were introduced into two correlation matrices (one
for farmers and one for farmers’ advisor group) that included
statements as observations and participants as variables (22, 23)
(Supplementary Figure 2). Principal component analysis
(PCA) was performed on these correlation matrices in order
to shortlist a number of factors (3–10) for the next step of
analysis (17, 24). The number of factors selected was based on
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the level of heterogeneity of participants’ views, subjectively
evaluated by the researchers (25). The correlation matrices
generated were subjected to factor analysis separately in order to
identify discourses that best characterized clusters of participants
(25, 26) as described by Truong et al. (17). Rotation of k factors
(chosen from 3 to 10) was carried out during the factor analysis
on the basis of (a) the best factor combination could explain
40% of cumulative percentage of variation; and (b) each factor
comprised at least 5% of the total Q sort that loaded distinctly and
significantly (14, 17, 27). Respondents who were assigned tomore
than one factor were considered as confounders. The respective
score of each statement were recalculated through factor analysis
process and it represented the relative score of one statement
given by one particular discourse. The outcome was k discourses
which were represented by k selected factors at the beginning.
These discourses were a hypothetical Q-sorting that had been
reconstructed from the factor scores (17, 25) (Supplementary 2,
Supplementary Table 2). Statements were regarded as consensus
points when the difference between the scores attained in any pair
of factors were not statistically significant (based on the standard
error of differences) (27). Transcripts from CIs and Q-sorting
interviews were stored and extracted using the “rqda” package
in R (28). Those data were not being analyzed statistically but
were integrated in discussion section as explanation for the
results obtained from exercise in the field. All data analyses were
performed using R statistical software (29).
RESULTS
Study Population
A total 26 CIs with 198 participants were conducted: five CIs
with veterinary drug shop owners (34 participants), five CIs
with government veterinarians/CAHWs (39 participants), seven
CIs with chicken farmers (49 participants), six CIs with meat
duck farmers (30 participants), and three CIs with free-ranging
duck farmers (46 participants). The actual number of CIs and
participants were slightly different from the planned number due
to unpredictable field constrains. Of the 60 participants that had
been invited in the Q-sorting interview, six were removed from
the analysis either because of their misunderstanding of the Q-
sorting instructions or unwillingness to complete the procedure.
The analysis therefore included 28 farmers and 26 advisors. The
demographic features of participants are shown in Table 1.
Descriptive Data
The CIs identified a total of 15 poultry infectious diseases (data
not shown). Diseases were described using their local names
(often designing the etiological agent). The three chicken diseases
that ranked highest across all CIs were: Gumboro disease;
mycoplasmosis; and Newcastle Disease (Figure 2). The duck
diseases that ranked highest were duck hepatitis and duck plague
(Figure 3). The CIs indicated that antimicrobial use if flocks were
affected by bacterial disease was greatest for pasteurellosis (87.5%;
i.e., 14 CIs would use antimicrobials among 16 CIs reporting
this disease), colibacillosis (72.7%; 8/11), and mycoplasmosis
(78.6%; 11/14). For viral diseases usage was related to: Highly
Pathogenic Avian Influenza (HPAI) (40.0%; 4/10); ND (33.3%;
3/9); Gumboro disease (25.0%; 3/12); Duck plague (18.2%; 2/11);
Duck hepatitis (8.3%; 1/12). Other causative agents and usage
included hepatitis (66.7%; 2/3), coccidiosis (87.5%; 7/8), and
aspergillosis (100.0%; 6/6). A total of 15.0% of CIs reported
prophylactic antimicrobial use during seasonal transitions.
In quantitative terms, most of the antimicrobials were
administered during the second month of the production
cycle (MS 43.0 and 45.5% for chicken and duck production,
respectively), followed by the first month of the production cycle
(MS 19.0 and 29.0%) (Figure 4).
The most trusted sources of advice to farmers were
government veterinarian/CAHWs (MS = 28.0), their own
knowledge/experience (MS = 26.0), the veterinary drug shop
owners (MS = 21.0), and sales persons from pharmaceutical
and feed companies (MS = 0.0). The farmers’ advisor group
ranked the veterinary drug shop owner as the most important
source of advice to farmers (MS = 29.5), followed by
government veterinarians/CAHWs (MS = 22.5), the farmers’
own knowledge/experience (MS = 19.5), sales persons of
pharmaceutical companies (MS = 4.0) and sales persons of
feed companies (MS = 3.5) (Figure 5). Five positive and seven
negative outcomes of AMU were identified. Similarly, eight
positive and five negative outcomes were identified because of not
using antimicrobials, respectively (Table 2).
Q-Sorting Interviews
Based on the list of opinions from different stakeholders, 46
final statements were generated, representing the spectrum of
opinions on AMU around four thematic areas: (a) Farmers’
confidence in antimicrobials as a tool for prevention, treatment
or growth promotion; (b) Antimicrobial administration logistics;
(c) Costs of the antimicrobials used; and (d) Impact of
AMU/AMR on animal health/productivity and human health
(See list of the statements related to each of these areas in
Supplementary Table 1).
PCA and Factor Analysis
Among the farmer group, four discourses (F1–F4) were
identified. These explained 17, 15, 13, and 10% of the total
variability (55% cumulative variance). Among farmers’ advisors,
three discourses (A1–A3) were identified, explaining 18, 17,
and 15% of the total variability (50% cumulative variance). Six
respondents were considered as confounders. The discourses
were labeled based on the score attained on some relevant
statements. The statement numbers followed by their respective
scores are shown within brackets (i.e., 46, −2 means statement
number is 46 and its score is −2). The summary of the
reconstructed Q-sorting from a total of seven discourses in both
groups was shown in Figures 6, 7.
Discourse Description
Discourse F1 represented farmers who displayed knowledge of
AMU in poultry production (“Awareness”). Farmers allocated
to discourse F2 were reliant on antimicrobials to raise poultry
(“Dependency”). Discourse F3 represented farmers who freely
use antimicrobials without consulting anyone else (“Initiative”).
Discourse F4 constituted a group of farmers who had limited
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TABLE 1 | Demographic description of participants involved in CI and Q-sorting interviews phases of the study.






















































Male (%) 178 (89.9) 43 (87.8) 29 (96.7) 45 (97.8) 61 (83.6) 48 (88.9) 10 (90.9) 8 (100.0) 9 (100.0) 21 (80.8)
Female (%) 20 (10.1) 6 (12.2) 1 (3.3) 1 (2.2) 12 (16.4) 6 (11.1) 1 (9.1) 0 (0.0) 0 (0.0) 5 (19.2)
DISTRICT
Cao Lanh (%) 43 (21.7) 10 (20.4) 7 (23.3) 9 (19.6) 17 (23.3) 15 (27.8) 2 (18.2) 2 (25.0) 2 (22.2) 9 (34.6)
Lap Vo (%) 43 (21.7) 7 (14.3) 9 (30.0) 11 (23.9) 16 (21.9) 10 (18.5) 1 (9.1) 2 (25.0 2 (22.2) 5 (19.2)
Tam Nong (%) 40 (20.2) 9 (18.4) 0 (0.0) 18 (39.1) 13 (17.8) 7 (13.0) 0 (0.0) 0 (0.0) 3 (33.3) 4 (15.4)
Thanh Binh (%) 25 (12.6) 5 (10.2) 0 (0.0) 8 (17.4) 12 (16.4) 8 (14.8) 2 (18.2) 0 (0.0) 2 (22.2) 4 (15.4)
Thap Muoi (%) 47 (23.7) 18 (36.7) 14 (46.7) 0 (0.0) 15 (20.5) 14 (25.9) 6 (54.5) 4 (50.0) 0 (0.0) 4 (15.4)
FIGURE 2 | Classification of the most important diseases (top) and frequency of AMU conditional to disease present in their farm (bottom) for chicken farms. AI, Highly
Pathogenic Avian Influenza; MYC, Mycoplasmosis; ECO, Escherichia coli; GUM, Gumboro; IBH, Inclusion Body Hepatitis; COC, Coccidiosis; PAS, Pasteurellosis;
NEW, Newcastle.
knowledge on AMU (“Imperfectness”). Advisors following
discourse A1 (“Negativism”) thought that farmers generally lack
knowledge on AMU. Discourse A2 (“Hopefulness”) was assigned
to advisors who believed that farmers’ knowledge and attitude
although inadequate, will eventually improve. Finally, discourse
A3 (“Advice dependency”) characterized advisors that claimed
that farmers were dependent on external advice.
Farmers’ Discourse F1: “Awareness”
Eight of 26 farmer respondents (30.8%) contributed to the
“Awareness” discourse, which included four chicken farmers,
three duck farmers, and one free-grazing duck farmer. They
reported that they never used antimicrobials as the first
choice of treatment if they did not know the reason why
their birds were sick (3, −3), and reported that they never
used antimicrobials for disease prevention (14, +2). These
respondents knew that overuse of antimicrobials leads to their
loss of effectiveness (44, +3). They believed that improper AMU
might cause sudden death in some cases (40, +3). Furthermore,
these farmers appreciated the importance of biosecurity, and
completely disagreed with the notion that when flocks are given
antimicrobials, there was no further need for other disease
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FIGURE 3 | Classification of the most important diseases (top) and frequency of AMU conditional to disease present in their farm (bottom) for duck farms. AI, Highly
Pathogenic Avian Influenza; ECO, Escherichia coli; DH, Duck Hepatitis; PAS, Pasteurellosis; DPL, Duck Plague; MYC, Mycoplasmosis; DA, Duck Aspergillosis.
FIGURE 4 | Stakeholders’ opinion about source of advice to farmers on AMU. White: Farmers’ source of advice (farmers’ opinion); Gray: Farmers’ source of advice
(Farmers’ advisors opinion); VDSO, Veterinary drug shops owners; G.V/CAHW, Government Veterinary/Community Animal Health Workers; SPPC, Salespersons of
pharmaceutical companies; SPFC, Salespersons of feed companies; FC, Farmer colleagues; FKE, Own farmer’ knowledge/experience.
control methods (23, −3; 24, +2). They trusted the advice of
government veterinarians/CAHWs about AMU (21, +2), and
they did not seek advice on AMU from neighboring farmers (19,
−3). Some also believed that using antimicrobials to treat disease
by themselves was more costly than seeking veterinary advice
(30,−2).
Farmers’ Discourse F2: “Dependency”
Seven farmers (26.9%) (three chicken farmers, one meat duck
farmer, and three free-grazing duck farmers) contributed to the
“Dependency” discourse. Antimicrobials were always used by
these farmers both for prevention and treatment of disease (13,
−3; 14,−3; 15,−3). Even if flocks were kept in conditions of high
biosecurity, they would still use antimicrobials for prevention
(24, −3), since AMU gave them a sense of security (1, +2). They
also reported that they medicated their bird as soon as they heard
of a disease outbreak spreading in their area (17, +3). They also
perceived that the costs of antimicrobials were too high relative
to overall total production costs (36, −2). However, when asked
about how a potential three- to four-fold increase in price would
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FIGURE 5 | Timing of AMU during production cycle.
affect their AMU practices, these farmers stated that they would
not change their current AMU practice (41, −2). They trusted
the advice on AMU from government veterinarians/CAHWs (21,
+1). They believed that antimicrobials offered by veterinarians
were of good quality (6, +2), and were more willing to allow
veterinarians treat their sick flocks rather than undertaking this
task by themselves (31,−2).
Farmer’s Discourse F3: “Initiative”
The “Initiative” discourse corresponded to six respondents
(23.1%) owning larger flocks (two chicken farmers, one meat
duck, and three free-grazing duck farmers with more than
500 heads each). Farmers assigned to this discourse frequently
relied on antimicrobials for prevention and treatment of disease
in their flocks (13, −3; 14, −3). They felt secure when their
flocks were given antimicrobials for prevention (2, +3). They
reported that in spite of good farming practices, antimicrobials
were still necessary as prophylactic and therapeutic agents (26,
+3). They relied on their own knowledge and experience in
terms of choosing the most appropriate antimicrobial product
to treat their flocks (8, +2; 31, +2). They expressed a lack
of trust in private veterinary, veterinary drug shop owners
(22,−2).
Farmer’s Discourse F4: “Imperfectness”
The “Imperfectness” discourse was assigned to five respondents
(19.2%) (two chicken farmers, two meat duck farmers, and one
free-grazing duck farmer) who generally trusted the advice of
government veterinarians/CAHWs (21, +3). They believed that
antimicrobials were not needed if birds were raised in conditions
of good biosecurity (24, +3). They followed the recommended
full treatment course indicated in the product label (25,−3). They
believed that preventing disease by vaccination would be more
cost-effective than medicated sick birds (42, −3). However, if
their flocks became sick they applied antimicrobials to the whole
flock (including healthy-looking birds) as their first choice (3,
+2; 16, −2). They expressed relieve after their sick flock became
treated with antimicrobials (1,+2).
Advisors’ Discourse A1: “Negativism”
Eight respondents in this group (36%) (two veterinary drug shop
owners, six government veterinarians/CAHWs) believed that
farmers continued to have considerablemisunderstandings about
AMU. They assumed that farmers resorted to use antimicrobials
as their first choice when dealing with disease problems (3, +3),
farmers made their decisions about AMUwithout any input from
external advisors (18, +3; 31, +3). AMU gave farmers a sense
of security, reducing their stress and increasing their confidence
in their production system (1, +2; 2, +2). Most farmers used
antimicrobials for disease treatment and prevention, as well as for
growth promotion (13,−3; 14,−3; 15,−3). They considered that
farmers never followed the recommended dosing instructions in
the label when treating animals (11,+2).When a part of flock was
sick, instead of placing segregating it (i.e., in a sick pen), farmers
would rather give antimicrobials to the whole flock in an attempt
to prevent disease spreading (16,−3).
Advisors’ Discourse A2: “Hopefulness”
The advisors’ “Hopefulness” discourse described the actions
and beliefs of eight respondents (36%) (five veterinary drug
shop owners, three government veterinarians/CAHWs).
Respondents in this discourse believed that farmers would
not use antimicrobials for prevention if good biosecurity
were applied in their poultry farming (24, +2; 17, −2). These
advisors believed that farmers knew that overuse and misuse of
antimicrobials resulting in their loss of effectiveness (i.e., AMR)
(44, +3), contributing to decreasing animal productivity (39,
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TABLE 2 | Opinions about positive and negative aspects with regards to AMU reported in farmers’ CI (16) and in farmers’ advisors’ CI (10).
Farmers’ (CI = 16) opinions Farmers’ advisors’ (CI = 10) opinions
Positive aspects % Negative aspects % Positive aspects % Negative aspects %
Using
antimicrobial
Disease treatment 100 Increases production
costs
68.8 Disease prevention 80.0 Treatment failure 70.0
Disease prevention 87.5 Reduces productivity 62.5 Avoids mortality 80.0 Reduces productivity 50.0
Reduces mortality 50.0 Increases feed costs 50.0 Disease treatment 70.0 Antimicrobials residues
in meat and egg
40.0
Keeps flocks healthy 37.5 Treatment failure 37.5 Increases income 30.0 Increases production
costs
40.0












50.0 Increases mortality due
to disease
62.5 Saves money through
decreases costs of
production
50.0 Increases mortality due
to disease
60.0
Increases productivity 31.3 Weakens the immune
system
6.3 Increases meat and
egg quality
40.0 Reduces productivity 10.0
Provides safe products 31.2 Flock grows faster 20.0 Reduces income of vet
drug-shop owners
10.0
More time for other
activities
18.8 No antimicrobials
residues in meat and
egg
10.0 Unable to cure
diseases
10.0




The “Advice dependency” discourse was attributed to six advisors
(23.1%) who claimed that farmers generally had poor knowledge
of good AMU practices, and were dependant on advice provided
by private veterinarians and veterinary drug shop owners (22,
+3). This group believed that farmers used antimicrobials to both
prevent and treat disease in their flocks (13, −3; 14, −3). They
believed that farmers would use antimicrobials over the entire
production cycle even if only a proportion of birds in the flocks
were sick (16, −2), and would also use them when hearing of
a disease outbreak in the surrounding area (17, +2). They also
thought that farmers would decrease AMU when the price of
antimicrobials increased (41,+2).
Consensus Points From Q-Sorting Analysis
Among farmers, only one consensus point was found: they all
believed that the cost of antimicrobials was more expensive than
the cost of other biosecurity methods as currently applied in
their farms (Statement 38). All advisors agreed on the following
statements: (a) The cost of treating flocks using antimicrobials
wasmore expensive than the cost of using vaccines for prevention
(Statement 35); (b) Farmers would use antimicrobials as first
choice when dealing with their sick flock over other practices
such as segregating sick birds and early mortality culling
(Statement 12); (c) They all had no opinion about the price
of antimicrobials in relation to the total production costs
(Statement 36); and (d) They had no knowledge about the
timing when antimicrobials are most commonly used by farmers
(Statement 27).
DISCUSSION
Through the Q-sorting we identified four distinct attitudes
(discourses) on AMU among farmers. They were all relatively
evenly distributed, with each of these accounting for 19.2–30.8%
of farmers investigated. The “Awareness” discourse was the most
prevalent (30.8%). Farmers assigned to this discourse were aware
of the limitations and issues regarding AMU/AMR, and reported
never using antimicrobials to prevent disease. On the other
extreme, a group of farmers (26.9%) were assigned to a discourse
(“Dependency”) that reflected total dependency on antimicrobial
for raising their flocks.
In contrast with traditional questionnaire-based interviewing
methods, PE allows farmers to freely explore the topics
by themselves, and therefore it was considered to be most
appropriate in this setting. This study fulfilled the criteria
outlined for PE studies described by Catley et al. (12): (1)
active involvement of respondents allowing them to express their
opinions and perceptions; (2) local knowledge about concrete
problems collected fromCI was used to generate statements in Q-
sorting interviews (bottom-up approach); (3) the collected data
was triangulated during interviews and between interviews with
the help of open-ended questions. However, the choice of specific
themes proposed in the CI phase was naturally influenced by
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FIGURE 6 | Four discourses summarizing farmers’ opinions. Number from +3
to −3: Score in one discourse; Number in red cells: Consensus statements;
Number in gray cells: Distinguished statements (see Supplementary Table 1
for detailed information).
FIGURE 7 | Three discourses summarizing farmers’ advisors’ opinions.
Number from +3 to −3: Score in one discourse; Number in red cells:
Consensus statements; Number in gray cells: Distinguished statements (see
Supplementary Table 1 for detailed information).
the experience and knowledge of the researchers on AMU/AMR.
Farmers were selected from a farm census maintained and
updated annually by SDAH-DT. The census is not balanced with
regards to gender, since the overwhelming majority of registered
farm owners were male. The reason is that in rural Vietnamese
households, the named farm owner is typically the husband,
even if the responsibility for tending poultry flocks often lies
within the wife. During the initial telephone call to the owner
as part of the recruitment process, we aimed to achieve a more
balanced sample by inviting the person (male or female) directly
responsible for tending the poultry flocks. In spite of that, 90%
of the participating farmers were male. We believe this is due
to the fact that in Vietnamese culture it is normally the male
who liaises with external agents. Because of this, we might not
have captured all of the women’s opinions related to the study
research questions. Another potential bias might be an under-
representation in our sample of part-time farmers or farmers
having other occupations in addition to tendering poultry. We
used the same 46 statements to investigate attitudes on AMU in
both farmers and their advisors. Since some farmers’ advisors had
limited knowledge/experience on AMU, this might have been a
source of bias in the Q-sorting interviews. Therefore, some of
their opinions about farmers’ attitudes may be more a reflection
of circulating views than actual hands-on advisory experience.
Farmers reported that the highest amounts of antimicrobials
were used during the first half of the production cycle. This
corresponds to the brooding and early grow-out periods. This
period often involves changes in housing and feeding conditions
and is perceived to be the period when flocks are at their
highest risk of disease. Increased risk of disease was also reported
during at two critical time points: during vaccination against viral
diseases to control secondary bacterial infections, and during
transition from the dry to the rainy season. Farmers believed that
using antimicrobials during this period helped them reduce their
anxiety about the risk of diseases. Keeping the flock healthy and
maximizing number of live birds sold to the market (outputs)
whilst lowering the input costs as much as possible are the two
main targets of poultry farmers (30). Therefore, in the eyes of
many farmers, antimicrobials are seen as part of “good farming
practice.” Because of this, they might also neglect other disease
control measures (31).
All farmer participants agreed that the costs incurred in
AMU were higher than the cost of biosecurity and disease
control methods as were currently implemented in their flocks
(Statement 38). They however recognized that should they
upgrade biosecurity and other disease control methods, this
would eventually lead to greater reductions in the incidence
of disease and therefore this would result in reduced need
of antimicrobials. From our observations, biosecurity methods
implemented by most farmers in the area typically consist of
keeping pens visibly clean and regularly applying disinfectants.
Most farmers are also regularly supplied with disinfectants and
HPAI vaccines free of charge by the veterinary authorities.
Farmers often think that disease control programmes supported
by the veterinary authorities are crucial in reducing the risks
to their flock. A recent study showed that Vietnamese cattle
farmers felt more secure after taking part in an official vaccination
campaign (17). However, it has been shown that even well-
established vaccination campaigns such as HPAI in poultry may
in fact provide limited protection against circulating viruses (32).
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Therefore, the provision of vaccines by the veterinary authorities
may have a negative impact by creating a false sense of security.
The fact that some farmers in the area were prepared to
accept a three- to four-fold increase in the price of antimicrobials
suggests that there is a potential for revising pricing policies,
increasing them to deter AMU in situations when antimicrobials
are not strictly necessary. However, rapid increases in prices
could potentially result in the creation of a black market
for antimicrobials.
Compared with private veterinarians and veterinary drug
shop owners, government veterinarians/CAHWs were ranked by
famers as a more trustworthy source of information on AMU
(Figure 3). Farmers also reported that they had more regular
contact with private veterinary drug shop owners than with other
stakeholders. In each commune in the area, there is typically
only one or two government veterinarian/CAHW, compared
with three-six veterinary drug shop owners. Veterinary drug
shop owners have a vested interest in antimicrobial sales. Many
smallholder farmers tend to rely on their own experience with
regards to AMU (“Initiative” discourse). Participants in this
discourse would just ask for advice when they encounter more
serious disease. This attitude was closely linked to large (>500
heads) free-grazing (mobile) duck flocks that typically travel long
distances to graze on paddy fields. Farmers of these flocks feel
they need to be prepared to administer antimicrobials should
their flocks become diseased in locations far from their “local”
veterinary drug shops.
The lack of understanding of animal health advisors on
poultry farm-level economics is of concern. The advisors’
belief that poultry production costs could be easily reduced
by adopting alternative disease control practices contrasts
with the farmers’ understanding of the costs of AMU vs.
biosecurity and vaccination. This lack of agreement is an area
for education and training policy, whilst requiring further




A combination of PE and Q-sorting approach provided
meaningful insights into the attitudes of the different
stakeholders involved in the procurement and usage of
antimicrobials in poultry farming. Through the study of 203
participants in Dong Thap province, we characterized the
purpose of AMU (treatment and prevention), the timing
associated with higher AMU levels (first half of the production
cycle), and the cost of AMU (cheaper than other biosecurity
methods). Farmers were aware of good husbandry practices
(including good biosecurity) as effective disease control tools.
However, these practices were regarded as expensive alternatives
to AMU, and their implementation would require sustained
training efforts. Given that farmers have relatively greater trust
of official government veterinarians, we recommend reinforcing
their advisory role in order to counteract the influence of
veterinary drug shop owners (currently the first point of contact
to farmers). From an educational perspective, veterinarians, and
animal health advisors need guidance on farm-level economics
of poultry farming and a better understanding of costs. This
reinforced advisory capacity should focus on improving overall
farming practices whilst discouraging prophylactic AMU. Given
the complexity and diversity of poultry production systems in
the Mekong Delta region of Vietnam, we recommend scaling up
research on socio-economic factors driving AMU in small-scale
farms in the region. Furthermore, the clear gender imbalance
evidenced in our study population suggests that more research
is needed to understand the perceptions and views of female
Vietnamese farmers with regards to AMU.
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A B S T R A C T
Raising chickens in small-scale flocks following all-in-all-out management is common in the Mekong Delta of
Vietnam. These flocks represent an intermediate category between backyard and intensive (industrial) farming
systems. However, little is known about the occurrence and burden of disease and/or mortality in such flocks,
and their potential association with antimicrobial usage (AMU). We investigated mortality, disease and weekly
antimicrobial use (AMU) in 124 cycles of meat chicken flocks raised in 88 farms in the Mekong Delta of Vietnam
(with a median cycle duration of 18 weeks [inter-quartile range IQR 17–20]). We visited each farm 4 times per
cycle to review data collected weekly by the farmers on clinical signs, mortality, and AMU. The overall prob-
ability of disease and AMU were 0.31 (95% CI 0.29–0.32) and 0.26 (95% CI 0.24–0.28), respectively. The
average weekly incidence of mortality was 2.6 (95% CI 2.2–3.0) per 100 birds. Both the probabilities of a flock
experiencing disease and mortality, as well as of using antimicrobials decreased with the flock’s age. However,
mortality peaked at the 5–10 week period. The only significant explanatory factors associated with presence of
disease was the stage of production ≥5 weeks (protective) (OR≤0.51). Factors independently associated with
AMU (p < 0.05) were: (1) Number of chickens (log) (OR=1.46), (2) Stage of production ≥5 weeks (OR≤0.67)
(protective), (3) Cao Lanh district (OR=2.23), (4) Density of veterinary drug shops at commune level (log)
(OR=1.58), and (5) Disease in flocks (OR=1.80). Factors independently associated with overall increased
weekly incidence of mortality (p < 0.05) were: (1) High level of education attainment (secondary education or
higher) (Hazard rate Ratio [HR]=1.70), (2) number of chickens (log) (HR=1.39), and (3) Stage of produc-
tion> 5 weeks (HR≤2.14). In flocks reporting disease, AMU significantly reduced the incidence of mortality
(HR=0.90). These results confirm an exceptionally high mortality in chicken flocks in the area, jeopardizing the
profitability and sustainability of these small-scale farming systems. The data also suggest an association be-
tween nearby access to antimicrobials and AMU, and a high correlation of AMU over consecutive cycles. The
atomized farming landscape of the Mekong Delta, the high incidence of disease and mortality, and the unrest-
ricted and easy access to antimicrobials present major challenges to the implementation of policies aimed at
AMU reductions.
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1. Introduction
With over 100 million tons produced per year (2014) chicken meat
is the second most common animal food commodity worldwide (FAO,
2017). In low- and middle-income countries, chickens are often raised
in backyard and small-scale and flocks, supporting rural livelihoods by
providing animal protein and nutrients (meat and eggs), as well as
manure and feather bio-products. In many countries chicken meat is
also central to festivities and traditional ceremonies (Alders and Pym,
2009; FAO, 2010). Therefore, high levels of disease and mortality in
small-scale farms pose major constraints to the livelihoods of large
numbers of poor people worldwide, and infectious diseases are thought
to be responsible to a large extent (Bell, 2009). Over recent years, more
and more farms in the Mekong Delta have been upgrading their pro-
duction capacity, transitioning from ‘backyard’ to confined housing and
flock management using all-in-all-out principles. Much of the published
research on poultry diseases in southeast Asia has consisted on the
detection and characterization of single bacterial and viral pathogens
(Jonas et al., 2001; Eagles et al., 2009; Chukiatsiri et al., 2012). In
Vietnam, research has overwhelmingly focused on Highly Pathogenic
Avian Influenza (HPAI) (Lee et al., 2015; Nguyen et al., 2017), due to its
high pathogenicity in poultry, and its pandemic potential. Although
HPAI is still endemic in the Mekong Delta of Vietnam, large outbreaks
of the disease are now less common compared with the 2003–2006
period, when the HPAI H5N1 epidemic was first reported (Anon, 2018;
FAO, 2018; Meyer et al., 2018). In addition to HPAI, several viral
poultry diseases, such as Newcastle Disease (Choi et al., 2014), In-
fectious Bursal Disease (IBD), and Infectious Bronchitis (IB) (de Witt
et al., 2010) are all suspected to be widely circulating in Vietnam, and
therefore vaccination programmes largely focus on these diseases (Bui
et al., 2001). However, no data on circulation/incidence of these viral
diseases, as well as major bacterial diseases and coccidiosis in the area
are available.
Antimicrobial use (AMU) in animal production is a key driver of
antimicrobial resistance (AMR) worldwide (O’Neill, 2015). It has been
estimated that, worldwide, on average, 148mg of antimicrobial active
principle are used to raise 1 kg of live chicken, closely following anti-
microbial use in pig production (172mg) (Van Boeckel et al., 2015). In
the Mekong Delta region of Vietnam high levels of AMU in chicken
production have been reported (˜260mg kg of chicken, excluding
medicated feed) (Carrique-Mas et al., 2014; Trung et al., 2015). These
quantities are, in part, due to the widespread circulation of infectious
diseases, which in turn is associated with deficient levels of sanitation
and health management – often termed ‘poor farm biosecurity’ (Hong
Hanh et al., 2007b). In 2015 there were 277 million chicken heads in
Vietnam, ˜20% of which were in the Mekong Delta (FAO, 2017). The
number of households engaged in small-scale poultry production in the
country is estimated in about 8 million, with an average flock size of ˜32
birds (Burgos et al., 2007). Small-scale poultry production plays an
important role in rural areas, contributing to 19% of household income
(Desvaux et al., 2008). In spite of the importance of small-scale chicken
farming in Southeast Asia, there is limited information on disease pat-
terns and mortality in these systems. To address this critical gap, we
investigated a large sample of chicken farms with the following aims:
(1) to quantify mortality; (2) to characterise disease patterns; and (3) to
investigate associations between AMU, disease and mortality in flocks.
The knowledge on disease and associated mortality in smallholder
poultry flocks is an important and necessary step to improve farm
management and adopt effective control measures to improve farm
productivity and help reduce the farmer’s reliance on antimicrobials.
2. Materials and methods
2.1. Study location and farm recruitment
This study was carried out on farms raising chickens for meat with a
flock capacity of> 100 birds (case definition) in the districts of Cao
Lanh and Thap Muoi within Dong Thap province (Mekong Delta region
of Vietnam), as part as the baseline phase of a research project
(Carrique-Mas and Rushton, 2017). These small-scale commercial
flocks lie between ‘backyard’ flocks and intensively managed ‘in-
dustrial’ systems. These flocks roughly correspond to FAO Sectors 2 and
3 (between 50 and 2000 birds, with feed and water supplied to the
birds) (FAO, 2010). Meat chicken flocks are typically based on slow-
growing local breeds (4–5 months to reach a market weight of 1.6-
2.0kg), raised as single age and confined in a dedicated house/pen. The
chickens are kept at ambient temperature, except for the brooding
period (first 4 weeks), where chicks receive additional heating. How-
ever, in some cases, chickens may have some access to grazing areas
within the farm. In some instances, farmers may purchase day-old
chicks from several sources over the first few weeks, and birds are often
sold over a period of 1–4 weeks. All feed- and water-dispensation is
manual, with flocks being predominantly raised on commercial feed. A
total of 207 farmers randomly selected from the census were contacted
by letter by the veterinary authorities (sub-Department of Animal
Health and Production of Dong Thap, SDAHP). A meeting was held with
199 attending farmers (96%), where the project aims and methods were
presented. Farmers where asked to contact project staff as soon as they
restocked with day-old chicks. From each study farm, chicken flocks
(defined as a group of birds raised together in the same building) that
met the case definition and had completed at least one full production
cycle over the time frame of the study were included (study flocks).
Of 106 farmers that met the case definition that planned to restock
within 4 months of the meeting, 88 agreed to participate in the study
(84% participation). These 88 farms were investigated over a total of
124 fully completed production flock cycles from October 2016 to
March 2018 (54 farms over 1 cycle, 32 over 2, and 2 over 3 consecutive
cycles). Farm visits were carried out by veterinarians affiliated to the
SDAHP. Farm location is shown in Fig. 1.
2.2. Data collection
Farmers were provided with a notebook laid out as two A4 sides by
week, and were instructed to note down the following information re-
lated to their flock: (1) Movements of chickens in and out of their farm
(i.e. numbers of birds bought, sold and dead on farm); (2) Any observed
clinical signs, including: malaise (ruffled feathers, prostration), signs of
respiratory infection (sneezing, coughing, wheezing, nasal secretion),
enteric infection (diarrhoea), signs of central nervous system (CNS)
disorder (ataxia, torticollis, circling) or other signs (i.e. lameness); (3)
Use of health-supporting products (including vaccines). Farmers were
instructed to keep bottles and containers of all health-supporting pro-
ducts used on their flocks. Farms were visited four times during each
production cycle to review the data. On the first visit, generic data on
the farmer, the farm and the chicken house were collected. On this first
visit farmers were also trained by project veterinarians to recognize the
main clinical signs, supported by a Vietnamese text book on poultry
diseases that contains a description and visual images of the most
common signs of chicken flocks where appropriate. This training was
repeated several times on subsequent visits to the farms. Data on flock-
related variables were collected on subsequent visits. Visiting veter-
inarians reviewed the labels of all commercial products given to the
chickens and determined which products contained antibacterial anti-
microbial active ingredients.
2.3. Statistical analyses
‘Disease’ was defined for a flock on a given week when signs of
disease were observed in at least 5% of the birds in the flock. The
probability of ‘Disease’, and the probability of using antimicrobials was
computed for each week of the production cycle, with the total number
of flocks observed on any given week taken as the denominator. The
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‘weekly (cumulative) incidence of mortality’ was calculated for all
study flocks by dividing the total number of chickens dying each week
by the total number of chickens present on farms at the beginning of
each week. Any chickens purchased halfway through the week were
included in the denominator for the calculation of the following week
period. The flock cycle (cumulative) incidence of mortality was calcu-
lated for each flock cycle by dividing the total number of birds dying
from restocking to sale, divided by the total size of the flock at re-
stocking. The weekly incidence of mortality was modelled using a
Poisson model, with ‘Farm’ included as a random effect, and the size of
the flock at the beginning of the week (log) as the offset. The associa-
tion between farmer, farm, and flock characteristics (outcomes) and the
variables ‘Disease’ (Yes/No)’ and ‘Antimicrobial Use (AMU)’ (Yes/No)
(responses) were investigated by building multivariable logistic re-
gression models, with ‘Farm’ modelled as a random effect. The fol-
lowing independent variables were investigated: Farmer-related: (1)
Farmer/farm owner’s gender, (2) Age of farm owner (Years) (log), (3)
Highest level of education attainment of farmer/farm owner, (4)
Experience in chicken farming (Years) (log); Farm-related: (5) Type of
chicken house, (6) Presence of chickens other than the target flock in
the farm, (7) Presence of other poultry species other than chickens;
Flock-related: (8) Number of chickens, (9) Week of production;
Geographical variables: (10) District (Cao Lanh/Thap Muoi), (11)
Number of chickens per km2 by commune, and (12) Number of veter-
inary drug shops per km2 by commune. Variables were ranked by their
degree of significance, and were included in the models using a step-
wise forward approach, starting with the ones with the lowest p-value
obtained from the likelihood ratio test (LRT) comparing a model with
and without the variable. The variables The variables ‘Disease’ and
‘Mortality’ (Yes/No) were investigated in the model with AMU as re-
sponse variable to investigate to what extent AMU was a function of
health events on farm. Variables with p ≤0.05 from the LRT were re-
tained in final multivariable models. The Intra-cluster Correlation
Coefficient (ICC) was calculated for the two final multivariable logistics
models to investigate the percent of the total variation associated with
the clusters (farms). The potential impact of AMU on the weekly in-
cidence of mortality given disease was investigated by fitting a model
on a subset of data corresponding to weeks where disease was reported,
with weekly mortality as response, and the variables AMU (Yes/No)
and clinical signs reported (respiratory, diarrhoea, CNS and malaise) as
explanatory variables. The correlation between AMU in weeks with and
without disease, as well as the correlation between AMU over sub-
sequent cycles of production was estimated using the Pearson correla-
tion coefficient. All statistical analyses were performed using the lme4
and MASS packages within R statistical software (http://www.r-
project.org).
2.4. Ethics
This study was part of the ViParc project, which was granted ethics
approval by the Oxford Tropical Research Ethics Committee (OXTREC)
(Ref. 5121/16) and by the local authorities (People’s Committed of
Dong Thap province) (May 2016).
Fig. 1. Location of study farms (n=88) in the two study districts (Cao Lanh and Thap Muoi) within Dong Thap province. The average weekly incidence of mortality
(per 100 birds), as well as the proportion of weeks that farmers used antimicrobials, and the density of veterinary drug shops are displayed.
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3. Results
3.1. Study farms
The median flock size at restocking was 303 birds [inter-quartile
range (IQR) 202–500]. The unadjusted prevalence of disease and/or
mortality, AMU and the average mortality (per 100 birds) (per week) by
levels of the variables investigated are shown in Table 1. The median
duration of one production cycle was 18 [IQR 17–20] weeks. Most
(81.8%) flocks were raised on houses/pens on solid ground, whereas
others were housed on stilts, either over a canal (8.8%) or on the
ground (5.7%). One flock was raised on two types of housing: solid
house during the brooding period, and then transferred to a stilted
house over a water canal during the grow-out period. A total of 44.3%
farms were raising domestic ducks, 12.5% Muscovy ducks, 19.3% pigs
and 2.3% cattle at the beginning of the study (Table 2)
3.2. Disease and mortality of chicken flocks
The presence of disease and mortality in a given week in a given
flock were highly related (χ2= 1780; p < 0.001). The mean weekly
incidence of mortality in a given week in a given flock was 0.31 (95% CI
0.29-0.32). The highest probability of disease corresponded to the first
week of the cycle (0.64; 95% CI 0.55-0.72), and was inversely corre-
lated with the flocks’ age in weeks (r=−0.95; p < 0.001). After 16
weeks, the probability of disease decreased to<0.1 (Fig. 2a). The
(unadjusted) mean weekly incidence of mortality was 0.026 (95% CI
0.022-0.030) (i.e. 2.58 per 100 birds). Mortality was highest during the
5–10 week period, ranging from 0.027 to 0.055 (Fig. 2b). In flocks
reporting disease the probability of a bird dying generally increased
with the age of the flock (Fig. 2c). The average cumulative mortality
over one production cycle was 32.9 per 100 birds (SD ± 30.4), al-
though it was considerably skewed (median 20.9 [IQR 8.9–52.9%]),
Table 1
Unadjusted weekly probability of disease and/or mortality and antimicrobial use, and weekly incidence of mortality (per 100 birds) by study variables in chicken
flocks for 124 cycles of production (Dong Thap, Mekong Delta, Vietnam).
No. farms (*flocks)
(No. weeks)
Disease (Y/N) Weekly incidence of mortality
(per 100 birds)
Antimicrobial use (Y/N)
Prop. 95% CI Mean 95% CI Prop. 95% CI
Farmer’s gender
Male 11 (337) 0.32 0.30-0.34 2.60 2.14-3.05 0.27 0.25-0.29
Female 77 (1890) 0.23 0.19-0.27 2.48 2.03-2.94 0.21 0.16-0.25
Farmer's age
Up to 45 44 (979) 0.31 0.28-0.38 2.90 2.22-3.58 0.27 0.24-0.30
Over 45 44 (1248) 0.30 0.28-0.33 2.33 1.83-2.83 0.26 0.23-0.28
Farmer's highest education attainment
Primary school 22 (638) 0.25 0.21-0.28 1.56 1.02-2.11 0.27 0.24-0.31
Secondary school 36 (904) 0.32 0.29-0.35 2.35 1.76-2.93 0.26 0.23-0.29
High school 25 (544) 0.34 0.30-0.38 3.62 2.58-4.67 0.28 0.24-0.32
Post high school 5 (141) 0.35 0.28-0.43 4.67 2.37-6.98 0.20 0.13-0.26
Farmer's experience in chicken farming (years)
0-1.5 20 (506) 0.28 0.24-0.32 2.96 2.02-3.91 0.25 0.22-0.29
1.6-2.3 32 (745) 0.31 0.28-0.34 2.71 1.94-3.48 0.27 0.24-0.30
2.4-3.5 21 (595) 0.34 0.30-0.38 2.22 1.57-2.87 0.25 0.21-0.28
3.6-11.0 15 (381) 0.28 0.24-0.33 2.39 1.46-3.33 0.28 0.24-0.33
Type of chicken house*
Solid ground 72 (1873) 0.32 0.30-0.34 2.61 2.15-3.62 0.26 0.24-0.28
Stilts on ground 5 (79) 0.14 0.06-0.22 2.16 0.18-4.13 0.30 0.20-0.40
Stilts on water 10 (265) 0.27 0.22-0.33 2.21 1.36-3.06 0.26 0.21-0.31
Solid and stilts 1 (10) 0.30 0.02-0.58 10.52 0.0-30.0 0.50 0.19-0.81
Presence of chickens other than the target flock*
No 57 (1015) 0.28 0.25-0.30 2.76 2.09-3.44 0.26 0.24-0.29
Yes 67 (1212) 0.33 0.30-0.36 2.43 1.93-2.93 0.26 0.24-0.29
Presence of non-chicken poultry species*
No 55 (839) 0.30 0.27-0.33 2.78 2.18-3.38 0.27 0.24-0.30
Yes 69 (1389) 0.31 0.28-0.34 2.35 1.80-2.89 0.26 0.23-0.28
No. chickens restocked*
100-199 22 (372) 0.20 0.16-0.24 1.82 1.25-2.39 0.23 0.19-0.27
200-299 30 (527) 0.28 0.24-0.32 2.02 1.22-2.83 0.24 0.21-0.28
300-499 38 (692) 0.31 0.28-0.35 3.40 2.52-4.28 0.26 0.23-0.29
500+ 34 (636) 0.38 0.34-0.42 2.60 1.83-3.37 0.30 0.27-0.34
Week of production (age of flock)*
1-5 124 (494) 0.48 0.44-0.53 2.42 1.95-2.88 0.39 0.33-0.42
>5-10 124 (607) 0.36 0.32-0.39 3.66 2.62-4.70 0.29 0.25-0.33
>10-14 116 (457) 0.22 0.18-0.25 1.96 1.18-2.74 0.21 0.17-0.24
>14-26 111 (545) 0.09 0.06-0.11 2.09 1.22-2.95 0.05 0.03-0.06
District
Thap Muoi 46 (1282) 0.29 0.26-0.31 2.46 1.98-2.93 0.20 0.18-0.22
Cao Lanh 42 (945) 0.33 0.30-0.36 2.75 2.03-3.46 0.35 0.32-0.38
Commune density of chickens (per km2)*
1-320 46 (1119) 0.28 0.25-0.31 2.68 2.12-3.25 0.21 0.18-0.23
>320 42 (1028) 0.33 0.30-0.36 2.46 1.87-3.05 0.33 0.30-0.358
0-1 50 (1226) 0.29 0.26-0.32 2.78 2.21-2.35 0.28 2.21-3.35
Commune density of veterinary drug shops (per 10km2)
>1 38 (1001) 0.31 0.29-0.34 2.34 1.76-2.92 0.24 1.76-2.92
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since there were some flocks where all birds died (Fig. 2d). The most
commonly reported clinical signs reported in flocks were, in decreasing
order, malaise (weekly probability 0.20; 95% CI 0.19-0.23); diarrhoea
(0.06; 95% CI 0.05-0.07); respiratory signs (0.05; 95% CI 0.04-0.06);
sudden death (i.e. no prior sign of disease) (0.03; 0.02-0.03), CNS signs
(0.01; 95% 0.006–0.014), and lameness (0.01; 95% CI 0.01-0.02)
(Supplementary Material Figure S1). ‘Other’ disorders included lack of
appetite, dehydration, and anaemia. These were reported with a com-
bined probability of 0.09 (95% CI 0.08-0.11). There were differences in
the timing of the different conditions: whereas malaise, sudden death,
diarrhoea were more often reported in the earlier period, respiratory
signs were reported most commonly in weeks 7-13. The weekly in-
cidence of mortality conditional to the presence of respiratory signs was
2.69 (1.27–4.11) for the first 1 to 4 week period, and 9.34 (95% CI
6.15–12.50) for the period spanning from 5 weeks to sale. For weeks
reporting diarrhea, the weekly incidence of mortality increased from
4.87 (95% CI 2.91–6.84) (1 to 4 week period) to 13.7 (95% CI
8.98–18.40) (late period).
Table 2
Risk factors for mortality/disease and antimicrobial use (random effects logistic regression models) and mortality (Poisson models).
Disease (Y/N) AMU (Yes/No) Weekly incidence of mortality (overall) Weekly incidence of mortality (in weeks
reporting disease)
Univariable Univariable Multivariable† Univariable Multivariable†† Multivariable†††
OR (p-value) OR (p-value) OR [95% CI] HR (p-value) HR [95% CI] HR [95% CI]
Gender (female) 0.72 (0.210) 0.67 (0.120) 1.14 (0.688)
Farmer’s age (years) (log) 1.03 (0.943) 0.96 (0.900) 0.90 (0.797)
High school or higher education 1.37 (0.151) 1.07 (0.730) 1.69 (0.030) 1.70* [1.04-2.80] 1.58* [1.03-2.44]
Experience in chicken farming
(years) (log)
1.04 (0.841) 1.10 (0.540) 1.24 (0.279)
Solid ground chicken house (Ref.
Stilts)
1.52 (0.136) 0.95 (0.840) 0.76 (0.394)
Other chicken flock/s 1.30 (0.192) 1.01 (0.970) 0.90 (0.660)
Other (non-chicken) poultry 1.04 (0.842)
No. chickens (log) 1.17 (0.236) 1.48 ** 1.46‡‡ [0.98-2.17] 1.04* 1.39*** [1.31-1.47] 0.89*** [0.84-0.94]
Week of production (Ref. 1-4)
5-10 0.51*** 0.39 *** 0.67** [0.51-0.90] 1.98*** 2.14*** [2.06-2.22] 2.87*** [2.74-3.0]
> 10-14 0.21*** 0.22*** 0.42*** [0.30-0.59] 1.31*** 1.55*** [1.46-1.64] 3.15*** [2.95-3.38]
> 14-26 0.05*** 0.03*** 0.06*** [0.04-0.10] 1.33*** 1.72*** [1.31-1.47] 7.52*** [6.93-8.17]
Cao Lanh district 1.27 (0.241) 2.16*** 2.23** [1.25-3.96] 0.86 (0.511)
Log(Density of veterinary drug
shops)
0.79 (0.121) 1.12 (0.367) 1.58** [1.13-2.20] 0.85 (0.350)
Log(Density of chickens) 1.08 (0.436) 1.39 (< 0.001) 0.85 (0.121)
Disease (Yes/No) – 4.28 (< 0.001) 1.80*
[1.02-3.18]
–
Mortality (Yes/No) 4.64 (< 0.001)
AMU – – – 0.90*** [0.86-0.94]
HR = Hazard rate Ratio; *p<0.05; **p< 0.01; ***p<0.001; ‡‡p = 0.061; †Model intercept: −1.320 (SE 0.218); ††Model intercept: −6.644 (SE 0.221); †††
Model intercept = −3.150 (SE 0.218).
Fig. 2. (a) Probability of disease in flocks as a
function of their age; (b) Overall weekly in-
cidence of mortality over the observation
period; (c) Probability of a bird dying condi-
tional to being in a flock experiencing disease;
(d) Frequency distribution of flock cycle (cu-
mulative) incidence of mortality among 124
study flock cycles. The blue lines correspond to
a smoothing function fitted by loess regression.
(For interpretation of the references to colour
in this figure legend, the reader is referred to
the web version of this article).
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3.3. Use of antimicrobials, vaccines and other health-supporting products
The five most common antimicrobials administered to flocks were
colistin (13.9% observation weeks), followed by oxytetracycline
(11.4%), tylosin (5.4%), doxycycline (4.4%), and gentamicin (3.0%)
(data not shown). Flocks were vaccinated against a median of four
different pathogens [IQR 3–4], the most common being Newcastle
Disease (91.2% flocks), Highly Pathogenic Avian Influenza (82.4%),
Infectious Bursal Disease (Gumboro) (80.0%), Fowlpox (43.2%) and
Avian Pasteurellosis (28.0%). The impact of vaccination on disease was
not investigated, since vaccines were applied at different times and data
on timing of the application was missing in some cases. However, initial
analyses did not reveal a significant association between vaccination
against specific diseases (Yes/No) and the probability of disease (data
not shown). In addition, other non-antimicrobial health-supporting
products were used by farmers. These included vitamins/mineral
complexes (93.6% flocks), digestive enzymes (77.7%), antiviral pro-
ducts (including interferon) (71.3%), mineral supplements (68.8%),
coccidiostats (67.8%), electrolytes (49.5%), and anthelmintics (35.1%).
The crude probability of AMU in a given week was 0.26 (95% CI 0.24-
0.28) (Fig. 3a). This probability was inversely correlated with the age of
the flock (r=−0.89; p < 0.001). In weeks when disease was reported,
the probability of antimicrobial use was 0.43 (95% CI 0.41–0.48)
(Fig. 3b, 3c), and 0.18 (95% CI 0.16–0.20) in weeks without disease.
There was no difference in the probability of AMU depending on the
reported clinical sign (range from 0.43 to 0.49 by clinical sign) (data
not shown). There was a weak significant correlation between the
probability of AMU in weeks with and without disease in the same
flocks (Pearson’s correlation=0.391, p < 0.001) (Supplementary
Figure S2). The probability of antimicrobials being used in weeks over
subsequent cycles showed moderate correlation (Pearson’s correla-
tion=0.459, p < 0.001). This observed correlation was greater than
that correlation between the proportion of weeks with disease and/or
mortality (Pearson’s correlation=0.040, p=0.8) or average weekly
incidence of mortality over two consecutive cycles (Pearson’s correla-
tion=0.108, p=0.5). There were marked differences in the probability
of use of antimicrobials between the two study districts (Supplementary
Figure S3).
3.4. Models of disease, mortality and antimicrobial use
Only the week of production was associated with ‘Disease’ (pro-
tective after 5 weeks) (OR≤0.51). Factors independently associated
with ‘AMU’ were: (1) No. of chickens (log) (OR=1.46), (2) Stage of
production ≥5 weeks (OR≤0.67) (protective), (3) Cao Lanh district
(OR=2.64), (4) Density of veterinary drug shops at commune level
(log) (OR=1.58), and (5) Disease (OR=1.80). The variable ‘Density
of veterinary drug shops at commune level’, which was not significant
in the univariable model, became significant after adjusting by district.
Conversely, the variable Density of chickens became non-significant
when the variable ‘District’ was added to the model. The variable
Mortality become not significant when the variable Disease was in-
troduced. The ICC associated with farm was for models explaining
disease/mortality and AMU were 0.288 and 0.226, respectively.
Factors independently associated with overall increased weekly in-
cidence of mortality (p < 0.05) were: (1) High level of education at-
tainment (secondary education or higher) (Hazard rate Ratio [HR]
=1.70), (2) Number of chickens (log) (HR ≥1.39), and (3) Stage of
production> 5 weeks (HR≤2.14). In the model using the subset of
weeks where farmer reported disease (N=679) with weekly incidence
of mortality as the response variable, all three variables fitted in the
overall weekly incidence of mortality model remained significant: (1)
High level of education attainment (secondary education or higher)
(HR=1.58), (2) Number of chickens (log) (protective) (HR=0.89), and
(3) Stage of production (HR≥2.87). In addition, AMU remained as a
significant (protective) factor (HR=0.90). The two study districts dif-
fered in the percent of female farmers: 21.7% (10/46) in Thap Muoi vs.
2.4% (1/42) in Cao Lanh (Fisher’s test, p=0.08). The density of ve-
terinary drug shops by commune in Cao Lanh was also higher than in
Thap Muoi (3.1 vs. 1.80 per 10 sq. km) (Kruskal-Wallis χ2= 3.46;
p=0.062). Also, the density of chickens in Cao Lanh communes was
greater than in Thap Muoi (595.2 vs. 190.6 chickens per km2, respec-
tively (Kruskal-Wallis χ2= 2.76; p=0.039). Unlike the variables
‘Density of chickens’ and ‘Density of veterinary drug shops’, the variable
‘Female’ did not remain significant in the AMU model, suggesting that
other unmeasured district-associated factors may account for the ob-
served differences.
Fig. 3. (a) Overall probability of AMU by week;
(b) Probability of AMU in weeks with mor-
tality; (c) Probability of AMU in weeks with
disease; (d) Probability of AMU in weeks
without either disease and mortality (d). The
blue lines correspond to a smoothing function
fitted by loess regression. (For interpretation of
the references to colour in this figure legend,
the reader is referred to the web version of this
article).
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4. Discussion
We characterized disease, mortality, and AMU in small-scale
chicken flocks in the Mekong Delta of Vietnam. Although highly vari-
able across all production cycles, the average weekly incidence of
mortality was 2.6% (equivalent to a monthly mortality of ˜11%), and
the average flock cycle incidence of mortality was ˜33%. We believe
that the data collected in this study reflect ‘typical’ farming practices,
given that farmers did not receive any advice on husbandry/manage-
ment practices from the research team. A major limitation of the study
lies in the fact that disease status was assessed by farmers, introducing
an element of subjectivity, since for some farmers some clinical signs
may have appear to be ‘normal’ but not for others, based on their
knowledge and experience. In addition, the data on flock disease,
mortality and AMU was collected weekly, rather than daily. This did
not allow determining in some cases whether the use of antimicrobials
precluded the disease onset (prophylactic) or occurred in response to
disease (i.e. therapeutic). We believe that, however, the data as a whole
represents a valuable source of information on disease and mortality in
these small-scale farming systems.
The observed high losses represent a major constraint to the pro-
ductivity of small-scale systems. This magnitude was considerably
higher than that reported from other studies from southern Asia. For
example, a study on rural backyard chicken flocks in Cambodia re-
ported average monthly mortalities of 4.5–6.3% (Conan et al., 2013),
and a study on scavenging flocks in Bangladesh reported a 2.5%
monthly mortality attributable to infectious disease (Biswas et al.,
2006). However, in the latter study an additional 2.3% (monthly)
mortality due to predation was reported. All our study flocks were
penned and often fenced/protected by a mesh during the early brooding
period, yet in a few cases chicks were predated by rats in the first few
days of life (data not shown). A study from Nigeria reported an average
cumulative mortality of 10.4% in small-scale poultry flocks
(Muhammad et al., 2010). Our results also indicate a two to three times
higher weekly incidence of mortality in these small, commercial
farming systems, than in small backyard (median 16 birds [IQR 10–40])
flocks in the Mekong Delta of Vietnam (˜0.75 birds per week)
(Delabouglise et al., 2018). There are no comparable data with slow-
growing meat chicken flocks. Our observed flock incidence of mortality
(˜33%) was also considerably higher than in broiler flocks in Nigeria
(12%) (Odemero and Oghenesuvwe, 2016), Norway (2.9% excluding
outliers) (Heier et al., 2002) and France (2.7%) (Chauvin et al., 2011).
The probability of disease was highest during the first period of the
life of the flock, gradually decreasing thereafter. In contrast, mortality
reached a peak during the central 5 to 10-week period, coinciding with
the first phase of the ‘grow-out’ period, when chicks are allowed to
access to a larger surface of the chicken house, often involving sig-
nificant changes in feed type and litter conditions. A number of reasons
may explain this: (1) waning of maternal and/or vaccinal protective
antibodies; (2) increased pathogen challenge in the new environment;
and (3) reduced attention paid to the flock by the farmer. Interestingly,
it was during the mid-period, when respiratory problems were more
often reported. Since diagnostic tests were not performed in our study,
it is possible to determine the pathogens responsible for this. Pathogens
such as Newcastle Disease virus, HPAI, Infectious Laringotracheitis
(ILT) and IBV followed by secondary bacterial infections, or fowl cho-
lera may account for some of this mortality. In addition to HPAI, there
is the certainty that Newcastle Disease virus (Choi et al., 2014), and
Infectious Bronchitis virus (IBV) (de Witt et al., 2010) are widely cir-
culating in the area (Bui et al., 2001).
Our study confirmed that the presence of disease, rather than
mortality, was a key explanatory factor for AMU in small-scale chicken
flocks. Older flocks were less likely to be medicated, regardless of the
presence of disease. The practice of using antimicrobials to prevent
(rather than to treat) disease has been reported previously in chicken
farms in the region (Carrique-Mas et al., 2014). Overall, the timing of
AMU overlapped well with the presence of disease on farms. In Vietnam
a large number of products are marketed as ‘brooding medicine’ (‘thuôc
um’), which almost invariably include one or several antimicrobial
active ingredients. These products are often supplied by traders to-
gether the purchased day-old chicks as a ‘package’ (See Supplementary
Figure S4 for a description of four representative products). Day-old
chicks are typically brought to the farm by traders on motorbike, often
involving travelling for over 100 km under a hot and humid climate,
often resulting in poor condition of birds on arrival. Hatchery sources
have been found to be associated with mortality in a number of studies
(Heier et al., 2002; Muhammad et al., 2010). The data clearly showed
that farmers tend to repeat their antimicrobial use patterns over sub-
sequent cycles. Surprisingly, we found that in about ˜50% of weeks
where flocks had overt signs of disease farmers did not administer an-
timicrobials. This occurred in situations when farmers judged the dis-
ease episode as mild, or in situations when farmers administered non-
antimicrobial medicinal products such as vitamin complexes, minerals,
enzymes, antibodies, and interferon (against suspected viral infections).
We found that larger flocks had generally increased mortality and in-
creased AMU levels. This contrasts with previous findings from a survey
of poultry farms in a different province in the Mekong Delta, where
smaller farms were at increased risk of AMU (Carrique-Mas et al.,
2014). However, in that study smaller flocks were mostly backyard
flocks, whereas all our study flocks were confined and single age. In-
terestingly, the density of veterinary drug shops was positively asso-
ciated with increased AMU (OR=1.58), suggesting that the avail-
ability of antimicrobials in veterinary drug shops may be a driving
factor for AMU. In a previous study in another province in the Mekong
Delta the veterinary drug shop was cited by 56% chicken farmers as
their main source of procurement and advice of antimicrobial drugs to
the farmers (Carrique-Mas et al., 2014). The differences observed be-
tween districts may also respond to differences in purchasing power of
farmers these two districts. In addition, Cao Lanh district is closer to the
provincial capital, with many more veterinary drug shops within close
range. We have no explanation for the higher levels of mortality in
flocks owned by farmers with higher education attainment. We did not
find that this association was confounded by experience, district or any
other variable. A possible explanation for this is that education is a
proxy of wealth, and wealthier farmers have a wider range of occupa-
tions, and may therefore be less committed to tending their flocks.
Given the presence of disease in the flock, the use of antimicrobials
resulted in significantly lower weekly incidence of mortality
(HR=0.90), suggesting that therapeutic use of antimicrobials
somehow reduces losses due to disease, although the magnitude of the
observed reduction is small.
Our study focused on non-intensive, commercial chicken farms.
Non-industrial farming production still account for the majority (60%)
of chicken production in Vietnam (65% in the Mekong Delta region)
(VCNST, 2018). The fragmentation of the Vietnamese farming land-
scape and the country’s dependence on imported animal feeds, re-
present a major constraint to large-scale industrialization of poultry
production (Ipsos Business Consulting, 2018). In addition, the Vietna-
mese consumer has a predilection for traditional, slow-growing breeds
due to improved taste and texture. However the prolonged raising
period required for these breeds represents an additional risk of disease
introduction (Hong Hanh et al., 2007a).
5. Conclusions
We report exceptionally high levels of mortality in small-scale
chicken flocks based on slow-growing breeds, and a clear association
between the early brooding phase and the presence of disease and/or
mortality and AMU in flocks. In addition, the link between AMU and
the density of veterinary drug shops at commune level, as well as other
unidentified district-related factors, suggest that the market availability
of antimicrobials and other cultural factors may contribute to explain
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AMU on farms. The study also highlights the benefits of regular (ideally
daily) data collection on disease and mortality at farm-level, and
therefore we encourage producers in the area to follow this practice.
The results strongly suggest that farmers need to focus their efforts on
controlling disease and mortality during the first 10 weeks of the life of
the flock, improving chicken house sanitation and stepping up biose-
curity to reduce the risk of introduction of disease. The presence of
large numbers of small-scale chicken farms presents major challenges to
the development of policies aimed at AMU reductions. We recommend
that these policies include the stewardship of the antimicrobial use in
farming systems in the region.
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Abstract
Background: Antimicrobials are used by poultry farmers in Vietnam as a tool to treat and prevent infectious diseases.
We aimed to determine the fraction of disease episodes likely to remain untreated due to the administration of
antimicrobials on non-susceptible pathogens in chicken flocks in the Mekong Delta of Vietnam. Weekly data on
antimicrobial use and clinical signs were collected from 88 randomly chosen chicken flocks over 124 full production
cycles (i.e. time between restocking flocks with day-old chicks and sale for slaughter). A naïve Bayes model was trained
to infer the probabilities of disease episodes having been caused by each of 24 pathogens, given the observed clinical
sign profile, and expert knowledge on their relative incidence.
Results: A total of 224 disease episodes were observed, of which 44.8% were attributed to viruses (95% CI 31.1–58.4%),
54.6% (CI 40.4–68.7%) to bacteria, and 0.6% (CI 0–1.7%) to a protozoan (Eimeria spp.). Antimicrobials were more
frequently administered on weeks with disease than on weeks without disease (43.3% vs. 17.8%; p < 0.001). A median
of 2 [IQR 0–4] antimicrobials were used by episode. The choice of specific antimicrobials was independent on whether
the flocks had disease clinical signs or not. Antimicrobials were not used in 30.3% of the episodes. The overall
probability that episodes were not effectively treated was 74.2, and 53.7% when discounting cases where the inferred
aetiology is viral. Considering only episodes where antimicrobials were given, these probabilities were 57.4 and 23.8%
respectively.
Conclusions: This study highlights untargeted use of antimicrobials on small-scale Vietnamese chicken farms, as well
as the limitations of antimicrobials as effective tools to control infectious diseases.
Keywords: Antimicrobial usage, Chicken farm, Low- and middle-income country, naïve Bayes model
Background
Resistance against antimicrobials (“antimicrobial resist-
ance”, AMR) in animal production has received a great
deal of attention in recent times, particularly given its
serious implications for human health [1–3]. Zoonotic
transmission of resistant organisms or AMR-encoding
genes may result from environmental exposure of
humans to livestock or its excreta, and/or from the
transmission of livestock-borne resistant bacteria/genes
through the food chain [4]. Antimicrobials are useful
tools to control infectious diseases in animal populations
[5]. Recently a consensus has built around the need to
restrict their use other than for strict therapeutic pur-
poses, in order to limit the emergence of antimicrobial
resistant bacteria [6]. AMR in bacterial pathogens is hy-
pothesized to reduce the effectiveness of antimicrobials
in livestock production systems leading to lower levels
of profitability and productivity of these systems [7].
With over 100 million tons of meat produced per year
(2014), chicken represents the second most common ani-
mal food commodity worldwide [8]. Antimicrobials are
extensively used in poultry farming, especially in low- and
middle-income countries (LMICs) [9]. Faced with an epi-
sode of disease in the flock, the administration of
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antimicrobials is likely to be ineffective when there is mis-
match between the chosen antimicrobials and the causa-
tive pathogens. This is expected when antimicrobials are
administered to treat diseases caused by (1) a non-target
organism (i.e. a virus, a fungus, or an intrinsically resistant
parasite or bacterial strain), or (2) bacterial organisms that
have acquired resistance to the antimicrobial. This is likely
to be a common situation where the aetiological agent is
not adequately diagnosed, and the choice of antimicrobial
is not based on diagnostic or antimicrobial susceptibility
testing results. Since veterinary diagnostics are normally
not available to small-scale farmers typical of many devel-
oping countries, the antimicrobial susceptibility patterns
of bacterial organisms is unknown, and choice of antimi-
crobials is mostly determined by their availability and cost.
Here we develop an original naïve Bayes model ap-
proach integrating clinical signs and weekly antimicro-
bial use (AMU) data from 124 chicken production cycles
in 88 small-scale farms of the Mekong delta, Vietnam,
allowing to estimate to what extent disease episodes are
not effectively treated. Ineffective treatments are ex-
pected to fail to treat the disease, leading to a cost due
not only to the treatment itself, but also to the loss of
production. Ineffective treatments are also likely to con-
tribute to increase the level of resistance in both com-
mensal and pathogenic bacteria. Our method makes full
use of available information from the literature and ex-
pert opinion in view of the considerable information
gaps on diagnostics and antimicrobial sensitivity test
(AST), which is often the case in LMICs. These are also
the countries that bear the greatest burden of AMR in-
fections [10]. There is unfortunately no way to validate
our method. However, since the whole approach is en-
tirely probabilistic, we were able to quantify and accu-
mulate sources of uncertainty along the different steps
of the analysis, building confidence intervals around our
final estimates. Thus, if not perfect, this method has the
advantage of being affordable whilst providing estimates
that take into account any uncertainties about the data.
Our method may not be useful to improve the situation
of a particular farm but it is likely to be of invaluable use
in giving recommendations for a local geographical level
(district of province).
Methods
Farm selection and on-farm data collection
Eighty-eight (88) small-scale farms raising meat chicken
flocks were randomly selected from the official census held
by the veterinary authorities of Dong Thap province (Me-
kong Delta, Vietnam) (Sub-Department of Animal Health
and Production, SDAHP) in the Cao Lanh and Thap Muoi
districts, as part of the “baseline” (observational) phase of a
research project [11]. All study farms restocked with 100–
2000 chickens for each cycle of production. The chickens
are predominantly of native breeds, with a growing period
of 3–5months. The farmers typically sell their birds to local
markets with limited household consumption, and their in-
puts, including day-old-chicks, are also sourced locally.
Farmers were provided with a structured diary and were
instructed to weekly record information including: (1) clin-
ical signs of disease in the flock: malaise (i.e. prostration,
unwillingness to move, ruffled feathers), respiratory distress
(sneezing, coughing, nasal/ocular discharge, difficult breath-
ing), diarrhoea (watery faeces), alterations of the central
nervous system (CNS) (ataxia, circling, torticollis), leg le-
sions, sudden death (i.e. death with no clinical signs); and
(2) use of antimicrobial drugs (commercial products).
Farmers were trained by SDAHP veterinarians on recogni-
tion of the six above-listed clinical signs, and were asked to
keep containers of all antimicrobial products used. For each
production cycle, farms were visited four times, during
which records in the farm’s diary were checked, and labels
of antimicrobial products used reviewed. Individual anti-
microbial active ingredients were entered into a dedicated
database through a web application. All visits and data
entry were carried out by trained veterinarians affiliated to
the SDAHP.
Expert opinion on disease frequency
Three veterinarians based in Southeast Asia with experi-
ence in poultry medicine were independently asked to
score the frequencies of 25 common chicken infectious
diseases in the region. These pathogens included 14 bac-
teria: Listeria monocytogenes, Avibacterium paragalli-
narum, Chlamydia psittaci, Clostridium perfringens,
Escherichia coli, Erysipelothrix rhusiopathiae, Gallibacter-
ium anatis, Mycoplasma gallisepticum, Ornithobacterium
rhinotracheale, Pasteurella multocida (acute and chronic
infections), Pseudomonas spp., Salmonella Gallinarum,
Salmonella Pullorum, Staphylococcus aureus; 9 viruses:
Avian Encephalomielitis virus, Highly Pathogenic Avian
Influenza (HPAI) virus, Avian Metapneumovirus, Chicken
Anaemia virus, Infectious Bursal disease (Gumboro) virus,
Infectious Bronchitis virus, Infectious Laryngotracheitis
virus, Marek’s disease virus, Newcastle disease virus; and 1
protozoarian parasite (Eimeria spp.). The scores of each
expert were then scaled to sum up 100, in order to pro-
duce values of relative frequency and the average of these
3 scorings was considered in the analysis. Because we dis-
tinguished between the acute and chronic infections
caused by Pasteurella multocida, we will refer to 25 “path-
ogens” instead of 24 in the rest of the article.
Aetiology and antimicrobial resistance data from the
literature
We reviewed standard veterinary textbooks on avian dis-
eases [12, 13] to compile a presence/absence matrix of the
6 above-listed clinical signs caused by the 25 above-listed
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pathogens. We added to this matrix age information, i.e.
whether the pathogens are reported for young (< 7week-
old) and old (> 6 week-old) individuals, producing a final
“aetiology” matrix of 25 (pathogens) rows and 6 (clinical
signs) plus 2 (young and old) columns (Fig. 1).
We used a recently published literature review on the
resistance of bacterial pathogens against antimicrobials
[14] to produce a “resistance” matrix of 25 (pathogens)
rows and n (drugs) where n was the total number of drugs
recorded during the study, see Fig. 2. Each cell of this
matrix contains values between 0 (fully susceptible) and 1
(fully resistant), quantifying the resistance of a pathogen
to an antimicrobial drug. Missing values from a given
drug/pathogen combination were imputed from the mean
of the values for the drugs of the same class and the same
pathogen when possible. When imputation was not pos-
sible (because absence of data on all the drugs of one
class), we considered the mean of the values given by the
three independent veterinarian experts.
Analysis
A “disease episode”, defined as a succession of weeks
during which clinical signs were reported, was consid-
ered out unit of analysis. In order to account for defi-
ciencies in detecting/reporting clinical signs on farm, we
assumed that single weeks without clinical signs but pre-
ceded and followed by weeks where clinical signs were
reported were all part of the same disease episode. A
disease episode was then characterized by the set of
clinical signs observed and the set of antimicrobials ad-
ministered during any week of the episode.
The analysis was then developed in two stages. The
first one consisted in inferring the aetiologies of disease
episodes from their sets of clinical signs, as well as the
aetiology matrix and the expert opinion data, using a
naive Bayes model framework [15]. The aetiology matrix
was used to train the model, and expert opinion data
was used as prior information. Note that here, in ab-
sence of diagnostic tests, the training phase did not in-
clude any validation step. The aetiology matrix from the
literature was the only source of information available to
train the model. Once trained, the model was applied to
the set of clinical signs of each disease episode in order
to derive a vector of 25 probabilities (adding up to 1),
each probability of that vector quantifying the relative
chance that the disease episode was caused by a particu-
lar pathogen. We used a Laplace correction factor of 1
in order to account for the fact that observed combina-
tions of clinical signs may not perfectly match any of the
combinations of the aetiology matrix. The successive
steps leading to the inference of aetiologies of disease
episodes are sketched in Fig. 1.
In the second stage of the analysis, for each disease
episode, the above-derived aetiology probabilities were
then used together with the set of antimicrobials used
during the episode and the resistance matrix in order to
derive the probability that the applied treatment was in-
effective for treating the disease. For that, the resistance
matrix was subsetted by column for the drugs used
Fig. 1 Inferring the aetiologies of diseases episodes. (1) A 25 × 8 presence/absence matrix of clinical signs (and age of infection) per pathogen
and the average relative prevalence scores from 3 independent veterinarian experts (top) are used to train a naive Bayes model (centre). (2) The
naive Bayes model is then used to convert, for each disease episode, clinical signs and age surveillance data (presence/absence, left) into a vector
of aetiology probabilities (right)
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during the disease episode. The minimal values by row
(i.e. for a given pathogen) were then computed, produ-
cing a vector column of 25 values for the 25 pathogens.
The values of this vector were weighted (element-wise
multiplications) by the values of the vector of aetiology
probabilities and then averaged, producing a probability
that the used antimicrobials are ineffective in treating
the disease. The successive steps leading to inference of
this probability are sketched in Fig. 2.
Results
Farms, production cycles and disease episodes
The 88 farms were followed to include a total of 124 full
production cycles (54 over one cycle, 32 over 2 cycles; 2
over 3 consecutive cycles). A total of 224 disease epi-
sodes were observed over all cycles. The median dur-
ation of one cycle of production was 18 [IQR 17–20]
weeks. Clinical signs were recorded in 116/124 (93.5%)
cycles of production. The median duration of disease ep-
isodes was 2 [IQR 1–4] weeks. Disease episodes spanned
a median of 22.7% [IQR 10.0–40.0] observation weeks.
The most common clinical signs reported were, in de-
creasing order, malaise (81.2% episodes), diarrhoea
(29.0%), respiratory distress (24.1%), sudden death
(15.2%), leg lesions (11.1%), and alteration of the CNS
(0.8%). The probability of disease markedly decreased
with the age of the flock (Fig. 3).
Inference of aetiological agents from observed clinical
signs
The most common types of clinical signs of the 25
poultry etiologic agents (“aetiology matrix”) are pre-
sented in Additional file 1: Table S1. There was reason-
able agreement between all three reviewers in their
scoring of disease by their relative frequency (r values
between 0.78 and 0.89) (Additional file 1: Fig. S1).
Results from the naïve Bayes model expressed as rela-
tive probability (by episode and by cycle of production)
are presented in Table 1. There was a very strong correl-
ation between the relative probability of each pathogen
expressed by week and by episode (r = 0.954; p < 0.001).
The model attributed 44.8% (95% CI 31.1–58.4%) epi-
sodes to viral pathogens, 54.6% (95% CI 40.4–68.7%) to
bacterial pathogens, and 0.6% (95%CI 0–1.7%) to
Eimeria spp. (Table 2). The bacterial infections most
commonly predicted were, in decreasing order: (1) Erysi-
pelothrix rhusiopathiae (probability per episode 0.079);
(2) Gallibacterium anatis (0.073); (3) Mycoplasma galli-
septicum (0.068); (4) Salmonella Pullorum (0.068), and
S. Gallinarum (0.043). The most commonly predicted
viral infections were, in decreasing order: (1) Infectious
Bursal disease (IBD) (0.162); (2) Avian Metapneumovirus
infection (0.105); (3) Marek’s disease (0.057); (4) Infec-
tious Laryngotracheitis (0.038); and (5) Newcastle dis-
ease (0.034) (Table 1). There was a strong positive
correlation between the probability attributed to a
Fig. 2 Computing the probability of treatment failure of disease episodes. (1) For each disease episode, we subset the resistance matrix with the
drugs used during the disease episode. (2) Then, for each pathogen of the subsetted matrix, we select the minimal level (min) of resistance
across the used drugs. (3) The resulting vector is weighted (element-wise multiplication) by the vector of aetiology probabilities computed for
that disease episode by the naive Bayes model (Fig. 1); and, (4) The mean of that weighted vector is used as the probability of treatment failure
in the disease episode
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bacterial pathogen and the duration of episodes (r =
0.37; p < 0.001).
Overall, there was a reasonable agreement between
the prior probabilities estimated by the naïve Bayes
model and the average of the three poultry veterin-
ary experts. However, the assessments of the experts
on HPAI, E. coli, Infectious Bronchitis virus, Avibac-
terium paragallinarum and Eimeria spp. are higher
than the incidences predicted by the model (Fig. 4).
Conversely, their assessments on Avian Metapneu-
movirus, G. anatis, E. rhusiopathiae, and Clamydia
psittaci are lower than the incidences predicted by
the model (Fig. 4).
Antimicrobial use and disease episodes
Antimicrobials were more frequently administered on
disease episode weeks (296/683, 43.3%), than in weeks
without disease (281/1582, 17.8%) (χ2 = 163.0, p = 0.001)
. Similar to the probability of disease, the weekly prob-
ability of antimicrobial usage decreased with the age of
the flock: from 0.84 (week 1), to 0.31–0.44 (weeks 2–7),
0.10–0.30 (weeks 8–15), and < 0.10 thereafter. Farmers
did not use antimicrobials in 88/224 (39.3%) of disease
episodes. Thirty-eight (38) different types of antimicro-
bials were used by farmers (Additional file 1: Table S2).
The most frequently used antimicrobials were: colistin
(12.2% weeks across farms), oxytetraycline (9.8%), tylosin
Fig. 3 Disease episodes of over the 124 full cycles of production. Top: prevalence of clinical signs of disease on farms (with 95% confidence
interval), by week. Bottom: production weeks with (red) and without (blue) disease episode
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(4.8%), and doxycycline (3.7%). These four antimicrobials
represented 53.1% of total usage. In episodes where anti-
microbials were used, the median number of different
antimicrobials used was 3 [IQR 2–4]. There was no evi-
dence that different antimicrobials are more likely to be
used in situations of disease, compared with no disease
(Fig. 5). Episodes where no antimicrobials were used
had a shorter duration (median 1 [IQR 1–2] weeks)
compared with episodes where antimicrobials were
used (median 3 [IQR 1–5] weeks) (Wilcoxon test,
W = 3120; p < 0.001).
Phenotypic resistance of bacterial organisms
The full list of antimicrobials used, alongside the preva-
lence of resistance of poultry pathogens against them is
presented in Additional file 1: Table S2.
Probability that disease in flocks remains untreated
The overall probability (all episodes) that a disease
episode remains untreated (either because of absence
of treatment, or because of ineffective treatment)
was 74.2% (95% CI 68.4–79.9%) for all episodes, and
53.7% (95% CI 47.2–60.3%) for episodes due to bac-
terial pathogens (including Eimeria spp.). For epi-
sodes where antimicrobials were given, the estimated
treatment failure was 57.4 (51.0–63.9%) (all patho-
gens), and 23.8% (95% CI 18.2–29.4%) (bacterial
pathogens). The probability of failing to treat the
disease in episodes where antimicrobials were given
was very variable, ranging from 0.423 (Ornithobac-
terium rhinotracheale) to 0.030 (Pasteurella multo-
cida) (Table 2). For bacterial pathogen, this
probability was strongly dependent on the number of
antimicrobials used (Fig. 6).
Table 1 Average probabilities (with 95% confidence intervals) of each of the pathogens (in row) to be the etiological cause of a
disease episode or a disease episode in a cycle of production. Note that the probabilities do not necessarily sum to 1 by row
because they are averages by episode and cycle of production. Note also that the probabilities averaged by episode can be
compared to the mean of the score of the 3 independent experts
Pathogen Episode Cycle of production
Model 95% CI Expert opinion Model 95% CI
Infectious Bursal Disease virus 0.162 0.113–0.210 0.101 0.303 0.101–0.506
Avian Metapneumovirus 0.105 0.064–0.145 0.014 0.194 0.044–0.345
Erysipelothrix rhusiopathiae 0.079 0.044–0.115 0.009 0.147 0.044–0.251
Gallibacterium anatis 0.073 0.039–0.107 0.008 0.137 0.030–0.244
Mycoplasma gallisepticum 0.068 0.035–0.101 0.074 0.127 0.029–0.225
Salmonella Pullorum 0.068 0.035–0.101 0.042 0.127 0.042–0.213
Marek’s Disease virus 0.057 0.026–0.087 0.059 0.105 0.000–0.219
Salmonella Gallinarum 0.043 0.016–0.069 0.028 0.080 0.028–0.133
Infectious Laringotracheitis virus 0.038 0.013–0.063 0.022 0.036 0.007–0.064
Clostridium perfringens (necrotic) enteritis) 0.038 0.013–0.063 0.059 0.071 0.004–0.138
Escherichia coli (colibacillosis) 0.034 0.011–0.058 0.106 0.063 0.023–0.102
Newcastle Disease virus 0.034 0.010–0.057 0.079 0.064 0.000–0.133
Chlamydia psittaci 0.034 0.010–0.057 0.006 0.063 0.016–0.111
Staphylococcus aureus 0.032 0.009–0.054 0.024 0.059 0.013–0.105
Chicken Anaemia virus 0.031 0.008–0.053 0.022 0.057 0.016–0.098
Pasteurella multocida (acute) (fowlcholera) 0.025 0.004–0.045 0.035 0.047 0.003–0.091
Ornithobacterium rhinotracheale 0.023 0.003–0.042 0.025 0.042 0.007–0.077
Listeria monocytogenes 0.012 0.000–0.026 0.009 0.022 0.000–0.043
Infectious Bronchitis virus 0.011 0.000–0.024 0.060 0.020 0.008–0.033
Avian Encephalomielitis virus 0.009 0.000–0.021 0.011 0.008 0.000–0.016
Avibacterium paragallinarum 0.008 0.000–0.020 0.031 0.015 0.000–0.032
Eimeria spp. 0.006 0.000–0.017 0.038 0.012 0.003–0.022
Pasteurella multocida (chronic) 0.005 0.000–0.015 0.011 0.010 0.000–0.020
Pseudomonas spp. 0.005 0.000–0.014 0.011 0.009 0.000–0.018
Highly Pathogenic Avian Influenza virus 0.002 0.000–0.008 0.113 0.004 0.000–0.011
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Table 2 Average probabilities (with 95% confidence intervals) that a disease episode caused by a given bacteria (by row) remains
untreated either because of absence of treatment or because of ineffective treatment (first two columns), or because of ineffective
treatment only (last two columns). The probabilities in the last two columns are necessarily smaller than in the first two columns
Bacterial pathogen Overall treatment failure Treatment ineffective when antimicrobial/s given
Mean 95% CI Mean 95% CI
Avibacterium paragallinarum 0.499 0.433–0.564 0.175 0.125–0.224
Chlamydia psittaci 0.554 0.488–0.619 0.265 0.207–0.322
Clostridium perfringens (necrotic enteritis) 0.595 0.530–0.659 0.332 0.271–0.394
Eimeria spp. 0.895 0.855–0.935 0.827 0.778–0.877
Erysipelothrix rhusiopathiae 0.611 0.547–0.675 0.360 0.297–0.422
Escherichia coli (colibacillosis) 0.555 0.490–0.620 0.266 0.209–0.324
Gallibacterium anatis 0.562 0.497–0.627 0.278 0.220–0.337
Listeria monocytogenes 0.602 0.538–0.666 0.344 0.282–0.406
Mycoplasma gallisepticum 0.645 0.582–0.707 0.415 0.350–0.479
Ornithobacterium rhinotracheale 0.650 0.587–0.712 0.423 0.359–0.488
Pasteurella multocida (acute (fowl cholera)) 0.411 0.347–0.475 0.030 0.008–0.052
Pasteurella multocida (chronic) 0.411 0.347–0.475 0.030 0.008–0.052
Pseudomonas spp. 0.479 0.413–0.544 0.142 0.096–0.187
Salmonella Gallinarum 0.425 0.360–0.490 0.053 0.024–0.082
Salmonella Pullorum 0.425 0.360–0.490 0.053 0.024–0.082
Staphylococcus aureus 0.472 0.407–0.537 0.130 0.086–0.175
Overall (all episodes) 0.537 0.472–0.603 0.238 0.182–0.294
Fig. 4 Relationship between prior estimates from veterinary expert
opinion and posterior probabilities predicted by the naïve Bayes
model. Lines above the diagonal have slopes increasing from 2
(black dashed line), 3, … 10, 20, …50 (all grey lines). Similarly, lines
below the diagonal have slopes decreasing from ½ (black dashed
line), 1/3, … 1/10, 1/20, … 1/50 (all grey lines)
Fig. 5 Probability of use of antimicrobial active ingredients in weeks
with and without disease. Relationship, for each antimicrobial,
between the probability of use during a week with disease and
without disease. The black line is the regression line and the light
and grey areas are the 99 and 95% confidence intervals respectively.
The dashed line is the expected relationship in case there is no
difference of usage between the weeks with and without disease
(the slope is equal to the ratio of weeks with and without disease).
cst = colistin, oxt = oxytetracycline, tyl = tylosin, dxc = doxycycline,
neo = neomycin, gen = gentamicin, str = streptomycin, amp =
ampicillin, amx = amoxicillin, gen = gentamicin, efx = enrofloxacin,
tmp = trimethoprim, smx = sulfamethoxazole,
ffc = florfenicol, tmp = thiamphenicol
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Discussion
Antimicrobials are formidable tools for the control of in-
fectious diseases in animal production. The trade-offs of
antimicrobial usage have been discussed, although focused
on their costs vs. the benefits from protecting flocks/herds
from disease [16]. This study is, to our knowledge, the first
one to look into the likelihood of unsuccessful treatment
of infectious diseases in small-scale farming systems in
Asia, either because antimicrobials were not used, or be-
cause an ineffective antimicrobial were used. Key findings
of this study are: (1) half (48.7%) antimicrobial use oc-
curred on weeks without disease; (2) for episodes where
antimicrobials were used, they were expected to be inef-
fective in 57.4% (CI 51.0–63.9%) episodes (for all patho-
gens considered), and 23.8% (18.2–29.4%) (for bacterial
pathogens); (3) antimicrobials were not used in over a
third (39%) of disease episodes.
Our analysis estimated that approximately a fourth
(23.8%) of treated bacterial episodes are likely to be inef-
fective due to the organisms treated being resistant to
the antimicrobials used. This outcome is likely a com-
bination of “intrinsic” and “acquired” resistance proper-
ties of bacterial pathogens. However, in this paper we
have not attempted to investigate the fraction likely due
to acquired resistance since for many antimicrobials and
pathogens this is now well known. Most published AMR
data on poultry pathogens comes from studies in devel-
oped countries. Given the higher levels of antimicrobial
use in Vietnamese chicken farms [17], it is likely that the
resulting values of expected antimicrobial resistance are
underestimated. We ignored the timing of application of
the antimicrobial in relation to the onset of disease, or
the order of the administration because this could not
be determined from weekly data collection. Surprisingly
however, in over a third of disease episodes (39%)
farmers gave no antimicrobials at all, resulting in an
even higher percent in overall failure to efficiently treat
a bacterial disease episode (53.7%). When viruses are
also considered, the overall fraction of treatment failure
reached 74.2%, as ~ 45% of disease episodes were ex-
pected to be caused by viral pathogens.
Two assumptions of our study may have resulted in
biased results. Firstly, the assumption that all disease ep-
isodes were either due to a bacterial or a viral pathogen,
excluding helminth infections and other non-infectious
aetiologies (i.e. toxicosis, metabolic disorders, etc.).
However, given the farming conditions of small-scale
farms in Vietnam, with generally serious deficiencies in
biosecurity, it is likely that the overwhelming majority of
over disease is infectious in nature. Secondly, the study
is necessarily biased towards diseases that are easier to
diagnose/detect. Interestingly the expert panel predicted
HPAI and colibacillosis (E. coli) to be more common
than what the model predicted after integrating data on
clinical signs. Further diagnostic testing in the area by
the authors has confirmed a lack of HPAI in the areas at
the time of the study (data not shown). Surprisingly, the
model and the experts predicted generally relatively low
incidence of coccidiosis (Eimeria spp.), which is
regarded as a major health problem in industrialised
poultry production systems. It is believed that coccidial
infectious are indeed present, but mostly the subclinical
form is predominant, contributing to reduced intestinal
functions [18]. Thirdly, we ignored data on vaccination
(mostly to prevent viral infections) and assumed that the
probability of an episode due to a given virus was not af-
fected by whether the flock had been vaccinated or not.
Farmers in the area apply vaccines notably against HPAI,
IBD and Newcastle disease. However, the application of
the vaccine requires careful logistics including adequate
strain choice and logistics (timing, booster, storage and
administration logistics) than more often than not were
Fig. 6 Predicted summary treatment failure of individual episodes attributed to bacterial pathogens. The box indicates median values and 75%
interquartile-range; whiskers indicate extreme values
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not met. In the case of HPAI, there is some evidence
that vaccination coverage is either low or application is
performed poorly [19].
A third of disease episodes did not trigger farmers to ad-
minister antimicrobials. These episodes were typically
short (one week) with non-specific signs of disease (i.e.
malaise). Often in these cases, farmers used vitamins, pro-
biotics, yeasts and antibodies to manage poultry health is-
sues (data not shown). Interestingly, episodes attributed to
bacteria tended to last longer, giving further empirical evi-
dence to the phenomenon of AMR on farms.
Although most episodes were addressed by the admin-
istration of two antimicrobials, in some instances up to
10 different antimicrobial active principles were used by
the farmer. This is not surprising, since many commer-
cial antimicrobial formulations in the area include at
least two antimicrobial active ingredients [20] and con-
firms high usage of antimicrobials in Vietnamese small-
scale chicken farms [20, 21]. However, over 50% of total
antimicrobial use corresponded to weeks with no disease
reported (i.e. prophylactic use). This is likely to be partly
triggered by fear of disease, either from previous experi-
ence or by the knowledge of presence of nearby disease,
coupled with the lack of competent veterinary diagnos-
tic/advisory capacity. As suggested in the introduction,
there is a strong suspicion that the choice of antimicro-
bials is currently based on costs.
Some of the most commonly used antimicrobials (i.e.
colistin, oxytetracycline) were associated with a high
probability of ineffective treatment of the disease (data
not shown). In the case of colistin, this reflects a high
predicted incidence of Gallibacterium anatis infection
(characterized by respiratory, diarrhoea and malaise, in
all ages), and Erysipelothrix rhusiopathiae (malaise, sud-
den death, in all ages), both of which are often very re-
sistant against these antimicrobials (≥40%). To the best
of our knowledge, Gallibacterium anatis has never been
isolated in Vietnam. Our results suggest that it could be
valuable to include this pathogen in the diagnostic test-
ing protocols. The use of colistin (and to lesser extent
fluoroquinolones, macrolides, aminoglycosides and β-
lactams), some of which are considered of critical im-
portance for human medicine [22] is particularly worry-
ing from a public health point of view.
Our approach is particularly useful in settings where
diagnostic capacity (and AMR testing) is limited, such as
many LMICs [23]. As more local epidemiological and
microbiological data becomes available, through improved
diagnostic and AMR testing, these can easily be integrated
in our modelling framework to improve the precision and
accuracy of our estimates. The approach can also help to
focus diagnostic efforts towards those diseases that are
considered more likely, as well as to review vaccination
programmes. In generally, the model framework we
developed here can be used for any system (animal or hu-
man) where clinical signs, antimicrobial use and AMR
data are known to improve treatment success.
In summary, using a novel integrated methodology that
combined data from expert opinion, literature and field
observations, we investigated the relationship between
AMU and infectious disease in smallholder poultry sys-
tems. When farmers used antimicrobials to address dis-
ease episodes in their flocks, failure to treat disease was
expected in about ~ 57% cases (~ 24% assuming a bacter-
ial causative agent). Our study shows a high frequency of
usage of antimicrobials in situations with no disease, and
absence of use when disease is present on flocks, the wide-
spread use of multiple courses of different antimicrobials,
and the random use of different antimicrobial products
suggesting that there is ample room for improvement in
the targeting of antimicrobials on farms in small-scale
farming systems in Vietnam.
Conclusions
This study shows how clinical signs and antimicrobials
usage surveillance data can be used to infer the level of
antimicrobial misuse in chicken farms. The naïve Bayes
framework that we employ allows to do so probabilistic-
ally, rigorously accounting for all sources of uncertainty.
Our results show that a vast majority of disease episodes
are likely to be not treated effectively, representing an
important loss for the farmers. The method that we de-
velop is general and can be applied to any set-up, includ-
ing human infections. The model can also be used to
improve the current treatments at use.
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Letter to the Editor 
Affordability of antimicrobials for animals and humans in 
Vietnam: A call to revise pricing policies 
Sir , 
A recent review in the International Journal of Antimicrobial 
Agents revealed how the practice of purchasing antimicrobials 
over-the-counter and without a prescription is widespread in most 
low- and middle-income countries (LMICs) [1] . 
Antimicrobials for human medicine are commonly acquired 
without a prescription in Vietnam, despite legislation restrict- 
ing this practice. Conversely, antimicrobials aimed at veterinary 
medicine can be legally purchased without prescription by anyone 
from any of the ∼12 0 0 0 veterinary drug stores across the country. 
It is not known to what extent the ease of access and affordabil- 
ity contributes to excessive antimicrobial usage (AMU) in animal 
production. Furthermore, there is little information regarding the 
affordability of antimicrobials in different countries, or how their 
pricing compares with the equivalent antimicrobial drugs sold in 
human medicine. 
As a component of a study of 270 cycles of production in 112 
chicken farms in the Mekong Delta region of Vietnam [2] , we iden- 
tified 236 different products containing 42 different active antimi- 
crobial ingredients. On average, five (interquartile range 2.25–10) 
antimicrobial products were used per flock cycle, which typically 
lasts for 16–18 weeks; the majority of AMU occurs during the early 
(‘brooding’) phase of production. 
We calculated the cost incurred for the daily treatment of 1 kg 
of live chicken (equivalent of administering one animal daily dose 
kg, ADD kg ) for the 10 most common antimicrobial products used 
by farmers. The vast majority of products are powder based, and 
are administered orally after dilution with water. All products were 
purchased as 0.1-kg powder sachets. In calculating the dose, we 
followed the manufacturer’s guidelines for their preparation and 
administration, assuming that a 1-kg chicken typically drinks 225 
ml of water per day under local environmental conditions. We ex- 
pressed the costs in cents of a US dollar (US$) ( Table 1 ). 
The price of 1 ADD kg of antimicrobial product ranged from 
0.19 to 1.03 US$ cents (average 0.56 US$ cents per kg of chicken). 
However, in many cases, the product labels include guidelines for 
prophylactic administration, requiring a lower ( ≤50%) concentra- 
tion, and therefore representing less than half of the cost (i.e. on 
average < 0.28 US$ cents per kg of chicken). The most commonly 
used product contained colistin, which was also the most afford- 
able (0.19 and 0.07 US$ cents for therapeutic and prophylactic use, 
respectively). As a comparison, the equivalent costs of products 
containing the same antimicrobial sold for human use in Vietnam 
per kg recommended therapeutic dose (assuming a 60-kg weight 
for a human adult) were: thiamphenicol (1.61 US$ cents), gentam- 
icin (0.87 US$ cents), streptomycin (0.78 US$ cents), doxycycline 
(0.55 US$ cents) and sulfamethoxazole (0.50 US$ cents). Vietnam 
is among the countries where AMU is expected to increase rapidly 
in the coming years [3] . It has been suggested that increasing user 
fees may deter excessive AMU in food animal production, and the 
increased revenues could be used to mitigate the consequences of 
antimicrobial resistance [4] . 
Assuming that a typical chicken is supplemented with antimi- 
crobials for 40 of its 126-day life cycle), with an average weight 
at treatment of 0.25 kg, this would represent a cost of antimi- 
crobials equivalent to ∼0.03 US$ cents per chicken. Farmers in 
the Mekong Delta of Vietnam sell their slaughter-age chickens at 
6 US$ per bird; thus, the cost of antimicrobials represents approx- 
imately 0.5% of the income raised from chicken sales. Although we 
do not have data on the price of antimicrobials in other animal 
species or in other LMICs, these prices seem to be remarkably 
low and are unlikely to be a limiting factor for unnecessary 
AMU. Directions for use indicating prophylactic dilution con- 
tribute to re-inforce the concept that the use of antimicrobials 
when the flock is healthy is appropriate. More often than not, 
antimicrobials are sold in combination with vitamins and other 
health-supporting substances. More worryingly, some of the most 
commonly used products in animals contain colistin, which is a 
critically important antimicrobial of the highest priority for human 
medicine. 
Vietnam is an LMIC that does not manufacture active antimicro- 
bial ingredients itself, instead relying on imports. These chemicals 
are mixed, packed and distributed within the country to meet lo- 
cal demand. We propose that an import tax on antimicrobials of 
critical importance for human use should be considered. With the 
exception of ampicillin, amoxicillin and their derivatives (subjected 
to 5% and 10% import tax, respectively), most antimicrobials are 
currently exempt of import tax in Vietnam [5] . In order to avoid 
these increases having a negative impact on the availability of an- 
timicrobials of critical importance for human use when genuinely 
needed, we recommend effective enforcement of existing legisla- 
tion to restrict over-the-counter access, while subsidising the use 
of these antimicrobials if acquired with a doctor’s prescription. 
An alternative would be to levy a tax for veterinary antimi- 
crobial products. Anecdotal information from our interaction with 
farmers suggests that the majority would not alter their AMU be- 
haviour substantially, even with a four-fold increase in the price 
of antimicrobials. Within the proposed tax system, antimicrobials 
of critical importance used in veterinary medicine should be allo- 
cated to the highest tax bracket. There is a risk that such increases 
may lead to the undesirable creation of a black market of cheap 
counterfeit products. However, as most farmers are not aware of 
the differential effectiveness or impact on antimicrobial resistance 
associated with the use of antimicrobials of critical importance, we 
believe this would likely result in a preferential choice of ‘older- 
generation’ types of antimicrobials. The revenues raised from this 
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Table 1 
The 10 most common antimicrobials used by a cohort of 112 farmers investigated over 270 cycles of production, and the prices of animal daily dose kg (ADD kg) 
Product Antimicrobial active principle Volume (L) of antimicrobial 
solution prepared per sachet of 
product (prophylaxis/therapy) 
No. of ADD kg per sachet 
(prophylaxis/therapy) 
Cost of 1 ADD kg (range) (in US$ cents) 
Prophylaxis Therapeutic 
1 Colistin + oxytetracycline 250/100 1111/4 4 4 0.07 (0.06–0.17) 0.19 (0.14–0.43) 
2 Colistin + oxytetracycline -/100 -/4 4 4 – 0.28 (0.10–0.48) 
3 Colistin + gentamicin -/50 -/222 – 0.44 (0.33–0.62) 
4 Colistin + oxytetracycline 100/50 4 4 4/222 0.51 (0.29–0.58) 1.02 (0.58–1.16) 
5 Oxytetracycline + streptomycin -/50 -/222 – 0.42 (0.19–0.58) 
6 Colistin + oxytetracycline 100/50 4 4 4/222 0.20 (0.15–0.43) 0.40 (0.29–0.97) 
7 Sulphamethoxazole + thiamphenicol 67/33 296/148 0.51 (0.22–0.72) 1.03 (0.43–1.45) 
8 Methenamine 100/67 4 4 4/296 0.53 (0.43–0.63) 0.79 (0.65–0.94) 
9 Doxycycline + tylosin 40 0/20 0 1778/889 0.12 (0.04–0.16) 0.23 (0.07–0.31) 
10 Gentamicin + tylosin 100/50 4 4 4/222 0.43 (0.14–0.58) 0.85 (0.29–1.15) 
NI, not indicated. 
Prices are expressed in US$ cents, based on an exchange rate of 1 US$ = 23 319 VND (23 September 2018)]. The products are sorted by frequency of use. All products were 
purchased as 100-g sachets. 
tax could help train veterinary pharmacists to improve their pre- 
scription practices. 
There is remarkable diversity in retail prices of antimicrobials 
for animal use [3] across LMICs, presumably reflecting differences 
in production capacity, market structure and AMU practices. As 
such, we propose that such a taxation system should be defined 
on a country-by-country basis. Crucially, the use of (any) antimi- 
crobials as prophylactic agents should be discouraged in all cases, 
and veterinary drug manufacturers should make this explicit in the 
product labels. 
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Abstract: In the Mekong Delta of Vietnam, small-scale poultry farmers use large amounts of
antimicrobials to raise their flocks, and veterinary drug shops owners and their staff are a key source
of advice to farmers on antimicrobial use (AMU). We described the network of veterinary drug
shops (n = 93) in two districts within Dong Thap province (Mekong Delta). We also interviewed a
randomly selected sample of chicken farmers (n = 96) and described their linkages with veterinary
drug shops. Antimicrobials represented 15.0% [inter quartile range (IQR) 6.0–25.0] of the shops’
income. Fifty-seven percent shop owners had been/were affiliated to the veterinary authority, 57%
provided diagnostic services. The median number of drug shops supplying antimicrobials to each
farm during one production cycle was 2 [IQR 1–2]. Visited shops were located within a median
distance of 3.96 km [IQR 1.98–5.85] to farms. Drug shops owned by persons affiliated to the veterinary
authority that did not provide diagnostic services had a higher fraction of their income consisting of
antimicrobial sales (β = 1.913; p < 0.001). These results suggest that interventions targeting veterinary
drug shop owners and their staff aiming at improving their knowledge base on livestock/poultry
diseases and their diagnosis may contribute to reducing overall levels of AMU in the area.
Keywords: veterinary drug shop; farmers; antimicrobial sales; Vietnam
1. Introduction
The indiscriminate use of antimicrobials in animal production is now recognised as a major driver
of antimicrobial resistance (AMR) worldwide [1,2]. Approximately 80% of total antimicrobial usage
(AMU) is thought to be aimed at animal production [3]. In the European Union, where data on AMU
in humans and animals are regularly collated, AMU in animals represented 70.2% of a total of 12,720
tonnes used in 2014 [4]. Antimicrobials are used in animal production to treat and prevent disease, as
well as for growth promotion in many countries [5,6]. In the Mekong Delta of Vietnam, veterinary
drug shops are the main source of antimicrobials to chicken farmers [7].
A recent study showed that the density of veterinary drug shops at commune level was positively
correlated with AMU in chicken flocks in this area [8]. In Vietnam, in 2015 there were ~10,400 licenced
Antibiotics 2019, 8, 195; doi:10.3390/antibiotics8040195 www.mdpi.com/journal/antibiotics
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veterinary drug shops (average 150–200 per province). There are approximately ~5000 licensed
veterinary products on the market containing more than 70 antimicrobial ingredients [9]. The most
significant recent development in the country is the launch (2017) of the National Action Plan (NAP) for
the management of AMU and control of AMR in livestock production and aquaculture 2017–2020 [10].
The Vietnamese NAP is aligned with the Food and Agriculture Organisation Action Plan on AMR
2016–2020 [11] and includes key activities to support awareness, surveillance, governance and good
AMU practices. However, the Vietnamese NAP does not specifically focus on the network of veterinary
drug shops. As in many other low- and middle-income countries (LMICs) antimicrobials are sold ‘over
the counter’ without a prescription [12].
High levels of AMU have been reported both in chicken and pig production in the Mekong
Delta of Vietnam [13–15]. This behaviour is partly driven by the prevailing farming conditions that
lead to a high incidence of disease and mortality [8]. In addition, farmers often use antimicrobials
prophylactically as a replacement for good farming practices [16]. In the Mekong Delta of Vietnam,
there are three to six veterinary drug shops per commune (~32 km2), compared with only one or
two government veterinarian/s or commune animal health worker/s. Farmers have more regular
access to local veterinary drug shops than contact with any other animal health advisors [16]. It has
been suggested that pharmacy owners should play a central role in antimicrobial stewardship [17,18].
Therefore, owners of veterinary drug shops and their staff are likely to play an important role in
advising farmers on issues related to animal health, including AMU. However, it is of concern that
owners and staff of these shops may have vested interests in the sale of antimicrobials. Here, the aims
were: (1) To characterise and map out the veterinary drug shop network in the study area; (2) and to
investigate linkages between veterinary drug shops with 96 randomly selected chicken farmers in a
selected area of the Mekong Delta of Vietnam
2. Results
2.1. Characteristics of Veterinary Drug Shops
Of the 138 registered drug shops, 45 (32.6%) exclusively sold products for aquaculture. The
owners of the remaining 93 veterinary drug shops (i.e., those targeting terrestrial animals) (50 in
Cao Lanh, 43 in Thap Muoi) were interviewed. Demographic information and business activities
of these shops are described in Table 1. Most (66.7%) owners were male and of a median age of 40
[IQR 36–51] years-old. The majority (59.1%) of veterinary shop owners had a vocational (animal
science) qualification obtained in a technical college, whilst the remainder had a degree in veterinary
medicine. One owner had a post-graduate (Master’s) degree. Farmers were the main customer of
these establishments (median 100% [IQR 90–100]), followed by animal health workers (mentioned
by 36.6% veterinary drug shop owners). The median number of staff members (including the owner)
working in each shop was 2 [IQR 1–2], the respective values were 2 [IQR 2–2] and 2 [IQR 1–2] for Cao
Lanh and Thap Muoi. In term of staffing capacity, the median value was 12 person-days [IQR 7–14]
per week, 14 [IQR 9–14] for Cao Lanh and 10 [7–14] for Thap Muoi drug shops. There were 5 (5.4%)
shops staffed by personnel adding a total of 22.5–28.0 days/week. A total of 53 (57%) shop owners had
links with the local veterinary authority (Sub-Department of Animal Health of Dong Thap, SDAH-DT)
(50% in Cao Lanh and 65% in Thap Muoi). Of those, 6 (6.5%) shop owners were currently working at
SDAH-DT. A total of 68.8% of shops provided loan services to farmers for specific goods, consisting of
commercial feed (60.2% shops) and veterinary medicines (34.4%). Of the total income of antimicrobial
sales, products for pig farming represented 30% [IQR 15–60%] income, followed by ducks (20% [IQR
13–40%]), chickens (15% [IQR 10–25]), aquatic species (0% [IQR 0–3]) and other (cows, goats) (2 [IQR
0–10]) respectively. Diagnostic services (including post-mortem necropsy) were available in 57% drug
shops (76.0% in Cao Lanh and 34.8% in Thap Muoi).
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Table 1. Descriptive characteristics of veterinary drug shops. The breakdown of total sample size into
a fraction of antimicrobial sales is based on a median of 15% of antimicrobial sales.








Male 62 (66.7%) 31 31
Female 31 (33.3%) 14 17
Owner’s age in year (median [IQR]) 40 [36–51] 39 [36–48] 44 [38–52]
Education status (%)
Master’s degree 1 (1.1) 1 0
Degree in Vet Medicine/Animal husbandry 37 (39.8) 17 20
Vocational 55 (59.1) 27 28
District (%)
Cao Lanh 50 (53.8) 29 21
Thap Muoi 43 (46.2) 16 27
Number of years in business (median [IQR]) 13 [6–18] 12 [6–16] 14 [7–12]
Percent of customer by type (median [IQR])
Farmer 100 [90–100] 100 [97–100] 100 [88–100]
Other vet shops 0 [0–0] 0 [0–0] 0 [0–0]
Animal health worker 0 [0–10] 0 [0–2] 0 [0–2]
Staffing (median [IQR])
No. staff 2 [1–2] 2 [2–2] 2 [1–2]
Person-days per week 12 [7–14] 14 [9–14] 11 [7–14]
Affiliation (%)
Veterinary authority (current) 6 (6.5%) 2 4
Veterinary authority (previous) 47 (50.5%) 19 28
No veterinary authority affiliation 40 (43.0%) 24 16
Diagnostic service available (%)
Yes 53 (57.0%) 32 21
No 40 (43.0%) 13 27
Loan service (%)
Any product (feed or health products) 64 (68.8) 32 32
Feed 56 (60.2) 31 25
Health products 32 (34.4) 14 18
Percent of antimicrobial sales by species
(median/[IQR])
Pig 30 [15–60] 30 [15–70] 30 [18–60]
Duck 20 [13–40] 25 [10–50] 20 [15–36]
Chicken 15 [10–25] 10 [10–20] 15 [10–25]
Aquatic animals 0 [0–3] 0 [0–3] 0 [0–5]
Other 2 [0–10] 4 [0–10] 1 [0–10]
The types of commodities and services offered by veterinary drug shop are displayed in Figure 1.
A total of 85% shops retailed commercial feed, representing a median of 50.0% [IQR 20.0–70.0] of total
income across shops. All shops dispensed antimicrobial products and other health-related products.
Antimicrobial sales represented a median of 15.0% [IQR 6.0–25.0] of income. Non-antimicrobial drugs
health-related products represented a median income of 16.0% [IQR 8.0–27.0] of income). A total of
11.8% and 3.2% veterinary drug shops respectively offered services, such as selling day-old chicks and
collecting slaughtered-age chickens.
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Figure 1. Types of commodities and services provided by veterinary drug shops in the study area. 
Each colour represents a type of commodity/service, including antimicrobials, non-antimicrobial 
health-supporting products, commercial feed, day-old-chicks, collection slaughter-age chickens, and 
‘Other’ (services and other equipment: Drinkers, feeders, rice husks, etc.). 
2.2. Mapping of Veterinary Drug Shops and Livestock Populations 
The overall mean density of drug shops in the study area was 1.76 (SD ±1.94) per 10 km2 (1.84/10 
km2 in Cao Lanh; 1.48/10 km2 in Thap Muoi). Drug shops were unevenly distributed across the 
geographical space, with 5 clusters with a density of >5 shops/10 km2 accounting for 47% of all shops 
(Figure 2). Overall, there were 745 ducks, 167 chickens, 36 pigs, and <8 of each other species (Muscovy 
ducks, goats, geese, cows etc.) per km2 in the two study districts, representing an average of 2.5 tonnes 
of animal bodyweight per km2 (2.4–2.6 in each study district).  
Overall there were 3.8 shops (total 46.3 person-days) per 100 tonnes of animal bodyweight, 4.5 
in Cao Lanh (57.2 person days), 3.2 (37.3 person-days) in Thap Muoi. These values were equivalent 
to 1 veterinary drug shop per 26.3 tonnes (~32,875 chickens/ducks or 669 pigs), and 1 person-
day/week per 2.2 tonnes (~2,750 chickens/ducks or 56 pigs) (Table 2). 
Figure 1. Types of co odities and services provided by veterinary drug shops in the study area.
Each colour represents a type of co odity/service, including anti icrobials, non-anti icrobial
health-supporting products, commercial feed, day-old-chicks, collection slaughter-age chickens, and
‘Other’ (services and other equipment: Drinkers, feeders, rice husks, etc.).
2.2. Mapping of Veterinary Drug Shops and Livestock Populations
The overall mean density of drug shops in the study area was 1.76 (SD ±1.94) per 10 km2 (1.84/10
km2 in Cao Lanh; 1.48/10 km2 in Thap Muoi). Drug shops were unevenly distributed across the
geographical space, with 5 clusters with a density of >5 shops/10 km2 accounting for 47% of all shops
(Figure 2). Overall, there were 745 ducks, 167 chickens, 36 pigs, and <8 of each other species (Muscovy
ducks, goats, geese, cows etc.) per km2 in the two study districts, representing an average of 2.5 tonnes
of animal bodyweight per km2 (2.4–2.6 in each study district).
Overall there were 3.8 shops (total 46.3 person-days) per 100 tonnes of animal bodyweight, 4.5 in
Cao Lanh (57.2 person days), 3.2 (37.3 person-days) in Thap Muoi. These values were equivalent to 1
veterinary drug shop per 26.3 tonnes (~32,875 chickens/ducks or 669 pigs), and 1 person-day/week per
2.2 tonnes (~2750 chickens/ducks or 56 pigs) (Table 2).
2.3. Correlation between Number of Veterinary Drug Shops and Livestock Population
There were no significant correlations between the number of veterinary drug shops and the total
animal bodyweight, as well as each of the three major species (duck, chicken and pig) at commune
level. The Spearman’s rank correlation coefficients were of 0.20, 0.19, 0.08 and 0.17 respectively, (all p >
0.280). Similarly, the animal population of total bodyweight and three species of duck, chicken and
pig were also not significantly correlated with the staffing capacity per commune (all p > 0.520), the
correlation coefficients were 0.07, 0.12, 0.05 and 0.06 respectively. (Table S2, Figure S1).
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Figure 2. Geographical distribution of veterinary drug shop and livestock density at commune level in
the study area. (A) Geographical distribution and kernel density of veterinary drug shops within an
area of 10 km2; (B) density of animal populations by commune expressed as animal bodyweight, and
location of veterinary drug shops; (C) density heat map displaying the number of veterinary drug shops
per 100 tonnes of animal bodyweight; (D) density heat map of staffing capacity (person-days/week) per
100 tonnes of animal bodyweight.
2.4. Linkages between Veterinary Drug Shops and Chicken Farms
A total of 96 chicken farmers were interviewed. The median number of veterinary drug shops
visited by each farmer to purchase antimicrobials was 2 [IQR 1–2]. Farmers in Cao Lanh visited more
veterinary drug shops than those in Thap Muoi (median 2 [IQR 2–2] vs. 1 [IQR 1–2] respectively)
(Fisher’s Exact Test, p < .000). Three farmers (3.1%) (2 in Cao Lanh, 1 in Th p Muoi) had visited
>3 shops to buy antimicrobi , and 1 bought antimicrobial from 8 different veterinary drug shops.
Two farmers had travelled utside th ir district for purchasing antimicrobials (Table S3). The distance
between farms and the shops where farmers had purchased antimicrobials ranged from 0.03 to 14.97
km (median 3.96, [IQR 1.98–5.85]; 2.33 [IQR 1.43–4.36] for Cao Lanh, 5.15 [IQR 3.80–8.25] for Thap
Muoi). Farms were located at a median distance of 1.92 km [IQR 0.96–2.76] from their closest veterinary
drug shop (1.25 [IQR 0.73–2.06] for Cao Lanh, 2.53 [IQR 1.51–3.08] for Thap Muoi) (Figure 3).
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Cao Lanh District 464.7 50 635.0 12.7 1109.7 2.4 4.5 57.2
An Binh 8.2 0 0.0 0.0 28.9 3.5 0.0 0.0
Ba Sao 62.7 2 22.5 11.3 77.9 1.2 2.6 28.9
Binh Hanh Tay 14.4 6 63.0 10.5 60.7 4.2 9.9 103.9
Binh Hang Trung 19.9 4 31.5 7.9 95.6 4.8 4.2 32.9
Binh Thanh 27.6 0 0.0 0.0 75.5 2.7 0.0 0.0
Gao Giong 51.4 3 43.0 14.3 59.8 1.2 5.0 72.0
My Hiep 22.5 2 21.0 10.5 72.2 3.2 2.8 29.1
My Hoi 15.9 4 46.0 11.5 105.4 6.6 3.8 43.7
My Long 21.0 3 42.0 14.0 42.7 2.0 7.0 98.5
My Tho 23.9 1 7.0 7.0 66.8 2.8 1.5 10.5
My Tho town 8.2 5 75.0 15.0 59.2 7.2 8.4 126.7
My Xuong 9.9 2 30.5 15.3 39.5 4.0 5.1 77.1
Nhi My 26.0 1 14.0 14.0 49.2 1.9 2.0 28.4
Phong My 28.2 3 35.0 11.7 103.2 3.7 2.9 33.9
Phuong Thinh 44.3 2 38.0 19.0 45.1 1.0 4.4 84.2
Phuong Tra 17.5 6 81.5 13.4 33.1 1.9 18.1 246.2
Tan Hoi Trung 40.7 4 70.0 17.5 46.2 1.1 8.7 151.6
Tan Nghia 22.4 2 15.0 7.5 48.7 2.2 4.1 30.8
Thap Muoi District 517.7 43 502.0 11.7 1346.9 2.6 3.2 37.3
Doc Binh Kieu 32.6 4 73.5 18.8 216.0 6.6 1.9 34.0
Hung Thanh 49.6 1 7.0 7.0 74.0 1.5 1.4 9.5
Lang Bien 23.3 1 7.0 7.0 73.4 3.1 1.4 9.5
My An 18.6 1 9.5 9.5 97.4 5.2 1.0 9.8
My An town 17.1 12 149.5 12.5 107.9 6.3 11.1 138.6
My Dong 25.2 1 7.0 7.0 108.7 4.3 0.9 6.4
My Hoa 36.7 2 15.0 7.5 63.4 1.7 3.2 23.7
My Quy 61.3 6 63.0 10.5 112.0 1.8 5.4 56.2
Phu Dien 45.4 4 40.5 10.1 143.8 3.2 2.8 28.2
Tan Kieu 42.4 2 16.0 8.0 100.1 2.4 2.0 16.0
Thanh Loi 47.8 1 14.0 14.0 45.9 1.0 2.2 30.5
Thanh My 44.7 2 14.0 7.0 127.2 2.8 1.6 11.0
Truong Xuan 73.0 6 86.0 14.3 77.1 1.1 7.8 111.5
Whole study area 982.4 93 1137 12.2 2456.6 2.5 3.8 46.3
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decreasing order: (1) Animal health services (including advice on husbandry, diagnostic support, 
including post-mortem, vaccination support, sales of day-old-chicks) (mentioned by 47.9% farmers) 
(standardised score 38.5%); (2) Kinship (a relative or friend), mentioned by 37.5% farmers (score 
31.7%); (3) Quality of products retailed (including the perception of being effective) (mentioned by 
37.5% farmers (score 27.6%); (4) Distance from farm (26% farmers) (score 14.7%); and (5) price (7.2% 
farmers) (score 4.8%). Other, less commonly mentioned reasons (mentioned by 14.6% farmers in total) 
were: Knowledge, experience of qualification of the owner, availability of special products (drugs 
used in the brooding period) (scores 4.1) (Figure 4). 
Figure 3. The geographical distance between farms (n = 94), their closest veterinary drug shop, and
the visited veterinary drug shops from which farmers purchased antimicrobials. Data from 2 farms
were excluded, since farmers visited other districts to buy antimicrobials. Solid red line: The median
distance between farms and visited shops (3.96 km); Dashed red lines: Inter quartile range [1.98–5.85].
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The reasons given by farmers to justify their choice of specific veterinary drug shops were, in
decreasing order: (1) Animal health services (including advice on husbandry, diagnostic support,
including post-mortem, vaccination support, sales of day-old-chicks) (mentioned by 47.9% farmers)
(standardised score 38.5%); (2) Kinship (a relative or friend), mentioned by 37.5% farmers (score 31.7%);
(3) Quality of products retailed (including the perception of being effective) (mentioned by 37.5%
farmers (score 27.6%); (4) Distance from farm (26% farmers) (score 14.7%); and (5) price (7.2% farmers)
(score 4.8%). Other, less commonly mentioned reasons (mentioned by 14.6% farmers in total) were:
Knowledge, experience of qualification of the owner, availability of special products (drugs used in the
brooding period) (scores 4.1) (Figure 4).Antibiotics 2019, 8, x 8 of 13 
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Figure 4. Standardised scores for the reasons stated by farmers for their choice of veterinary drug shops.
2.5. Risk Factor Analyses
Factors associated with a higher proportion of their income associated with antimicrobial sales
in univariable models (p < 0.2) were: (1) Owner ≥ 40 years-old; (2) District of Thap Muoi; (3)
Person-days per week (protective) (log), (4) Affiliation to government veterinary uthority; and (5)
Diag ostic services available. The latter two variables (Affiliation to government veterinary authority
and Diagnostic services availab e) were comb ned in a new variable with four levels. In the final
multivariable mod l, the variable ‘District’, ‘Age’, nd ‘Person-days’ became non-significant, since they
were confounded by affiliation to the v terinary authority. The highest risk corresponded to shops
owned by vet rinarians affiliated to the veterinary authority that id not provide diagnost services
(Table 3).
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Table 3. Linear models that investigate factors associated with a higher share of income consisting of
antimicrobial sales.
Univariable Multivariable *
β 95% CI p-Value β 95% CI p-Value
Owner’s gender (baseline = Male)
Female 0.011 −0.77–0.79 0.976
Owner’s age (baseline <40 years old)
≥40 years old 0.647 −0.07–1.37 0.079 0.156 −0.57–0.88 0.672
Education status (baseline = Vocational)
Bachelor or higher 0.341 −0.40–1.08 0.366
District (baseline = Cao Lanh)
Thap Muoi 0.993 0.28–1.70 0.006 0.462 −0.31–1.24 0.241
No. of years in business (log) 0.207 −0.18–0.59 0.296
Person-days per week (log) −0.910 −1.81–0.00 0.049 −0.726 −1.62–0.16 0.110
Affiliation to veterinary government authority
(baseline = No)
Yes 0.773 0.04–1.50 0.037
Diagnostic service (baseline = Yes)
No 0.989 0.27–1.70 0.007
Affiliation of shop owner and diagnostic
service (baseline = No affiliation to veterinary
government authority, diagnostic service)
Affiliation to veterinary government authority,
diagnostic service 0.656 −0.28–1.59 0.167 0.565 −0.38–1.51 0.239
Affiliation to veterinary government authority,
no diagnostic service 1.913 0.88–2.94 <0.001 1.497 0.32–2.66 0.012
No affiliation to veterinary government
authority, no diagnostic service 0.801 −0.25–1.85 0.135 0.692 −0.44–1.82 0.229
Loan service of any product (baseline = Yes)
No 0.454 −0.33–1.24 0.257
Kernel density of shops (log) −0.087 −0.67–0.50 0.769
* Intercept = 4.578; SE = 1.156.
3. Discussion
To our knowledge, this is the first study describing veterinary drug shops and their linkages
with farmers in a low- and middle-income country. Our results indicate a poor spatial correlation
between veterinary drug shops and animal populations at commune level. This is consistent with our
observation that farmers often purchase antimicrobials from shops for reasons other than geographical
proximity, preferring to travel to longer distances. In contrast, the provision of services (diagnostics,
vaccination support, advice on flock health) were major factors influencing the farmers’ choice/s of
veterinary drug shop.
According to the farmers’ opinions, antimicrobial retail prices had little impact on their specific
choice of veterinary drug shop. This is consistent with a previous study conducted in the area, where
poultry farmers stated that they would be willing to accept a three to four-fold hike in prices without
altering their AMU behaviour [16]. It has been shown that antimicrobials intended for veterinary
use are extremely affordable in the region (average of 0.56 cents of a USD per kilogram treated) and
represent only a small fraction of overall chicken production costs [12]. We found that, despite high
levels of AMU by chicken flocks in the area [15], antimicrobial sales represented a relatively small
fraction of the total income of veterinary drug shops. There were, however, the large difference
across establishments.
We found interesting differences in antimicrobial sales depending on the geographical location
and the profile of the shop owner. Shops in Thap Muoi district obtained a higher fraction of their
income from antimicrobial sales. However, this was explained by a higher fraction of drug shops in this
district that did not offer diagnostic services. Interestingly, the provision of diagnostic services was not
linked to the shop being owned by a fully qualified veterinarian (data not shown). Antimicrobials were
more likely sold in establishments where diagnostic support services, even basic (i.e., post-mortem),
were not available. This is consistent with studies in human medicine showing that uncertainty
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of diagnosis or the absence of diagnostic facilities is factors leading to an excessive prescription of
antimicrobials [19,20].
The higher density of pharmacies in Cao Lanh district is likely to result in competition among
shop owners and be reflected in more likely availability of diagnostic services in their shops. Despite
differences observed in antimicrobial sales and staff capacity in shops in these two districts, a previous
study identified larger overall levels of AMU among chicken farmers in this district [8]. This was
probably explained by a larger number of veterinary drug shops accessed by farmers in this district.
We mapped out veterinary drug shops and related these to animal bodymass. A previous study
conducted in one district within Ho Chi Minh City estimated that there were 301 drug shops for a
resident human population of 396,175 people [21]. Assuming an average bodyweight of 50 kilograms
per person, we calculate that one pharmacy supplied to a total of 65.8 tonnes of human bodyweight. In
contrast, in our study, there was one veterinary drug shop for 26.3 tonnes of animal bodyweight (i.e.,
2.5 times higher than human drug shops).
Our study had a number of limitations: We only interviewed drug shop owners, even though
other persons for which we did not gather information often staffed these shops. Also, there were a
number of veterinary drug shops falling outside the district boundaries. This was more likely for farms
located close to the edges of the district (data not shown). This may have resulted in an underestimation
of the distances between farms and their chosen drug shops. We focused on small- scale chicken
farms since small-scale farming is the most common type of farming system in the Mekong Delta and
elsewhere in Southeast Asia. The chosen farms had already been enrolled as part of a large field-based
project (www.viparc.org), and previous data indicated exceptionally high levels of AMU in these
systems. We believe that, to a certain extent, our findings can be extrapolated to small farms raising
other poultry species and pigs in the region.
4. Materials and Methods
4.1. Study Area, Populations and Veterinary Drug Shops
The study was conducted in two districts (Cao Lanh and Thap Muoi) within Dong Thap province
(Mekong Delta of Vietnam) in October 2018. These two districts had a combined area of 982.6 km2,
representing 27% of the whole province, and have a combined population of 313,445 people (population
density 319 people/km2). Rice and fruit crops, as well as raising livestock (pigs, cattle, goats) and
poultry (ducks, chickens and Muscovy ducks) are the main economic activities in this rural area. Data
on animal populations by commune (an administrative sub-division within the district) were provided
by the Sub-Department of Animal Health of Dong Thap (SDAH-DT) (official census, 2017). In Cao
Lanh and Thap Muoi districts, there were a combined population of 732,337 ducks, 163,572 chickens,
35,647 pigs, 7843 Muscovy ducks, 2934 cows, 1160 goats, and 784 geese. A total of 138 active veterinary
drug shops were registered in these two districts.
4.2. Correlation between Veterinary Drug Shop and Livestock Population
Data on the total number of animals (ducks, Muscovy ducks, chickens, pigs, geese, bovines, goats)
in each commune were converted into animal bodyweight based on 50% of the average weight of
slaughtered animals in Mekong region [22]: Duck, chicken (1.6 kg), goat (44.4 kg), pig (78.6 kg), cow
(200 kg). The Muscovy duck and goose slaughter weights were estimated in 3.2 kg. We calculated
the Spearman’s rank correlation coefficient between the number of veterinary drug shops and animal
bodyweight at commune level. Detailed on animal population by species at commune level are
provided in Table S2.
4.3. Mapping of Veterinary Drug Shops and Livestock Density
The location coordinates of all veterinary drug shops and chicken farms in the two study districts
were obtained. These were plotted using Quantum GIS (QGIS), version 2.18.15 (QGIS Development
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Team) based on DIVA-GIS boundary data (https://www.diva-gis.org). A kernel density algorithm was
used to create density heat maps of veterinary drug shop within a radius of 5 kilometers [23]. Likewise,
the ratio of veterinary drug shops and person-days per week (the sum of working days of all staff
including the shop owner per week) to total tonnes of animal bodyweight per commune was plotted
using a kernel density.
4.4. Survey of Veterinary Drug Shops and Chicken Farmers
Veterinary drug shop owners in Cao Lanh and Thap Muoi district were interviewed using
structured questionnaires. Information on demographic characteristics of the shop owners (i.e., age,
gender, educational status) and other shop-related variables (district, number of years in business,
type/s of customer, opening times, staffing capacity, types of products sold, diagnostic services, loan
service of feed, health products and sales by species) were collected. In addition, we interviewed
small-scale chicken farmers (raising between 100 and 2000 chickens) that had previously been randomly
selected for a longitudinal study [24]. Farmers were asked to list the veterinary drug shops from
where they purchased veterinary drugs over their latest flock production cycle. Farmers were asked to
list and rank the reasons behind their choice of each drug shop, adding up to 100%. We calculated
a standardised score for each reason by multiplying each of these ranks by the share of expenditure
on each veterinary drug shop. The distances between veterinary drug shops and chicken farms were
determined using the Distance Matrix Tool on QGIS.
4.5. Risk Factor Analysis
Risk factor analyses for the outcome variable ‘proportion of business income consisting of
antimicrobial sales (square root transformed) were carried out by linear regression. The variables
investigated were: (1) Owner’s gender; (2) Owner’s age (as determined with a cut-off of median value
of 40 years old); (3) Qualification of owner (vocational/bachelor or higher); (4) District; (5) Numbers of
years in business (log); (6) Staffing capacity (person-days per week) (log); (7) Affiliation to veterinary
authority (previous or current); (8) Diagnostic services available (including post-mortem); (9) Loan
services available; (10) Kernel density of veterinary drug shop (log). A multivariable model was built
using a step-wise forward approach to select the final model. Univariable models were screened, and
those with a p < 0.20 were kept as a candidate for multivariable models. All statistical analyses were
done using R (http://www.r-project.org).
5. Conclusions
Our findings suggest that improving the knowledge base of veterinary drug shops owners and
their staff on animal diseases and diagnostics may contribute to reducing excessive dispensation of
antimicrobials, whilst improving their awareness on the consequences of antimicrobial misuse. This
should be coupled with more stringent licencing requirements and training certificates to owners of
these shops, as well as any staff operating them.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6382/8/4/195/s1,
Figure S1: Correlation between animal population and number of veterinary drug shops/ total person-day per
week at commune level, Table S1: Data on survey of veterinary drug shop, Table S2: Total animal population in
study area, Table S3: Geographical coordinates and distance between veterinary drug shops and chicken farms,
Table S4. Standardised scores of reasons for choosing a veterinary drug shop by chicken farmers.
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1  | INTRODUC TION
Antimicrobials are widely used in animal production, both to pre‐
vent and to treat diseases. In some countries, antimicrobials are also 
added to commercial feed formulations to promote rapid growth 
(Page & Gautier, 2012). It has been estimated that in African coun‐
tries about 50% of antimicrobials available in the market correspond 
to non‐standard and non‐registered veterinary medicines (Clifford 
et al., 2018). There is a concern that inadequate formulation of 
these products may lead to exposure to sub‐therapeutic levels of 
antimicrobials, therefore promoting resistance among bacterial pop‐
ulations (Nwokike, Clark, & Nguyen, 2018). Recent studies on the 
quality of antimicrobial products used in shrimp and catfish farming 
in Vietnam indicated that only ~8% and ~29% products contained an 
AAI within ±10% (accepted level of variation) (Phu, Phuong, Scippo, 
& Dalsgaard, 2015; Tran, Tran, Phan, & Dalsgaard, 2018). Globally, 
the quantity of antimicrobials used in chicken production is esti‐
mated at 138.0 doses/1,000 animal‐days [inter quartile range (IQR) 
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Abstract
Background: The Mekong Delta of Vietnam is a hotspot of antimicrobial use (AMU), 
but there is no information on the quality of the labelling and strength of antimicro‐
bial products used in poultry production.
Methods: Based on a large random sample of farms, we identified the 20 most used 
antimicrobial products in the area, and investigated their antimicrobial active ingredi‐
ent (AAI) content by UPLC‐MS/MS (91 analytical tests).
Results: Only 17/59 (28.8%) batches contained all AAIs within 10% of the declared 
strength. Worryingly, 65.0% products provided in their label preparation guidelines 
for both therapeutic and prophylactic use. Withdrawal times for both meat and eggs 
were stated in 8/20 (40%) products.
Conclusion: Results highlight deficiencies in quality and labelling contents that un‐
dermine authorities’ efforts to discourage inappropriate use of antimicrobials.
K E Y W O R D S
animal production, antimicrobials, poultry, veterinary, Vietnam
†Correction added on 11 September 2019, after first online publication: the first name and surname for the third author were interchanged in the original 
publication; this has now been corrected to Nguyen Van Cuong.
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91.1–438.3], a higher amount than AMU in the two other major 
terrestrial food animal species (pig and cattle) (Cuong, Padungtod, 
Thwaites, & Carrique‐Mas, 2019). Previous studies have reported 
exceptionally high levels of antimicrobial use (AMU) in chicken farms 
in the Mekong Delta region of Vietnam (Carrique‐Mas et al., 2015; 
Carrique‐Mas et al., 2019; Cuong et al., 2019; Nguyen et al., 2016). 
However, there are currently no published data on the quality of 
antimicrobial products used in these farming systems. We investi‐
gated the labelling and strength of AAIs of the most commonly used 
products in representative chicken farms in the Mekong Delta of 
Vietnam.
Antimicrobial products were identified from a survey of 102 ran‐
domly selected farms raising meat chickens in Dong Thap province 
from November 2016 to March 2018. A total of 203 flocks raised 
in those farms with a completed full cycle of production were in‐
cluded in the study (Carrique‐Mas & Rushton, 2017; Cuong et al., 
2019). All flocks consisted of native breed chickens raised over a 
median period of 18 [Interquartile Range 16‐20] weeks, with birds 
typically raised using all‐in‐all‐out system. At the beginning of the 
project, farmers were given purposefully designed diaries to record 
their AMU, as well as containers where farmers were asked to store 
all packages of antimicrobials. A team of trained animal health work‐
ers visited each farm four times during each production cycle to re‐
view the collected data. The 20 most frequently used antimicrobial 
products were identified. Three different batches of each product 
were purchased from veterinary drug shops within the province of 
Dong Thap. The 20 most commonly used antimicrobial‐containing 
products (defined as the proportion of flocks using) were identified, 
and information on strength on AAIs, species target, prophylactic/
therapeutic indication, and withdrawal times for meat and egg pro‐
ductions was compiled. The products’ contents were tested (single 
blinded) for the presence and strength of the AAIs declared in the 
label at an accredited laboratory (Center for Analysis Service of 
Experiment, Ho Chi Minh City, ISO 9001:2008 accredited) using 
Ultra High Performance Liquid Chromatography coupled to tandem 
Mass Spectrometry (UPLC‐MS/MS). Three aminoglycoside antimi‐
crobials (gentamicin, neomycin and streptomycin) were not investi‐
gated. For colistin, the number of International Units (IU) indicated 
in the label was converted to miligrams. Results were expressed as a 
percent of the declared strength indicated in the label (percent con‐
tent). The inter‐batch variability (in relation to the overall variability) 
was investigated by fitting a null random effects model with product 
fitted as a random effect and percent content as the outcome using 
lme4 package and R software.
The 20 products identified were marketed by nine different com‐
panies, and all except one (a French company selling product AB008) 
were Vietnamese (Table 1). All products were formulated for oral 
administration: Nineteen (95%) were powder‐based formulations 
and one (5%) was a liquid solution. Five (25%) products contained 
a single antimcrobial and 16 (75%) a mixture of two antimicrobials. 
In order to investigate the inter‐batch variability, three batches of 
19 products and two batches of one product (AB051) were investi‐
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Twelve different AAIs were identified in the 20 products, the 
most common being: colistin (8 products), oxytetracycline (6), genta‐
micin (2), tylosin (2), doxycycline (2), amoxicillin (2) and enrofloxacin 
(2). Other AAIs (trimethoprim, streptomycin, tilmicosin, erythromy‐
cin and neomycin) were contained in one product each. Six of those 
AAIs (colistin, gentamicin, tylosin, erythromycin, tilmicosin and neo‐
mycin) are considered to be critically important antimicrobials ac‐
cording to the World Health Organization (Anon 2017).
In six (30.0%) products the label provided an explicit indication 
for therapeutic administration only, 13 (65.0%) products provided 
an indication for both therapeutic and prophylactic use, and one 
(5.0%) did not include any indication. Withdrawal times for both egg 
and meat production were provided in the labels of eight (40.0%) 
products; in 11 (55.0%) products withdrawal times were indicated 
only for meat (but not for eggs); one product contained no indica‐
tions with respect to withdrawal time. A total of 11 (55.0%) products 
contained only one AAI, and the remaining had other substances 
(including vitamins, mineral supplements and expectorants and anal‐
gesic substances). Twenty‐eight (30.8%) samples tested were within 
10% of the strength declared in the label. Thirty‐four (37.4%) con‐
tained AAIs above the declared upper limit, and 27 (29.7%) below 
the declared lower limit. Two extreme values were observed for two 
AAIs: one (Product AP16) contained oxytetracycline with strength 
ranging from 10.3% to 11.9% and another (AB09) product had doxy‐
cycline strength ranging from 141.5% to 165.0% of the stated value 
(Figure 1).
In 27/91 (29.7%) of the tests conducted the AAIs had a strength 
below the acceptable lower limit (−10%). Unexpectedly, 34/91 (37.4%) 
had AAIs with strength higher than that indicated in the label. Of the 
59 individual product batches investigated, only 17 (28.8%) had all 
their AAIs within the ±10% acceptable range. Only 3 of the 20 (15.0%) 
products had all batches and all their AAIs within the ±10% range. A 
total of 24.5% of the variance was attributed to between‐batch varia‐
tion, the remainder being due to between‐product variation.
Since our study is based on a random sample of farms, we are confi‐
dent that these results are representative of antimicrobial products most 
commonly used by poultry farmers in the Mekong Delta of Vietnam. 
Currently there are >10,000 licensed veterinary products in the country, 
of which about ~50% consist of antibacterial antimicrobial formulations 
(Anon 2016). This makes quality control monitoring extremely challeng‐
ing, particularly in a limited‐resource setting such as Vietnam.
Quality testing of AAIs is very costly, and there is a lack of unbiased 
information about this issue in animal production in most countries. 
It has been previously estimated that one in 10 medicinal products in 
low‐ and middle‐income countries is substandard or falsified (Nwokike 
et al., 2018). Given that the identity of antimicrobials declared in the 
label was confirmed in all cases, we do not believe that outright falsi‐
fication is a major issue here. Furthermore, ‘legal’ antimicrobials are 
currently very affordable in Vietnam, and two‐thirds of the products in‐
vestigated had an indication for ‘prophylactic use’ in the label (normally 
followed by a list of bacterial diseases). This labelling openly conflicts 
with the animal health authorities’ efforts to discourage routine use of 
antimicrobials for preventing disease (Aidara‐Kane et al., 2018; Anon 
2013) and sends a ‘wrong’ message to farmers (the end users), who 
will not be able unable to discern in the few instances that medication 
may be required in the absence of disease. This is particularly relevant 
in the context of  small‐scale farmers in many low‐ and middle‐income 
countries. Farmers in these settings  often do not have access to veteri‐
nary services capable of providing them with unbiased advice on AMU.
Under dosing is expected to result because of either sub‐optimal 
quality of the manufactured product, or inadequate preparation at 
the point of administration by the farmer. For most products, the 
guidelines for product preparation (mixing with water) for prophy‐
laxis were about half the strength required for therapeutic purposes. 
There is a risk that this may increase the probability of selection 
of AMR in bacterial populations (Ungemach, Mueller‐Bahrdt, & 
Abraham, 2006). Withdrawal times for egg production were not 
specified in 60% of the antimicrobial products investigated. This is 
a concern, since these products are likely to be used both in meat 
and layer flocks. The observed inter‐batch variation in product qual‐
ity suggests deficiencies in the mixing/packaging process, since in 
Vietnam most AAIs sold in Vietnam are bulk‐imported and then 
mixed, packaged and distributed within the country.
Based on a representative field survey, we identified the most 
common antimicrobial products used in poultry farming in the 
F I G U R E  1   Results of the analyses of strength of antimicrobial 
AAIs in the 20 most commonly used products in poultry farms 
in the Mekong Delta of Vietnam. Products are sorted by 
decreasing prevalence of use by flock. Each dot across horizontal 
line corresponds to the results of the concentration of one AAI 
analysed
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Mekong Delta. Results indicate variable quality results, with only 
17 (28.8%) product batches containing AAIs within the acceptable 
±10% range. In addition to improving quality control of veterinary 
medicine products, we strongly advocate for enhancing regulation 
and inspection of antimicrobial product labelling, crucially removing 
the indication for prophylactic use. In all cases, products should in‐
dicate withdrawal times for meat, eggs and milk (for products aimed 
at ruminants). It would be desirable to limit the access to antimi‐
crobials of critical importance for human health for veterinary use, 
and therefore development of policies aiming at this should be a 
priority.
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A survey of retail prices of antimicrobial
products used in small-scale chicken farms
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Abstract
Background: In the Mekong Delta region of Vietnam, high quantities of products containing antimicrobial are used
as prophylactic and curative treatments in small-scale chicken flocks. A large number of these contain antimicrobial
active ingredients (AAIs) considered of ‘critical importance’ for human medicine according to the World Health
Organization (WHO). However, little is known about the retail prices of these products and variables associated with
the expense on antimicrobials at farm level. Therefore, the aims of the study were: (1) to investigate the retail price
of antimicrobials with regards to WHO importance criteria; and (2) to quantify the antimicrobial expense incurred in
raising chicken flocks. We investigated 102 randomly-selected small-scale farms raising meat chickens (100–2000 per
flock cycle) in two districts in Dong Thap (Mekong Delta) over 203 flock production cycles raised in these farms.
Farmers were asked to record the retail prices and amounts of antimicrobial used.
Results: A total of 214 different antimicrobial-containing products were identified. These contained 37 different
AAIs belonging to 13 classes. Over half (60.3%) products contained 1 highest priority, critically important AAI, and
38.8% 1 high priority, critically important AAI. The average (farm-adjusted) retail price of a daily dose administered
to a 1 kg bird across products was 0.40 cents of 1 US$ (₵) (SE ± 0.05). The most expensive products were those that
included at least one high priority, critically important AAI, as well as those purchased in one of the two study
districts. Farmers spent on average of ₵3.91 (SE ± 0.01) on antimicrobials per bird over the production cycle. The
expense on antimicrobials in weeks with disease and low mortality was greater than on weeks with disease and
high mortality, suggesting that antimicrobial use had a beneficial impact on disease outcomes (χ2 = 3.8; p = 0.052).
Farmers generally used more expensive antimicrobials on older flocks.
Conclusions and recommendation: The retail prices of antimicrobial products used in chicken production in
Mekong Delta small-scale chicken farms are very low, and not related to their relevance for human medicine.
Farmers, however, demonstrated a degree of sensitivity to prices of antimicrobial products. Therefore, revising
pricing policies of antimicrobial products remains a potential option to curb the use of antimicrobials of critical
importance in animal production.
Keywords: Mekong Delta, Vietnam, Chicken, Poultry, Antimicrobial, Animal daily dose, Cost
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Background
Antimicrobial resistance (AMR) is a global health con-
cern and excessive antimicrobial use (AMU) in animal
production is one of the contributing factors [1]. The
AMR situation has reached critical levels, and countries
are being urged to take immediate action to mitigate the
problem [2]. The practice of purchasing antimicrobials
‘over the counter’ without a prescription is widespread
in many low- and middle-income countries (LMICs) [3].
This is also common practice in Vietnam, a country that
currently ranks as the 15th most populous in the world
(~ 97M in 2019), in spite of existing legislation restrict-
ing access to antimicrobials for human use without pre-
scription [4]. In contrast, antimicrobials intended for
animal use can be legally purchased without a prescrip-
tion by anyone from any of the approximately 10,000
veterinary drug shops across the country [5].
In 2011, the World Health Organization of the United
Nations (WHO) ranked antimicrobial active ingredients
(AAI) based on prioritization criteria for human medicine.
This list has been modified on several occasions, and in
2018 the highest priority, critically important AAI category
included 3rd and 4th generation cephalosporins, glycopep-
tides, macrolides, ketolides, polymyxins and quinolones [6].
There is growing consensus that use of antimicrobials
of critical importance for human medicine in animals
should be restricted/reduced [7–9]. However, a large
number of AAIs considered by WHO to be of critical
importance are currently used in animal production
worldwide [10]. The Mekong Delta of Vietnam is
regarded as a hotspot for AMU in animal production
[11–14], and levels of use of AAIs considered of critical
importance are high. A recent study on small-scale
chicken farms in the Mekong Delta indicated that 76.2%
antimicrobial products contained AAIs of critical im-
portance according to WHO [14]. It has been suggested
that antimicrobials used in animal production in
Vietnam are very affordable. A study on the 10 most
popular products used by farmers showed that the aver-
age cost of a daily dose was 0.56 cents of 1 US$ (range
ranged from 0.19 to 1.03) [15]. It is not clear whether re-
tail prices reflect their AAIs composition and their rele-
vance to human health, and to what extent low pricing
contributes to excessive AMU in animal production in
Vietnam. We investigated antimicrobial products used
in a sample of 112 randomly selected small-scale com-
mercial farms (203 flocks) raising native chickens in the
Mekong Delta of Vietnam. We quantified AAIs con-
tained in these products as well as their retail prices.
The aims of this study were: (1) to investigate the price
of antimicrobials with regards to WHO importance cri-
teria and formulation (single AAIs or combined AAIs)
and (2) to investigate changes in the expense on antimi-
crobials over the production cycle.
Results
Total and weekly expense on antimicrobials
Data on AMU and their retail prices were obtained from
203 complete cycles of native chicken flocks raised for
meat in 102 farms. The median flock size at restocking
was 300 [Inter-quartile range (IQR) 200–495], and the
median duration of production cycles was 18 [IQR 16–20]
weeks. The median cumulative mortality over the whole
production cycle across flocks was 14.10% [IQR 6.8–29.2].
The average probability of AMU by week across flock cy-
cles was 0.21 (SE ± 0.02) (Fig. 1a). The total expense on
antimicrobials by farmers over the 203 cycles of produc-
tion was US$2529.50 (Fig. 1b). The average expense on
antimicrobials per flock cycle was US$12.50. The average
cumulative expense on antimicrobials to raise one bird
was ₵3.91 (SE ± 0.03). On average, farmers spent ₵64.07
(SE ± 2.45) on antimicrobials per week (Fig. 1b), and ₵0.20
(SE ± 0.01) per bird per week (Fig. 1c).
The highest probability of AMU corresponded to the
first week of age of flocks (0.76; SE ± 0.03), decreasing
thereafter (Fig. 1a). The weekly total expense on antimi-
crobials was highest during the 8–12 period week, peak-
ing on week 10 (per flock mean ₵128.60; SE ±13.36)
(Fig. 1b). After week 13, overall expense on antimicro-
bials decreased considerably (≤₵52.19 per week). In rela-
tion to live chicken weight, the weekly average expense
on antimicrobials was was ₵0.75 per kg of live bird (SE ±
0.05). The highest expense corresponded to the first
week of production (per flock mean ₵6.36; SE ±0.35)
and quickly decreasing thereafter (≤₵2.21 per week)
(Fig. 1d).
Antimicrobials and disease
The probability of disease was highest during the first
week of the production cycle (0.56 SE ± 0.02), decreasing
thereafter. Overall bird mortality peaked during the 5–
10 week period (Fig. 2a). Of a total of 3948 weeks ob-
served across all of 203 flocks, 1113 (28.19%) corre-
sponded to weeks with disease (clinical signs reported)
and 2835 (71.81%) to weeks without disease.
On average, farmers spent ₵125.38 (SE ± 6.76) and
₵40.0 (SE ± 1.97) on antimicrobials on their flocks in
weeks with and without disease, respectively (Kruskal-
Wallis χ2 = 367.3; p < 0.001). The (average) expense (per
bird) on antimicrobials in weeks with and without dis-
ease was ₵0.34 (SE ± 0.02) and ₵0.15 (SE ± 0.01), respect-
ively (Kruskal-Wallis χ2 = 315.7; p < 0.001). Of weeks
with disease, the highest overall expense on antimicro-
bials corresponded to weeks 8–12, with a peak in week
10 (flock mean ₵210.81; SE ± 39.75) (Fig. 2b). Weekly
mortality was categorized as low or high based on a
(mean) cut-off of 2.8 per 100 birds (2.8%). The average
expense on antimicrobials (per flock) in weeks with dis-
ease with high and low mortality was ₵137.86 (SE ± 8.34)
Dung et al. Globalization and Health            (2020) 16:8 Page 2 of 10
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and ₵157.40 (SE ± 7.98), respectively (Kruskal-Wallis
χ2 = 2.9; p = 0.085) (Fig. 2c). The equivalent per bird ex-
pense was ₵0.37 (SE ± 0.02) and ₵0.47 (SE ± 0.03) for
weeks with, respectively, high and with low mortality
(Kruskal-Wallis χ2 = 1.2; p = 0.274). The average cost of
antimicrobial products used (expressed as cost of prod-
uct ADDkg) chosen in weeks with and without disease
was, respectively, ₵0.60 (SE ± 0.04) and ₵0.54 (SE ±0.05)
(Kruskal-Wallis χ2 = 0.4; p = 0.528) (Fig. 2d).
Retail prices of antimicrobial products and AAIs
Retail prices of antimicrobial-containing products were
collated from farmers’ records documenting AMU on 191
full flock cycles (raised in 100 farms). A total of 619 differ-
ent health-supporting products were identified, of which
236 products contained AAIs. Data on 22 antimicrobial-
containing products intended for human use (tablets) and
injectable antimicrobials for animal use were excluded,
since it was not clear how these were administered to
flocks, the quantities used and number of birds treated. A
total of 775 pricing records on the remaining 214 anti-
microbial products were used to summarize retail prices.
These 214 products contained 37 different AAIs belong-
ing to 13 classes. A total of 71.9% products contained only
antimicrobial active ingredients (AAIs) (apart from excipi-
ent), whilst 28.1% contained AAIs mixed with substances
such as vitamins, mineral and electrolytes. Examination of
the products’ labels indicated that 76 contained one AAI,
137 contained two AAIs, and one contained four AAIs
(tylosin, sulphamethoxazole, sulfadiazine, and trimetho-
prim) (used by one farm on one flock) An additional file
gives a detailed description of all 214 products (Add-
itional file 1). Data from a total of 775 price estimates
from farmers were used to summarize the price of prod-
ucts based on their AAI composition (see
Additional file 2). A table with information on all anti-
microbial products broken down by their AAIs content,
the number of farms using these products and their mean
retail price is given in an additional file (see Add-
itional file 3). These are further aggregated by class of AAI
in Table 1.
A total of 129 (60.3%) products contained at least one
critically important of the highest priority AAI; 82
(38.3%) contained at least one critically important of
Fig. 1 a Probability of flocks using antimicrobials by age (weeks); b Weekly expense (per flock) on antimicrobials during the flock production
cycle by age; c Total expense (per bird) on antimicrobials; d Total expense per kilogram of bird. Costs are expressed in cents of 1 US$ (₵). The
blue lines represent the crude (unadjusted) mean across all observation weeks. Vertical bars represent the standard error of the mean (SE)
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high priority AAI; 107 (50%) contained an antimicrobial
of high importance, and 19 (8.9%) at least one anti-
microbial of any other type.
The average farm-adjusted retail price of products
(expressed as a daily dose of an antimicrobial product
administered to a 1 kg bird, or 1 ADDkg) was ₵0.40 (SE ±
0.05). The retail price (per ADDkg of product), from
more to less affordable, corresponded to antimicrobial
products containing: (1) exclusively high priority, critic-
ally important AAIs (mean ₵0.31 SE ± 0.04 per ADDkg);
(2) highest priority, critically important in combination
with highly important AAIs (₵0.36; SE ± 0.03); (3) highly
important AAIs in combination with other types (mean
₵0.84; SE ± 0.42); and (4) high priority, critically import-
ant in combination with other AAIs (mean ₵0.86; SE ±
0.18). With regards to products containing one AAIs,
the mean retail price per ADDkg ranged from ₵0.16
(SE ± 0.03) (lincomycin) to ₵5.44 (sulphathiazole) (aver-
age price ₵0.48; SE ± 0.03). With regards to products
containing two AAIs, the average retail price (per
ADDkg) corresponding to each of the AAIs contained
was ₵0.21 (SE ± 0.03) ranging from ₵0.03 (SE ± nc)
(sulfadiazine) to ₵0.58 (SE ±0.16) (apramycin) (Fig. 3).
Frequency of use and price of antimicrobial products
There was no significant correlation between the fre-
quency of use (number of weeks each product was used
on flocks) and the average price of each antimicrobial
product (Spearman rank ρ = 0.05; p = 0.495).
Association between product- and farm-related factors
and retail price of products
Three factors were independently associated with a
higher retail price of antimicrobial-containing products:
(1) Those including AAIs only (p = 0.007); (2) Cao Lanh
district (compared with Thap Muoi) (p < 0.001); and (3)
Type of antimicrobial. We evaluated pair-wise differ-
ences between all four categories of antimicrobials, and
Fig. 2 a Probability of disease across all flocks; b Total expense (per flock) on antimicrobials by production week conditional to the presence of
disease in flocks; c Total expense (per flock) on antimicrobials by production week regarding to flock we ekly mortality (expressed in cents of 1
US$); d Average cost of ADDkg product by production week. Black lines in each bar represent the mean ± SE. High mortality indicates ≥2.8 birds/
100 per week
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only differences between the high priority (the most ex-
pensive) and highly important (the least expensive) cat-
egories remained significantly different (p = 0.034)
(Table 2).
Data corresponding to 904 weeks when AMU was re-
ported were used to investigate farm-related factors as-
sociated with price (standardized per ADDkg) of
antimicrobial product used. These data are shown separ-
ately (see Additional file 4). Only two factors remained
significant in multi-variable model: (1) age of flock
(higher ADDkg retail price in older flocks) (p < 0.001)
and (2) Cao Lanh district (p < 0.001) (Table 3).
Discussion
To our knowledge, this is the first study reporting pri-
cing of antimicrobials intended for veterinary use. Since
the study is based on a large random sample of farms
and a large number of products, we believe that these re-
sults accurately reflect the types of antimicrobials used
and their associated prices in the Mekong Delta region
of Vietnam. Much of this area shares a similar agro-
ecological, demographic, as well as a similar antimicro-
bial retail landscape. We describe here a high diversity
of AAIs used in poultry with a relatively low retail price
(mean product price ₵0.40 per ADDkg), in line with a
Table 1 Classification of 214 antimicrobial-containing products based on their AAI composition and WHO classification, as well as
their frequency of use and retail price (based on 775 farmer pricing records)
WHO category No. products
(N = 214) (%)
AAIs in products (No. of products in bracket) No. farms











43 (20.1) colistin+amoxicillin (12), colistin+ampicillin (12),
colistin+neomycin (8), colistin+gentamicin (2),
colistin+apramycin (1), tylosin+gentamicin (5),
tylosin+amoxicillin (2), tylosin+streptomycin (1)
65 (65.0%) 103 (53.9%) 0.52 (±0.03)
Highest priority only 41 (19.2) enrofloxacin (12), flumequine (9), tilmicosin (6),
erythromycin (2), norfloxacin (2), tylosin (1),
colistin (2), colistin+tylosin (3), colistin+spiramycin (2),
colistin+enrofloxacin (1), colistin+erythromycin (1)
52 (52.0%) 85 (44.5%) 0.45 (±0.07)
Highest priority
+Highly important
38 (17.8) colistin+oxytetracycline (8), colistin+doxycycline (1),
colistin+lincomycin (1), colistin+sulfadimethoxine (1),
doxycycline+tylosin (6), doxycyline+tilmicosin (1),
erythromycin+sulphamethoxazole (2), erythromycin
+oxytetracycline (1), kitasamycin+thiamphenicol (1),
oxytetracycline +neomycine (2), oxytetracycline+
spiramycin (3), oxytetracycline+tylosin (2), tylosin+
sulfadimidine (3), tylosin+tetracycline (2),
tylosin+sulfachloropyridazine (1), tylosin+
sulfamethazine (1), tylosin+sulphamethoxazole (1)
88 (88.0%) 163 (85.3%) 0.36 (±0.03)
Highly important only 35 (16.4) oxytetracycline (9), oxytetracycline+sulfadimidine (1),
oxytetracycline+thiamphenicol (1), doxycycline (5),
doxycycline+florfenicol (3), doxycycline+lincomycin
(1), florfenicol (8), lincomycin (2), cephalexin (1),
cefadroxil (1), sulphathiazole (1), sulfamethoxypyridazine
+tetracycline (1), sulphamethoxazole+ thiamphenicol (1)
58 (58.0%) 77 (40.3%) 0.46 (±0.06)
High priority+Highly
important
25 (11.7) lincomycin+spectinomycin (6), doxycycline+gentamicin (5),
doxycycline+neomycin (1), doxycycline+ampicillin (1),
oxytetracycline+streptomycin (5), oxytetracycline+neomycin (4),
ampicillin+sulfadimethoxine (1), gentamicin+sulfadimidine (1),
streptomycin+sulphamethoxazole (1)
43(43.0%) 63 (33.0%) 0.45 (±0.07)
High priority only 12 (5.6) amoxicillin (7), neomycin (3), ampicillin (1), streptomycin (1) 19 (19.0%) 23 (12.0%) 0.31 (±0.04)
Highly important
+Other
8 (3.7) sulfadimethoxine+trimethoprim (4), sulfadiazine+
trimethoprim (1), sulfadimidine+trimethoprim (1),
sulphamethoxazole+trimethoprim (1), doxycycline+
tiamulin (1)
14 (14.0%) 14 (7.3%) 0.84 (±0.42)
Highest priority
+Other
6 (2.8) colistin+trimethoprim (3), josamycin+trimethoprim (1),
spiramycin+trimethoprim (1), colistin+enramycin (1)
14 (14.0%) 14 (7.3%) 0.46 (±0.09)
Other only 3 (1.4) trimethoprim (2), methenamine (1) 23 (23.0%) 32 (16.8%) 0.57 (±0.04)




1 (0.5) tylosin+trimethoprim+sulfadiazine+sulphamethoxazole (1) 1 (1.0%) 1 (0.5%) 0.67 (nc)
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preliminary study [15]. Overall, retail prices did not
greatly differ across WHO classes, with the excep-
tion of high priority, critically important antimicro-
bials, largely driven by the higher prices of
apramycin, gentamicin (aminoglycosides) and spec-
tinomycin (aminocyclitol). Over two thirds of the
products (68.7%) contained two AAIs. This situation
is very different in the European Union where most
licenced antimicrobial products contain only one ac-
tive ingredient [16].
A low retail price of antimicrobial-containing products
was not reflected in a higher frequency of use. This is
surprising, since often most popular consumer goods
and brands tend also to be the most affordable. A study
on antimicrobials of human use in Mongolia found that
lower-priced antimicrobials were also those purchased
more frequently e [17]. This underlines that factors
other than retail price drive antimicrobial consumption
intended for animal use in the Mekong Delta, and is
consistent with the farmers’ perception that retail price
is not a limiting factor for AMU [18]. Results indicate
that the farmers are making judgements on the value of
the products when confronted with disease or when
treating older flocks that are more valuable. Further re-
search in the area confirmed that farmers chose veterin-
ary drug shops for reasons others than strict pricing,
including other services such as advice, diagnostics or
even loan services [19].
One of the two study districts (Cao Lanh) was associ-
ated with higher retail prices. This district is located
Fig. 3 Average price per ADDkg product stratified by type of AAIs contained. Separate analyses were done from products containing one or two
AAIs (*cephalexin ₵2.43; sulphathiazole ₵5.43; tylosin 3.74). The blue dash line indicates the average price per ADDkg (₵) across all products
Table 2 Linear random effects models investigating factors associated with the retail price of antimicrobial products. Data
corresponding to 775 price measurements corresponding to 213 products containing one or two AAIs were included in the model
Univariable Multivariablea
β SE p-value β SE p-value
Two AAIs (baseline = 1 AAI) 0.102 0.060 0.089
Type of AAI included (baseline = Highly important)
Highest priority 0.001 0.061 0.993
High priority 0.141 0.059 0.017 0.122b 0.057 0.034
Other 0.111 0.101 0.274
Pure AAI in product (baseline = mixed with other products) 0.186 0.056 < 0.001 0.152 0.056 0.007
Cao Lanh district (baseline = Thap Muoi) 0.464 0.070 < 0.001 0.468 0.071 < 0.001
aIntercept = −1.221 (SE = 0.062); bBaseline = All other types of AAIs combined
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closer to the provincial capital, and has a greater density
of veterinary drug shops than the other study district.
This difference confirms the existence of the variability
in terms of market structure across districts. A recent
study also showed a higher frequency of AMU in farms
located in this district [20], suggesting that demand for
these products could be partly responsible for higher
prices. This observation, however, does raise the ques-
tion of whether marginal changes in price will reduce
AMU in small-scale livestock systems.
Regardless of the AAI contained, antimicrobial prod-
ucts that contained pure AAIs were more expensive than
AAIs mixed with other substances. These products were
generally imported and likely to be more expensive. De-
tails on the compounding and wholesale of AAIs re-
quires further investigation.
Notably, in terms of frequency and expressed per kg of
live animal, AMU was highest during the first week of the
life of flocks. However, the greatest overall expense corre-
sponded to the 8–12 week period, where the incidence of
mortality was highest and birds had reached a higher
bodyweight. This is consistent with a previous study when
mortality was highest during the same period [20]. The
older age of the flock was also associated with the choice
of more expensive antimicrobial products. These results
indicate that farmers are sensitive to the antimicrobial
products’ cost in relation to their perceived potential
effectiveness. Therefore, farmers use more expensive anti-
microbials in the face of disease threat, as well as to pro-
tect the higher value of older birds. A previous study
indicated that giving antimicrobials to chicken flocks
made farmers feel more secure, since more expensive anti-
microbials are also perceived to be more effective [18].
The study provides conclusive evidence that prices of
antimicrobial-containing products used in chicken pro-
duction systems in the Mekong Delta are extremely low.
Even though many of these products contained AAIs of
high importance to human medicine, this is not reflected
in the retail price. Retail price is only a component of
cost for accessing antimicrobials, the other relates to
travel to retail sites and barriers restricting their pur-
chase. In the study area, access to retail points is rela-
tively easy, with farmers located on average ~ 2 km from
their closest veterinary drug shop [19]; once there the
purchase involves a simple request for the product of
preference or a consultation describing the flock health
and the needs. There is currently no need for prescrip-
tion (i.e. veterinary fee), therefore the retail cost is an ac-
curate reflection of the actual cost to the farmer of using
antimicrobials in their livestock production system.
It has been stated that overuse of antimicrobials and
antimicrobial resistance is partly the result of a dysfunc-
tional health system, and that antimicrobial stewardship
requires long-term commitment to healthcare provision
Table 3 Linear random effects models investigating farm-related factors associated with ADDkg price of antimicrobial products used.
Data on 904 price estimates corresponding to weeks when farmers administered antimicrobials were used
Univariable Multivariablea
β SE p-value β SE p-value
Farm owner’s age (years)(Baseline = < 36)
36–54 0.197 0.139 0.161
> 54 0.031 0.156 0.843
Farm owner’s gender (Baseline = Female)
Male 0.323 0.150 0.033
Farm owner’s experience in raising chickens (years)(Baseline = 0–2)
> 2–4 − 0.021 0.114 0.853
> 4 −0.008 0.154 0.958
Farm owners’ education attainment(Baseline = Post high school)
Primary school 0.514 0.236 0.033
Secondary school 0.387 0.229 0.096
High school 0.320 0.235 0.177
Chicken total (log) 0.061 0.061 0.319
Age of flock (weeks) (log) 0.157 0.025 < 0.001 0.153 0.024 < 0.001
Disease status (baseline = No disease)
Disease 0.085 0.050 0.084
Mortality > 2.8/100 birds/week (Baseline ≤2.8/100 birds/week) 0.091 0.056 0.108
Cao Lanh district (Baseline = Thap Muoi) 0.533 0.083 < 0.001 0.514 0.081 < 0.001
aIntercept = −1.331 (SE = 0.066)
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[21]. Policies need to strike a balance between access to
antimicrobials by those that really need them whilst pre-
venting unnecessary use [22]. A potential measure that
may reduce excessive AMU includes the compulsory re-
quirement of a prescription for purchasing antimicro-
bials intended for veterinary use similar to that currently
in place in some developed countries [23]. However,
given the large size of the farming community and the
limitations of the veterinary services in Vietnam, such
policy would be difficult to implement in the short- to
mid-term. Levying a tax on antimicrobial products
intended for animal use has been suggested as a policy
intervention with a potential to reduce excessive AMU
[24]. In view of these results, we consider that levying
taxes on the most critical important antimicrobial cat-
egories would be reasonable policy intervention.
Conclusions
Our study provides conclusive evidence of the compara-
tively low prices of antimicrobial-containing products
used in chicken production systems in the Mekong Delta
of Vietnam, and their lack of relatedness with their hu-
man medicine relevance. Implementing pricing mecha-
nisms that provide a signal to retailers and farmers and
that the products they are selling and using (antimicro-
bials) are of importance to society is a policy measure
worth exploring. We recommend that retail surveys of
antimicrobials should be conducted in other areas within
Vietnam as well as other countries in region, so that
large-scale pricing policy interventions may be imple-
mented. Any changes in pricing policies would require
careful monitoring of the demand response of retailers
and farmers whilst ensuring lack of adverse effect on
animal health. Such work would provide a true basis for
evidence-based policy on the pricing of antimicrobial-
containing veterinary products.
Materials and methods
Study flocks and data collection
The study was conducted in Dong Thap province (Me-
kong Delta). Farmers were randomly chosen from the
census (2015) of chicken farmers of two districts (Cao
Lanh and Thap Muoi). All flocks investigated corre-
sponded to the baseline (i.e. observational) phase of an
intervention study. The aim was to recruit 120 farms
raising 100–2000 chickens per cycle [25]. There were 13,
264 and 5371 registered chicken farms in Cao Lanh and
Thap Muoi districts. According to this census, 275 (Cao
Lanh) and 201 (Thap Muoi) farms had a capacity of
100–2000 chickens. A total of 207 farmers raising > 100
chickens according to the 2015 census were randomly
chosen and were contacted by letter by the veterinary
authorities (sub-Department of Animal Health and Pro-
duction of Dong Thap, SDAHP). A meeting was held
with 199 attending farmers (96%), in which the project
aims and methods were introduced. Farmers were asked
to contact the project team should they wish to restock
within the following 6 months. A total of 102 (51.3%)
such farmers restocking with 100–2000 chickens con-
tacted the project team within 6 months of the meeting
and expressed their willingness of being enrolled in the
study. Each participating farmer was given a purposefully
designed diary alongside a large plastic container.
Farmers were asked to weekly record in the diary infor-
mation on the number of chickens, presence of disease
and the amounts of any health-related products used,
their costs, and the route of administration (oral-water,
oral-feed, injectable) in the diaries. They were also asked
to keep all containers of any health-related product in
the plastic container, as well as the receipts reflecting
the purchases of these products. A research team visited
each farm on four different times during the duration of
each flock production cycle (typically 3–5months). On
the day of the visit, information on the antimicrobial
products recorded in the diaries was compiled, and pic-
tures were taken of the products’ labels. The data were
subsequently uploaded onto a central database. The pic-
tures of the labels of all health-related products adminis-
tered to the flocks were carefully examined to determine
which products contained AAIs, their strength and the
mode of administration. Recruited farms were investi-
gated from October 2016 to March 2018.
Data analyses
Retail prices paid by farmers to purchase antimicrobial
products for oral administration were compiled. The re-
tail prices of each product was standardized to ‘amount
required to treat one kg of live chicken’ (ADDkg). This
was calculated based on the manufacturers’ guidelines
on product preparation for therapeutic purposes (dilu-
tion of the product in water and/or feed), the retail costs
of the product (from farmer’s diaries), and the estimated
‘daily intake’ of a 1 kg chicken (estimated in 225ml
water or 63 g feed). For products with an indication for
both water and feed preparation, indications for dilution
in water were followed. Prices were expressed in cents of
1 US$ (₵), based on an exchange rate of 1 US$ = 23,319
VND (as of 23rd September 2018).
DF ¼ Dilution factor ðvolume or weight of antimicrobial
product related to volume or weigh of water or feedÞ
The probability of AMU by week was calculated by
dividing the number of flocks using antimicrobials by
the number of flocks observed across all weeks. The
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total expense on antimicrobial products over the pro-
duction cycle was calculated by week from usage data,
and was related to the number and weight of birds, as
well as the presence/absence of disease in the flock. The
weight of birds in flocks by week was estimated from a
previous study [1]. We compared the farmers’ expense
on antimicrobials in weeks with and without disease,
stratified by level of flock mortality (computed by the
number of dead birds divided by the total birds at the
beginning of that week). The average retail price of
chosen antimicrobial products (expressed in ADDkg) was
computed stratified by flock age and disease status.
Comparisons between retail prices of antimicrobials
used at different ages and between flocks with and with-
out disease were performed using the Kruskal-Wallis
statistic.
The correlation between frequency of use and the
average price of each antimicrobial product (standard-
ized as ADDkg) was investigated using the Spearman
rank correlation coefficient. The frequency of use was
expressed as the number of weeks using of each anti-
microbial containing products was used.
The price associated with each specific AAI contained
in antimicrobial products was expressed in relation to 1
kg of chicken treated with the product (ADDkg). These
were calculated by dividing the price of the product by
1, 2 or 4, depending on the number of AAIs included.
Antimicrobial products were then classified by their
AAI composition according to the WHO criteria: (1)
‘Highest priority, critical important’, (2) ‘High priority,
critical important’, (3) ‘Highly important’, and (4) ‘Other’.
The potential association between product-related fac-
tors and their retail price to the farmer (expressed as
ADDkg product) was investigated by building a random
effect multivariable linear model with ‘Farm’ specified as
a random effect. Factors investigated as fixed-effect co-
variates were: (1) Number of AAIs in the product (one
or two); (2) Type of AAIs based on WHO classification;
(3) Product composition (‘only AAIs’ or ‘AAIs mixed
with other substances’ in the product); and (4) farm dis-
trict location (Thap Muoi, Cao Lanh). We also investi-
gated the association between farm- and farmer-related
factors and retail price by building an additional model
with he following covariates as fixed effects: (1) Farm
owner’s age (log); (2) Farm owner’s gender; (3) Farm
owner’s experience in poultry farming (years); (4) Farm
owner’s highest education attainment; (5) Flock size
(number of chickens) (log); (6) Age the flock (weeks)
(log); (7) Flock disease status (yes/no); (8) Flock weekly
mortality; (9) District location (Cao Lanh/Thap Muoi). A
step-wise forward approach was followed in model
building. First univariable models were built, and vari-
ables with an associated p < 0.20 were screened for mul-
tivariable analyses. Only variables with p ≤ 0.05 were
retained in the final multivariable model. Final model re-
siduals were checked for normality and outliers were ex-
cluded in a subsequent analysis. All analyses were
carried out using R software (version 3.4.3) with the
‘lme4’ and ‘lmerTEST’ packages.
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An estimation of total antimicrobial usage
in humans and animals in Vietnam
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Abstract
The accurate assessment of antimicrobial use (AMU) requires relating quantities of active ingredients (AAIs) with
population denominators. These data can be used to prioritize potential sources of selective pressure for
antimicrobial resistance and to establish reduction targets. Here, we estimated AMU in Vietnam (human population
93.4 M in 2015), and compared it with European Union (EU) data (population 511.5 M in 2014). We extrapolated
AMU data on each key animal species and humans from different published sources to calculate overall AMU (in
tonnes) in Vietnam. We then compared these data with published statistics on AMU in the European Union (EU). A
total of 3838 t of antimicrobials were used in Vietnam, of which 2751 (71.7%) corresponded to animal use, and the
remainder (1086 t; 28.3%) to human AMU. This equates to 261.7 mg and 247.3 mg per kg of human and animal
biomass, compared with 122.0 mg and 151.5 mg in the EU. The greatest quantities of antimicrobials (in decreasing
order) were used in pigs (41.7% of total use), humans (28.3%), aquaculture (21.9%) and chickens (4.8%). Combined
AMU in other species accounted for < 1.5%. These results are approximate and highlight the need to conduct
targeted surveys to improve country-level estimates of AMU.
Keywords: Antimicrobial use, Surveillance, Human medicine, Veterinary medicine, Vietnam, European Union
Main text
Antimicrobial resistance (AMR) in bacterial pathogens is
now firmly recognized as major global health problem
[1]. AMR arises as a direct consequence of antimicrobial
usage (AMU) in humans and animals and resistant or-
ganisms and AMR-encoding genes are capable of cross-
ing species barriers [2]. Therefore, the emergence and
transfer of AMR means that control solutions need to be
conducted from a ‘One Health’ perspective [3]. However,
if we are to reduce AMR we need accurate estimates of
where the majority of AMU occurs. Sustained surveil-
lance and monitoring of AMU are widely acknowledged
as critical components of the fight against AMR and one
of the strategic priorities of the AMR Global Action Plan
(GAP) [4].
There is considerable uncertainty regarding AMU in
different animal species and humans in most countries.
This knowledge gap is due to the absence of reliable
AMU data in humans and animals and ill-defined animal
population denominators. Many higher income coun-
tries, such as those within the European Union (EU),
regularly publish their data on AMU in humans and ani-
mals, and relate these values to denominator populations
in terms of biomass [5]. Conversely, the majority of low-
and middle-income countries (LMICs) do not regularly
collect and report equivalent AMU statistics.
Recently, the World Organization for Animal Health
(OIE) estimated that worldwide, on average 168.7 mg of
antimicrobial active ingredients (AAIs) were used to
raise 1 kg of animal biomass [6]. Although the report
does not include between-country- or species-specific
data, it shows however considerable differences between
different OIE regions. However, this report did not indi-
cate which animal production sectors are responsible for
the largest degree of AMU. Such data are essential for
estimating where AMR is most likely to be generated
and maintained and pivotal for policy makers to set re-
duction targets. Here, by integrating various data
sources, we aimed to estimate AMU in humans and dif-
ferent animal populations in Vietnam. These data were
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compared against available human and animal AMU sta-
tistics from the EU.
Human biomass in Vietnam was calculated using 2015
population data stratified by age [7]. Adult (> 18 years-
old) body weight was taken from published Figs. (58.4 kg
males; 50.8 kg females) [8]. For non-adult age-gender
strata, we assigned bodyweights to US populations [9],
after adjusting for the difference in body mass between
populations in the two countries. This was achieved by
applying the correction factors of 0.642 and 0.651, which
represent, respectively, the ratios of weights of adult
males and adult females in the two countries. The total
biomass of terrestrial animals in Vietnam was calculated
from official statistics [10] following the approach used
by the OIE [6] that combined data on the number of
slaughtered animals and standing populations. For aqua-
culture (farmed fish and shellfish), production data
broken down by type of market (domestic, export)
(2016) were used [11].
Data on human AMU in Vietnam were extracted from
a multi-country survey in hospitals and the community
[12]. The reported number of Defined Daily Doses
(DDD) (per 1000) were converted to weight of anti-
microbial active ingredient (AAI) using the four most
common administered antimicrobials (ceftriaxone, ampi-
cillin, azithromycin and levofloxacin). The daily con-
sumption data was extrapolated for a whole year (365
days).
For pigs, chickens, and aquaculture (all aquatic species
combined) data on AMU were obtained from quantita-
tive published surveys [13–16]. Data on on AMU
through consumption of commercial feed (i.e. antimicro-
bial growth promoters) were extrapolated from a survey
of 1462 pig and chicken commercial feeds in Vietnam
[17]. Antimicrobial consumption in aquaculture was ex-
trapolated from a previous study [18], assuming that, on
average, antimicrobial products have a 20% strength
(weight of AAI related to total weight of product) based
on the same study. For ruminants (bovines, buffaloes,
sheep, goats) data on AMU in Japan (a high-income
country in Asia) for 2010 were used [19]. For non-
chicken poultry species (ducks, Muscovy ducks, geese
and quails) the authors could not find any published
data. AMU was, therefore, conservatively estimated as
50% of that reported in chickens, based on the authors’
field experience. We excluded companion animals and
equines since no AMU data are available. Best and
worst-case AMU scenarios (i.e. lowest and highest
AMU) were calculated for all species: for poultry species,
upper and lower limits were calculated based on ±25%
of the final AMU estimate. For ruminants, the lower
limit of AMU was taken from Japanese cattle AMU sta-
tistics [19]. The upper limit was set at 50% higher than
this estimate; for our summary estimations we used the
intermediate value between these two limits. We com-
pared the resulting AMU data with those published in
the second ECDC/EFSA/EMA Joint Report on AMU
(data for 2014), corresponding with AMU data in rela-
tion to the total biomass of terrestrial animal species in
28 EU countries [5] as well as with the Third World
Organization for Animal Health (OIE) Report [6] (data
for 2015).
Our estimates of human and animal biomass in
Vietnam from the above calculations are 4153 and 11,
125 thousand tonnes, respectively (Table 2 in Appendix
1 and Table 1). Estimates of AMU showed that in 2015,
a total of 3842 t of antimicrobials were used in Vietnam,
of which 2751 (71.7%) was associated with animal use,
and the remainder (1086 t; 28.3%) corresponded to hu-
man AMU. The greatest quantities of antimicrobials (in
decreasing order) were used in pigs (41.7% of total use),
humans (28.3%), aquaculture (21.9%) and chickens
(4.8%). Combined AMU in other species accounted for
< 1.5% (Table 1 and Fig. 1). We estimate that, in total,
261.7 mg (131.4–394.3 mg) of AAI were administered
per 1 kg of human and 247.3 mg (130.3–364.3 mg) per 1
kg of animal in Vietnam. The corresponding figures
from the EU were 122.0 mg/kg and 151.1 mg/kg in
humans and animals, respectively (Fig. 2).
Here, using a combination of available statistics along-
side published AMU survey and extrapolation data, we
estimated AMU related to biomass in humans and ani-
mal production in Vietnam. Our results suggest that in
this country pig production and aquaculture should be
the main target if the country aims to reduce its AMU
footprint in animal production. AMU in humans in
Vietnam (32.0 DDD per 1000 inhabitants per day) ranks
higher than in most countries in the EU. These human
data were generated using limited retail surveys [12].
However, EU countries such as Romania, Greece,
France, Spain, and Ireland featured a higher magni-
tude of AMU (in terms of DDD related to popula-
tion) than Vietnam. A recent report from Thailand,
a LMIC country which is more comparable to
Vietnam, estimated that in 2017 a total of 53.0 DDD
per 1000 inhabitants per day were used in 2017 [20].
The Thai study used surveillance data on declared
quantities of antimicrobials, which is a compulsory
requirement for companies trading with antimicro-
bials in that country.
Whilst these are the first specific calculations for
AMU in Vietnam, there is a considerable uncertainty
around these estimates due to the lack of reliable
data. For example, AMU data in humans, pigs, and
aquaculture originate from single studies, all con-
ducted prior to 2015. Furthermore, there are no data
whatsoever on AMU in non-chicken poultry species
and ruminants. The situation is likely to be even
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worse in other LMICs where there are practically no
AMU data in any production sector.
Since different animal types are raised over vari-
able periods, the same magnitude of AMU related to
body mass may have different implications for the
development and maintenance of AMR For example,
in Vietnam chickens are raised over a period ranging
from 1 to 5 months, compared with 5–8 months for
pigs. The implications of this need to be further
investigated.
Because of its relative simplicity, we propose to regu-
larly (i.e. annually) estimate/update quantities of antimi-
crobials used in relation to body mass as a first step to
develop a fully-fledged AMU surveillance system. These
estimates could be fine-tuned by conducting targeted
surveys tailored to different production types (i.e. meat
chickens, layers, breeders, fattening pigs, etc.). It may
also be necessary to differentiate the extent of AMU by
level of intensification of the production system (i.e.
backyard, small-scale, large-scale, industrial), as different
systems require variable quantities of antimicrobials. It
has been shown that in the Mekong Delta of Vietnam
smaller chicken farms tend to use more antimicrobials
[13]. Lastly, it would be desirable to incorporate detailed
information regarding the classes and formulations of
antimicrobials used, since there is a great variability
Table 1 Calculation of total annual AMU in each animal production type


















Swine Breeding pigs 4,128,
032







46.11 286.62 332.7 1270.1
Poultry Chickens 88,777,
000
Production 1.8 699,798,600 187.73, 4 77.42 265.1 185.5
Ducks 101,931,
884
Production 2 203,863,767 93.95 38.75 132.6 27.0
Muscovies 17,652,
638
Production 3.2 56,488,440 93.95 38.75 132.6 7.5
Geese 641,212 Production 3.2 2,051,877 93.95 38.75 132.6 0.3
Quails 13,526,
147
Production 0.13 1,758,399 93.95 38.75 132.6 0.2










Production 200 244,026,240 52.46 0.0 52.4 12.8
Buffalo Breeding buffaloes 378,549 Population 500 189,274,500 52.46 0.0 52.4 9.9
Slaughter buffaloes 297,216 Production 300 89,164,711 52.46 0.0 52.4 4.7
Sheep Breeding animals (est.) 26,901 Census 75 2,017,556 52.46 0.0 52.4 0.1
Number slaughtered
(except breeders)
64,368 Production 75 4,827,600 52.46 0.0 52.4 0.3
Goats Breeding animals (est.) 444,411 Census 75 33,330,833 52.46 0.0 52.4 1.7
Number slaughtered
(except breeders)
699,515 Production 75 52,463,597 52.46 0.0 52.4 2.7
Aquaculture All species (domestic) – Production 835,000,000 477.17 – 477.17 398.5
All species (export) – Production 2,775,000,
000




AMU Antimicrobial use, AGPs Antimicrobial growth promoters (in commercial feed)
aData derived from official country statistics [10, 11]. ‘Census’ refers to ‘No. standing animals’, ‘Production’ refers to ‘No. of slaughtered animals’, except for
aquaculture, where it refers to ‘No. of kg produced’
bExcluding antimicrobial growth promoters in commercial feed; 1 Nguyen et al. (2016) [15]; 2 Van Cuong et al. (2016) [17]; 3,4 Average of two studies: Carrique-Mas
et al. (2014) [13] and Cuong et al. (2019) [14]; 5 Based on 50% of quantities used in chicken production; 6 Hosoi et al. (2014) [19]; 7 Pham et al. (2015) [16]; 8
Assuming that AMU for export production is 1/3 of the magnitude of AMU for domestic production
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regarding the strength of different antimicrobial prod-
ucts and their impact on development of AMR.
In conclusion, in the absence of reliable statistics on
sales of AAIs, the challenges of monitoring AMU in ani-
mal production in LMICs such as Vietnam can be
overcome by the use of innovative approaches that
maximize the use of existing animal population statistics
and AMU data. These estimates should help elucidate
secular changes in AMU and help refine policies and in-
terventions aimed at reducing AMU at country level.
Fig. 1 Two-dimensional diagram representing the estimated annual amounts (areas of bars) of antimicrobials used in each of species (including
humans) in Vietnam, and whether these quantities are more affected by the total biomass (width of bars) or the intensity of AMU (height of
bars). Bars are sorted from higher to lower overall AMU. AMU = Antimicrobial use. The vertical lines represent the range between best- and worst-
case scenarios. ‘Other avian’ includes ducks, muscovies, geese and quails
Fig. 2 Two-dimensional diagram showing the relative annual amounts of AMU in the European Union (2014) and in Vietnam. In order to render
comparison between European Union and Vietnam possible, the biomasses of animals and humans on the x-axis have been scaled to
proportions. AMU = Antimicrobial use
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Abstract: In the Mekong Delta of Vietnam, farmers use large quantities of antimicrobials to raise
small-scale chicken flocks, often including active ingredients regarded of “critical importance’” by
the World Health Organization. Due to limitations in laboratory capacity, the choice of antimicrobials
normally does not follow any empirical criteria of effectiveness. The aim of this study was to
highlight non-critically important antimicrobials against which chicken pathogens are likely to be
susceptible as a basis for treatment guidelines. Microtiter broth dilution method was performed
to determine the minimal inhibitory concentration (MIC) of 12 commonly used antimicrobials for
58 isolates, including Ornithobacterium rhinotracheale (ORT) (n = 22), Gallibacterium anatis (n = 19),
and Avibacterium endocarditidis (n = 17). Unfortunately, internationally accepted breakpoints for
resistance in these organisms do not exist. We drew tentative epidemiological cut-offs (TECOFFs)
for those antimicrobial-pathogen combinations where MIC distributions suggested the presence
of a distinct non-wild-type population. Based on the observed results, doxycycline would be the
drug of choice for A. endocarditidis (11.8% presumptive non-wild type) and G. anatis infections
(5.3% presumptive non-wild type). A total of 13.6% ORT isolates were non-wild type with regards
to oxytetracycline, making it the drug of choice against this pathogen. This study illustrates the
challenges in interpreting susceptibility testing results and the need to establish internationally
accepted breakpoints for veterinary pathogens.
Keywords: antimicrobial resistance; minimal inhibitory concentration; chicken pathogens; bacteria;
diseases; Vietnam; low- and middle-income countries
1. Introduction
Antimicrobial resistance (AMR) is a major worldwide health emergency [1]. Much of the concern
derives from its impact on human health. It has been estimated that AMR-related infections will reach
10 million cases per year in 2050 [2]. There is a scientific consensus that excessive antimicrobial use
(AMU) and AMR in animal populations are contributing factors to global AMR [3]. The issue of AMR
in animal pathogens has received much less attention than AMR in human pathogens, and thus there
Antibiotics 2020, 9, 499; doi:10.3390/antibiotics9080499 www.mdpi.com/journal/antibiotics
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is a deficit of published surveillance and research data. This is partially due to limited veterinary
diagnostic capacity, especially in low and middle-income countries (LMICs) [4]. The presence of AMR
traits in animal pathogens is likely to entail considerable, but yet to be quantified, economic losses
derived from the failure to treat diseases [5]. Globally, over 110,000 tons of chicken meat are produced
each year, making it the second most consumed type of meat in the world. Furthermore, by 2025,
chicken meat production is expected to surpass that of pork [6]. A large number of bacterial pathogens
can infect chicken flocks, and many such organisms are resistant to commonly used antimicrobials
in farms [7]. High levels of disease and mortality are regarded as major drivers of AMU in flocks in
the region, and respiratory diseases are among the most prevalent ones [8]. A number of bacterial
pathogens, including colisepticaemic E. coli, Avibacterium paragallinarum, Ornitobacterium rhinotracheale
(ORT) and Mycoplasma gallisepticum were detected in diseased chicken flocks in the Mekong Delta of
Vietnam [9]. Previous reports have indicated extremely high levels of AMU in small-scale chicken
flocks in the same region, as well as high levels of antimicrobial resistance in commensal E. coli of
chicken origin [10–12]. However, there are no published data regarding levels of phenotypic resistance
in chicken pathogens in flocks in the country. Current scientific consensus indicates that antimicrobials
regarded by the World Health Organization (WHO) to be of critical importance for human medicine
should be restricted in veterinary medicine [13] and this has recently become integrated in the
policy of several countries [14,15]. Using microtiter broth dilution, we characterized the phenotypic
resistance of three global chicken bacterial pathogens in the Mekong Delta (Vietnam) to commonly used
antimicrobials in the area. The data on the antimicrobial susceptibility of these organisms should form
the basis of treatment guidelines that prioritize the choice of antimicrobial classes that do not include
critically important antimicrobials according to the WHO [16]. However, widely accepted breakpoints
for the interpretation of resistance for most poultry pathogens do not exist. In veterinary medicine,
setting clinical breakpoints is challenging given the range of animal species and pathogens involved.
Resistance has often been defined in terms of epidemiological cut-offs (ECOFFs). These cut-offs are
drawn based on the MIC distributions that have been used to distinguish between wild-type and
non-wild-type populations [17]. Based on the minimal inhibitory concentration (MIC) distributions
of different antimicrobial-pathogen combinations, we proposed “tentative” epidemiological cut-offs
(TECOFFs) for three different poultry pathogens common in the Mekong Delta region of Vietnam.
This work is the first step aiming to characterize antimicrobial susceptibility of veterinary pathogens in
Vietnam. These results should be the basis of future guidelines to veterinarians and drug shop owners
in the country.
2. Results
MIC results are shown in Supplementary Table S1 and are summarized in Table 1 and Figure 1.
For 29 (80.5%) antimicrobial-pathogen combinations, we observed a bimodal (n = 18) or multimodal
(n = 11) distribution. The lower mode of these suggested a wild-type sub-population, and therefore
TECOFFs were proposed. For ORT, TECOFFs could be drawn for 8/12 antimicrobials tested. For four
of those antimicrobials (enrofloxacin, tylosin, amoxicillin, doxycycline), the proposed TECOFFs agreed
with the cut-off values reported previously [18–20].
Given the observed patterns, and in the absence of susceptibility testing of isolates from a
given flock, we would suggest doxycycline as the drug of choice for A. endocarditidis infections
(11.8% presumptive non-wild type) or G. anatis infection (5.3% presumptive non-wild type). For ORT
oxytetracycline would be a good choice (13.6% non-wild type). As a second choice we would propose
florfenicol (17.6% non-wild type) for A. endocarditidis and thiamphenicol (22.7% non-wild type) for
ORT (Figure 1).
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Table 1. Distribution of minimal inhibitory concentrations (MICs) of 12 antimicrobials commonly used
for three chicken pathogens from the Mekong Delta of Vietnam.Antibiotics 2020, 9, x FOR PEER REVIEW 3 of 8 
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COL - - 0 0 0 0 0 0 0 0 14 86 - - Unimodal 
ENR - - 14 14 0 0 9 9 23 18 9 5 - - Bimodal 
TYL - 0 14 5 18 32 9 0 18 5 0 0 0 0 Multimodal 
GEN - - - - 0 0 0 9 9 55 27 0 0 0 Unimodal 
NEO - - - - 5 0 0 18 5 36 32 5 0 0 Bimodal 
STR - - - - 0 0 0 9 32 41 18 0 0 0 Unimodal 
AMX - - - - 14 0 5 27 23 14 18 0 0 0 Multimodal 
FFN - - 0 32 64 5 0 0 0 0 0 0 0 0 Unimodal 
THA - - - 0 9 32 23 14 0 0 0 0 23 0 Bimodal 
OXY - - - 0 9 14 27 18 14 5 0 0 14 0 Bimodal 
DOX - - - 0 5 18 23 18 32 5 0 0 0 0 Bimodal 

















COL - - 0 0 5 79 11 0 0 0 5 0 - - Unimodal 
ENR - - 0 5 5 5 5 0 11 16 21 32 - - Bimodal 
TYL - - - - 0 0 0 0 0 5 32 11 16 37 Bimodal 
GEN - - 0 5 37 16 5 5 0 16 16 0 - - Bimodal 
NEO - - - - 0 32 5 0 11 11 0 11 5 26 Multimodal 
STR - - - - 0 0 11 16 0 0 0 5 21 47 Bimodal 
AMX - - - 0 5 0 0 5 32 5 0 11 0 42 Multimodal 
FFN    0 47 0 0 0 0 5 26 16 5 0 Bimodal 
THA - - - 0 11 16 0 0 0 0 0 0 16 58 Bimodal 
OXY - - - - 0 0 0 0 0 0 5 16 26 53 Unimodal 
DOX - - - - 0 0 0 32 42 21 0 0 0 5 Bimodal 





















COL - - 0 0 18 29 41 6 6 0 0 0 - - Unimodal 
ENR -  12 6 0 24 0 12 6 18 12 12 - - Multimodal 
TYL - - - - 0 0 6 0 12 29 6 18 12 18 Multimodal 
GEN - - - 0 12 18 29 18 0 0 6 18 0 0 Bimodal 
NEO - - - - 0 0 24 24 6 12 29 6 0 0 Bimodal 
STR - - - - 0 0 0 18 29 6 0 6 6 35 Bimodal 
AMX - - - - 12 18 12 24 12 12 6 0 0 6 Multimodal 
FFN - - - - 76 6 0 0 0 18 0 0 0 0 Bimodal 
THA - - - - 6 12 6 0 0 0 0 0 6 71 Bimodal 
OXY - - - - 0 0 6 0 0 6 41 41 0 6 Multimodal 
DOX - - - 0 12 0 41 35 0 6 0 6 0 0 Multimodal 
SXT 0 12 6 0 0 29 18 0 12 24 - - - - Multimodal 
Key: COL = colistin, ENR = enrofloxacin, TYL = tylosin, GEN = gentamicin, NEO = neomycin, STR = 
streptomycin, AMX = amoxicillin, FFN = florfenicol, THA = thiamphenicol, OXY = oxytetracycline, 
DOX = doxycycline, SXT = co-trimoxazole. NC= Not calculated.   
Key: COL = colistin, ENR = enrofloxacin, TYL = tylosin, GEN = gentamici , NEO = neomycin, STR = streptomycin,
AMX = amoxicillin, FFN = florfenicol, THA = thiamphenicol, OXY = oxytetracycline, DOX = doxycycline,
SXT = co-trimoxazole. NC= Not calculated.
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distribution for a relatively high number (n = 11) of combinations. Given the limited number of 
isolates tested and the uncertainty associated with the chosen interpretative criteria, our results need 
to be taken with great caution. Data from a larger set of isolates are therefore required to validate 
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in chicken production, interpretation guidelines are restricted to human pathogens [21]. Our data 
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Figure 1. Estimated prevalence of presumptive non-wild phenotypes with regards to 12 antimicrobials
among Ornithobacterium rhinotracheale (ORT), G. anatis, and A. endocarditidis isolates from Mekong Delta
chicken flocks. Bars indicate percent of isolates that are fully resistant, with 95% binomial confidence
intervals drawn around these percentages. Red = highest priority, orange = high priority, blue = highly
important antimicrobial according to the WHO. Key: COL = colistin, ENR = enrofloxacin, TYL = tylosin,
GEN = gentamicin, NEO = neomycin, STR = streptomycin, AMX = amoxicillin, FFN = florfenicol,
THA = thiamphenicol, OXY = oxytetracycline, DOX = doxycycline, SXT = co-trimoxazole. * Tentative
epidemiological cut-offs (TECOFFs) could not be established.
3. Discussion
Susceptibility testing of bacterial animal pathogens aims to provide a rational basis for the choice
of appropriate antimicrobial therapy. Based on this, the use of non-critically important antimicrobials
should be prioritized. In our study, doxyxycline (tetracycline class) is likely to be effective against
A. endocarditidis and G. anatis (11.8% and 5.3% presumptive non-wild types, respectively); thiamphenicol
(amphenicol class) is likely to be effective against ORT (22.7% non-wild type), whereas florfenicol
(amphenicol class) is likely to be effective against A. endocarditidis (17.6% non-wild type). Neither
amphenicols nor tetracyclines are classified as critically important antimicrobials by the WHO [16].
For a considerable number (n = 7) of antimicrobial–pathogen combinations, we obtained a
unimodal distribution that did not allow TECOFFs to be drawn; further, we observed a multimodal
distribution for a relatively high number (n = 11) of combinations. Given the limited number of isolates
tested and the uncertainty associated with the chosen interpretative criteria, our results need to be
taken with gre t cautio . Data from a l rger set of isolates ar th refore required to validat these
TECOFFs. These results highlight the pressing ne d to establish internationally accepted interpre ation
guidelines. As in human medicine, ideally MIC data of antimicrobi l–pathoge combinations should
be shared across countries, and these should be updated periodic lly [17]. For c l stin, a critically
important antimicrobial “of the highest priority” according to WHO widely used in chicken production,
interpretation guidelines are restricted to human pathogens [21]. Our data indicate a unimodal
distribution for these organisms, and therefore TECOFFs could not be established. Based on the
magnitude of the MICs for colistin, it is likely effective against G. anatis and, to a lesser extent,
A. endocarditidis.
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Most LMICs have limited capacity for isolating bacterial pathogens and performing antimicrobial
susceptibility testing [4]. These deficiencies are particularly severe in veterinary medicine. In Vietnam,
diagnostic investigations are seldom carried out in small-scale farming settings due to economic and
logistic constraints. Faced with disease, farmers and their advisors often treat flocks with antimicrobials
irrespective of the pathogen [5]. A complicating factor is the fact that for many bacterial infections,
clinical signs are often non-specific, and mixed infections are common [10].
Since in Vietnam veterinary drug shops are the main points of supply and advice to farmers on
AMU [22], results of phenotypic AMR testing of pathogens should be made available to drug shop
owners and other animal-health advisors (i.e., commune animal health workers). The study presented
here is limited in terms of bacterial species and production types. Therefore, we recommend expanding
it to other bacterial pathogens in different production systems. This would require establishing
a well-equipped, reference laboratory capable of performing micro-agglutination antimicrobial
susceptibility testing and the archiving of isolates. Examination of a (representative) sufficient
number of isolates should enable the establishment of reliable ECOFFs. Monitoring changes in MIC
distributions over time of commonly used antimicrobials should allow the detection of emerging
resistance phenotypes, as well as drafting AMU guidelines aiming at improving the efficacy of
antimicrobials used in poultry production whilst preserving those that are critically important
antimicrobials for human medicine.
4. Materials and Methods
4.1. Bacterial Isolates
A total of 58 bacterial isolates including Ornithobacterium rhinotracheale (ORT) (n = 22), Gallibacterium
anatis biovar haemolytica (n = 19) and Avibacterium endocarditidis (n = 17) were investigated. ORT
is an emerging respiratory pathogen [23]. G. anatis is an opportunistic pathogen that also causes
diarrhea, peritionitis, oophoritis [24], as well as systemic infections with high mortality [25] in flocks.
A. endocarditidis causes vascular as well as hepatic/spleen lesions [26]. All isolates were recovered from
diseased chickens that were subjected to a diagnostic necropsy in different locations in Dong Thap
province (Mekong Delta). All isolates were recovered at the Sub-Department of Animal Health (Dong
Thap) diagnostic laboratory between September 2017 and September 2019. No two isolates came
from the same flock. Isolates were recovered using blood agar and chocolate agar (Oxoid, Cheshire,
Great Britain) incubated in 5% CO2 at 35 ± 2 ◦C for 20–44 h. The species identification of strains
was performed using matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-TOF MS) (Bruker, Germany). The diagnostic work was carried out under the umbrella of
the ViParc project (www.viparc.org). The project was granted ethics approval by the Oxford Tropical
Research Ethics Committee (OXTREC) (Minimal Risk) (Ref. 5121/16).
4.2. Antimicrobial Susceptibility Testing
We investigated the 12 most commonly used antimicrobials in chicken flocks in the area [27],
including: colistin (COL), oxytetracycline (OXY), tylosin (TYL), doxycycline (DOX), gentamicin (GEN),
amoxicillin (AMX), enrofloxacin (ENR), neomycin (NEO), streptomycin (STR), florfenicol (FFN),
thiamphenicol (THA), and co-trimoxazole (SXT). The MIC of these antimicrobials was investigated
for study pathogens by broth micro-dilution following Clinical Laboratory Standards Institute (CLSI)
procedures outlined in VET01S [28] and M100 [29]. MIC experiments were carried out using
cation-adjusted Mueller Hinton-II broth (MHB2, Sigma-Aldrich, St. Louis MO, USA) with 2.5% lysed
horse blood (E & O Laboratories, Bonnybridge, UK) in 96-well plates (Corning, Corning, NY, USA).
The test ranges for antimicrobials were shown in Table 1. The MICs of bacteria were recorded after 24 h
(G. anatis and A. endocarditidis) or 48 h (ORT) incubation at 35 ± 2 ◦C. Reference strains E. coli ATCC
25,922 and Enterococcus faecalis ATCC 29,212 were used to verify the quality and accuracy of the testing
procedures [30].
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4.3. Data Analyses
For antimicrobial–pathogen combinations where the MIC followed a distribution suggestive of the
existence of wild-type and non-wild type populations, we proposed a tentative epidemiological cut-off
(TECOFF) [17]. For antimicrobial–ORT combinations not meeting that criteria, these TECOFFs were
compared with those from published studies [18–20]. For each antimicrobial–pathogen combination, we
calculated a prevalence of “presumptive non-wild-types” highlighting the antimicrobials not belonging
to the WHO critical important classes. Analyses were carried out using R software (www.r-project.org).
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6382/9/8/499/s1,
Table S1: Raw MIC data of all 58 chicken pathogens investigated.
Author Contributions: Conceptualization, J.J.C.-M. and N.T.P.Y.; methodology, N.T.P.Y., J.C and N.T.B.V.;
laboratory work, N.T.P.Y., D.H.P. and N.T.N.; field investigation, N.V.C., N.C. and B.T.K.; data curation, V.B.H. and
D.H.P.; original draft preparation N.T.P.Y. and N.T.B.V.; writing, review and editing, N.T.P.Y., N.C. and J.J.C.-M.;
supervision, J.C. and J.J.C.-M; project administration, B.T.K., V.B.H. and G.E.T.; funding acquisition, J.J.C.-M. and
G.E.T. All authors have read and agreed to the published version of the manuscript.
Funding: This work was funded by the Wellcome Trust through an Intermediate Clinical Fellowship awarded to
Juan J Carrique-Mas (Grant Reference Number 110085/Z/15/Z).
Acknowledgments: The authors would like to thank all farmers submitting diagnostic specimens from diseased
chicken flocks to the Sub-Department of Animal Health of Dong Thap Province.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. World Health Organization. Global Action Plan on Antimicrobial Resistance (2015). Available online:
https://www.who.int/antimicrobial-resistance/global-action-plan/en/ (accessed on 12 May 2020).
2. O’Neill, J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. 2015. Available
online: https://amr-review.org/Publications.html (accessed on 2 April 2020).
3. Da Costa, P.M.; Loureiro, L.; Matos, A.J. Transfer of multidrug-resistant bacteria between intermingled
ecological niches: The interface between humans, animals and the environment. Int. J. Environ. Res. Public
Health 2013, 10, 278–294. [CrossRef] [PubMed]
4. Grace, D. Review of evidence on antimicrobial resistance and animal agriculture in developing countries. Dep. Int.
Dev. 2015. Available online: https://www.gov.uk/dfid-research-outputs/review-of-evidence-on-antimicrobial-
resistance-and-animal-agriculture-in-developing-countries-201309 (accessed on 18 April 2020). [CrossRef]
5. Choisy, M.; Cuong, N.V.; Bao, T.D.; Kiet, B.T.; Hien, V.B.; Thu, H.V.; Chansiripornchai, N.; Setyawan, E.;
Thwaites, G.; Rushton, J.; et al. Assessing antimicrobial misuse in small-scale chicken farms in Vietnam from
an observational study. BMC Vet. Res. 2019, 15, 206. [CrossRef] [PubMed]
6. OECD/FAO. OECD-FAO Agricultural Outlook 2016–2025; OECD Publishing: Paris, France, 16 July 2020;
Available online: http://www.fao.org/3/a-i5778e.pdf (accessed on 27 April 2020). [CrossRef]
7. Nhung, N.T.; Chansiripornchai, N.; Carrique-Mas, J.J. Antimicrobial Resistance in Bacterial Poultry Pathogens:
A Review. Front. Vet. Sci. 2017, 4, 126. [CrossRef] [PubMed]
8. Carrique-Mas, J.; Van, N.T.B.; Cuong, N.V.; Truong, B.D.; Kiet, B.T.; Thanh, P.T.H.; Lon, N.N.; Giao, V.T.Q.;
Hien, V.B.; Padungtod, P.; et al. Mortality, disease and associated antimicrobial use in commercial small-scale
chicken flocks in the Mekong Delta of Vietnam. Prev. Vet. Med. 2019, 165, 15–22. [CrossRef] [PubMed]
9. Van, N.T.B.; Yen, N.T.P.; Nhung, N.T.; Cuong, N.V.; Kiet, B.T.; Hoang, N.V.; Hien, V.B.; Chansiripornchai, N.;
Choisy, M.; Ribas, A.; et al. Characterization of viral, bacterial, and parasitic causes of disease in small-scale
chicken flocks in the Mekong Delta of Vietnam. Poult. Sci. 2020, 99, 783–790. [CrossRef] [PubMed]
10. Carrique-Mas, J.J.; Trung, N.V.; Hoa, N.T.; Mai, H.H.; Thanh, T.H.; Campbell, J.I.; Wagenaar, J.A.; Hardon, A.;
Hieu, T.Q.; Schultsz, C. Antimicrobial usage in chicken production in the Mekong Delta of Vietnam. Zoonoses
Public Health 2015, 62, 70–78. [CrossRef] [PubMed]
11. Nhung, N.T.; Cuong, N.V.; Campbell, J.I.; Hoa, N.T.; Bryant, J.E.; Truc, V.N.; Kiet, B.T.; Jombart, T.; Trung, N.V.;
Hien, V.B.; et al. High levels of antimicrobial resistance among escherichia coli isolates from livestock farms
and synanthropic rats and shrews in the Mekong Delta of Vietnam. Appl. Environ. Microbiol. 2015, 81,
812–820. [CrossRef] [PubMed]
Page 305 of 342
Antibiotics 2020, 9, 499 7 of 7
12. Nguyen, N.T.; Nguyen, H.M.; Nguyen, C.V.; Nguyen, T.V.; Nguyen, M.T.; Thai, H.Q.; Ho, M.H.; Thwaites, G.;
Ngo, H.T.; Baker, S.; et al. Use of colistin and other critical antimicrobials on pig and chicken farms in
southern Vietnam and its association with resistance in commensal Escherichia coli Bacteria. Appl. Environ.
Microbiol. 2016, 82, 3727–3735. [CrossRef] [PubMed]
13. World Health Organization. Guidelines on Use of Medically Important Antimicrobials in Food-Producing
Animals. 2017. Available online: https://www.who.int/foodsafety/areas_work/antimicrobial-resistance/cia_
guidelines/en/ (accessed on 2 April 2020).
14. Advice on Impacts of Using Antimicrobials in Animals. Available online: https://www.ema.europa.eu/en/
veterinary-regulatory/overview/antimicrobial-resistance/advice-impacts-using-antimicrobials-animals#
advice-on-classification,-authorisation-and-risk-mitigation-section (accessed on 29 April 2020).
15. Department of Health 2017. Ireland’s National Action Plan on Antimicrobial Resistance 2017–2020. Available
online: http://health.gov.ie/national-patient-safety-office/patient-safety-surveillance/antimicrobialresistance-
amr (accessed on 15 April 2020).
16. World Health Organization. Critically Important Antimicrobials for Human Medicine (WHO CIA List), 6th
revision. World Health Organization. 2019. Available online: https://www.who.int/foodsafety/areas_work/
antimicrobial-resistance/cia/en/ (accessed on 10 April 2020).
17. Turnidge, J.; Patterson, D.L. Setting and revising antibacterial susceptibility breakpoints. Clin. Microbiol. Rev.
2007, 20, 391–408. [CrossRef] [PubMed]
18. Devriese, L.A.; Hommez, J.; Vandamme, P.; Kersters, K.; Haesebrouck, F. In vitro antibiotic sensitivity of
Ornithobacterium rhinotracheale strains from poultry and wild birds. Vet. Rec. 1995, 137, 435–436. [CrossRef]
[PubMed]
19. Devriese, L.A.; De Herdt, P.; Haesebrouck, F. Antibiotic sensitivity and resistance in Ornithobacterium
rhinotracheale strains from Belgian broiler chickens. Avian Pathol. 2001, 30, 197–200. [CrossRef] [PubMed]
20. Szabo, R.; Wehmann, E.; Magyar, T. Antimicrobial susceptibility of Bordetella avium and Ornithobacterium
rhinotracheale strains from wild and domesticated birds in Hungary. Acta Vet. Hung. 2015, 63, 413–424.
[CrossRef] [PubMed]
21. Ezadi, F.; Ardebili, A.; Mirnejad, R. Antimicrobial susceptibility testing for polymyxins: Challenges, issues,
and recommendations. J. Clin. Microbiol. 2019, 57. [CrossRef] [PubMed]
22. Phu, D.H.; Giao, V.T.Q.; Truong, D.B.; Cuong, N.V.; Kiet, B.T.; Hien, V.B.; Thwaites, G.; Rushton, J.;
Carrique-Mas, J. Veterinary Drug Shops as Main Sources of Supply and Advice on Antimicrobials for Animal
Use in the Mekong Delta of Vietnam. Antibiotics (Basel) 2019, 8, 195. [CrossRef] [PubMed]
23. Barbosa, E.V.; Cardoso, C.V.; Silva, R.C.F.; Cerqueira, A.M.F.; Liberal, M.H.T.; Castro, H.C. Ornithobacterium
rhinotracheale: An update review about an emerging poultry pathogen. Vet. Sci. 2020, 7, 3. [CrossRef] [PubMed]
24. El-Adawy, H.; Bocklish, H.; Neubauer, H.; Hafez, M.; Hotzel, H. Identification, differentiation and antibiotic
susceptibility of Gallibacterium isolates from diseased poultry. Ir. Vet. J. 2018, 71, 5. [CrossRef] [PubMed]
25. Singh, S.V.; Singh, B.R.; Sinha, D.K.; Kumar, V.; Vadhana, P.A.; Bhardwaj, M.; Dubey, S. Gallibacterium anatis:
An emerging pathogen of poultry birds and domiciled birds. J. Vet. Sci. Technol. 2016, 7, 3.
26. Moller, B.H.; Bisgaard, M.; Pors, S.E.J. Pathology and localization of Avibacterium endocarditidis in
experimentally infected broiler breeders. Comp. Path. 2014, 150, 266–275. [CrossRef] [PubMed]
27. Cuong, N.V.; Phu, D.H.; Van, N.T.B.; Dinh Truong, B.; Kiet, B.T.; Hien, B.V.; Thu, H.T.V.; Choisy, M.; Padungtod, P.;
Thwaites, G. High-resolution monitoring of antimicrobial consumption in Vietnamese small-scale chicken farms
highlights discrepancies between study Metrics. Front. Vet. Sci. 2019, 6. [CrossRef] [PubMed]
28. Clinical and Laboratory Standards Institute. VET01S: Performance Standards for Antimicrobial Disk and Dilution
Susceptibility Tests for Bacteria Isolated from Animals, 3rd ed.; CLSI: Wayne, NJ, USA, 2015.
29. Clinical and Laboratory Standards Institute. M100: Performance Standards for Antimicrobial Susceptibility
Testing, 29th ed.; CLSI: Wayne, PA, USA, 2019.
30. National Committee for Clinical Laboratory Standards. M31-A2, Performance Standards for Antimicrobial Disk
and Dilution Susceptibility Tests for Bacteria Isolated from Animals, 2nd ed.; NCCLS: Wayne, PA, USA, 2002;
Volume 22.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Page 306 of 342
1 
 
A novel method for measuring phenotypic colistin resistance in Escherichia coli 1 
populations from chicken flocks 2 
Nhung Thi Nguyen
a
, Nguyen Thi Phuong Yen
a
, Nguyen Van Ky Thien
a











, Ronald B. Geskus
a,c





Oxford University Clinical Research Unit,
 
Ho Chi Minh City, Vietnam 6 
b
Sub-Department of Animal Health and Production, Dong Thap province, Vietnam 7 
c
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, 8 
Oxford University, Oxford, United Kingdom 9 
d
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of 10 
Cambridge, Cambridge, United Kingdom 11 
Running title: Method for measuring colistin resistance in chicken 12 
KEYWORDS 13 
Poultry, colistin resistance, broth microdilution, colistin use. 14 
Corresponding author 15 
Nguyen Thi Nhung 16 
Senior Microbiologist 17 
ViParc Project Laboratory co-ordinator 18 
Oxford University Clinical Research Unit 19 
764 Vo Van Kiet, Ward 1, District 5 20 
Ho Chi Minh City (Vietnam) 21 
E-mail: nhungnt@oucru.org 22 
AEM Accepted Manuscript Posted Online 18 December 2020
Appl Environ Microbiol doi:10.1128/AEM.02597-20
Copyright © 2020 Nguyen et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.












Colistin is extensively used in animal production in many low- and middle-income countries. 24 
There is a need to develop methodologies to benchmark and monitor changes in resistance 25 
among mixed commensal bacterial populations in farms. We aimed to evaluate the performance 26 
of a broth microdilution method based on culturing a pooled Escherichia coli suspension (30-50 27 
organisms) obtained from each sample. To confirm the biological basis and sensitivity of the 28 
method, we cultured 16 combinations of one colistin-susceptible and one mcr-1 encoded colistin-29 
resistant E. coli in the presence of 2mg/L colistin. Optical density (OD600nm) readings over time 30 
were used to generate a growth curve, and these values were adjusted to the values obtained in 31 
the absence of colistin (adjusted Area Under the Curve, AUCadj). The median limit of detection 32 
was 1 resistant in 10
4








:1]. We applied this 33 
method to 108 pooled faecal samples from 36 chicken flocks from the Mekong Delta (Vietnam), 34 
and determined the correlation between this method and the prevalence of colistin resistance in 35 
individual colonies harvested from field samples, determined by the Minimum Inhibitory 36 
Concentration. The overall prevalence of colistin resistance at sample and isolate level 37 
(estimated from the AUCadj) was 38.9% [95%CI, 29.8-48.8%] and 19.4% (SD± 26.3%), 38 
respectively. Increased colistin resistance was associated with recent (2 weeks) use of colistin 39 
(OR=3.67) and other, non-colistin antimicrobials (OR=1.84). Our method is a sensitive and 40 
affordable approach to monitor changes in colistin resistance in E. coli populations from faecal 41 
samples over time.42 












Colistin (polymyxin E) is an antimicrobial with poor solubility in agar-based media, and 44 
therefore broth microdilution is the only available method for phenotypic resistance. However, 45 
estimating colistin resistance in mixed Escherichia coli populations is laborious since it requires 46 
individual colony isolation, identification and susceptibility testing. We developed a growth-47 
based microdilution method suitable for pooled faecal samples. We validated the method by 48 
comparing it with individual MIC of 909 E. coli isolates; we then tested 108 pooled faecal 49 
samples from 36 healthy chicken flocks collected over their production cycle. A higher level of 50 
resistance was seen in flocks recently treated with colistin in water, although the observed 51 
generated resistance was short-lived. Our method is affordable, and may potentially be integrated 52 
into surveillance systems aiming at estimating the prevalence of resistance at colony level in 53 
flocks/herds. Furthermore, it may also be adapted to other complex biological systems, such as 54 












Colistin (polymyxin E) is a last-resort drug used for the treatment of severe multi-drug resistant 57 
(MDR) infections in many countries, and currently is classified by the World Health 58 
Organization (WHO) as a ‘highest priority, critically important’ antimicrobial (1). The 59 
emergence of mcr-1 plasmid-encoded colistin resistance among Gram-negative bacteria is 60 
considered a serious threat to global health (2). It has been hypothesized that colistin use in 61 
animal production is a major contributing factor to the emergence of colistin resistance 62 
worldwide (3). Colistin is still used in poultry and pig farming in many countries (4). In terms of 63 
frequency, colistin is the most commonly used antimicrobial in chicken production in the 64 
Mekong Delta region of Vietnam (5, 6). Studies in the same region have shown that resistance 65 
against colistin in commensal Escherichia coli from chicken flocks is often encoded by the mcr-66 
1 gene (7, 8). At sample level, the prevalence of mcr-1 in chicken faecal samples in the Mekong 67 
Delta was 59.4%. The prevalence of this gene has also be found to be higher among in-contact 68 
humans (chicken farmers) than in urban individuals (7). 69 
E. coli is an ubiquitous commensal enteric organism globally used to monitor phenotypic 70 
antimicrobial resistance (AMR) in national surveillance programmes, both in humans and in 71 
animals (9, 10). Given the diversity of this organism within the enteric microbiome, the 72 
characterisation of phenotypic resistance in a mixed population of commensal E. coli requires 73 
selecting a representative and sufficiently large number of strains. This is often achieved by 74 
performing differential colony counts on agar media with and without antimicrobials (11). 75 
However, agar-based methods are not appropriate for colistin given the antimicrobials’ poor 76 
diffusion (12). Determination of the minimal inhibitory concentration (MIC) by broth 77 
microdilution is regarded as the gold standard for testing of colistin resistance of 78 
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Enterobacteriaceae (ISO 20776-1) both by the Clinical and Laboratory Standards Institute 79 
(CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (12, 80 
13). Establishing accurately the prevalence of resistance at colony level requires the investigation 81 
of a sufficiently large, representative number of isolates from each sample, which is extremely 82 
laborious and costly (8, 11, 14). Therefore, there is a need for developing cost-effective 83 
methodologies for evaluating resistance against colistin in mixed E. coli populations from animal 84 
faecal samples. Here, we designed and evaluated a broth microdilution-based method to quantify 85 
colistin resistance in E. coli populations from pooled chicken faecal samples. We then related the 86 
observed results to data on antimicrobial use (AMU) from the same flocks. 87 
RESULTS 88 
Growth of standard suspensions 89 
The AUCadj values generated from all susceptible:resistant combinations are presented in Fig.1. 90 
Based on the AUCadj value obtained with susceptible strains (0.09; SD ±0.02), we considered any 91 
sample with AUCadj > 0.13 as positive to colistin resistance.  In all cases, AUCadj values 92 
increased with increasing ratio of resistant to susceptible organisms. Growth was detected at a 93 












for 43.7%, 12.5%, 94 
18.5% and 12.5% and 12.5% of combinations, respectively. There was no difference in average 95 
AUCadj between resistant strains with low (R1 and R2, colistin MIC= 4mg/L) and moderate (R3 96 
and R4, colistin MIC= 8mg/L) levels of resistance (both AUCadj= 0.39, Kruskal Wallis test, p= 97 
0.688). The observed variation in AUCadj values depended on both the choice of resistant and 98 





 quartile, 0.07-0.29]) as well as the lowest limit of detection (average S:R 100 

















 quartile, 0.48-0.69]) as 101 
well as the highest limit of detection (average S:R ratio of 10
5
:1). 102 
Study flocks and their AMU 103 









 quartile, 105 
17-20] weeks. Colistin had been administered to 22/36 (61.1%) flocks. Among flocks given 106 
colistin, the average number of Animal Daily Doses (ADD) per 1,000 chicken-days of this 107 
antimicrobial administered over the production cycle was 149.5 Standard deviation [SD] ±261.6. 108 
Colistin was used more during the early flock cycle period (281.7 SD ±321.2 ADDs per 1,000 109 
chicken-days) compared with the second period (17.4 SD ±18.1 ADDs per 1,000 chicken-days) 110 





 quartile, 2-6] weeks. The data of colistin use among study flocks is displayed in Fig. 112 
S1. 113 
In addition to colistin, a total of 27 non-colistin antimicrobials (belonging to 12 classes) were 114 
administered to study flocks. In decreasing order, oxytetracycline, tylosin, neomycin, ampicillin, 115 
streptomycin and doxycycline were the antimicrobials most used. The average number ADDs 116 
per 1,000 chicken-days of other antimicrobials among flocks using colistin was higher than 117 
flocks that did not use colistin (350.9 SD ±383.8 vs. 187.2 SD ±366.2, Wilcoxon test, p= 0.004). 118 
Among both type of flocks, antimicrobials were administrated more commonly during the first 119 
period (average No. ADD per 1,000 chicken-days 629.3 SD ±359.8 and 345.5 SD ±471.5, 120 
respectively) compared to the second period of chicken life (average No. ADDs per 1,000 121 
chicken-days 72.5 SD± 98.5 and 29.0 SD ±48.6, respectively) (Table 1). Frequencies use of on-122 
colistin antimicrobials in studied flocks were presented in Table S1.  123 
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Prevalence of colistin resistance at colony level 124 
A total of 909 E. coli strains were isolated from 23 selected samples (~40 E. coli isolates/ 125 
sample) and were tested for their MIC against colistin. Among those, total of 129 strains (14.2%) 126 
were resistant to colistin. Of resistant strains, 75.2% strains had a MIC of 4 mg/L, whereas 127 
24.0% had a MIC of 8mg/L. Only 1 isolate (0.8%) displayed a MIC of 16mg/L (Fig. S2). The 128 
beta-regression model that relates the AUCadj (obtained from suspensions of 40 E. coli strains) to 129 
the percentage of resistant of those E. coli strains is shown in Fig. 2. The trend over AUCadj was 130 
highly significant (p< 0.001). The equation 100/(1+e
4.8-(7.04*AUCadj)
) associated with this model 131 
was applied for estimating the prevalence of colistin resistance at colony level among field 132 
samples. 133 
Changes of AUCadj over production cycle and prevalence of colistin resistance  134 
Overall, there was no significant change colistin resistance (AUCadj) over the production cycle 135 
(p= 0.569, Fig. S3). Among flocks not exposed to colistin (n= 14), the differences AUCadj 136 
between sampling points were small. However, among flocks using colistin (n= 22), the AUCadj 137 









 quartile, 0.04-0.52]) (Wilcoxon paired test, p= 0.063) and end of 139 




 quartile, 0.06-0.55]) (Wilcoxon paired test, p= 0.046). There 140 
was little to no difference in AUCadj values between day-old and end of production samples 141 
(Table 1). 142 
The prevalence of colistin resistance at sample level was 38.9% [95%CI, 29.8-48.8%] (42/108 143 
positive samples). The prevalence of resistance level of day-old, mid-, and end of production 144 
samples was 36.1%, 50.0% and 30.5%, respectively (χ
2
 test, p= 0.219). The overall average 145 
estimated prevalence of resistance at colony level (generated from AUCadj) was 19.4 SD ±26.3%. 146 
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Among flocks using colistin, the highest level of resistance corresponded to mid-production 147 
samples (27.0 SD ± 26.4%), followed by day-old (15.7 SD ± 24.7%) and end production (12.8 148 
SD ±18.1%) (Kruskal Wallis test, p= 0.070). In contrast, among non-using flocks, day-old 149 
samples showed higher prevalence of resistance (28.8 SD ±36.0%) compared to mid (17.3 SD 150 
±28.7%) and end production (16.2 SD ±24.8%) (Kruskal Wallis test, p= 0.453). Summary results 151 
are presented in Table 1 and individual sample results are given in Table S2. 152 
Risk factors for colistin resistance 153 
Table 2 shows results for univariable and multivariable analyses. In the multivariable model, use 154 
of colistin during the two weeks prior to sampling (OR= 3.67; 95% [Confidence Interval] CI 155 
0.68-19.7) and use of non-colistin antimicrobials (OR= 1.84; 95% CI 0.88-3.85) were associated 156 
with colistin resistance at sample level. 157 
Estimation of test costs 158 
The reagent and media costs of broth microdilution and Etest for testing one sample based on the 159 
investigation of 10 E. coli isolates were ~25 and ~63 US dollars (USD), respectively. The cost 160 
for testing one sample by the growth-based method (based on 40 isolates) was ~6.5 USD. In 161 
addition, broth microdilution involved a higher labour cost (average of ~1 person-day per 162 
sample) compared with either the Etest or the growth-based method (~0.5 person-day) (Table 163 
S3). 164 
DISCUSSION 165 
Here we developed a method that may be effectively used to quantify colistin resistance in 166 
commensal E. coli in chicken flocks. Colistin is widely used in poultry and pig production 167 
worldwide (4, 15, 16). In the Mekong Delta of Vietnam, colistin is typically administered to 168 
chicken flocks in drinking water during the brooding period (1-4 weeks) with a prophylactic 169 
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purpose (i.e. to prevent disease) (5). Colistin is also included in some pig and poultry commercial 170 
feeds as a growth promoter (AGP) (17). However, from 2020 onwards, AGPs are longer be 171 
allowed in Vietnam (Law No. 32/2018/QH14), in line with legislative restrictions in Thailand 172 
(2015) (18), China (2016) (19) and India (2019) (20).  173 
In contrast with the study of human patients, where colistin susceptibility testing is required to 174 
inform therapeutic choices (21) our method is aimed at estimating colistin resistance in mixed 175 
commensal E. coli populations. Through evaluation of the growth curves of standard E. coli 176 
suspensions from faecal samples, our method enables the detection of colistin resistance in a 177 
dichotomous fashion (presence/absence), as well as providing a quantitative assessment of 178 
colistin resistance at colony level (prevalence of resistant E. coli). The sensitivity of this 179 
methodology is, however, limited by the number of colonies harvested per sample (30-50), and 180 
may therefore miss colistin resistant strains in situations of very low prevalence. Indeed, 181 
statistically, given a sample of 40 colonies, there is a 5% probability of not detecting colistin 182 
resistance in any of them when the prevalence of resistant falls below 7.5%. Because of this, the 183 
method is more suitable advised for situations of medium to high prevalence of colistin 184 
resistance. The sensitivity could however be potentially increased by collecting several samples 185 
or increasing the number of E. coli colonies used in each suspension. For example, detection of a 186 
prevalence of 2% would require the investigation of 150 isolates (~4 samples, each with 30-50 187 
colonies), detection of a prevalence of 1% would require 300 isolates (~8 samples); 0.1% a total 188 
of 3,000 isolates (~75 samples).  189 
Although there was a statistically significant correlation between the prevalence of resistance and 190 
AUCadj, we observed considerable variation in AUCadj for similar prevalence values both in our 191 
laboratory validation as well as in our flock samples. This suggests variable growth capacity 192 
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among resistant strains, which may depend on their relative fitness. In the case of field 193 
suspensions containing a diversity of susceptible and resistant strains, it is also likely that the 194 
relative composition of strains may result in variable growth among the resistant strains due to 195 
the liberation of bacteriocin (i.e. colicins) in the culture media (22), or the presence of 196 
bacteriophages. This may also explain the variable limit of detection confirmed in laboratory 197 
conditions with different susceptible strains. In general, given identical prevalence of resistant 198 
strains, we observed higher AUCadj values for individual susceptible-resistant strain 199 
combinations, compared to the specific mix of E. coli in field samples (Fig 2). It could be 200 
probably explained by less competition exerted in mixes containing a single strain, compared 201 
with heterogenous mixes containing ~40 different strains. Because of these reasons, prevalence 202 
estimates derived from AUCadj should always be interpreted with caution. 203 
We believe that our testing approach is more efficient than isolating and investigating individual 204 
colonies, at a relatively lower cost. However, it requires investment on a microplate reader 205 
costing between 3,000 and 10,000 USD. The technique presented here could potentially be 206 
adapted to the investigation of other types of phenotypic resistance in E. coli (i.e. tetracycline, 207 
ampicillin, etc.) but it would necessarily require optimizing working concentrations. 208 
At the colony level, we obtained a median prevalence of 19.4% colistin resistance in flocks. 209 
These results are comparable with previous studies on chicken E. coli isolates in the area (12-210 
22%) (7, 8). Furthermore, the observed ~40% resistance at sample level is consistent with a 211 
previous study on chickens in the Mekong Delta of Vietnam, where 5 E. coli colonies were 212 
investigated from each of 18 faecal samples (8). In such study, a total of 8/18 (44%) samples 213 
included at least one resistant strain (NT Nhung, personal communication). A PCR-based study 214 
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in this region reported that 59.4% chicken samples investigated tested positive for mcr-1 gene 215 
(7). 216 
We demonstrated a short-term increase in phenotypic colistin resistance following administration 217 
of colistin use as well as non-colistin antimicrobials. This contrasts with a study conducted on a 218 
broiler flock in France, where administration of colistin failed to induce colistin resistance in 219 
Enterobacteriacea (including E. coli) (23). However, unlike in Vietnam, colistin use and 220 
resistance (including mcr-1) is relatively rare in European livestock (10). Overall, we found 221 
relatively high levels of colistin resistance (~40%), even in flocks that had not been given 222 
colistin (33.3%). There was evidence of colistin resistance in mid-production samples from 223 
flocks that had previously tested negative in day-old samples, and had not been administered 224 
colistin (3 of 8 flocks) (data not shown). This suggests that colistin resistance may have been 225 
generated or introduced to study flocks from other sources, such as contaminated water or feed, 226 
or due to contamination with bacteria from other animal species present in these small-scale 227 
farms.  228 
Our findings of increased colistin resistance in flocks treated with antimicrobials other than 229 
colistin are intriguing. In a previous study on Mekong Delta pig farms, colistin resistance in E. 230 
coli strains was associated with use of non-colistin antimicrobials such as quinolones and 231 
cephalosporins (8). The presence of genes conferring for resistance against several different 232 
antimicrobial classes in mcr-harboring plasmids may explain these findings, and suggest that the 233 
use of non-colistin drugs may also select for colistin resistance (24). 234 
We observed a peak of colistin resistance in mid-production samples among flocks using 235 
colistin, and generally levels of resistance decayed subsequently. This is likely to reflect the 236 
higher frequency of colistin use during the brooding period. A longitudinal study on travelers 237 








Page 317 of 342
12 
 
colonized by mcr-1-carrying bacteria showed that they were able to completely eliminate these 238 
bacteria within one month after returning to their home country (25). The reasons for a reduction 239 
in resistance over time are unknown and may be due to a combination of factors leading to 240 
plasmid loss and/or fitness costs. However, studies in the laboratory have shown that the 241 
presence of plasmid-mediated colistin resistance has been shown to confer no fitness costs to E. 242 
coli (26). It is worthwhile noting that in our study chicken flocks were of local native breed, and 243 
they were typically raised over a 4-5 month period, a period much longer than that required by 244 
industrial broilers (typically 1.5 months). This suggests that birds slaughtered earlier may have a 245 
higher prevalence of colistin resistance, and this potentially represents an additional risk to the 246 
consumer.  247 
In summary, our method may be adapted to benchmark and monitor changes over time in colistin 248 
resistance in faecal samples in other complex biological systems such as abattoirs, slaughter-249 
points and sewage, or even in human individuals. Our results indicate a high background of 250 
colistin resistance even in flocks not using this antimicrobial. The observed increases after 251 
colistin use were short-lived and suggest that in small-scale farming systems reducing colistin 252 
resistance may require increasing biosecurity as well as restocking colistin-negative day-old 253 
chicks.  254 
MATERIALS AND METHODS 255 
Study design 256 
In order to investigate the biological basis and the limit of detection of the proposed method, 257 
we used four previously characterized mcr-1 colistin resistant E. coli strains, two displaying 258 
moderate-level (MIC= 8mg/L) and two low-level (MIC= 4mg/L) colistin resistance, alongside 259 
four colistin-susceptible strains. We prepared standard bacterial suspensions consisting of a 260 
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mix of each of the resistant and the susceptible strains at different ratios; these were incubated 261 
in medium with and without 2mg/L of colistin. A growth curve from each suspension was 262 
obtained by measuring the optical density (OD600nm) during incubation. The area under the 263 
curve (AUCadj) of each colistin-containing standard suspension was adjusted by the AUC 264 
values obtained from its equivalent colistin-free suspension. We investigated the relationship 265 
between the prevalence of resistance at colony level and the observed AUCadj from the 266 
examination of 30-50 individual E.coli isolates from each of 23 samples and obtained a model 267 
equation. We calculated AUCadj values of suspensions consisting 30-50 E. coli colonies 268 
harvested from each of 108 pooled faecal samples from 36 small-scale (single-age) chicken 269 
flocks raised in Dong Thap province (Mekong Delta, Vietnam) (27). We inferred the 270 
prevalence of resistant E. coli in flock samples investigated by extrapolation using the model 271 
equation. The contribution of colistin use and other antimicrobials administered to flocks on 272 
the observed phenotypic colistin resistance was investigated by building logistic regression 273 
models with age as primary time variable. 274 
Culture of standard suspensions; calculation of the AUCadj and limit of detection 275 
Each of the chosen resistant E. coli strains (named R1 to R4, where R1 and R2 had MIC= 276 
4mg/L; R3 and R4 had MIC= 8mg/L) and susceptible (all MIC≤ 1mg/L) strains (S1 to S4) 277 
were incubated in cation adjusted Mueller Hinton II Broth II (MHB2, Sigma-Aldrich, USA) at 278 
37
o
C, 200 rpm for 4h (log-phase) and these bacterial inoculum were adjusted to 10
8 
CFU/mL 279 
(OD600nm= 0.1), and then diluted down with MHB2 to 10
6 
CFU/mL. Each susceptible strain 280 
was mixed with a resistant strain, giving a total of 16 combinations with susceptible: resistant 281 











:1. A total of 100µL of each suspension was 283 
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added into a well of polystyrene microplate (Corning, USA), containing 100µL of colistin 284 
solution (final working concentration was 2mg/L). In addition, respective colistin-free 285 
(control) suspensions were prepared. Plates were incubated in a microplate reader 286 
(SPECTROStar, BMG Labtech, Germany) at 37
o
C for 20h, and the turbidity (OD600nm) 287 
readings were recorded every hour. All experiments were conducted in triplicate. 288 
The areas under the curves (AUC) generated over the 20-hour observation period were 289 
computed. The AUC value generated from each standard suspension (AUC[i]) was related to the 290 
AUC generated by its respective colistin-free control (AUCadj= AUC[i] /AUC[0]). Samples with 291 
AUCadj greater than the average value obtained with each of the four susceptible strains +2 SD 292 
were considered positive to colistin resistance. 293 
Flock sample and AMU data collection 294 
Fresh pooled faecal samples were collected from each flock at three time-points: (1) day-old 295 
chicks, (2) mid-production (~2-3 months-old) and (3) end of production (~4-6 months-old). 296 
Day-old faecal (i.e. meconium) samples were collected from the crates at the time when 297 
chicks were delivered to the farms. For mid- and end-production sampling, sterile paper liners 298 
were placed near drinkers and feeders in the chicken house/pen to collect deposited droppings. 299 
After a minimum of 10 droppings had been deposited, liners were swabbed using sterile 300 
gauzes. Each of collected gauze was placed in a universal jar and mixed vigorously with 301 
50mL saline buffer. One ml of the resulting eluate was stored at -20
o
C with glycerol. Data on 302 
AMU had been collected using purposefully designed diaries where farmers were asked to 303 
note down all antimicrobials used. Farmers were instructed to keep all packages of 304 
antimicrobials used on their flocks (5). Sample and data collection were conducted between 305 
October 2016 and October 2018. 306 
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Testing of pooled faecal samples 307 
Eluates from pooled faecal samples were plated onto ECC agar (CHROMagar, France) and 308 
incubated at 37
o
C for 20h. A total of 30-50 E. coli (blue) colonies from each agar sample were 309 
picked, pooled and incubated in CAMHB to log-phase. The resulting bacterial suspensions 310 
were investigated as described above. 311 
Estimation of the prevalence of colistin resistance at colony level 312 
We selected a number of positive samples with variable levels of AUCadj. From each sample, 40 313 
E. coli were isolated and tested individually for colistin MIC by standard broth micro-dilution. 314 
These pools of 40 E. coli were also investigated for their AUCadj as described previously.  315 
Data analyses and cost estimation 316 
 In order to relate the AUCadj value to the measured prevalence of resistance among selected 317 
samples, we fitted a beta-regression model using the ‘betareg’ package in R (28). Both the trend 318 
and the dispersion were allowed to vary over AUCadj in a linear way.  319 
AMU in flocks was quantified for the two periods defined by the sampling schedule: (1) between 320 
restocking and mid-production, and (2) between mid- and end of production. Weekly estimates 321 
of colistin use were expressed as the number of ADDs (number of Animal Daily Doses 322 
administered per 1,000 chicken days) calculated for each of the two periods (5). Risk factors 323 
associated with colistin resistance at mid- and end of production were investigated by logistic 324 
regression. The outcome was colistin resistance (Yes/No) at sample level. The variables 325 
investigated were: (1) Age of chicken flock (weeks); (2) Use of colistin within two weeks prior 326 
to sampling (Yes/No); (3) Number of ADDs per 1,000 chicken-days of colistin in each period; 327 
(4) Colistin resistance of day-old chicks (Yes/No); and (5) Number of ADDs per 1,000 chicken-328 
days of non- colistin antimicrobials used in each period. The variable Age of chicken flock was 329 
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included in all univariable models because it is the principal time variable. Since we had two 330 
measurements per flock (mid and end cycle samples), we used generalized estimation equations 331 
with an exchangeable correlation structure to estimate the parameters using the ‘geepack’ R 332 
package (29, 30). 333 
The change in AUCadj over age of chicken was modeled using a random effects linear regression. 334 
In order to allow for a nonlinear trend, we used a natural spline for the fixed effect term (knots at 335 
0, 8, 12 and 20 weeks). We allowed for a random intercept and linear trend by age. 336 
The overall costs (per sample) of the method described above were calculated based on expenses 337 
on medium, reagents and consumables (excluding staff time, which was estimated separately). 338 
The estimated costs were compared with those incurred in testing one sample by broth 339 
microdilution and Etest in Vietnam as of January 2020. Our calculations were based on the 340 
investigation of 40 E. coli isolates per sample using the growth-based method, compared with 10 341 
isolates each by broth microdilution and by Etest. 342 
SUPPLEMENTAL MATERIAL 343 
Table S1 Non-colistin antimicrobials used in studied flocks 344 
Table S2 Estimated percentage of resistant E. coli from 108 samples  345 
Table S3 Estimated costs (in US dollar) of testing 1 sample to determine colistin phenotypic 346 
resistance of E. coli 347 
FIG S1 Usage of colistin among study flocks by week. 348 
FIG S2 Distribution of MIC values among 909 E. coli isolates 349 
FIG S3. Changes in AUCadj over time (weeks) in chicken flocks 350 
 351 
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TABLE 1 Description of AMU and estimated prevalence of colistin resistance in 36 small-scale 456 
chicken flocks stratified by whether farmers administered colistin or not. 457 




 All flocks 
(n=36)  




 quartile]) 19 [17-20] 20 [17-21]  19 [17-20] 




 quartile]) 249 [194-482] 208 [128-398]  231 [189-401] 
No. ADDs of colistin (per 1,000 chicken-days) (mean ± SD) 
First period  0 281.7 ±321.2  172.1 ± 285.1 
Second period 0 17.4 ±18.1  10.6 ± 16.4 
Whole production cycle 0 149.5 ±261.6  91.4 ± 216.4 
No. ADDs of non-colistin antimicrobials (per 1,000 chicken-days) (mean ± SD) 
First period  345.5 ± 471.5 629.3 ±359.8  518.9 ± 424.2 
Second period 29.0 ± 48.6 72.5 ± 98.5  55.6 ± 84.7 
Whole production cycle 187.2 ±366.2 350.9 ± 383.8  287.3 ± 382.9 
No. flocks using colistin two weeks prior to 
Mid-sampling 0 11  11 





 quartile])     
Day-olds 0.07 [0.04-0.42] 0.06 [0.04-0.52]  0.07 [0.04-0.65] 
Mid-production 0.06 [0.03-0.43] 0.54 [0.07-0.65]  0.20 [0.05-0.63] 
End of production 0.07 [0.06-0.55] 0.07[0.06-0.55]  0.07 [0.05-0.56] 
Prevalence of resistance (%) at sample level (95% CI) 
Day-olds 42.8 (18.8-70.3) 31.8 (14.7-54.9)  36.1 (21.3-53.8) 
Mid-production 28.6 (9.5-58.0) 63.6 (40.8-82.0)  50.0 (34.5- 65.5) 
End of production 28.6 (9.5-58.0) 31.8 (14.7-54.9)  30.5 (16.9- 48.3) 
Estimated prevalence of resistance (%) at colony level (mean ± SD) 
Day-olds 28.8 ±36.0 15.7 ±24.7  20.8 ±29.8 
Mid-production 17.3 ±28.7 27.0 ±26.4  23.3 ±27.4 
End of production 16.2 ±24.8 12.8 ±18.1  14.1 ±20.7 
AUC= area under the growth curve; CI= Confidence interval; SD= standard deviation458 
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TABLE 2 Logistic regression models investigating risk factors associated with colistin resistance 459 
in chicken flocks at sample level. Models were based on a total of 72 samples (mid and end 460 
production); 29 were positive resistance to colistin. 461 
Variable Univariablea  Multivariable 
OR 95% CI p-value  OR 95% CI p-value 
Age of chicken flock (weeks) 0.93 0.84-1.02 0.156  1.04 0.91-1.18 0.605 
Use of colistin within last two weeks (Yes/No) 5.30 1.17-24.08 0.030  3.67 0.68-19.70 0.128 
No. ADDs per 1,000 chicken-day of colistin
b
 1.66 1.00-2.76 0.049  1.06 0.55-2.06 0.845 
Colistin resistance of day-old chicks (Yes/No) 1.45 0.53-3.97 0.461  1.61 0.54-4.84 0.395 




2.10 1.18- 3.73 0.012  1.84 0.88-3.85 0.102 
aThe variable ‘Age of chicken flock’ was included in all univariable models to calculate estimates for all subsequent 462 
variables. blogarith transformed after adding 1, ADD= animal daily dose; OR= Odds ratio; CI= Confidence interval.  463 












FIG 1 AUCadj of standard suspensions. Positive growth values are represented by increasing strength of color. R= Resistant, S= 465 
Susceptible. Average of AUCadj of resistant strain 1, 2, 3 and 4 was 0.40, 0.30, 0.41 and 0.26, respectively.  Average AUCadj of 466 
susceptible strain 1, 2, 3 and 4 was 0.41, 0.19, 0.31 and 0.54 respectively.467 












FIG 2 Relationship between AUCadj (from mix of 40 E. coli per sample) and prevalence of 469 
colistin resistance at colony level. The figure shows the predicted mean value of resistance with 470 
pointwise 95% confidence as shaded area. The dotted lines give the 5% and 95% prediction 471 
intervals. Circle symbols indicated AUCadj values of mixed E. coli in field samples. Size of dot 472 
represented the average MIC of each sample. Cross symbols indicated AUCadj values of mixed 473 
susceptible and resistant strains. 474 
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Indiscriminate antimicrobial use (AMU) in animal production is a driver of antimicrobial
resistance globally. There is a need to define sustainable interventions to reduce AMU
in small-scale production systems, which currently represent the most widespread
farming systems in South East Asia and many low- and middle-income countries. We
conducted a before-and-after intervention study on a random sample of small-scale
chicken farms in the Mekong Delta of Vietnam from 2016 to 2019. The study included
a baseline followed by an intervention phase where farmers were provided with regular
veterinary advice on flock health and husbandry, as well as antimicrobial replacement
products. Of 102 recruited farms (raising >100 chickens per flock cycle), thirty-five
(34.2%) entered the intervention phase, whilst the rest stopped raising chickens, mainly
due to suboptimal flock performance. Through the implementation of our intervention,
chicken flocks reduced levels of AMU by 66% [adjusted hazard ratio (HR) = 0.34; p
= 0.002) from a baseline of 343.4 Animal Daily Doses per 1,000 chicken-days and
decreased weekly mortality by 40% (adjusted HR = 0.60; p = 0.005) from a baseline
mortality of 1.60 per 100 birds. Chicken bodyweight increased by 100 g (p = 0.002)
in intervention flocks. Our findings demonstrate that the provision of veterinary advice
can achieve substantial reductions in AMU in small-scale production systems without
compromising flock health and productivity.
Keywords: antimicrobial use, disease, smallholder farms, poultry, Vietnam
INTRODUCTION
In many low- and middle-income countries (LMICs) small-scale poultry farming plays a crucial
role in supporting the livelihoods of rural communities (1). Compared with other species, poultry
production has relatively low investment and production costs (2). Globally, poultry (mainly
chicken) is the second most consumed type of meat (117 million tons in 2017), and by 2026 it
is expected to surpass pork (3).
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Antimicrobial use (AMU) in animal production has been
recognized as a driver of antimicrobial resistance (AMR) globally
(4, 5). In terms of frequency, chickens are the target of
the highest AMU levels of all animal food species (6). In
addition, many antimicrobial active ingredients (AAI) regarded
as critically important for human medicine by the World Health
Organization (7) are often used in chicken production (8).
In Vietnam, it has been estimated that three quarters
(72%) of all AMU (3,842 tons in 2015) are aimed at animal
production (9). Studies in the Mekong Delta region of Vietnam
have described very high amounts of antimicrobial to small-
scale chicken flocks (8, 10–12). The high levels of disease in
flocks in the area is a major driver of AMU in such systems
(13). In chicken farms, antimicrobials are used primarily for
disease prevention (10), since farmers regard them as a cheaper
alternative to other disease control measures (14). Recent studies
have shown that some of the most commonly used AAIs
in small-scale chicken flocks in the area also belong to the
WHO highest priority, critically important antimicrobial classes
such as polymyxins and fluoroquinolones (8, 12, 15). This
situation is aggravated by a general lack of awareness about
antimicrobials and the negative consequences of AMR among
farmers (16). In addition, the ease of access to antimicrobials
over-the-counter in veterinary drug shops (17) and their
affordability (18) are factors that contribute to excessive AMU
in Vietnam.
There is a pressing need to identify sustainable interventions
that reduce AMU in food animal production systems. Such
interventions will need to overcome the diversity of production
systems and value chains they depend on and the patterns
of AMU in these systems and their policy contexts. A
number of interventions have already taken place in developed
countries based on improvements in biosecurity and husbandry
practices aiming at reducing AMU in pigs (19–21) and
broilers (22). However, no intervention studies targetting
AMU in small-scale farming systems from LMICs have been
published. We conducted a “before-and-after” randomized
intervention study on small-scale chicken farms in the Mekong
Delta region of Vietnam. The intervention consisted of
providing farmers with regular veterinary advice, alongside
antimicrobial replacement products (23). The aim was to
investigate the impact of this intervention on AMU, as
well as on flock disease and productivity. Results and the
lessons from this study can be adapted to comparable




The intervention was designed as a randomized “before-and-
after” controlled study on small-scale farms raising chickens
for meat in two districts (Cao Lanh and Thap Muoi) within
Dong Thap province (Mekong Delta, Vietnam) (Figure 1 and
Supplementary Figure 1). We aimed to recruit farmers raising
chicken flocks (defined as a group of birds raised together in the
same building) meeting the criterion “>100 meat chickens raised
as single age.”
Our small-scale commercial flocks lie between “backyard”
flocks and intensively managed “industrial” systems, roughly
corresponding to FAO Sectors 2 and 3 (between 50 and 2,000
birds, with feed and water supplied to the birds) (24). The
study was designed in two stages, a “baseline” followed by
an “intervention” phase. Two intervention arms (Arm 1 and
Arm 2) were initially planned, both including the provision
of training and advice to farmers, as well as a control arm
(Arm 3) (no training or advice). The difference between both
intervention arms was that Arm 2 also included the withdrawal
of medicated commercial feed. This aimed at investigating
whether restriction of medicated feed might have affected
disease outcomes, therefore contributing to changes in levels of
AMU (23).
Farmers registered in the official SDAH census (2014)
were contacted by post and were invited to participate in an
introductory meeting held in October 2016 in each of the two
study districts. In these meetings, the project aims and methods
were outlined. Farmers willing to enroll in the study were asked to
contact project staff as soon as they restockedwith day-old chicks.
Description of the Baseline and the
Intervention
During the baseline phase of the study, routine AMU and
productivity data were collected from enrolled farms without
the provision of any advice. Using a random number generator,
we allocated enrolled farms to either an intervention or a
control arm. All farms allocated to the intervention arm were
supported with a Farmer Training Programme (FTP), where
farm owners were invited to participate in six workshops where a
poultry veterinarian instructed them on the principles of chicken
husbandry, prevention, control of infectious diseases and waste
management and a Farm Health Plan (FHP), where each farm
was assigned to a Project Veterinarian (PV) who was responsible
for providing specific advice to farmers. The PV visited each
farm on three different occasions for each flock cycle: (i) early-
brooding (weeks 1–2), (ii) late brooding (weeks 3–4), and (iii)
grow-out (>2 months) periods. Prior to each visit, the PV
reviewed records of productivity and disease over previous cycles,
inspected the flock and house/pen, reviewed farmers’ records,
discussed with farm owner about current production/health
issues, and then drafted a list of recommendations to address
them. In addition, the PV recommended the farm owner to use
an antimicrobial replacement product, either a liquid phytogenic
solution containing essential oils (Product A) or a yeast fraction-
containing product (Product B) for 3 days a week over the first 10
weeks of the production cycle. Product A was recommended to
flocks with a history of diarrhoeal disease in previous cycles; for
all other flocks the PV recommended Product B. By providing
these products we aimed at allaying the farmers’ anxiety about
reducing or eliminating antimicrobials during the early phase of
production, which is critical in terms of disease and mortality. In
all visits, the PVs reminded the farmers that healthy birds should
not be given any antimicrobials.
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FIGURE 1 | Recruitment and follow-up of study farms. Modified from design of project named ViParc published in 2017 (23).
Data Collection
Each farmer was provided by project staff with a diary to weekly
record data on farming practices, including number of chickens
purchased, number of chickens in and out of the flock (number
of dead and sold chickens), as well as the types and quantities
of antimicrobial products used. The average bodyweight of
slaughter-age chickens was also measured by average of total
bodyweight of chickens divided for total number of chickens
sold. Project staff visited study farms four times (different from
PV visits) to verify the data collected, which was subsequently
transferred to validated questionnaires and double-entered into a
web-based database.
Statistical Analyses
The initially proposed sample size was based on previous
quantitative data on AMU in Mekong Delta chicken farms (10).
We aimed at recruiting 120 farms and estimated a total of 40
farms for each arm. A sample size of 40 farms per arm, each
contributing with 2 cycles investigated during baseline and 2
during the intervention, and a two-sided significance level of 5%,
will have 82% power to detect a ∼33% reduction, and a 91%
power to detect a 50% reduction. Since the study design exploited
within-farm correlation of unknown magnitude, the true power
was expected to be higher.
The primary outcome was the weekly number doses of
antimicrobial active ingredient (AAI) corresponding to 1 kg of
live chicken administered to a flock (Weekly ADDkg). Secondary
outcomes were “Weekly mortality,” calculated by dividing the
number of chickens dying over the week by the total chicken
present at the beginning of each week (%), and “Weight of the
birds (in units of 100 g) at the time of sale.” The latter was
calculated by dividing the total flock weight by the number of
chickens sold at the end of the cycle. The correlation between all
three outcomes at flock and at week level was investigated using
the Spearman’s rank correlation coefficient.
Weekly antimicrobial consumption in each flock was
expressed as No. of Animal Daily Doses-kilogram (ADDkg).
ADDkg was calculated for each antimicrobial contained in each
product based on the preparation instructions included in its
technical dossier/label. The amounts of antimicrobial product
administered each week were multiplied by a dilution factor
[for water-administered products, Volume of water (ml)/Weight
of product (g); for feed feed administered products, Weight of
feed (g)/Weight of product (g)]. The obtained amounts were
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then divided by the estimated weekly water of feed consumption
corresponding to a 1 kg chicken (7∗0.225 l of water, 7∗0.063 kg
of feed). The number of ADDkg per 1,000 kg chicken-days on
any given week was calculated by dividing the total of number
of ADDkg by the estimated weight of the flock at a given week,
and then multiplied by 1,000. The estimated total weight of the
flock by week was calculated by multiplying the total number of
chickens at the beginning of the week by their estimated weight.
The No. ADDkg per 1,000 chicken-days can be interpreted as the
number of days (per 1,000) when one chicken is treated or the
number of treated chickens daily (per 1,000) (8).
No.ADDkg =




∗ dilution factor in water (l/g) or feed (kg/g)
Daily consumption of water (0.225l) or feed (0.063kg) of 1 kg chicken
No.ADDkgper 1, 000 kg chicken− days =
No. ADDkg
Estimated weight (kg) of the flock
∗1, 000
We built Poisson regression models with for “Weekly ADDkg”
and “Weekly mortality.” For the former the offset was the
(weekly) total number of chicken-kg days (log); for the latter
it was the number of chickens at the beginning of the week
(log). In addition, a linear regression model was developed with
bodyweight of chickens at the point of sale (kg) as outcome.
In all cases, “Farm,” “Flock cycle” and “Week” were modeled as
random effects, where “Week” was nested within “Flock cycle,”
and the latter was nested within “Farm.” The main variable of
interest was the impact of the intervention delivered; therefore,
we investigated “Status” (baseline, transition, and intervention)
as an explanatory variable in Intervention Arm and “Status”
(baseline, intervention calendar time) as an explanatory variable
in the Control Arm. “Status = transition” was assigned to those
flocks that were not exposed to all three advisory visits for
Intervention Arm farms. This occurred to a number of flocks at
the beginning of the intervention phase, given that some advisory
visits (typically the first and second) were missed. In order to
account for the potential confounding effects of “District” and
“Flock size” these were forced into a multivariable model; we
tested the interactions between “Status = intervention” with
“District” and “Flock size” to investigate whether the observed
effects were dependent on the geographical location or the size of
the flock. Moreover, we investigated whether subsequent cycles
over the intervention resulted in improved outcomes by splitting
“Status = intervention” into “Status = first intervention cycle”
and “Status = subsequent intervention cycle.” The presence of
overly influential observations was investigated by testing the
model with and without those observations yielding the largest
residuals. We used the “survey” package to calculate (farm-flock-
week) adjusted estimates and “lme4” package to build statistical
models (http://www.r-project.org).
RESULTS
Recruitment of Study Farms
The study took place between October 2016 and November 2019.
A meeting with 199 randomly selected farmers from the farm
census registered as owners of chickens was held in October 2016.
Eighty-eight participating farmers indicating their willingness to
restock within 6 months were enrolled. The remaining 14 farms
were identified by commune animal health workers or through
contact with farmers that had already been enrolled in the study.
Therefore, a total of 102 farms were enrolled over the period
October 2016 to October 2017. The baseline phase spanned
October 2016 to April 2018. The intervention was delivered from
May 2018 to November 2019.
The flow of participating farms was complicated by many
(n = 63) that stopped farming during the study for financial
reasons unrelated to the study. The recruitment and allocation to
arms is summarized in Figure 1. Their location is presented in
Supplementary Figure 1.
In December 2017 farms that remained in production at the
time (n = 66) were randomized to either intervention Arm 1
(n = 22), intervention Arm 2 (n = 22) or a Control arm (n =
22). Following discussion with the farmers, it became apparent
that replacement of medicated feed as initially planned for Arm
2 would not be acceptable; therefore, the two intervention arms
were merged into one single arm. At the time of the onset of the
intervention (May 2018), of 44 farms initially allocated to the
intervention, only 31 remained in business; of the 22 allocated
to the control, only 8 were still raising chickens. To compensate
for the reduced sample size and associated loss in study power,
we further allocated four randomly-selected control farms to the
intervention arm. Therefore, a total of 35 and 4 farms allocated to
the intervention and control arm, respectively, proceeded to the
intervention phase (Figure 1).
The intervention commenced with the delivery of the Farmer
Training Programme (FTP) in May 2018 to owners of the
35 intervention farms; however, at that time 18 had already
restocked with day-olds. Since flocks (n = 22) in these farms
were not exposed to all four advisory visits, they were therefore
analyzed as “transition” flocks. Four farms assigned to the
intervention arm stopped raising chickens shortly after having
attended the FTP modules, and were classified as “Baseline-
Transition-Stop” farms.
Data collected from 35 farms (31 intervention, 4 control) were
eligible for the final analyses. One hundred flock cycles were
analyzed as baseline phase (87 in intervention; 13 in control
arms) and 89 flock cycles corresponded to the intervention phase
(77 intervention farms; 12 in control farms). Of the 77 flocks, 28
(14 farms) were given Product A (an essential oil); and 43 (14
farms) were given Product B (a yeast fraction-based product). Six
flocks (3 farms) did not agree with the supplementation of either
Product A or Product B.
The median number of chickens restocked per flock was 303
[IQR (inter-quartile range) 200–500], and the median duration
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TABLE 1 | Categorization of farms based on number of flocks investigated during the baseline phase, transition period, and intervention phase.
Farm group No. farms (%) No. flock cycles by status(%)
Baseline Transition Intervention Control Total
Baseline-Transition-Stop 4 (3.9%) 9 4 – – 13 (3.9%)
Baseline-Transition-Intervention* 14 (13.7%) 42 18 37 – 97 (29.4%)
Baseline-Intervention* 17 (16.7%) 45 – 40 – 85 (25.8%)
Baseline-Control* 4 (3.9%) 13 – – 12 25 (7.6%)
Baseline-Stop 63 (61.8%) 110 – – – 110 (33.3%)
Total 102 (100%) 219 22 77 12 330 (100%)
*Data used in further statistical modeling.
of one production cycle was 18 weeks (IQR 16.0–20.0). Each
farm raised a median of 5 flocks (IQR 4.0–7.0), 2 (IQR 1.0–2.2)
during the baseline and 2 (IQR 1.0–2.5) during the intervention
phase. Details of number of flocks per farm and status are
shown in Table 1 and Figure 2. Descriptive characteristics of
chicken farms by total farms, flocks and weeks were presented
in Supplementary Table 1.
AMU, Mortality, and Bodyweight of
Chicken Flocks
We collected data over 5,872 production-weeks for all study
flocks combined; of which 3,899 (66.4%) corresponded to the
baseline and 1,973 (33.6%) to the intervention phase. The latter
included 396 (6.7%) weeks from transition flocks, 1,350 (23.0%)
weeks of full intervention flocks, and 277 (3.9%) weeks from
flocks allocated to the control arm. Data on AMU, mortality
and bodyweight in these flocks over the baseline, transition and
intervention cycles are presented in Table 2.
During the baseline phase, flocks (n = 110) raised in the
63 farms that dropped out prior to the implementation of the
intervention phase had a higher mortality (weekly average 3.18
per 100 birds; SE ± 0.3), than flocks (n = 109) in 39 farms that
proceeded to the intervention (1.52 per 100 birds; SE ± 0.1)
(Wilcoxon Test, p= 0.020).
The weekly summary data of the outcome variables and
the distribution of flocks concerning these in flocks during the
baseline (n= 87) and intervention phases (n = 77) are displayed
in Figure 3. Weekly AMU in these flocks was reduced from 343.4
(SE± 33.5) (baseline) to 223.9 (SE± 30.0) (intervention) Animal
Daily Doses (ADDkg) per 1,000 kg chicken-days (−34.8%) (one-
sided Wilcoxon test, p < 0.001). The bodyweight at slaughter-
age of chickens of intervention flocks was 1,670 g (SE ± 30),
compared with 1,560 g (SE ± 20) during baseline (+7.1%) (one-
sided Wilcoxon test, p = 0.006). However, weekly mortality
increased from 1.60 (per 100 birds) (SE ± 0.2) to 1.64 (SE ± 0.2)
(+2.4%), although the difference was not significant (one-sided
Wilcoxon test, p= 0.999).
The unadjusted overall mortality increased slightly during the
intervention. However, the number of farms that experienced
a reduction in mortality exceeded (19/31) than those that
increasing it (12/31). The changes in (flock average) values of
ADDkg per 1,000 kg chicken-days, mortality and bodyweight
between the baseline and intervention phases are displayed
in Figure 4. Among intervention flocks, there were 3/77
(3.9%) with an average weekly mortality greater than 12%
(12.8, 24.8 and to 26.0%) and a cumulative mortality
of >98%; two of these flocks were detected with Highly
Pathogenic Avian Influenza (HPAI) and one with Avibacterium
paragallinarum, compared with 2/87 flocks experiencing
>10% weekly mortality among baseline flocks (one 12.4% and
one 12.8%) and cumulative mortality of 100% in these two
baseline flocks.
In the four farms that were allocated to the control arm, a
total of 13 flocks were investigated during the baseline phase,
and 12 during the intervention phase. AMU in these decreased
from 216.8 (SE± 71.8) to 182.5 (SE± 56.3) (Wilcoxon Test, p=
0.857); weekly mortality changed from 1.17 to 1.29 per 100 birds
(Wilcoxon test, p = 0.493) and bodyweight changed from 1,680
to 1,600 g (Wilcoxon test, p= 0.511).
Correlation Between AMU and Mortality,
Bodyweight
There were significant correlations between weekly AMU
(ADDkg per 1,000 kg chicken-days) and mortality (Spearman’s
rank correlation R = 0.26; p < 0.001). There were, however,
no correlations between average bodyweight and AMU (R =
−0.06, p = 0.292) or mortality (R = −0.09, p = 0.128) at
flock level. The details of these calculations are provided in
Supplementary Figure 2.
Modeling
The statistical models investigating the effectiveness of the
intervention on AMU, mortality and chicken bodyweight
are presented in Table 3. In the univariable models for the
Intervention Arm, “Status = intervention” was associated with
an overall decreased AMU (HR = 0.33; 95% CI = 0.17–0.65;
p = 0.001) (−67%), decreased mortality (HR = 0.57; 95% CI
= 0.40–0.82; p = 0.002) (−43%) and increased bodyweight
(+100 g; 95% CI 37–164 p = 0.002). The size of the flock was
negatively associated with AMU (HR = 0.55, 95% CI 0.36–
0.85, p = 0.007), but positively associated with mortality (HR =
1.34; 95% CI 1.02–1.47; p = 0.032). Adjustment for flock size
resulted in minimal change in the estimates of AMU (−66%)
(HR = 0.34; 95% CI 0.18–0.66; p = 0.002), mortality (−40%)
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FIGURE 2 | Calendar and observation time of the 39 farms recruited during the baseline and intervention phases. These included: Baseline-Transition-Stop farms (n =
4), Baseline-Control farm (n = 4), Baseline-Transition-Intervention (n = 14) and Baseline-Intervention farms (n = 17). A total of 63 farms (61.8% of recruited farms)
stopped raising chickens and are not displayed in the graphs.
TABLE 2 | Descriptive data on AMU, mortality and bodyweight of chicken study flocks.
Status Farms No. flocks No. weeks AMU Mean (±SE) Mortality Mean (±SE) Birds at point of sale
Mean weight (g) (±SE) Mean age (±SE)
Baseline Baseline-Transition-Stop 9 179 160.0 (±44.2) 1.26 (±0.4) 1,590 (±40) 19.9 (±0.8)
Baseline-Transition-Intervention 42 728 333.3 (±46.0) 1.43 (±0.2) 1,560 (±30) 17.5 (±0.3)
Baseline-Intervention 45 823 352.3 (±48.4) 1.75 (±0.3) 1,560 (±30) 18.5 (±0.4)
Baseline-Intervention (all) 87 1,551 343.4 (±33.5) 1.60 (±0.2) 1,560 (±20) 18.0 (±0.3)
Baseline-Control 13 253 216.8 (±71.8) 1.17 (±0.2) 1,680 (±110) 19.5 (±0.7)
Baseline-Stop 110 1,916 387.7 (±36.2) 3.18 (±0.3) 1,540 (±20) 18.3 (±0.3)
All baseline 219 3,899 348.5 (±22.8) 2.33 (±0.2) 1,560 (±10) 18.4 (±0.2)
Transition Baseline-Transition-Stop 4 74 316.1 (±107.4) 2.62 (±0.8) 1,540 (±70) 18.5 (±1.0)
Baseline-Transition-Intervention 18 322 407.3 (±82.0) 1.78 (±0.4) 1,530 (±30) 17.9 (±0.5)
All Transition 22 396 390.3 (±69.6) 1.94 (±0.3) 1,530 (±30) 18.0 (±0.5)
Intervention Baseline-Transition-Intervention 37 648 191.3 (±35.6) 1.92 (±0.4) 1,620 (±40) 17.8 (±0.4)
Baseline-Intervention 40 702 254.1 (±47.4) 1.39 (±0.4) 1,710 (±50) 17.7 (±0.4)
All Intervention 77 1,350 223.9 (±30.0) 1.64 (±0.2) 1,670 (±30) 17.8 (±0.3)
Control Baseline-Control 12 227 182.5 (±56.3) 1.29 (±0.3) 1,600 (±60) 18.9 (±0.9)
All 330 5,872 316.3 (±17.5) 2.11 (±0.1) 1,580 (±10) 18.2 (±0.2)
AMU: Expressed as weekly average No. of ADDkg per 1,000 kg chicken-days. Mortality: Percent of chickens dying weekly. Bodyweight: Weight of chickens at slaughter-age.
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TABLE 3 | Mixed regression models investigating the effectiveness of the intervention on AMU, mortality, and chicken bodyweight.
Models Weekly ADD†kg Weekly mortality
††† Chicken bodyweight††† (unit = 100 g)
HR 95% CI p-value HR 95% CI p-value β 95% CI p-value
Intervention Arm
Univariable
Thap Muoi district (baseline = Cao Lanh) 0.68 0.37–1.26 0.220 1.60 1.13–2.26 0.007 0.73 −0.30 to 1.77 0.179
No. of restocked chickens (log) 0.55 0.36–0.85 0.007 1.34 1.02–1.47 0.032 −0.08 −0.78 to 0.65 0.820
Status (baseline = Baseline)
Transition 0.77 0.30–2.01 0.598 1.38 0.76–2.52 0.294 −0.46 −1.49 to 0.58 0.390
Intervention 0.33 0.17–0.65 0.001 0.57 0.40–0.82 0.002 1.00 0.37 to 1.64 0.002
Multivariable 1
Thap Muoi district (baseline = Cao Lanh) 1.61 1.14–2.29 0.007
No. of restocked chickens (log) 0.55 0.36–0.85 0.007 1.39 1.07–1.81 0.015 −0.05 −0.72 to 0.65 0.884
Phase (baseline = Baseline)
Transition 0.86 0.34–2.18 0.743 1.35 0.74–2.45 0.327 −0.45 −1.49 to 0.59 0.393
Intervention 0.34 0.18–0.66 0.002 0.60 0.41–0.86 0.005 1.00 0.37 to 1.64 0.002
Multivariable 2
Thap Muoi district (baseline = Cao Lanh) 1.62 1.14–2.30 0.007
No. of restocked chickens (log) 0.55 0.36–0.85 0.007 1.39 1.07–1.81 0.015 −0.06 −0.73 to 0.63 0.842
Phase (baseline=Baseline)
Transition 0.86 0.34–2.18 0.743 1.35 0.74–2.45 0.327 −0.46 −1.48 to 0.60 0.404
First intervention cycle 0.46 0.20–1.05 0.066 0.57 0.36–0.92 0.022 0.77 −0.04 to 1.59 0.068
Subsequent intervention cycle 0.26 0.10–0.63 0.003 0.61 0.40–0.94 0.025 1.19 0.44 to 1.97 0.003
Control Arm
Univariable
Thap Muoi district (baseline = Cao Lanh) 0.95 0.15–6.13 0.958 1.88 0.49–7.32 0.360 1.49 −3.74 to 6.71 0.672
No. of restocked chickens (log) 0.19 0.04–0.87 0.033 0.08 0.04–0.17 <0.001 1.26 −2.01 to 4.49 0.471
Status (baseline = Baseline)
Intervention calendar time 1.07 0.18–6.23 0.937 0.60 0.17–2.09 0.419 −0.02 −2.72 to 2.23 0.983
Multivariable 3
Thap Muoi district (baseline = Cao Lanh) 0.64 0.09–1.73 0.666 0.53 0.22–1.27 0.156 2.33 −3.19 to 7.88 0.594
No. of restocked chickens (log) 0.15 0.03–0.87 0.034 0.07 0.04–0.15 <0.001 1.73 −1.65 to 4.65 0.383
Phase (baseline = Baseline)
Intervention calendar time 1.42 0.24–8.44 0.696 0.81 0.38–1.74 0.591 0.14 −2.74 to 2.21 0.905
Multivariable 1 intercepts:
†
−11.887 (SE = 1.303);
††
−11.400 (SE = 0.794);
†††
16.093 (SE = 1.908). Multivariable 2 intercepts:
†
−11.897 (SE = 1.308);
††
−11.400 (SE = 0.793);
†††
16.093 (SE = 1.908). Multivariable 3 intercepts:
†
−5.135 (SE = 5.539);
††
7.382 (SE = 2.297);
†††
4.558 (SE = 12.129).
(HR = 0.60; 95% CI 0.41–0.86; p = 0.005) and bodyweight
(+100 g; 95% CI 37–164 g; p = 0.002). When the variable level
“status = intervention” was replaced by two new variables (first,
subsequent cycles), greater reductions in AMU were seen in the
subsequent (HR= 0.26, p = 0.003) compared with the first cycle
(HR = 0.46; p = 0.066), although the difference between both
was not statistically significant (p = 0.298). Similarly, chicken
bodyweight further increased during subsequent intervention
cycles (+119 g per chicken sold, p = 0.003) compared with
the first intervention cycle (+77 g, p = 0.068). However, there
was no statistical significance in chicken bodyweight between
first and subsequent intervention cycles (p = 0.378). Levels of
mortality did not change between first and subsequent cycles (p
= 0.967). There were no significant interactions between either
“flock size” and “district” and “Status= intervention.” There was
no statistical difference in AMU and mortality between flocks
using Product A, Product B or those given no additional product.
However, flocks that were administered with either Product A
and B had increased bodyweight compared with flocks not given
any supplementary product (data not shown). Data from these
flocks were kept in the final models after confirming that their
removal did not change model coefficients to a large degree:
AMU reduced from HR = 0.34 including them compared with
HR= 0.33 when excluded.With regards tomortality, the removal
of these observations resulted in HR = 0.53 compared with HR
= 0.60 obtained with the whole dataset.
In the control arm, there were no significantly associations
between “Status = intervention calendar time” and any of the
three outcome variables in either univariable or multivariable
models (all p > 0.419). After adjustment of flock size and
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FIGURE 3 | Comparisons between AMU, mortality and bodyweight by weeks and flocks between baseline (in gray color) and intervention phase (in green color) in 31
eligible farms. Dot-dash red line: Mean. Dashed blue line: Median.
study district in multivariable models, estimates of AMU and
bodyweight increased (+42% and +14 g, respectively) and
mortality was reduced (−19%).
DISCUSSION
Through a locally delivered veterinary intervention, we
achieved a 66% reduction in antimicrobials (quantified
as daily doses) administered to small-scale commercial
chicken flocks, alongside a reduction in mortality (−40%).
In our crude (unadjusted) analyses AMU reductions were,
however, modest (−35%), since our analysis implicitly
adjust for week of use and most AMU took place during
the early weeks (i.e., the brooding period). Similarly, the
crude data indicated a slightly higher mortality during
the intervention (+2.4%). However, the adjusted analysis
indicated a ∼40% reduction in mortality, and weekly mortality
was reduced in a majority (19/31, 61.3%) of farms. This
discrepancy was explained by unusually high mortality in three
intervention flocks.
Unlike other studies involving the delivery of a uniform
treatment (i.e., vaccination) (25), our intervention consisted of
providing farmers with veterinary advice. The nature of this
advice was variable across farms, and was based on specific
observations and information collected by project veterinarians
from their flocks. This advice includedmeasures to improve flock
health and productivity, whilst emphasizing the message that
“antimicrobials should not be admnistered to healthy chickens.”
In addition to providing antimicrobial replacement products,
the main advice given to farmers focused on biosecurity,
cleaning and disinfection, vaccination, litter management,
and administration of medicines (including antimicrobials,
antiparasitic drugs and other health-enhancing products). The
detail of this advice provided and its uptake will be presented
elsewhere. The advice provided was based on a persuasive,
rather than a restrictive advice. We believe this approach
is likely to be more sustainable in the mid-to-long term
(26). A similar holistic approach was adopted on a study
on pig farms in Belgium, resulting in 52% AMU reduction
in pigs raised from birth to slaughter, and by 32% among
breeding animals; furthermore, the study resulted in additional
productivity gains (20). Similarly, a study conducted in four
European Union (EU) countries reported AMU reductions of 3
and 54% in fattening and weaned pigs, respectively, following
improvements of herd management practices (19). However,
reductions in AMU were not seen in breeding pigs, and the
authors attributed it to the concurrent incursion of Porcine
Epidemic Diarrhea (PED) in Germany. A study in 20 industrial-
scale broiler farms in Europe using a holistic approach resulted
in 20% reductions in levels of AMU and 14% increase in gross
margins (22).
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FIGURE 4 | Bi-dimensional arrow charts showing crude (unadjusted) changes between the baseline and the intervention phases with regards to Variable 1
(No. ADDkg per 1,000 kg chicken-days) and Variable 2 (mortality and bodyweight). The arrow indicates the direction of change. Large gray arrows indicate summary
result for each pair of variables. Large white arrows indicate overall results. The log10-transformed scale for easier visualization.
After consultation with participating farmers during the
baseline phase, we were compelled to modify our original
protocol by offering selected health-enhancing, antimicrobial
replacement products (27) to chicks during the brooding
phase. This aimed at allaying the farmers’ anxiety about
reducing or eliminating antimicrobials during this critical phase
of production. Administration of antimicrobials during the
brooding phase is standard practice and many antimicrobial-
containing commercial formulations are marketed as “brooding
medicine” (13). Similarly, many of our study farmers expressed
their opposition about changing the feed and therefore we
consolidated the two intervention arms into only one arm. Often
the advice provided by project veterinarians to farmers was
overrun by that given at local veterinary drug shops. Farmers
often visit these shops to buy animal feed and other supplies
(17). In addition, the antimicrobial product labels often include
indications for prophylactic use at a lower dose (28).
Small-scale commercial chicken production using native
breeds is widespread in the Mekong Delta of Vietnam, and often
represents an upgrade from backyard production. The popularity
of this system resides in the preference of the Vietnamese
consumer for meat of long-cycle native birds. Native chicken
meat reaches a considerably higher price compared with broiler
meat (29). However native chickens (and their crosses) are
slow growing (>4 months), and preventing disease over such a
prolonged period requires sustained efforts (13).
In our study, the identification and enrollment of study farms
was challenging due to the fluidity of this type of production
system, with many households setting up chicken farms as
well as stopping raising chickens altogether. Because of this,
a large number of farms did not remain in business over the
extended duration of the study. Indeed, flock mortality was an
important predictor for farmers giving up raising chickens (data
not shown) and a large fraction of our study farms (61.8%)
had gone out of business even before the start of the planned
intervention phase.
In addition to their previous experience with disease, farmers
may start or stop raising chickens depending on circumstances,
such as market price of day-olds, commercial feed and poultry
meat, income from the sale of the previous flocks or other rural
activities. Furthermore, many farmers raised one cycle per year,
but not necessarily every year. This was reflected in the lack of
experience in chicken husbandry of many farmers (and farm
workers). This represents a hurdle for the implementation of
correct management practices. This contrasts with a recent study
in Belgium, where pig farmers had on average 22.6 years of
experience (20). In this context, often antimicrobials are used
as replacement of other, most costly, but demanding husbandry
practices (14). The incursion of African Swine Fever (ASF) in
Vietnam in January 2019 and its spread within the country (30)
coincided with the intervention phase in this study. This may
have exerted additional pressures over our study farmers. During
this time, many farms in ASF-affected provinces switched to
chicken production, resulting in increased market availability of
low-cost chicken meat, therefore reducing the value of chicken
production in our area.
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The changes to the initial study design are a testament to
the challenges of conducting intervention studies in small-scale
farming systems. Initially, we planned to allocate one third of
all recruited farms to the control arm in order to measure
any environmental influences on AMU, for example, due to
public engagement initiatives (television campaigns, work in
schools, etc.) that took place in the province under the umbrella
of this project. Exposure to these may have inadvertently had
an influence on the farmers’ decision on AMU beyond the
intervention. Given the high number of farms that stopped
chicken production, we opted for reducing the size of the
control arm to a minimum of four, thus reducing the statistical
power of any analysis in that group. However, the descriptive
data from this small control group suggests no change between
baseline and intervention, and gives additional validity of the
observed findings.
The study demonstrates that reducing current high levels of
AMU through the provision of veterinary advice is achievable in
the Vietnamese small-scale commercial farming context. There
was an indication that farmers responded to the advice given.
Many farmers, especially the larger ones may even be willing to
pay for such a service, since labor costs in Vietnam are relatively
low (∼25 USD for a 2-h visit). We believe that results and
lessons from this study can be adapted other LMICs where small-
scale animal production systems are common. However, the
usefulness of this approach for with regards to intensive farming
systems requires further investigation, since such systems already
have their own technical advisory services. Sustainable, long-
term reductions in AMU could be reached if links between
veterinarians/animal health workers and farmers are built and
reinforced. Supplementation with health-enhancing products
may be beneficial, but this needs to be further explored. We
propose to develop a business case for an advisory service
targeting the main livestock-producing regions in the country
(Mekong River Delta, Southeast, Central region, Red River
Delta), with the value proposition that healthy livestock means
profitable businesses.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by Oxford Tropical Research Ethics Committee
(OxTREC). The patients/participants provided their written
informed consent to participate in this study. The animal study
was reviewed and approved by Oxford Tropical Research Ethics
Committee (OxTREC). Written informed consent was obtained
from the owners for the participation of their animals in
this study. Written informed consent was obtained from the
individual(s) for the publication of any potentially identifiable
images or data included in this article. The study has been
granted ethics approval by the Oxford Tropical Research Ethics
Committee (OXTREC) (Ref. 5121/16).
AUTHOR CONTRIBUTIONS
JC-M, JR, and NC conceived and designed study.
DP, NC, and DT conducted field survey. BK and VH
designed and aided data collection. HT, LY, NM, and
ES aided intervention packages. DP, JC-M, NC, and DT
contributed to data analyses. DP, NC, JC-M, PP, JR, and
GT contributed to writing up and editing the manuscript.
All authors contributed to the article and approved the
submitted version.
FUNDING
This work was funded by the Wellcome Trust through an
Intermediate Clinical Fellowship awarded to JC-M (Grant
Reference Number 110085/Z/15/Z).
ACKNOWLEDGMENTS
The authors would like to thank all farmer participants, the staff
affiliated to the Dong Thap Sub-Department of Animal Health,
Production and Aquaculture, the staff at Agricultural Service
Center of Cao Lanh and ThapMuoi district, Dong Thap province
for their help and support. This manuscript has been released as
a pre-print at: https://www.biorxiv.org/content/10.1101/2020.09.
13.295659v1 (31).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fvets.
2020.612993/full#supplementary-material
Supplementary Figure 1 | Study area in the province of Dong Thap, Mekong
Delta of Vietnam.
Supplementary Figure 2 | Correlation between AMU, mortality and bodyweight
by week (left block) and by flock (right block). The data have been log-transformed
scale for easier visualization.
Supplementary Table 1 | Descriptive characteristics of chicken farms by total of
farms, flocks, and weeks.
Supplementary Data 1 | Raw data for calculation of ADDkg per 1,000
kg chicken-days.
Supplementary Data 2 | Raw data on AMU, mortality, and bodyweight.
REFERENCES
1. Wong JT, de Bruyn J, Bagnol B, Grieve H, Li M, Pym R, et al. Small-scale
poultry and food security in resource-poor settings: a review.Glob Food Secur.
(2017) 1:43–52. doi: 10.1016/j.gfs.2017.04.003
2. Hilmi M, Dolberg F, Clarke B. Products and Profit From Poultry. 2nd
ed. Rome: Rural Infrastructure and Agro-Industries Division, Food and
Agriculture Organization of the United Nations (2011).
3. OECD, Food and Agriculture Organization of the United Nations.
OECD-FAO Agricultural Outlook 2017-2026. Paris: OECD (2017).
Frontiers in Veterinary Science | www.frontiersin.org 10 January 2021 | Volume 7 | Article 612993Page 341 of 342
Phu et al. Intervention Study on Antimicrobial Reduction
4. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human
health. Clin Microbiol Rev. (2011) 2:718–33. doi: 10.1128/CMR.00002-11
5. O’neill J. Antimicrobials in Agriculture and the Environment: Reducing
Unnecessary Use and Waste. (2015). Available online at: https://amr-
review.org/sites/default/files/Antimicrobials%20in%20agriculture%20and
%20the%20environment%20-%20Reducing%20unnecessary%20use%20and
%20waste.pdf (accessed June 23, 2020).
6. Cuong N, Padungtod P, Thwaites G, Carrique-Mas J. Antimicrobial usage in
animal production: a review of the literature with a focus on low- and middle-
income countries. Antibiotics. (2018) 7:75. doi: 10.3390/antibiotics7030075
7. WHO. Critically Important Antimicrobials for Human Medicine, 6th Revision.
(2019). Available online at: https://www.who.int/foodsafety/publications/
antimicrobials-sixth/en/ (accessed April 28, 2020).
8. Cuong NV, Phu DH, Van NTB, Dinh Truong B, Kiet BT, Hien BV, et al. High-
resolution monitoring of antimicrobial consumption in vietnamese small-
scale chicken farms highlights discrepancies between study metrics. Front Vet
Sci. (2019) 6:174. doi: 10.3389/fvets.2019.00174
9. Carrique-Mas JJ, ChoisyM, Van CuongN, Thwaites G, Baker S. An estimation
of total antimicrobial usage in humans and animals in Vietnam. Antimicrob
Resist Infect Control. (2020) 9:16. doi: 10.1186/s13756-019-0671-7
10. Carrique-Mas JJ, Trung NV, Hoa NT, Mai HH, Thanh TH, Campbell JI, et al.
Antimicrobial usage in chicken production in the mekong delta of Vietnam.
Zoonoses Public Health. (2015) 6:70–8. doi: 10.1111/zph.12165
11. Trung NV, Carrique-Mas JJ, Thi Hoa N, Mai HH, Tuyen HT, Campbell
JI, et al. Prevalence and risk factors for carriage of antimicrobial-resistant
Escherichia coli on household and small-scale chicken farms in the
Mekong Delta of Vietnam. J Antimicrob Chemother. (2015) 70:2144–52.
doi: 10.1093/jac/dkv053
12. Nhung N, Cuong N, Thwaites G, Carrique-Mas J. Antimicrobial usage and
antimicrobial resistance in animal production in Southeast Asia: a review.
Antibiotics. (2016) 5:37. doi: 10.3390/antibiotics5040037
13. Carrique-Mas J, Van NTB, Cuong NV, Truong BD, Kiet BT, Thanh PTH, et al.
Mortality, disease and associated antimicrobial use in commercial small-scale
chicken flocks in the Mekong Delta of Vietnam. Prevent Vet Med. (2019)
1:15–22. doi: 10.1016/j.prevetmed.2019.02.005
14. Truong DB, Doan HP, Doan Tran VK, Nguyen VC, Bach TK, Rueanghiran
C, et al. Assessment of drivers of antimicrobial usage in poultry farms in
the Mekong Delta of Vietnam: a combined participatory epidemiology and
Q-sorting approach. Front Vet Sci. (2019) 6:84. doi: 10.3389/fvets.2019.00084
15. Nguyen NT, Nguyen HM, Nguyen CV, Nguyen TV, Nguyen MT, Thai
HQ, et al. Use of colistin and other critical antimicrobials on pig and
chicken farms in Southern Vietnam and its association with resistance
in commensal Escherichia coli bacteria. Appl Environ Microbiol. (2016)
8:3727–35. doi: 10.1128/AEM.00337-16
16. Pham-Duc P, Cook MA, Cong-Hong H, Nguyen-Thuy H, Padungtod P,
Nguyen-Thi H, et al. Knowledge, attitudes and practices of livestock and
aquaculture producers regarding antimicrobial use and resistance in Vietnam.
PLoS ONE. (2019) 1:e0223115. doi: 10.1371/journal.pone.0223115
17. Phu DH, Giao VTQ, Truong DB, Cuong NV, Kiet BT, Hien VB, et al.
Veterinary drug shops as main sources of supply and advice on antimicrobials
for animal use in the Mekong Delta of Vietnam. Antibiotics. (2019) 8:195.
doi: 10.3390/antibiotics8040195
18. Dung NT, Truong BD, Cuong NV, Van NT, Phu DH, Kiet BT, et al.
A survey of retail prices of antimicrobial products used in small-scale
chicken farms in the Mekong Delta of Vietnam. Global Health. (2020) 16:8.
doi: 10.1186/s12992-019-0539-x
19. Raasch S, Collineau L, Backhans A, Sjölund M, Belloc C, Emanuelson U,
et al. Effectiveness of alternative measures to reduce antimicrobial usage in
pig production in four European countries. Porcine Health Manage. (2020)
6:6. doi: 10.1186/s40813-020-0145-6
20. Postma M, Vanderhaeghen W, Sarrazin S, Maes D, Dewulf J. Reducing
antimicrobial usage in pig production without jeopardizing production
parameters. Zoonoses Public Health. (2017) 6:63–74. doi: 10.1111/zph.12283
21. Rojo-Gimeno C, Postma M, Dewulf J, Hogeveen H,
Lauwers L, Wauters E. Farm-economic analysis of reducing
antimicrobial use whilst adopting improved management
strategies on farrow-to-finish pig farms. Prevent Vet Med. (2016)
1:74–87. doi: 10.1016/j.prevetmed.2016.05.001
22. Roskam JL, Lansink AGJMO, Saatkamp HW. The technical and economic
impact of veterinary interventions aimed at reducing antimicrobial use on
broiler farms. Poult Sci. (2019) 9:6644–58. doi: 10.3382/ps/pez517
23. Carrique-Mas JJ, Rushton J. Integrated interventions to tackle antimicrobial
usage in animal production systems: the ViParc project in Vietnam. Front
Microbiol. (2017) 8:1062. doi: 10.3389/fmicb.2017.01062
24. FAO. Smallholder Poultry Production—Livelihoods, Food Security and
Sociocultural Significance. Food and Agriculture Organization of the United
Nations (2010). Available online at: http://www.fao.org/3/al674e/al674e00.pdf
(accessed October 29, 2020).
25. Bessell PR, Kushwaha P, Mosha R, Woolley R, Al-Riyami L, Gammon
N. Assessing the impact of a novel strategy for delivering animal health
interventions to smallholder farmers. Prevent Vet Med. (2017) 1:108–16.
doi: 10.1016/j.prevetmed.2017.08.022
26. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al.
Interventions to improve antibiotic prescribing practices for hospital
inpatients. In: The Cochrane Collaboration, editors. Cochrane Database
of Systematic Reviews (p. CD003543.pub3). London: John Wiley & Sons,
Ltd. (2013).
27. Talkington K, Hoelzer K, Wong N, Thomas J. Alternatives to Antibiotics in
Animal Agriculture. (2017). Available online at: https://www.pewtrusts.org/~/
media/assets/2017/07/alternatives_to_antibiotics_in_animal_agriculture.pdf
(accessed August 28, 2020).
28. Yen NTP, Phu DH, Van Nguyen C, Kiet BT, Hien BV, Padungtod P,
et al. Labelling and quality of antimicrobial products used in chicken
flocks in the Mekong Delta of Vietnam. Vet Med Sci. (2019) 5:512–6.
doi: 10.1002/vms3.189
29. PoultryWorld. Niche Broiler Production in Vietnam, 2018. (2018).
Available online at: https://www.poultryworld.net/Home/General/
2018/10/Niche-broiler-production-in-Vietnam-347492E/ (accessed July
13, 2020).
30. VASFU. Vietnam: Vietnam African Swine Fever Update. USDA Foreign
Agricultural Service (2019). Available online at: https://www.fas.usda.
gov/data/vietnam-vietnam-african-swine-fever-update (accessed July
21, 2020).
31. Phu DH, Cuong NV, Truong BD, Kiet BT, Hien VB, Thu HTV, et al.
Reducing antimicrobial usage in small-scale chicken farms in Vietnam: a
three-year intervention study.Microbiology (2020). doi: 10.1101/2020.09.13.2
95659
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Phu, Cuong, Truong, Kiet, Hien, Thu, Yen, Minh, Padungtod,
Setyawan, Thwaites, Rushton and Carrique-Mas. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Veterinary Science | www.frontiersin.org 11 January 2021 | Volume 7 | Article 612993Page 342 of 342
